concept_id	concept_synonym_name	language_concept_id
957683	methyl 2-nonynoate	4180186
957683	methyl octine carbonate	4180186
957686	Cardiomyopathy, Dilated, with Ataxia	4180186
957686	MGA5	4180186
957686	MGA, Type V	4180186
957695	2-pinene	4180186
957695	alpha-pinene, pinene	4180186
957695	Wilt Pruf	4180186
957696	aluminum trifluoride	4180186
957698	qing hao su	4180186
957698	huanghuahaosu	4180186
957698	artemisininum	4180186
957698	artemisinine	4180186
957698	(3R,5AS,6R,8AS,9R,12S,12aR)-3,6,9-trimethyloctahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10(3H)-one	4180186
957698	arteannuin	4180186
957698	qinghaosu	4180186
957698	quinghaosu	4180186
957698	quing hau sau	4180186
957699	ayvakit	4180186
957699	(1S)-1-(4-Fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-5-pyrimidinyl)ethanamine	4180186
957699	5-Pyrimidinemethanamine, alpha-(4-fluorophenyl)-alpha-methyl-2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo(2,1-f)(1,2,4)triazin-4-yl)-1-piperazinyl)-, (alphaS)-	4180186
957699	BLU-285	4180186
957703	benzylamine hydrobromide	4180186
957703	benzylamine hydrochloride	4180186
957703	benzylamine monosulfate	4180186
957706	ESBA1008	4180186
957706	ESBA-1008	4180186
957706	RTH258	4180186
957706	RTH-258	4180186
957708	(4R)-2'-deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine	4180186
957709	S-649266	4180186
957712	cupric nitrate	4180186
957716	Nephrolithiasis 2	4180186
957716	Nephrolithiasis, hypercalciuria, x-linked	4180186
957716	Nephrolithiasis, Hypercalciuric, X-Linked	4180186
957716	Nphl2	4180186
957716	Urolithiasis, Hypercalciuric, X-Linked	4180186
957717	Dermatophilus congolensis infection	4180186
957717	lumpy wool in sheep	4180186
957717	mycotic dermatitis in sheep	4180186
957717	rain scald in horses	4180186
957718	2,3-DDQ	4180186
957718	2,3-dichloro-5,6-dicyano-1,4-benzoquinone	4180186
957718	2,3-dichloro-5,6-dicyanobenzoquinone	4180186
957725	3-pyridinecarboxamide, N-((1,3-dimethyl-1H-pyrazol-4-yl)sulfonyl)-6-(3-(3,3,3-trifluoro-2,2-dimethylpropoxy)-1H-pyrazol-1-yl)-2-((4S)-2,2,4-trimethyl-1-pyrrolidinyl)-	4180186
957725	VX445	4180186
957725	VX-445	4180186
957726	N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide	4180186
957726	NMS-E628	4180186
957726	Rozlytrek	4180186
957726	RXDX-101	4180186
957728	evodiamine, (S)-isomer	4180186
957728	isoevodiamine	4180186
957729	1,3-dioxolane	4180186
957729	dioxolane	4180186
957730	1,2-Ethanedione, 1-(4-benzoyl-1-piperazinyl)-2-(4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1-((phosphonooxy)methyl)-1H-pyrrolo(2,3-c)pyridin-3-yl)-	4180186
957730	(3-((4-Benzoyl-1-piperazinyl)(oxo)acetyl)-4-methoxy-7-(3-methyl-1H-1,2,4-triazol-1-yl)-1H-pyrrolo(2,3-c)pyridin-1-yl)methyl dihydrogen phosphate	4180186
957730	BMS-663068	4180186
957733	1-methyl-2-(phenylmethyl)-4(1H)- quinazolinone	4180186
957733	arborine	4180186
957734	gamma-D-glutamyl-L-tryptophan	4180186
957734	SCV-07	4180186
957737	alpha-caryophyllene	4180186
957737	alpha-humulene	4180186
957738	huperzine A, (5alpha,9beta,11Z)-(-)-isomer	4180186
957739	MEDI551	4180186
957739	MEDI-551	4180186
957741	beta-methyl-3-(1-methylethyl)benzenepropanal	4180186
957741	florhydral	4180186
957743	2,4,6-trifluoro-N-(6-((1-methylpiperidin-4-yl)carbonyl)pyridin-2yl)benzamide	4180186
957743	COL-144	4180186
957743	lasmiditan hydrochloride	4180186
957743	LY573144	4180186
957743	Reyvow	4180186
957745	(1R,2S)-2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide	4180186
957745	cyclopropanecarboxamide, 2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-	4180186
957745	dayvigo	4180186
957747	ITI-007	4180186
957747	ITI-722	4180186
957747	lumateperone tosylate	4180186
957748	ACE-536	4180186
957748	luspatercept-aamt	4180186
957748	Reblozyl	4180186
957748	RAP-536	4180186
957752	3,7,11-trimethyl-1,6,10-dodecatrien-3-ol	4180186
957752	nerolidol, (E)-isomer	4180186
957752	nerolidol, (S-(E))-isomer	4180186
957752	nerolidol, (S-(Z))-isomer	4180186
957752	nerolidol, (Z)-isomer	4180186
957752	peruviol	4180186
957755	oleoeuropeine	4180186
957755	oleoeuropein	4180186
957755	2-(3,4-dihydroxyphenyl)ethyl (2S-(2alpha,3E,4beta))-3-ethylidene-2-(beta-D-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2H-pyran-4-acetate	4180186
957756	ongentys	4180186
957756	2,5-dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide	4180186
957756	BIA 9-1067	4180186
957757	4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-benzonitrile	4180186
957757	benzonitrile, 4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-	4180186
957757	Isturisa	4180186
957757	LCI699	4180186
957757	(+)-Osilodrostat	4180186
957758	RPC1063	4180186
957758	zeposia	4180186
957759	2H-Pyrrolo(3',2':5,6)pyrido(4,3-d)pyrimidin-2-one, 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-1,3,4,7-tetrahydro-8-(4-morpholinylmethyl)-	4180186
957759	INCB054828	4180186
957759	INCB-054828	4180186
957759	Pemazyre	4180186
957764	2-nitro-6-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo(2,1-b)(1,3)oxazine	4180186
957764	PA 824	4180186
957764	PA-824	4180186
957764	PA824 cpd	4180186
957765	propanal	4180186
957765	propionaldehyde, 1-14C-labeled	4180186
957765	propionaldehyde, 2-14C-labeled	4180186
957775	bromelain, stem	4180186
957778	sulfonyl fluoride	4180186
957778	Vikane	4180186
957782	AZD1722	4180186
957782	RDX5791	4180186
957783	teprotumumab-trbw	4180186
957783	tepezza	4180186
957783	R1507	4180186
957783	R 1507	4180186
957783	R-1507	4180186
957783	R-1507 monoclonal antibody	4180186
957783	RO4858696	4180186
957783	RO-4858696	4180186
957783	RO-4858696000	4180186
957783	RO-4858696-000	4180186
957783	RO4858696-000	4180186
957783	RV001	4180186
957783	RV-001	4180186
957784	4-isopropylidene-1-methylcyclohexene	4180186
957785	barber's itch	4180186
957785	beard ringworm	4180186
957787	Hortaea werneckii infection	4180186
957794	2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-3-pyridinyl)methoxy)benzaldehyde	4180186
957794	GBT440	4180186
957794	Oxbryta	4180186
957795	(7S)-2-(4-phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide	4180186
957795	7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide	4180186
957795	BGB-3111	4180186
957795	Brukinsa	4180186
957796	0 paradol	4180186
957796	4-(4- hydroxy-3-methoxyphenyl)-2-butanone	4180186
957796	4-(4-hydroxy-3-methoxyphenyl)butan-2-one	4180186
957796	vanillylacetone	4180186
957796	vanillyl acetone	4180186
958608	1-Propanesulfonic acid, 3-(acetylamino)-	4180186
958608	Acamprosate Calcium	4180186
958608	Acamprostate	4180186
958608	Acetylhomotaurinate, Calcium	4180186
958608	Acetyl Homotaurinate, Calcium	4180186
958608	Acetylhomotaurine, Calcium	4180186
958608	Acetylhomotaurine, Sodium	4180186
958608	Aotal	4180186
958608	Calcium Acetylhomotaurinate	4180186
958608	Calcium Acetyl Homotaurinate	4180186
958608	Calcium Acetylhomotaurine	4180186
958608	Campral	4180186
958608	Campral EC	4180186
958608	N Acetylhomotaurine	4180186
958608	N-Acetylhomotaurine	4180186
958608	N-Acetylhomotaurine, Calcium (2:1) Salt	4180186
958608	N-Acetylhomotaurine, Magnesium (2:1) Salt	4180186
958608	N Acetylhomotaurine, Monolithium Salt	4180186
958608	N-Acetylhomotaurine, Monolithium Salt	4180186
958608	N Acetylhomotaurine, Monopotassium Salt	4180186
958608	N-Acetylhomotaurine, Monopotassium Salt	4180186
958608	N Acetylhomotaurine, Monosodium Salt	4180186
958608	N-Acetylhomotaurine, Monosodium Salt	4180186
958608	N-Acetylhomotaurine, Zinc (2:1) Salt	4180186
958608	Regtect	4180186
958608	Sodium Acetylhomotaurine	4180186
958608	Zulex	4180186
958609	Adenocarcinoma, Lung	4180186
958609	Adenocarcinomas, Lung	4180186
958609	Lung Adenocarcinoma	4180186
958609	Lung Adenocarcinomas	4180186
958610	2-Butenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydro-3-furanyl)oxy)-6-quinazolinyl)-4-(dimethylamino)-, (2E)-	4180186
958610	(2E)-N-(4-(3-Chloro-4-fluoroanilino)-7-(((3S)-oxolan-3-yl)oxy)quinoxazolin-6-yl)-4-(dimethylamino)but-2-enamide	4180186
958610	Afatinib Dimaleate	4180186
958610	Afatinib Maleate	4180186
958610	BIBW2992	4180186
958610	BIBW 2992	4180186
958610	BIBW-2992	4180186
958610	BIBW 2992MA2	4180186
958610	BIBW 2992 MA2	4180186
958610	BIBW-2992MA2	4180186
958610	BIBW-2992-MA2	4180186
958610	BIBW2992 MA2	4180186
958610	Gilotrif	4180186
958616	1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-	4180186
958616	2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)	4180186
958616	Anastrazole	4180186
958616	Arimidex	4180186
958616	ICI D1033	4180186
958616	ZD1033	4180186
958616	ZD 1033	4180186
958616	ZD-1033	4180186
958616	Zeneca ZD 1033	4180186
958617	1-((4R,5R)-4,5-Dihydroxy-N2-((4''-(pentyloxy)(1,1':4',1''-terphenyl)-4-yl)carbonyl)-L-ornithine)-echinocandin B	4180186
958617	Eraxis	4180186
958617	LY303366	4180186
958617	LY 303366	4180186
958617	LY-303366	4180186
958620	Arsenic(III) Oxide	4180186
958620	Arsenic Oxide (As2O3)	4180186
958620	Arsenic Oxide (As4O6)	4180186
958620	Arsenolite	4180186
958620	Arsenous Anhydride	4180186
958620	As2O3	4180186
958620	As4O6	4180186
958620	Diarsenic Trioxide	4180186
958620	Naonobin	4180186
958620	Tetraarsenic Hexaoxide	4180186
958620	Tetra Arsenic Hexaoxide	4180186
958620	Tetra-Arsenic Hexaoxide	4180186
958620	Tetraarsenic Oxide	4180186
958620	Tetra Arsenic Oxide	4180186
958620	Tetra-Arsenic Oxide	4180186
958620	Trisenox	4180186
958620	Trixenox	4180186
958622	Butanedioic acid, mono((5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester	4180186
958622	Dihydroartemisinine 12 alpha succinate	4180186
958622	Dihydroartemisinine-12-alpha-succinate	4180186
958622	Dihydroartemisinin, Succinyl	4180186
958622	Malacef	4180186
958622	Malartin	4180186
958622	SM804	4180186
958622	SM 804	4180186
958622	SM-804	4180186
958622	Sodium Artesunate	4180186
958622	Succinyl Dihydroartemisinin	4180186
958624	AG013736	4180186
958624	AG 013736	4180186
958624	AG-013736	4180186
958624	Benzamide, N-methyl-2-((3-((E)-2-(2-pyridinyl)ethenyl)-1H-indazol-6-yl)thio)-	4180186
958624	Inlyta	4180186
958627	Behavioral Rating Scale	4180186
958627	Behavioral Rating Scales	4180186
958627	Behavioral Test	4180186
958627	Behavioral Tests	4180186
958627	Behavior Rating Scales	4180186
958627	Behavior Test	4180186
958627	Behavior Tests	4180186
958627	Rating Scale, Behavior	4180186
958627	Rating Scale, Behavioral	4180186
958627	Rating Scales, Behavior	4180186
958627	Rating Scales, Behavioral	4180186
958627	Scale, Behavioral Rating	4180186
958627	Test, Behavior	4180186
958627	Test, Behavioral	4180186
958627	Tests, Behavior	4180186
958627	Tests, Behavioral	4180186
958628	3-methyl-TTNEB	4180186
958628	4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid	4180186
958628	LG69 compound	4180186
958628	LGD1069	4180186
958628	LGD 1069	4180186
958628	LGD-1069	4180186
958628	Targretin	4180186
958631	Aluminosilicate Anti-Diarrheal, Calcium	4180186
958631	Aluminosilicate, Calcium	4180186
958631	Aluminosilicate Clay, Calcium	4180186
958631	Anti-Diarrheal, Calcium Aluminosilicate	4180186
958631	Calcium Aluminosilicate Anti Diarrheal	4180186
958631	Calcium Aluminosilicate Anti-Diarrheal	4180186
958631	Calcium Aluminosilicate Clay	4180186
958631	CASAD	4180186
958631	Clay, Calcium Aluminosilicate	4180186
958634	14C-labeled Carvedilol	4180186
958634	2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-	4180186
958634	BM14190	4180186
958634	BM 14190	4180186
958634	BM-14190	4180186
958634	Carvedilol, (-)	4180186
958634	Carvedilol, (+)	4180186
958634	Carvedilol, 14C labeled	4180186
958634	Carvedilol, 14C-labeled	4180186
958634	Carvedilol Hydrochloride	4180186
958634	Carvedilol, (-)-isomer	4180186
958634	Carvedilol, (+-)-isomer	4180186
958634	Carvedilol, (+)-isomer	4180186
958634	Carvedilol, (R)-isomer	4180186
958634	Carvedilol, (S)-isomer	4180186
958634	Coreg	4180186
958634	Coropres	4180186
958634	Dilatrend	4180186
958634	Eucardic	4180186
958634	Kredex	4180186
958634	Querto	4180186
958635	Cancidas	4180186
958635	Caspofungin Acetate	4180186
958635	Caspofungin MSD	4180186
958635	L743872	4180186
958635	L 743872	4180186
958635	L 743,872	4180186
958635	L-743872	4180186
958635	L-743,872	4180186
958635	L743,872	4180186
958635	MK0991	4180186
958635	MK 0991	4180186
958635	MK-0991	4180186
958635	Tetradecanamide, N-((2R,6S,9S,11R,12S,14aS,15S,20S,23S,25aS)-12-((2-aminoethyl)amino)-20-((1R)-3-amino-1-hydroxypropyl)-23-((1S,2S)-1,2-dihydroxy-2-(4-hydroxyphenyl)ethyl)tetracosahydro-2,11,15-trihyd roxy-6-((1R)-1-hydroxyethyl)-5,8,14,19,22,25-hexaoxo-1H-dipyrrolo(2,1-c:2',1'-l)(1,4,7,10,13,16)hexaazacycloheneicosin-9-yl)-10,12-dimethyl-	4180186
958637	Cauda Equina Syndromes	4180186
958639	Axépim	4180186
958639	BMY28142	4180186
958639	BMY 28142	4180186
958639	BMY-28142	4180186
958639	Cefepim	4180186
958639	Cefepime Hydrochloride	4180186
958639	Maxipime	4180186
958639	Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, hydroxide, inner salt, (6R-(6alpha,7beta(Z)))-	4180186
958639	Quadrocef	4180186
958640	7-(2-(2-amino-4-thiazolyl)-4-carboxy-2-butenoylamino)-3-cephem-4-carboxylic acid	4180186
958640	7432 S	4180186
958640	7432-S	4180186
958640	Cedax	4180186
958640	SCH39720	4180186
958640	SCH 39720	4180186
958640	SCH-39720	4180186
958641	Cerebrospinal Fluid Drainage	4180186
958641	Cerebrospinal Fluid Drainage, Post Traumatic	4180186
958641	Cerebrospinal Fluid Drainage, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Drainages	4180186
958641	Cerebrospinal Fluid Drainage, Spontaneous	4180186
958641	Cerebrospinal Fluid Drainage, Traumatic	4180186
958641	Cerebrospinal Fluid Leakage	4180186
958641	Cerebrospinal Fluid Leakage, Post Traumatic	4180186
958641	Cerebrospinal Fluid Leakage, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Leakages	4180186
958641	Cerebrospinal Fluid Leakage, Spontaneous	4180186
958641	Cerebrospinal Fluid Leakage, Traumatic	4180186
958641	Cerebrospinal Fluid Leak, Post Traumatic	4180186
958641	Cerebrospinal Fluid Leak, Post-Traumatic	4180186
958641	Cerebrospinal Fluid Leaks	4180186
958641	Cerebrospinal Fluid Leak, Spontaneous	4180186
958641	Cerebrospinal Fluid Leak, Traumatic	4180186
958641	Drainage, Cerebrospinal Fluid	4180186
958641	Drainages, Cerebrospinal Fluid	4180186
958641	Fluid Drainage, Cerebrospinal	4180186
958641	Fluid Drainages, Cerebrospinal	4180186
958641	Fluid Leakage, Cerebrospinal	4180186
958641	Fluid Leakages, Cerebrospinal	4180186
958641	Fluid Leak, Cerebrospinal	4180186
958641	Fluid Leaks, Cerebrospinal	4180186
958641	Leakage, Cerebrospinal Fluid	4180186
958641	Leakages, Cerebrospinal Fluid	4180186
958641	Leak, Cerebrospinal Fluid	4180186
958641	Leaks, Cerebrospinal Fluid	4180186
958641	Spinal Cerebrospinal Fluid Leak	4180186
958641	Spinal Cerebrospinal Fluid Leak, Post Traumatic	4180186
958641	Spinal Cerebrospinal Fluid Leak, Post-Traumatic	4180186
958641	Spinal Cerebrospinal Fluid Leak, Spontaneous	4180186
958641	Spinal Cerebrospinal Fluid Leak, Traumatic	4180186
958643	2(1H)-Pyridinone, 6-cyclohexyl-1-hydroxy-4-methyl-	4180186
958643	6-Cyclohexyl-1-hydroxy-4-methyl-2(1H)-pyridone ethanolamine salt	4180186
958643	Batrafen	4180186
958643	Ciclopiroxolamine	4180186
958643	Ciclopirox Olamine	4180186
958643	Cyclopirox	4180186
958643	Cyclopyroxolamine	4180186
958643	Dafnegin CSC	4180186
958643	Dafnegin-CSC	4180186
958643	HOE296	4180186
958643	HOE 296	4180186
958643	HOE-296	4180186
958643	Loprox	4180186
958643	Penlac	4180186
958644	1-((3-Hydroxy-2-phosphonylmethoxy)propyl)cytosine	4180186
958644	1-(3-Hydroxy-2-phosphonylmethoxypropyl)cytosine	4180186
958644	Cidofovir Anhydrous	4180186
958644	Cidofovir, (+-)-isomer	4180186
958644	Cidofovir, (R)-isomer	4180186
958644	Cidofovir Sodium	4180186
958644	Cidofovir, Sodium Salt	4180186
958644	GS504	4180186
958644	GS 504	4180186
958644	GS-504	4180186
958644	HPMPC	4180186
958644	Phosphonic acid, (((1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy)methyl)-	4180186
958644	Vistide	4180186
958646	Alpha-methyl-N-(3-(3-(trifluoromethyl)phenyl)propyl)-1-naphthalenemethanamine, (alphaR)-hydrochloride	4180186
958646	AMG073	4180186
958646	AMG 073	4180186
958646	Cinacalcet Hydrochloride	4180186
958646	KRN 1493	4180186
958646	Sensipar	4180186
958648	2 Chloro 2' arabino fluoro 2' deoxyadenosine	4180186
958648	2-Chloro-2'-arabino-fluoro-2'-deoxyadenosine	4180186
958648	2 Chloro 2' fluoroarabino 2' deoxyadenosine	4180186
958648	2-Chloro-2'-fluoroarabino-2'-deoxyadenosine	4180186
958648	2-Chloro-9-(2-deoxy-2-fluoroarabinofuranosyl)adenine	4180186
958648	2-Chloro-9-(2-deoxy-2-fluoro-beta-D-arbinofuranosyl)adenine	4180186
958648	9H-Purin-6-amine, 2-chloro-9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-	4180186
958648	Cl-F-ara-A	4180186
958648	Clofarex	4180186
958648	Clolar	4180186
958648	Evoltra	4180186
958651	Cone Dystrophies	4180186
958651	Cone Dystrophies, Progressive	4180186
958651	Cone Dystrophies, Stationary	4180186
958651	Cone Dystrophy, Progressive	4180186
958651	Cone Dystrophy, Stationary	4180186
958651	Dystrophies, Cone	4180186
958651	Dystrophies, Progressive Cone	4180186
958651	Dystrophies, Stationary Cone	4180186
958651	Dystrophy, Cone	4180186
958651	Dystrophy, Progressive Cone	4180186
958651	Dystrophy, Stationary Cone	4180186
958651	Progressive Cone Dystrophies	4180186
958651	Progressive Cone Dystrophy	4180186
958651	Stationary Cone Dystrophies	4180186
958651	Stationary Cone Dystrophy	4180186
958655	4-(3,5-Bis-(2-hydroxyphenyl)-(1,2,4)-triazol-1-yl)benzoic acid	4180186
958655	Exjade	4180186
958655	ICL670	4180186
958655	ICL 670	4180186
958655	ICL-670	4180186
958655	ICL670A	4180186
958655	ICL 670A	4180186
958655	ICL-670A	4180186
958656	1,2 Dimethyl 3 hydroxy 4 pyridinone	4180186
958656	1,2-Dimethyl-3-hydroxy-4-pyridinone	4180186
958656	1,2 Dimethyl 3 hydroxypyrid 4 one	4180186
958656	1,2-Dimethyl-3-hydroxypyrid-4-one	4180186
958656	1,2 Dimethyl 3 hydroxypyridin 4 one	4180186
958656	1,2-Dimethyl-3-hydroxypyridin-4-one	4180186
958656	3 Hydroxy 1,2 dimethyl 4 pyridinone	4180186
958656	3-Hydroxy-1,2-dimethyl-4-pyridinone	4180186
958656	4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl-	4180186
958656	DMOHPO	4180186
958656	Ferriprox	4180186
958656	HDMPP	4180186
958657	1,2,2,2-Tetrafluoroethyl difluoromethyl ether	4180186
958657	Ethane, 2-(difluoromethoxy)-1,1,1,2-tetrafluoro-	4180186
958657	I653	4180186
958657	I 653	4180186
958657	I-653	4180186
958657	Suprane	4180186
958658	Behavior Therapy, Dialectical	4180186
958658	Dialectical Behavior Therapies	4180186
958661	1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-(((aminosulfonyl)amino)methyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-	4180186
958661	2-(5-sulfamoylaminomethylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-1-methylcarbapen-2-em-3-carboxylic acid	4180186
958661	S4661	4180186
958661	S 4661	4180186
958661	S-4661	4180186
958662	Methanesulfonamide, N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-	4180186
958662	Multaq	4180186
958662	SR 33589	4180186
958662	SR 33589B	4180186
958664	DP178	4180186
958664	DP 178	4180186
958664	DP-178	4180186
958664	Fuzeon	4180186
958664	Pentafuside	4180186
958664	Peptide T20	4180186
958664	T20 Peptide	4180186
958664	T20, Peptide	4180186
958666	9,11-Epoxy-7-(methoxycarbonyl)-3-oxo-17-pregn-4-ene-21,17-carbolactone	4180186
958666	Eplerenon	4180186
958666	Inspra	4180186
958666	Spiro(cyclopenta(7,8)phenanthro(4b,5-b)oxirene-7(3H),2'(3'H)-furan)-10-carboxylic acid, 2,4,4',4a,5',5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-4a,6a-dimethyl-2,5'-dioxo-, methyl ester, (4aS,4bR,5aR,6aS,7 R,9aS,9bR,10R)-	4180186
958667	7H-Pyrrolo(2,1-g)(1,2,5,8,11,14,17,20)dithiahexaazacyclotricosine-17-acetic acid, 3-(aminocarbonyl)-11-(4-((aminoiminomethyl)amino)butyl)docosahydro-20-(1H-indol-3-ylmethyl)-1,9,12,15,18,21-hexaoxo-, (3R,11S,17S,20S,25aS)-	4180186
958667	Epifibatide	4180186
958667	Epifibratide	4180186
958667	Integrelin	4180186
958667	Integrilin	4180186
958668	(4R,5R,6S)-3-((3S,5S)-5-((3-Carboxyphenyl)carbamoyl)pyrrolidin-3-yl)sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid	4180186
958668	Ertapenem Sodium	4180186
958668	Invanoz	4180186
958668	Invanz	4180186
958670	L791456	4180186
958670	L 791456	4180186
958670	2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-	4180186
958670	Arcoxia	4180186
958670	L-791456	4180186
958670	MK0663	4180186
958670	MK 0663	4180186
958670	MK-0663	4180186
958671	1,8 Cineol	4180186
958671	1,8-Cineol	4180186
958671	1,8 Cineole	4180186
958671	1,8-Cineole	4180186
958671	1,8 Epoxy p menthane	4180186
958671	1,8-Epoxy-p-menthane	4180186
958671	2-Oxabicyclo(2.2.2)octane, 1,3,3-trimethyl-	4180186
958671	Cineole	4180186
958671	Soledum	4180186
958673	AC 2993	4180186
958673	AC 2993 LAR	4180186
958673	Bydureon	4180186
958673	Byetta	4180186
958673	Ex4 Peptide	4180186
958673	Exendin 4	4180186
958673	Exendin-4	4180186
958673	ITCA 650	4180186
958673	Peptide, Ex4	4180186
958675	1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)	4180186
958675	9-(4-Acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine	4180186
958675	BRL42810	4180186
958675	BRL 42810	4180186
958675	BRL-42810	4180186
958675	Famvir	4180186
958676	1,3-Propanediol, 2-phenyl-, dicarbamate	4180186
958676	2 Phenyl 1,3 propanediol dicarbamate	4180186
958676	2-Phenyl-1,3-propanediol dicarbamate	4180186
958676	(3-Carbamoyloxy-2-phenyl-propyl) carbamate	4180186
958676	ADD03055	4180186
958676	ADD 03055	4180186
958676	ADD-03055	4180186
958676	Felbamyl	4180186
958676	Felbatol	4180186
958676	Taloxa	4180186
958676	W554	4180186
958676	W 554	4180186
958676	W-554	4180186
958677	D-Glucaric acid, iron(2+) salt (1:1)	4180186
958677	Ferric Saccharate	4180186
958677	Ferri Saccharate	4180186
958677	Ferri-Saccharate	4180186
958677	Hippiron	4180186
958677	Iron(III)-Hydroxide Sucrose Complex	4180186
958677	Iron Oxide (Saccharated)	4180186
958677	Iron Saccharate	4180186
958677	Iron-Saccharate	4180186
958677	Iron Sucrose	4180186
958677	Saccharated Ferric Oxide	4180186
958677	Venofer	4180186
958681	(2S,3S,4R,5R,6R)-6-((2R,3R,4R,5R,6R)-6-((2R,3S,4S,5R,6R)-2-carboxy-4-hydroxy-6-((2R,3S,4R,5R,6S)-4-hydroxy-6-methoxy-5-(sulfoamino)-2-(sulfooxymethyl)oxan-3-yl)oxy-5-sulfooxyoxan-3-yl)oxy-5-(sulfoamino)-4-sulfooxy-2-(sulfooxymethyl)oxan-3-yl)oxy-3-((2R,3R,4R,5S,6R)-4,5-dihydroxy-3-(sulfoamino)-6-(sulfooxymethyl)oxan-2-yl)oxy-4,5-dihydroxyoxane-2-carboxylic acid	4180186
958681	Arixtra	4180186
958681	Fondaparinux Sodium	4180186
958681	Quixidar	4180186
958684	7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol	4180186
958684	Faslodex	4180186
958684	ICI182780	4180186
958684	ICI 182780	4180186
958684	ICI 182,780	4180186
958684	ICI-182780	4180186
958684	ZM182780	4180186
958684	ZM 182780	4180186
958684	ZM-182780	4180186
958685	Capacities, Functional Residual	4180186
958685	Capacity, Functional Residual	4180186
958685	Functional Residual Capacities	4180186
958685	Residual Capacities, Functional	4180186
958685	Residual Capacity, Functional	4180186
958689	Iressa	4180186
958689	N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide	4180186
958689	ZD1839	4180186
958689	ZD 1839	4180186
958691	Coma Scale, Glasgow	4180186
958691	Scale, Glasgow Coma	4180186
958693	Appraisal, Health Risk	4180186
958693	Appraisals, Health Risk	4180186
958693	Health Risk Appraisal	4180186
958693	Health Risk Appraisals	4180186
958693	Health Status Index	4180186
958693	Health Status Indexes	4180186
958693	Health Status Indicator	4180186
958693	Health Status Indices	4180186
958693	Indexes, Health Status	4180186
958693	Index, Health Status	4180186
958693	Indicator, Health Status	4180186
958693	Indicators, Health Status	4180186
958693	Indices, Health Status	4180186
958693	Risk Appraisal, Health	4180186
958693	Risk Appraisals, Health	4180186
958695	Ceflatonin	4180186
958695	Cephalotaxine	4180186
958695	Cephalotaxine, O3-((2R)-2,6-dihydroxy-2-(2-methoxy-2-oxoethyl)-6-methyl-1-oxoheptyl)-	4180186
958695	Homoharringtonine (3(R))-isomer	4180186
958695	Omacetaxine	4180186
958695	Omacetaxine Mepesuccinate	4180186
958695	Synribo	4180186
958696	Extraneal	4180186
958696	Icodial	4180186
958698	Autoimmune Disease, IgG4-Associated	4180186
958698	IgG4 Associated Autoimmune Disease	4180186
958698	IgG4-Associated Autoimmune Disease	4180186
958698	IgG4-Associated Autoimmune Diseases	4180186
958698	IgG4-RD	4180186
958698	IgG4 Related Disease	4180186
958698	IgG4-Related Disease	4180186
958698	IgG4-Related Diseases	4180186
958698	IgG4 Related Kidney Disease	4180186
958698	IgG4-Related Kidney Disease	4180186
958698	IgG4-Related Kidney Diseases	4180186
958698	IgG4 Related Sclerosing Disease	4180186
958698	IgG4-Related Sclerosing Disease	4180186
958698	IgG4-Related Sclerosing Diseases	4180186
958698	IgG4 Related Systemic Disease	4180186
958698	Immunoglobulin G4 Related Disease	4180186
958698	Immunoglobulin G4-Related Diseases	4180186
958698	Immunoglobulin G4 Related Kidney Disease	4180186
958698	Immunoglobulin G4-Related Kidney Disease	4180186
958698	Immunoglobulin G4 Related Sclerosing Disease	4180186
958698	Immunoglobulin G4-Related Sclerosing Disease	4180186
958698	Kidney Disease, IgG4-Related	4180186
958698	Sclerosing Disease, IgG4-Related	4180186
958699	Injury Severity Scores	4180186
958699	ISS Score	4180186
958699	Score, Injury Severity	4180186
958699	Scores, Injury Severity	4180186
958700	Capacities, Inspiratory	4180186
958700	Capacity, Inspiratory	4180186
958700	Inspiratory Capacities	4180186
958701	Inspiratory Reserve Volumes	4180186
958701	Reserve Volume, Inspiratory	4180186
958701	Reserve Volumes, Inspiratory	4180186
958701	Volume, Inspiratory Reserve	4180186
958701	Volumes, Inspiratory Reserve	4180186
958704	2H-3-Benzazepin-2-one, 3-(3-((((7S)-3,4-dimethoxybicyclo(4.2.0)octa-1,3,5-trien-7-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-7,8-dimethoxy-	4180186
958704	7,8-Dimethoxy-3-(3-(((4,5-dimethoxybenzocyclobutan-1-yl)methyl)methylamino)propyl)-1,3,4,5-tetrahydro-2H-benzazepin-2-one	4180186
958704	Corlanor	4180186
958704	S16257	4180186
958704	S 16257	4180186
958704	S-16257	4180186
958704	S162572	4180186
958704	S 162572	4180186
958704	S 16257 2	4180186
958704	S 16257-2	4180186
958704	S-16257-2	4180186
958704	S162602	4180186
958704	S 162602	4180186
958704	S 16260 2	4180186
958704	S 16260-2	4180186
958704	S-16260-2	4180186
958706	N benzyl 2 acetamido 3 methoxypropionamide	4180186
958706	N-benzyl-2-acetamido-3-methoxypropionamide	4180186
958706	N benzyl AcMeOPrNH2	4180186
958706	N-benzyl-AcMeOPrNH2	4180186
958706	Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-	4180186
958706	Vimpat	4180186
958707	2,6-Piperidinedione, 3-(4-amino-1,3-dihydro-1-oxo-2H- isoindol-2-yl)-	4180186
958707	3-(4-Amino-1-oxoisoindolin-2-yl)piperidine-2,6-dione	4180186
958707	CC5013	4180186
958707	CC 5013	4180186
958707	CC-5013	4180186
958707	IMiD3 Cpd	4180186
958707	Revimid	4180186
958707	Revlimid	4180186
958709	1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-	4180186
958709	3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine	4180186
958709	3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine	4180186
958709	BW430C	4180186
958709	BW 430C	4180186
958709	BW-430C	4180186
958709	Crisomet	4180186
958709	Labileno	4180186
958709	Lamictal	4180186
958709	Lamiktal	4180186
958712	4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-	4180186
958712	Arava	4180186
958712	HWA486	4180186
958712	HWA 486	4180186
958712	HWA-486	4180186
958712	N-(4-Trifluoromethyphenyl)-5-methylisoxazole-4-carboxamide	4180186
958712	SU101	4180186
958714	4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)	4180186
958714	Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-	4180186
958714	CGS20267	4180186
958714	CGS 20267	4180186
958714	CGS-20267	4180186
958714	Femara	4180186
958714	Fémara	4180186
958716	2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (2S)-	4180186
958716	Chirocaine	4180186
958716	Levobupivacaine Hydrochloride	4180186
958717	Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1S,2R)-	4180186
958717	Fetzima	4180186
958717	Levomilnacipran Hydrochloride	4180186
958721	All trans Lycopene	4180186
958721	All-trans-Lycopene	4180186
958721	LYCOMATO	4180186
958721	LYC O MATO	4180186
958721	LYC-O-MATO	4180186
958721	Lycopene, (13-cis)-isomer	4180186
958721	Lycopene, (7-cis,7'-cis,9-cis,9'-cis)-isomer -	4180186
958721	Lycopene, (cis)-isomer	4180186
958721	Prolycopene	4180186
958721	Pro Lycopene	4180186
958721	Pro-Lycopene	4180186
958721	psi, psi-Carotene	4180186
958724	Flow Rate, Maximal Expiratory	4180186
958724	Forced Expiratory Flow 0.2 1.2	4180186
958724	Forced Expiratory Flow 0.2-1.2	4180186
958724	Forced Expiratory Flow 200 1200	4180186
958724	Forced Expiratory Flow 200-1200	4180186
958724	MEFR	4180186
958726	Breathing Capacities, Maximal	4180186
958726	Breathing Capacity, Maximal	4180186
958726	Capacities, Maximal Breathing	4180186
958726	Capacity, Maximal Breathing	4180186
958726	Maximal Breathing Capacities	4180186
958726	Maximal Breathing Capacity	4180186
958726	Maximal Voluntary Ventilations	4180186
958726	MVV (Ventilation)	4180186
958726	Ventilation, Maximal Voluntary	4180186
958726	Ventilations, Maximal Voluntary	4180186
958726	Voluntary Ventilation, Maximal	4180186
958726	Voluntary Ventilations, Maximal	4180186
958729	2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide	4180186
958729	Masflex	4180186
958729	Miloxicam	4180186
958729	Mobec	4180186
958729	Mobic	4180186
958729	Mobicox	4180186
958729	Movalis	4180186
958729	Movicox	4180186
958729	Parocin	4180186
958729	Reumoxicam	4180186
958729	Uticox	4180186
958730	1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-((5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-, (4R-(3(3S*,5S*),4alpha,5beta,6beta(R*)))-	4180186
958730	3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid	4180186
958730	Merrem	4180186
958730	Penem	4180186
958730	Ronem	4180186
958730	SM7338	4180186
958730	SM 7338	4180186
958730	SM-7338	4180186
958732	FK463	4180186
958732	FK 463	4180186
958732	FK-463	4180186
958732	Micafungin Sodium	4180186
958732	Mycamine	4180186
958733	1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl	4180186
958733	1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl	4180186
958733	Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-	4180186
958733	F2207	4180186
958733	F 2207	4180186
958733	F-2207	4180186
958733	Ixel	4180186
958733	Midalcipran	4180186
958733	Milnacipran Hydrochloride	4180186
958733	Savella	4180186
958735	BWB1090U	4180186
958735	BW B1090U	4180186
958735	BW B 1090U	4180186
958735	BW-B1090U	4180186
958735	BW-B 1090U	4180186
958735	BW-B-1090U	4180186
958735	BWB 1090U	4180186
958735	Isoquinolinium, 2,2'-((1,8-dioxo-4-octene-1,8-diyl)bis(oxy-3,1-propanediyl))bis(1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-1-((3,4,5-trimethoxyphenyl)methyl))-, (1R,1'R)-	4180186
958735	Mivacron	4180186
958735	Mivacurium Chloride	4180186
958739	Carcinoma, Nasopharyngeal	4180186
958739	Carcinomas, Nasopharyngeal	4180186
958739	Nasopharyngeal Carcinomas	4180186
958740	A4166	4180186
958740	A 4166	4180186
958740	A-4166	4180186
958740	AY4166	4180186
958740	AY 4166	4180186
958740	AY-4166	4180186
958740	DJN 608	4180186
958740	D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-	4180186
958740	Fastic	4180186
958740	N-((4-Isopropylcyclohexyl)carbonyl)phenylalanine	4180186
958740	Nate-Glinide	4180186
958740	Nateglinide, (cis,D-Phe)-isomer	4180186
958740	Nateglinide, (D-Phe)-isomer	4180186
958740	Senaglinide	4180186
958740	Starlix	4180186
958740	Starsis	4180186
958741	Cancer Staging	4180186
958741	Classifications, TNM	4180186
958741	Classification, TNM	4180186
958741	Staging, Cancer	4180186
958741	Staging, Neoplasm	4180186
958741	Staging Systems, TNM	4180186
958741	Staging System, TNM	4180186
958741	Staging, TNM	4180186
958741	Staging, Tumor	4180186
958741	Systems, TNM Staging	4180186
958741	System, TNM Staging	4180186
958741	TNM Classification	4180186
958741	TNM Classifications	4180186
958741	TNM Staging	4180186
958741	TNM Staging System	4180186
958741	TNM Staging Systems	4180186
958741	Tumor Staging	4180186
958742	Neurolymphomatoses	4180186
958742	Neurolymphomatoses, Primary	4180186
958742	Neurolymphomatosis, Primary	4180186
958742	Primary Neurolymphomatoses	4180186
958742	Primary Neurolymphomatosis	4180186
958744	2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine	4180186
958744	LY170052	4180186
958744	LY 170052	4180186
958744	LY-170052	4180186
958744	LY 170053	4180186
958744	Olanzapine Pamoate	4180186
958744	Zolafren	4180186
958744	Zyprexa	4180186
958747	4,5 Diphenyl 2 oxazolepropionic Acid	4180186
958747	4,5-Diphenyl-2-oxazolepropionic Acid	4180186
958747	Apo Oxaprozin	4180186
958747	Apo-Oxaprozin	4180186
958747	Danoprox	4180186
958747	Daypro	4180186
958747	Dayrun	4180186
958747	Rhoxal oxaprozin	4180186
958747	Rhoxal-oxaprozin	4180186
958747	Wy 21,743	4180186
958747	Wy-21,743	4180186
958749	1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-	4180186
958749	2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one	4180186
958749	2-QHBIQO	4180186
958749	Aloxi	4180186
958749	Palonosetron, (3R)-	4180186
958749	Palonosetron Hydrochloride	4180186
958749	Palonosetron, (R-(R*,R*))-isomer	4180186
958749	Palonosetron, (R-(R*,S*))-isomer	4180186
958749	Palonosetron, (S-(R*,S*))-isomer	4180186
958749	RS25233197	4180186
958749	RS 25233197	4180186
958749	RS 25233 197	4180186
958749	RS 25233-197	4180186
958749	RS-25233-197	4180186
958749	RS25233198	4180186
958749	RS 25233198	4180186
958749	RS 25233 198	4180186
958749	RS 25233-198	4180186
958749	RS-25233-198	4180186
958749	RS25259	4180186
958749	RS 25259	4180186
958749	RS-25259	4180186
958749	RS25259197	4180186
958749	RS 25259197	4180186
958749	RS 25259 197	4180186
958749	RS 25259-197	4180186
958749	RS-25259-197	4180186
958749	RS25259198	4180186
958749	RS 25259198	4180186
958749	RS 25259 198	4180186
958749	RS 25259-198	4180186
958749	RS-25259-198	4180186
958751	ABX-EGF MAb	4180186
958751	ABX EGF Monoclonal Antibody	4180186
958751	ABX-EGF Monoclonal Antibody	4180186
958751	Human Panitumumab Antibody	4180186
958751	Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer	4180186
958751	Monoclonal Antibody, ABX-EGF	4180186
958751	Panitumumab Antibody, Human	4180186
958751	Vectibix	4180186
958752	2-Propenamide, N-hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino) methyl)phenyl)-, (2E)-	4180186
958752	Farydak	4180186
958752	LBH589	4180186
958752	LBH 589	4180186
958752	NVP LBH589	4180186
958752	NVP-LBH589	4180186
958753	1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-	4180186
958753	BY1023	4180186
958753	BY 1023	4180186
958753	BY-1023	4180186
958753	Pantoprazole Sodium	4180186
958753	Protonix	4180186
958753	SKF96022	4180186
958753	SK&F96022	4180186
958753	SK&F 96022	4180186
958753	SK&F-96022	4180186
958753	SKF 96022	4180186
958753	SKF-96022	4180186
958754	Acetyl Hydroperoxide	4180186
958754	Acid, Peracetic	4180186
958754	Acid, Peroxyacetic	4180186
958754	Acid, Peroxyethanoic	4180186
958754	Desoxone1	4180186
958754	Desoxone 1	4180186
958754	Desoxone-1	4180186
958754	Dialax	4180186
958754	Ethaneperoxoic acid	4180186
958754	Peracetate, Sodium	4180186
958754	Peracetate, Zinc	4180186
958754	Peracetic Acid, Sodium Salt	4180186
958754	Peroxyacetic Acid	4180186
958754	Peroxyethanoic Acid	4180186
958754	Sodium Peracetate	4180186
958754	Zinc Peracetate	4180186
958755	2-Hexadecen-1-ol, 3,7,11,15-tetramethyl-, (R-(R*,R*-(E)))-	4180186
958759	3,6,9,12,15,18,21,24,27-Nonaoxanonatriacontan-1-ol	4180186
958759	Aethoxysclerol	4180186
958759	Aethoxysklerol	4180186
958759	Aetoxisclerol	4180186
958759	alpha-Dodecyl-omega-hydroxypoly(oxy-1,2ethanediyl)	4180186
958759	Atossisclerol	4180186
958759	Atoxysclerol	4180186
958759	Brij30	4180186
958759	Brij 30	4180186
958759	Brij-30	4180186
958759	Dodecyl Ethyleneglycol Monoether	4180186
958759	Dodecyl Ethyleneglycol Monoethers	4180186
958759	Ether, Nonaethyleneglycol Monododecyl	4180186
958759	Ether, Polyethylene Glycol-7-lauryl	4180186
958759	Ether, Polyoxyethylene-4-dodecyl	4180186
958759	Ether, Polyoxyethylene 9-lauryl	4180186
958759	Ether, Polyoxyethylene Lauryl	4180186
958759	Ether, Tetraethyleneglycol Lauryl	4180186
958759	Ethoxysclerol	4180186
958759	Ethyleneglycol Monoether, Dodecyl	4180186
958759	Hydroxypolyethoxydodecane	4180186
958759	Laureth	4180186
958759	Laureth 1	4180186
958759	Laureth-1	4180186
958759	Laureth 4	4180186
958759	Laureth-4	4180186
958759	Laureth 7	4180186
958759	Laureth-7	4180186
958759	Laureth 9	4180186
958759	Laureth-9	4180186
958759	Laureths	4180186
958759	Lauromacrogol	4180186
958759	Lauromacrogol 400	4180186
958759	Lauromacrogols	4180186
958759	Lauryl Ether, Tetraethyleneglycol	4180186
958759	Lubrol 12A9	4180186
958759	Lubrol PX	4180186
958759	Lubrol-PX	4180186
958759	Monododecyl Ether, Nonaethyleneglycol	4180186
958759	Monoether, Dodecyl Ethyleneglycol	4180186
958759	Nonaethyleneglycol Monododecyl Ether	4180186
958759	Nonaethylene Glycol Monododecyl Ether	4180186
958759	Nonaethyleneglycol Monododecyl Ethers	4180186
958759	Polidocanols	4180186
958759	Polyethylene Glycol 7 lauryl Ether	4180186
958759	Polyethylene Glycol-7-lauryl Ether	4180186
958759	Polyethylene Glycol-7-lauryl Ethers	4180186
958759	Polyethylene Glycol Monododecyl Ether	4180186
958759	Polyoxyethylene 4 dodecyl Ether	4180186
958759	Polyoxyethylene-4-dodecyl Ether	4180186
958759	Polyoxyethylene(4) Lauryl Ether	4180186
958759	Polyoxyethylene 9 lauryl Ether	4180186
958759	Polyoxyethylene 9-lauryl Ether	4180186
958759	Polyoxyethylene 9-lauryl Ethers	4180186
958759	Polyoxyethylenedodecyl Ether	4180186
958759	Polyoxyethylenedodecyl Ethers	4180186
958759	Polyoxyethylene Lauryl Ether	4180186
958759	Polyoxyethylene Lauryl Ethers	4180186
958759	Tetraethylene Glycol Dodecyl Ether	4180186
958759	Tetraethyleneglycol Lauryl Ether	4180186
958759	Tetraethyleneglycol Lauryl Ethers	4180186
958759	Thesit	4180186
958760	PLGA Acids	4180186
958760	PLGA Acid	4180186
958760	Acids, PLGA	4180186
958760	Acid, PLGA	4180186
958760	Copolymer, PL-PG	4180186
958760	Copolymer, Polylactic-co-glycolic Acid	4180186
958760	Copolymers, PL-PG	4180186
958760	Copolymers, Polylactic-co-glycolic Acid	4180186
958760	LactoSorb	4180186
958760	PLGA Compound	4180186
958760	PLGA Compounds	4180186
958760	PLG Polymer	4180186
958760	PLG Polymers	4180186
958760	PL PG Copolymer	4180186
958760	PL-PG Copolymer	4180186
958760	PL-PG Copolymers	4180186
958760	Poly (D,L-lactic-co-glycolic Acid)	4180186
958760	Poly(DL-lactide-co-glycolic Acid)	4180186
958760	Poly(D,L-lactide-co-glycolide)	4180186
958760	Poly(Glycolide-co-lactide)	4180186
958760	Polylactic Acid Polyglycolic Acid Copolymer	4180186
958760	Poly (Lactic-co-glycolic Acid) -	4180186
958760	Poly(Lactic-co-glycolic Acid)	4180186
958760	Polylactic co glycolic Acid Copolymer	4180186
958760	Polylactic-co-glycolic Acid Copolymer	4180186
958760	Polylactic-co-glycolic Acid Copolymers	4180186
958760	Poly L lactic polyglycolic Acid	4180186
958760	Poly-L-lactic-polyglycolic Acid	4180186
958760	Poly-L-lactic-polyglycolic Acids	4180186
958760	Poly(L-lactide)-co-glycolide	4180186
958760	Polymer, PLG	4180186
958760	Polymers, PLG	4180186
958760	RG 502	4180186
958762	Abdomino perineal Excision	4180186
958762	Abdomino-perineal Excision	4180186
958762	Abdominoperineal Excision	4180186
958762	Abdomino-perineal Excisions	4180186
958762	Abdominoperineal Excisions	4180186
958762	Abdominoperineal Rectum Excision	4180186
958762	Abdomino Perineal Rectum Excision	4180186
958762	Abdomino-Perineal Rectum Excision	4180186
958762	Abdominoperineal Rectum Excisions	4180186
958762	Abdomino-Perineal Rectum Excisions	4180186
958762	Abdominoperineal Resection	4180186
958762	Abdomino Perineal Resection	4180186
958762	Abdomino-Perineal Resection	4180186
958762	Abdominoperineal Resections	4180186
958762	Abdomino-Perineal Resections	4180186
958762	Excision, Abdominoperineal	4180186
958762	Excision, Abdomino-perineal	4180186
958762	Excision, Abdominoperineal Rectum	4180186
958762	Excision, Abdomino-Perineal Rectum	4180186
958762	Excision, Rectum	4180186
958762	Excisions, Abdomino-Perineal Rectum	4180186
958762	Proctectomies	4180186
958762	Rectum Excision	4180186
958762	Rectum Excision, Abdominoperineal	4180186
958762	Rectum Excision, Abdomino-Perineal	4180186
958762	Rectum Excisions	4180186
958762	Rectum Resection	4180186
958762	Rectum Resections	4180186
958762	Resection, Abdominoperineal	4180186
958762	Resection, Abdomino-Perineal	4180186
958762	Resection, Rectum	4180186
958762	Resections, Abdominoperineal	4180186
958763	QUALYs	4180186
958763	QUALY	4180186
958763	QALYs	4180186
958763	Adjusted Life Year	4180186
958763	Adjusted Life Years	4180186
958763	Equivalents, Healthy Years	4180186
958763	Healthy Years Equivalent	4180186
958763	Healthy Years Equivalents	4180186
958763	Life Year, Adjusted	4180186
958763	Life Year, Quality-Adjusted	4180186
958763	Life Years, Adjusted	4180186
958763	Life Years, Quality-Adjusted	4180186
958763	Quality Adjusted Life Year	4180186
958763	Quality-Adjusted Life Year	4180186
958763	Quality Adjusted Life Years	4180186
958763	Years, Adjusted Life	4180186
958766	1-Piperidinepropanoic acid, 4-(methoxy-carbonyl)-4-((1-oxopropyl)phenylamino)-, methyl ester	4180186
958766	3-(4-Methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine)propanoic Acid Methyl Ester	4180186
958766	GI87084B	4180186
958766	GI 87084B	4180186
958766	GI-87084B	4180186
958766	Remifentanil Hydrochloride	4180186
958766	Remifentanil Monohydrochloride	4180186
958766	Ultiva	4180186
958767	Dead Space, Respiratory	4180186
958767	Dead Spaces, Respiratory	4180186
958767	Respiratory Dead Spaces	4180186
958767	Space, Respiratory Dead	4180186
958767	Spaces, Respiratory Dead	4180186
958771	1-Hydroxy-2-(3-pyridyl)ethylidene diphosphonate	4180186
958771	2-(3-pyridinyl)-1-hydroxyethylidenebisphosphonate	4180186
958771	2-(3-pyridinyl)-1-hydroxyethylidene-bisphosphonate	4180186
958771	Actonel	4180186
958771	Atelvia	4180186
958771	Bisphosphonate Risedronate Sodium	4180186
958771	Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-	4180186
958771	Risedronate	4180186
958771	Risedronate Sodium	4180186
958771	Risedronate Sodium, Bisphosphonate	4180186
958771	Risedronic Acid, Monosodium Salt	4180186
958771	Sodium, Bisphosphonate Risedronate	4180186
958774	2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-	4180186
958774	5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate	4180186
958774	Avandia	4180186
958774	BRL49653	4180186
958774	BRL 49653	4180186
958774	BRL-49653	4180186
958774	Rosiglitazone Maleate	4180186
958775	Self Neglect	4180186
958776	Ultane	4180186
958776	BAX 3084	4180186
958776	Fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl Ether	4180186
958776	Fluoromethyl Hexafluoroisopropyl Ether	4180186
958776	Propane, 1,1,1,3,3,3-hexafluoro-2-(fluoromethoxy)-	4180186
958776	Sevorane	4180186
958778	2,3 Dehydrosilybin	4180186
958778	2,3-Dehydrosilybin	4180186
958778	4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-	4180186
958778	Alepa forte	4180186
958778	Alepa-forte	4180186
958778	Ardeyhepan	4180186
958778	Cefasilymarin	4180186
958778	Durasilymarin	4180186
958778	HepaBesch	4180186
958778	Hepa loges	4180186
958778	Hepa-loges	4180186
958778	Hepa Merz Sil	4180186
958778	Hepa-Merz Sil	4180186
958778	Hepar Pasc	4180186
958778	Hepar-Pasc	4180186
958778	Heparsyx	4180186
958778	Heplant	4180186
958778	Lagosa	4180186
958778	Legalon Forte	4180186
958778	Silibin	4180186
958778	Silibinin	4180186
958778	Silibinin A	4180186
958778	Silibinin B	4180186
958778	Silybin A	4180186
958778	Silybin B	4180186
958778	Silybinin	4180186
958779	Position, Seated	4180186
958779	Position, Sitting	4180186
958779	Positions, Seated	4180186
958779	Seated Position	4180186
958779	Seated Positions	4180186
958779	Sitting	4180186
958779	Sitting Positions	4180186
958780	Anhydrous Sodium Citrate	4180186
958780	Citra pH	4180186
958780	Monosodium Citrate	4180186
958780	Sodium Citrate, Anhydrous	4180186
958780	Sodium Citrate Dihydrate	4180186
958780	Sodium Citrate Monobasic	4180186
958780	Trisodium Citrate Dihydrate	4180186
958782	Carcinoma, Squamous Cell of Head and Neck	4180186
958782	Head and Neck Squamous Cell Carcinoma	4180186
958782	Head And Neck Squamous Cell Carcinomas	4180186
958782	HNSCC	4180186
958782	Hypopharyngeal Squamous Cell Carcinoma	4180186
958782	Laryngeal Squamous Cell Carcinoma	4180186
958782	Oral Cavity Squamous Cell Carcinoma	4180186
958782	Oral Squamous Cell Carcinoma	4180186
958782	Oral Squamous Cell Carcinomas	4180186
958782	Oral Tongue Squamous Cell Carcinoma	4180186
958782	Oropharyngeal Squamous Cell Carcinoma	4180186
958782	Squamous Cell Carcinoma, Head And Neck	4180186
958782	Squamous Cell Carcinoma of Larynx	4180186
958782	Squamous Cell Carcinoma of the Head and Neck	4180186
958782	Squamous Cell Carcinoma of the Larynx	4180186
958782	Squamous Cell Carcinoma of the Mouth	4180186
958782	Squamous Cell Carcinoma of the Nasal Cavity	4180186
958784	6-Perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt	4180186
958784	Bridion	4180186
958784	Gamma-cyclodextrin, 6A,6B,6C,6D,6E,7F,6G,6H-octakis-S-(2-carboxyethyl)-6A,6B,6C,6D,6E,7F,6G,6H-octathio-	4180186
958784	Org 25969	4180186
958784	Sugammadex Sodium	4180186
958787	5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide	4180186
958787	SU011248	4180186
958787	SU 011248	4180186
958787	SU-011248	4180186
958787	SU11248	4180186
958787	SU 11248	4180186
958787	SU-11248	4180186
958787	Sunitinib Malate	4180186
958787	Sutent	4180186
958789	3-((1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl)phenol	4180186
958789	Nucynta	4180186
958789	Tapentadol Hydrochloride	4180186
958791	1-(2-Deoxy-beta-L-erythropentafuranosyl)-5-methyl-2,4(1H,3H)-pyrimidinedione	4180186
958791	2,4(1H,3H)-Pyrimidinedione, 1-(2-deoxy-beta-L-erythro-pentofuranosyl)-5-methyl-	4180186
958791	beta L 2' Deoxythymidine	4180186
958791	beta-L-2'-Deoxythymidine	4180186
958791	Telbivudin	4180186
958791	Tyzeka	4180186
958792	(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-	4180186
958792	4'-((1,4'-Dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid	4180186
958792	BIBR 277	4180186
958792	BIBR-277	4180186
958792	Micardis	4180186
958792	Pritor	4180186
958793	8-Carbamoyl-3-methylimidazo(5,1-d)-1,2,3,5-tetrazin-4(3H)-one	4180186
958793	CCRG81045	4180186
958793	CCRG 81045	4180186
958793	CCRG-81045	4180186
958793	M&B39831	4180186
958793	M&B 39831	4180186
958793	M&B-39831	4180186
958793	Methazolastone	4180186
958793	NSC362856	4180186
958793	NSC 362856	4180186
958793	NSC-362856	4180186
958793	Temodal	4180186
958793	Temodar	4180186
958793	Temozolomide Hexyl Ester	4180186
958793	TMZA-HE	4180186
958793	TMZ Bioshuttle	4180186
958793	TMZ-Bioshuttle	4180186
958794	Metalyse	4180186
958794	TNKase	4180186
958795	1-Naphthalenemethanamine, N-((2E)-6,6-dimethyl-2-hepten-4-yn-1-yl)-N-methyl-	4180186
958795	DA 5505	4180186
958795	(E)-N-(6,6-Dimethyl-2-heptenynyl)-N-methyl-1-naphthalenementhamin hydrochloride	4180186
958795	Lamisil	4180186
958795	SF86327	4180186
958795	SF 86327	4180186
958795	SF 86 327	4180186
958795	SF 86-327	4180186
958795	SF-86-327	4180186
958795	TDT067	4180186
958795	TDT 067	4180186
958795	TDT-067	4180186
958795	Terbinafine Hydrochloride	4180186
958795	Terbinafine, (Z)-	4180186
958795	Terbinafine, (Z)-isomer	4180186
958799	3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-	4180186
958799	Gabitril	4180186
958799	N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid	4180186
958799	NO 328	4180186
958799	NO-328	4180186
958799	NO 329	4180186
958799	NO-329	4180186
958799	(R)-(4,4-bis(3-Methyl-2-thienyl)-3-butenyl)-3-piperidinecarboxylic acid, Hydrochloride	4180186
958799	Tiagabine Hydrochloride	4180186
958799	Tiagabine, (S)-isomer	4180186
958800	1,2-cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-	4180186
958800	3-(7-((2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1-3)-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol	4180186
958800	AZD6140	4180186
958800	AZD 6140	4180186
958800	AZD-6140	4180186
958800	Brilinta	4180186
958800	Brilique	4180186
958802	2 Propenoic acid, 3 phenyl	4180186
958802	2-Propenoic acid, 3-phenyl-	4180186
958802	3-phenyl- 2-Propenoic acid	4180186
958802	Innohep	4180186
958802	Tinzaparin Sodium	4180186
958804	3,4 Dihydroxy 5' methyl 5 nitrobenzophenone	4180186
958804	3,4-Dihydroxy-5'-methyl-5-nitrobenzophenone	4180186
958804	Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-	4180186
958804	Ro407592	4180186
958804	Ro 407592	4180186
958804	Ro 40 7592	4180186
958804	Ro 40-7592	4180186
958804	Ro-40-7592	4180186
958804	SOM0226	4180186
958804	Tasmar	4180186
958805	7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine	4180186
958805	Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-	4180186
958805	OPC41061	4180186
958805	OPC 41061	4180186
958805	OPC-41061	4180186
958805	Samsca	4180186
958806	2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate	4180186
958806	Epitomax	4180186
958806	McN4853	4180186
958806	McN 4853	4180186
958806	McN-4853	4180186
958806	Topamax	4180186
958806	USL255	4180186
958807	1-Isopropyl-3-((4-(3-methylphenylamino)pyridine)-3-sulfonyl)urea	4180186
958807	1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)urea	4180186
958807	3-Pyridinesulfonamide, N-(((1-methylethyl)amino)carbonyl)-4-((3-methylphenyl)amino)-	4180186
958807	Demadex	4180186
958807	Torasemide	4180186
958808	Capacities, Total Lung	4180186
958808	Capacity, Total Lung	4180186
958808	Lung Capacities, Total	4180186
958808	Lung Capacity, Total	4180186
958808	Total Lung Capacities	4180186
958809	Ecteinascidin 743	4180186
958809	ET743	4180186
958809	ET 743	4180186
958809	ET-743	4180186
958809	NSC 684766	4180186
958809	Yondelis	4180186
958810	Halstead Category Test	4180186
958810	Halstead-Reitan Battery	4180186
958810	Halstead-Reitan Neuropsychological Battery	4180186
958810	Seashore Rhythm Test	4180186
958810	Speech Sounds Perception Test	4180186
958810	Tactual Performance Test	4180186
958812	2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-	4180186
958812	5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione) - T	4180186
958812	CS045	4180186
958812	CS 045	4180186
958812	CS-045	4180186
958812	Prelay	4180186
958812	Rezulin	4180186
958815	Ganciclovir L valyl Ester	4180186
958815	Ganciclovir L-valyl Ester	4180186
958815	L-Valine, 2-((2-amino-3,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester	4180186
958815	Valcyt	4180186
958815	Valcyte	4180186
958815	Valganciclovir Hydrochloride	4180186
958816	1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-	4180186
958816	PLX4032	4180186
958816	PLX 4032	4180186
958816	R05185426	4180186
958816	RG7204	4180186
958816	RG 7204	4180186
958816	RG-7204	4180186
958816	Zelboraf	4180186
958817	Ratios, Ventilation-Perfusion	4180186
958817	Ratio, Ventilation-Perfusion	4180186
958817	Ventilation Perfusion Ratio	4180186
958817	Ventilation-Perfusion Ratios	4180186
958820	5' Nor anhydrovinblastine	4180186
958820	5'-Nor-anhydrovinblastine	4180186
958820	C'-Norvincaleukoblastine, 3',4'-didehydro-4'-deoxy-	4180186
958820	KW2307	4180186
958820	KW 2307	4180186
958820	KW-2307	4180186
958820	Navelbine	4180186
958820	Vinorelbine Tartrate	4180186
958822	18F-SAHA	4180186
958822	18F Suberoylanilide Hydroxamic Acid	4180186
958822	18F-Suberoylanilide Hydroxamic Acid	4180186
958822	M344	4180186
958822	MK0683	4180186
958822	MK 0683	4180186
958822	MK-0683	4180186
958822	N1 Hydroxy N8 phenyloctanediamide	4180186
958822	N1-Hydroxy-N8-phenyloctanediamide	4180186
958822	NHNPODA	4180186
958822	N Hydroxy N' phenyloctanediamide	4180186
958822	N-Hydroxy-N'-phenyloctanediamide	4180186
958822	Suberanilohydroxamic Acid	4180186
958822	Suberoylanilide Hydroxamic Acid	4180186
958822	Suberoyl Anilide Hydroxamic Acid	4180186
958822	Zolinza	4180186
958824	Brief Cognitive Status Exam	4180186
958826	CGP-42446	4180186
958826	2-(Imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid	4180186
958826	CGP42446	4180186
958826	CGP 42446	4180186
958826	CGP 42'446	4180186
958826	CGP-42'446	4180186
958826	CGP42'446	4180186
958826	CGP 42446A	4180186
958826	Zoledronate	4180186
958826	Zoledronic Acid Anhydrous	4180186
958826	Zometa	4180186
958828	1,2-Benzisoxazole-3-methanesulfonamide	4180186
958828	3 Sulfamoylmethyl 1,2 benzisoxazole	4180186
958828	3-Sulfamoylmethyl-1,2-benzisoxazole	4180186
958828	AD810	4180186
958828	AD 810	4180186
958828	AD-810	4180186
958828	CI912	4180186
958828	CI 912	4180186
958828	CI-912	4180186
958828	Zonegran	4180186
958828	Zonisamide Monosodium	4180186
958829	3,5-BTPE	4180186
958831	4-hydroxybenzenemethanol	4180186
958831	4-(Hydroxymethyl)phenol	4180186
958831	4-methylol phenol	4180186
958831	gastrodigenin	4180186
958831	p-hydroxybenzyl alcohol	4180186
958832	8-chlorotheophylline, sodium salt	4180186
958832	S8CT	4180186
958832	sodium-8-chlorotheophylline	4180186
958835	Aicardi Goutieres syndrome	4180186
958835	Aicardi-Goutieres Syndrome 1	4180186
958835	Aicardi-Goutieres Syndrome 2	4180186
958835	Cree Encephalitis	4180186
958835	Encephalopathy with Basal Ganglia Calcification	4180186
958835	Familial Infantile Encephalopathy with Intracranial Calcification and Chronic Cerebrospinal Fluid Lymphocytosis	4180186
958835	Pseudo-TORCH syndrome	4180186
958835	Pseudotoxoplasmosis syndrome	4180186
958837	Miosis, Congenital, with Spastic Ataxia	4180186
958839	Atkin Flaitz Patil Smith syndrome	4180186
958839	Atkin-Flaitz syndrome	4180186
958839	Mental retardation, X-linked, 21	4180186
958839	Mental Retardation, X-Linked 21	4180186
958839	Mental retardation X-linked Atkin type	4180186
958839	Mental retardation X-linked, Atkin type	4180186
958839	Mental retardation, X-linked, nonspecific	4180186
958839	Mental retardation, X-linked nonspecific, type 1	4180186
958839	MRX21	4180186
958839	X-linked mental retardation syndrome, Atkin type	4180186
958840	Russell Weaver Bull syndrome	4180186
958841	Choroideremia deafness obesity	4180186
958841	Choroideremia, obesity, and congenital deafness	4180186
958841	Choroideremia with Deafness and Obesity	4180186
958844	Bird-Headed Dwarfism, Montreal Type	4180186
958844	Bird-headed dwarfism with features of premature senility	4180186
958845	Birk-Barel Syndrome	4180186
958845	Mental Retardation with Hypotonia and Facial Dysmorphism	4180186
958846	Bos1	4180186
958846	BO syndrome 1	4180186
958846	Branchiootic dysplasia	4180186
958846	Branchiootic Syndrome 1	4180186
958847	burosumab-TWZA	4180186
958847	Crysvita	4180186
958847	KRN23	4180186
958847	KRN-23	4180186
958852	Trisomy 14 mosaic	4180186
958852	Trisomy 14 mosaicism	4180186
958852	Trisomy 14 mosaicism syndrome	4180186
958853	Trisomy 15 mosaicism	4180186
958853	Uniparental disomy of 15	4180186
958856	Ring chromosome 7	4180186
958856	Ring chromosome 7 syndrome	4180186
958858	Duplication 8p	4180186
958858	Trisomy 8p	4180186
958860	Chudley Rozdilsky syndrome	4180186
958860	Chudley syndrome	4180186
958866	Deafness, Conductive, with Ptosis and Skeletal Anomalies	4180186
958866	Jackson Barr syndrome	4180186
958868	Bitrex	4180186
958868	denatonium benzoate	4180186
958868	denatonium chloride	4180186
958871	Braftovi	4180186
958871	LGX818	4180186
958879	2-EHEC	4180186
958879	ethyl 2-hydroxyethyl ether cellulose	4180186
958880	EHEC cpd	4180186
958881	N-ETHYLUREA	4180186
958888	palmitaldehyde	4180186
958888	palmitoyl aldehyde	4180186
958889	Hartsfield Syndrome	4180186
958891	Hu-5A8	4180186
958891	ibalizumab-uiyk	4180186
958891	TMB-355	4180186
958891	TNX-355	4180186
958891	Trogarzo	4180186
958895	AG-120	4180186
958895	N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide	4180186
958895	Tibsovo	4180186
958895	AG120	4180186
958896	Ichthyosis alopecia eclabion ectropion mental retardation	4180186
958896	Ichthyosis With Alopecia, Eclabion, Ectropion, And Mental Retardation	4180186
958902	Receptaculum Nelumbinis	4180186
958904	Macrocrania, obesity, ocular abnormalities (retinal coloboma and nystagmus)	4180186
958904	Macrosomia, Obesity, Macrocephaly, And Ocular Abnormalities	4180186
958904	MOMO syndrome	4180186
958908	Ectrodactyly, spastic paraplegia and mental retardation	4180186
958908	Jancar syndrome	4180186
958908	Mental retardation, spasticity and transverse limb defects	4180186
958909	Wolff mental retardation syndrome	4180186
958909	Wolff type Mental retardation	4180186
958909	Wolff Zimmermann syndrome	4180186
958910	methyl hydrogen fumarate	4180186
958910	bafiertam	4180186
958910	methylhydrogenfumarate	4180186
958914	n-butyl maleate	4180186
958915	Mental retardation, truncal Obesity, Retinal dystrophy and Micropenis	4180186
958915	Mental Retardation, Truncal Obesity, Retinal Dystrophy, And Micropenis	4180186
958917	Ataxia-Pancytopenia Syndrome	4180186
958919	Keipert Syndrome	4180186
958921	Alacrimia-choreoathetosis-liver dysfunction syndrome	4180186
958921	Congenital disorder of deglycosylation	4180186
958921	Congenital disorder of glycosylation, type Iv	4180186
958922	Microcephaly and Spontaneous Chromosome Instability without Immunodeficiency	4180186
958922	RAD50 Deficiency	4180186
958923	acetic acid octyl ester	4180186
958924	Oblique facial clefts	4180186
958924	Oculomaxillofacial dysplasia with oblique facial clefts	4180186
958924	Richieri Costa Gorlin syndrome	4180186
958928	Familial oto-facio-cervical dysmorphia	4180186
958928	Fara Chlupackova syndrome	4180186
958928	Ofc Syndrome	4180186
958930	Impulsin	4180186
958930	MimyX	4180186
958930	N-(2-hydroxyethyl)palmitate	4180186
958930	N-palmitoylethanolamine	4180186
958930	palmitoylethanolamide	4180186
958930	palmitylethanolamide	4180186
958932	ALN-TTR02	4180186
958932	Onpattro	4180186
958933	PFMe-cyclopentane	4180186
958935	Trichodermodysplasia with dental alterations	4180186
958938	ACC With Abnormal Genitalia	4180186
958938	Corpus Callosum, Agenesis of, with Abnormal Genitalia	4180186
958940	Radio-renal syndrome	4180186
958941	radium chloride Ra 223	4180186
958941	Xofigo	4180186
958943	82Rb radioisotope	4180186
958943	Rb-82 radioisotope	4180186
958948	Spinocerebellar ataxia 18	4180186
958950	22Na radioisotope	4180186
958950	Na-22 radioisotope	4180186
958954	Sca10	4180186
958954	SCA10 Spinocerebellar Ataxia 10	4180186
958959	SCA19 Spinocerebellar ataxia 19	4180186
958962	Cerebellar ataxia, autosomal dominant, FGF14-related	4180186
958962	SCA27 Spinocerebellar ataxia 27	4180186
958964	Aplasia of cerebellar vermis	4180186
958964	Cerebellar ataxia, congenital, nonprogressive, autosomal dominant	4180186
958964	Cerebellar ataxia, early-onset, nonprogressive	4180186
958964	Cerebellar vermis aplasia	4180186
958964	SCA29 Spinocerebellar Ataxia 29	4180186
958965	SCA30 Spinocerebellar ataxia 30	4180186
958972	Brachydactyly with Joint Dysplasia	4180186
958972	Liebenberg Syndrome	4180186
958973	WR238605	4180186
958973	tafenoquine succinate, (R)-	4180186
958973	SB252263-AX	4180186
958973	SB252263AX	4180186
958973	(R)-tafenoquine succinate	4180186
958973	butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1), (R)-	4180186
958973	butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)	4180186
958973	Arakoda	4180186
958973	SB-252263-AX	4180186
958973	SB-252263AX	4180186
958973	Krintafel	4180186
958973	N(4)-(2,6-dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine	4180186
958973	tafenoquine maleate	4180186
958973	tafenoquine succinate	4180186
958973	WR 238605	4180186
958973	WR-238605	4180186
958975	thallium (+3) acetate	4180186
958975	thallium acetate (4:1:1)	4180186
958975	thallous acetate	4180186
958977	Ilumya	4180186
958977	MK-3222	4180186
958977	SCH 900222	4180186
958977	SCH-900222	4180186
958982	1,2-oxaborinane-6-acetic acid, 2-hydroxy-3-((2-(2-thienyl)acetyl)amino)-, (3R,6S)-	4180186
958984	Hemangioma, Intraosseous	4180186
958984	Vascular Malformation Osseous	4180186
958986	Cleft Limb Heart Malformation Syndrome	4180186
958986	Cleft-Limb-Heart Malformation Syndrome	4180186
958986	Verloove Vanhorick Brubakk syndrome	4180186
958991	Sex-linked mental retardation, short stature, obesity and hypogonadism	4180186
979195	1,2 Dihexadecyl sn Glycerophosphocholine	4180186
979195	1,2-Dihexadecyl-sn-Glycerophosphocholine	4180186
979195	1,2 Dipalmitoyl Glycerophosphocholine	4180186
979195	1,2-Dipalmitoyl-Glycerophosphocholine	4180186
979195	1,2 Dipalmitoylphosphatidylcholine	4180186
979195	3,5,9-Trioxa-4-phosphapentacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-((1-oxohexadecyl)oxy)-, inner salt, 4-oxide	4180186
979195	Dipalmitoylglycerophosphocholine	4180186
979195	Dipalmitoyllecithin	4180186
979195	Dipalmitoylphosphatidylcholine	4180186
979195	Dipalmitoyl Phosphatidylcholine	4180186
979195	Phosphatidylcholine, Dipalmitoyl	4180186
979196	2 Hydroxypropyl beta cyclodextrin	4180186
979196	2 Hydroxypropyl-beta-cyclodextrin	4180186
979196	Betadex, Hydroxypropyl	4180186
979196	beta Hydroxypropylcyclodextrin	4180186
979196	beta-Hydroxypropylcyclodextrin	4180186
979196	HPbetaCD	4180186
979196	HP-beta-CD	4180186
979196	Hydroxypropyl beta cyclodextrin	4180186
979196	Hydroxypropyl-beta-cyclodextrin	4180186
979196	Hydroxypropyl Betadex	4180186
979201	alpha D Galactopyranosidase	4180186
979201	alpha-D-Galactopyranosidase	4180186
979201	alpha D Galactosidase	4180186
979201	alpha-D-Galactosidase	4180186
979201	alpha-D-galactoside galactohydrolase	4180186
979201	alpha Galactisidase	4180186
979201	alpha-Galactisidase	4180186
979201	alpha Galactosidase	4180186
979201	alpha Galactosidase A	4180186
979201	alpha-Galactosidase A	4180186
979201	alpha Galactosidases	4180186
979201	alpha-Galactosidases	4180186
979201	Beano	4180186
979201	Melibiase	4180186
979203	5 L Isoleucine Angiotensin II	4180186
979203	5-L-Isoleucine Angiotensin II	4180186
979203	ANG-(1-8)Octapeptide	4180186
979203	Angiotensin-(1-8) Octapeptide	4180186
979203	Angiotensin II, 5-L-Isoleucine	4180186
979203	Angiotensin II, Ile(5)-	4180186
979203	Angiotensin II, Isoleucine(5)-	4180186
979203	Angiotensin II, Val(5)-	4180186
979203	Angiotensin II, Valine(5)-	4180186
979203	Isoleucine(5)-Angiotensin	4180186
979203	Isoleucyl(5)-Angiotensin II	4180186
979203	Valyl(5)-Angiotensin II	4180186
979207	Aphasias, Primary Progressive	4180186
979207	Mesulam's Syndrome	4180186
979207	Mesulam Syndrome	4180186
979207	Primary Progressive Aphasia	4180186
979207	Primary Progressive Aphasias	4180186
979207	Progressive Aphasia, Primary	4180186
979207	Progressive Aphasias, Primary	4180186
979207	Syndrome, Mesulam	4180186
979207	Syndrome, Mesulam's	4180186
979212	Bacilan	4180186
979212	Dipel	4180186
979212	Thuricide	4180186
979220	Blood Cultures	4180186
979220	Blood Culture Test	4180186
979220	Blood Culture Tests	4180186
979220	Culture, Blood	4180186
979220	Cultures, Blood	4180186
979220	Culture Test, Blood	4180186
979220	Culture Tests, Blood	4180186
979220	Test, Blood Culture	4180186
979220	Tests, Blood Culture	4180186
979222	Brain Injury, Diffuse	4180186
979222	Cerebral Injuries, Diffuse	4180186
979222	Cerebral Injury, Diffuse	4180186
979222	Diffuse Axonal Brain Injury	4180186
979222	Diffuse Brain Injuries	4180186
979222	Diffuse Brain Injury	4180186
979222	Diffuse Cerebral Injuries	4180186
979222	Diffuse Cerebral Injury	4180186
979223	Brain Injury, Traumatic	4180186
979223	Brain Trauma	4180186
979223	Brain Traumas	4180186
979223	Encephalopathies, Traumatic	4180186
979223	Encephalopathy, Traumatic	4180186
979223	Injury, Brain, Traumatic	4180186
979223	TBIs (Traumatic Brain Injuries)	4180186
979223	TBI (Traumatic Brain Injuries)	4180186
979223	TBI (Traumatic Brain Injury)	4180186
979223	Trauma, Brain	4180186
979223	Traumas, Brain	4180186
979223	Traumatic Brain Injuries	4180186
979223	Traumatic Brain Injury	4180186
979223	Traumatic Encephalopathies	4180186
979223	Traumatic Encephalopathy	4180186
979224	Brainstem Hematomas, Traumatic	4180186
979224	Brainstem Hematoma, Traumatic	4180186
979224	Brain Stem Hematoma, Traumatic	4180186
979224	Brainstem Hemorrhage, Post-Traumatic	4180186
979224	Brain Stem Hemorrhage, Post Traumatic	4180186
979224	Brain Stem Hemorrhage, Post-Traumatic	4180186
979224	Brainstem Hemorrhage, Traumatic	4180186
979224	Bulbar Hemorrhage, Traumatic	4180186
979224	Hemorrhage, Brain Stem, Traumatic	4180186
979224	Hemorrhage, Post-Traumatic Brainstem	4180186
979224	Hemorrhage, Traumatic Bulbar	4180186
979224	Hemorrhage, Traumatic Medullary	4180186
979224	Medullary Hemorrhage, Traumatic	4180186
979224	Midbrain Hemorrhage, Traumatic	4180186
979224	Pontine Hemorrhage, Traumatic	4180186
979224	Post Traumatic Brainstem Hemorrhage	4180186
979224	Post-Traumatic Brainstem Hemorrhage	4180186
979224	Post Traumatic Brain Stem Hemorrhage	4180186
979224	Post-Traumatic Brain Stem Hemorrhage	4180186
979224	Traumatic Brainstem Hematoma	4180186
979224	Traumatic Brain Stem Hematoma	4180186
979224	Traumatic Brainstem Hematomas	4180186
979224	Traumatic Brainstem Hemorrhage	4180186
979224	Traumatic Brain Stem Hemorrhage	4180186
979224	Traumatic Bulbar Hemorrhage	4180186
979224	Traumatic Medullary Hemorrhage	4180186
979224	Traumatic Midbrain Hemorrhage	4180186
979224	Traumatic Pontine Hemorrhage	4180186
979225	LCIS, Lobular Carcinoma In Situ	4180186
979225	Lobular Carcinoma In Situ	4180186
979227	Bunions	4180186
979229	Candida metapsilosis	4180186
979229	Candida orthopsilosis	4180186
979229	Candida parapsilosis Complex	4180186
979229	Candida parapsilosis Group	4180186
979229	C. metapsilosis	4180186
979229	C. orthopsilosis	4180186
979229	C. parapsilosis	4180186
979229	C. parapsilosis Complex	4180186
979229	Mycocandida parapsilosis	4180186
979229	Mycotorula parapsilopsis	4180186
979236	Closed Fracture Reductions	4180186
979236	Closed Reduction, Fracture	4180186
979236	Fracture Closed Reduction	4180186
979236	Fracture Closed Reductions	4180186
979236	Fracture Reduction, Closed	4180186
979236	Fracture Reductions, Closed	4180186
979236	Reduction, Fracture Closed	4180186
979236	Reductions, Fracture Closed	4180186
979240	Angiographies, Computed Tomography	4180186
979240	Angiographies, CT	4180186
979240	Angiography, Computed Tomography	4180186
979240	Angiography, CT	4180186
979240	Computed Tomography Angiographies	4180186
979240	CT Angiographies	4180186
979240	CT Angiography	4180186
979240	Tomography Angiographies, Computed	4180186
979240	Tomography Angiography, Computed	4180186
979242	Conservative Management	4180186
979242	Conservative Managements	4180186
979242	Conservative Therapies	4180186
979242	Conservative Therapy	4180186
979242	Conservative Treatments	4180186
979242	Management, Conservative	4180186
979242	Managements, Conservative	4180186
979242	Therapies, Conservative	4180186
979242	Therapy, Conservative	4180186
979242	Treatment, Conservative	4180186
979242	Treatments, Conservative	4180186
979243	Medical Contraindication	4180186
979243	Medical Contraindications	4180186
979243	Physical Agent Contraindication	4180186
979243	Physical Agent Contraindications	4180186
979243	Contraindication	4180186
979243	Contraindication, Medical	4180186
979243	Contraindication, Physical Agent	4180186
979243	Contraindications, Medical	4180186
979243	Contraindications, Physical Agent	4180186
979243	Agent Contraindication, Physical	4180186
979243	Agent Contraindications, Physical	4180186
979244	Coxa Magnas	4180186
979244	Deformities, Femoral Head	4180186
979244	Deformity, Femoral Head	4180186
979244	Femoral Head Deformities	4180186
979244	Femoral Head Deformity	4180186
979246	Crush Fracture	4180186
979246	Crush Fractures	4180186
979246	Crush Injury	4180186
979246	Fracture, Crush	4180186
979246	Fractures, Crush	4180186
979246	Injuries, Crush	4180186
979246	Injury, Crush	4180186
979247	Arthritides, Crystal	4180186
979247	Arthritides, Crystalline	4180186
979247	Arthritis, Crystal	4180186
979247	Arthritis, Crystalline	4180186
979247	Arthropathies, Crystal	4180186
979247	Arthropathies, Crystalline	4180186
979247	Arthropathy, Crystal	4180186
979247	Arthropathy, Crystalline	4180186
979247	Crystal Arthritides	4180186
979247	Crystal Arthritis	4180186
979247	Crystal Arthropathy	4180186
979247	Crystalline Arthritides	4180186
979247	Crystalline Arthritis	4180186
979247	Crystalline Arthropathies	4180186
979247	Crystalline Arthropathy	4180186
979249	Avulsion Injuries, Skin	4180186
979249	Avulsion Injury, Skin	4180186
979249	Avulsion, Skin	4180186
979249	Avulsions, Skin	4180186
979249	Degloving Injury	4180186
979249	Degloving Wound	4180186
979249	Degloving Wounds	4180186
979249	Injuries, Degloving	4180186
979249	Injuries, Skin Avulsion	4180186
979249	Injury, Degloving	4180186
979249	Injury, Skin Avulsion	4180186
979249	Skin Avulsion	4180186
979249	Skin Avulsion Injuries	4180186
979249	Skin Avulsion Injury	4180186
979249	Skin Avulsions	4180186
979249	Wound, Degloving	4180186
979249	Wounds, Degloving	4180186
979250	Diastases, Muscle	4180186
979250	Muscle Diastases	4180186
979250	Muscle Diastasis	4180186
979250	Myodiastases	4180186
979250	Myodiastasis	4180186
979251	DASH Diet	4180186
979251	DASH Diets	4180186
979251	Dietary Approaches To Stop Hypertension Diet	4180186
979251	Diet, DASH	4180186
979251	Diets, DASH	4180186
979255	Antibiotic Resistance, Neoplasm	4180186
979255	Antineoplastic Agent Resistance	4180186
979255	Antineoplastic Drug Resistance	4180186
979255	Drug Resistance, Antineoplastic	4180186
979255	Neoplasm Drug Resistance	4180186
979255	Resistance, Antineoplastic Agent	4180186
979255	Resistance, Antineoplastic Drug	4180186
979258	Streptococcus faecium	4180186
979259	Enthesopathies	4180186
979260	Primary Hypertensions	4180186
979260	Primary Hypertension	4180186
979260	Hypertensions, Primary	4180186
979260	Hypertension, Primary	4180186
979260	Hypertension, Essential	4180186
979262	Face Transplant	4180186
979262	Face Transplantation	4180186
979262	Face Transplantations	4180186
979262	Face Transplants	4180186
979262	Facial Transplant	4180186
979262	Facial Transplantations	4180186
979262	Facial Transplants	4180186
979262	Transplantation, Face	4180186
979262	Transplantation, Facial	4180186
979262	Transplantations, Face	4180186
979262	Transplantations, Facial	4180186
979262	Transplant, Face	4180186
979262	Transplant, Facial	4180186
979262	Transplants, Face	4180186
979262	Transplants, Facial	4180186
979264	Fasciectomy	4180186
979265	Transplants, Intestinal Microbiota	4180186
979265	Transplants, Intestinal Microbiome	4180186
979265	Transplants, Fecal Microbiota	4180186
979265	Transplant, Intestinal Microbiota	4180186
979265	Transplant, Intestinal Microbiome	4180186
979265	Transplant, Fecal Microbiota	4180186
979265	Transplantations, Intestinal Microbiota	4180186
979265	Transplantations, Intestinal Microbiome	4180186
979265	Transplantations, Fecal Microbiome	4180186
979265	Transplantation, Intestinal Microbiota	4180186
979265	Transplantation, Intestinal Microbiome	4180186
979265	Transplantation, Fecal Microbiome	4180186
979265	Transfers, Intestinal Microbiome	4180186
979265	Transfers, Fecal Microbiota	4180186
979265	Transfer, Intestinal Microbiome	4180186
979265	Transfer, Fecal Microbiota	4180186
979265	Microbiota Transplants, Intestinal	4180186
979265	Microbiota Transplants, Fecal	4180186
979265	Microbiota Transplant, Intestinal	4180186
979265	Microbiota Transplant, Fecal	4180186
979265	Microbiota Transplantations, Intestinal	4180186
979265	Microbiota Transplantation, Intestinal	4180186
979265	Microbiota Transfers, Fecal	4180186
979265	Microbiota Transfer, Fecal	4180186
979265	Microbiome Transplants, Intestinal	4180186
979265	Microbiome Transplant, Intestinal	4180186
979265	Microbiome Transplantations, Intestinal	4180186
979265	Microbiome Transplantations, Fecal	4180186
979265	Microbiome Transplantation, Intestinal	4180186
979265	Microbiome Transplantation, Fecal	4180186
979265	Microbiome Transfers, Intestinal	4180186
979265	Microbiome Transfer, Intestinal	4180186
979265	Intestinal Microbiota Transplants	4180186
979265	Intestinal Microbiota Transplantations	4180186
979265	Intestinal Microbiota Transplantation	4180186
979265	Intestinal Microbiota Transplant	4180186
979265	Intestinal Microbiome Transplants	4180186
979265	Intestinal Microbiome Transplantations	4180186
979265	Intestinal Microbiome Transplantation	4180186
979265	Intestinal Microbiome Transplant	4180186
979265	Intestinal Microbiome Transfers	4180186
979265	Intestinal Microbiome Transfer	4180186
979265	Fecal Microbiota Transplants	4180186
979265	Fecal Microbiota Transplant	4180186
979265	Fecal Microbiota Transfers	4180186
979265	Fecal Microbiota Transfer	4180186
979265	Fecal Microbiome Transplantations	4180186
979265	Fecal Microbiome Transplantation	4180186
979265	Donor Feces Infusion	4180186
979265	Donor Feces Infusions	4180186
979265	Fecal Microbiota Transplantations	4180186
979265	Fecal Transplant	4180186
979265	Fecal Transplantation	4180186
979265	Fecal Transplantations	4180186
979265	Fecal Transplants	4180186
979265	Feces Infusion, Donor	4180186
979265	Feces Infusions, Donor	4180186
979265	Infusion, Donor Feces	4180186
979265	Infusions, Donor Feces	4180186
979265	Intestinal Microbiota Transfer	4180186
979265	Intestinal Microbiota Transfers	4180186
979265	Microbiota Transfer, Intestinal	4180186
979265	Microbiota Transfers, Intestinal	4180186
979265	Microbiota Transplantation, Fecal	4180186
979265	Microbiota Transplantations, Fecal	4180186
979265	Transfer, Intestinal Microbiota	4180186
979265	Transfers, Intestinal Microbiota	4180186
979265	Transplantation, Fecal	4180186
979265	Transplantation, Fecal Microbiota	4180186
979265	Transplantations, Fecal	4180186
979265	Transplantations, Fecal Microbiota	4180186
979265	Transplant, Fecal	4180186
979265	Transplants, Fecal	4180186
979267	Food, Sensitivity	4180186
979267	Intolerance, Food	4180186
979268	Debilities	4180186
979268	Debility	4180186
979268	Frailness	4180186
979268	Frailties	4180186
979268	Frailty Syndrome	4180186
979270	Head Heave Test	4180186
979270	Head Heave Tests	4180186
979270	Head Impulse Tests	4180186
979270	Head Thrust Test	4180186
979270	Head Thrust Tests	4180186
979270	Test, Head Heave	4180186
979270	Test, Head Impulse	4180186
979270	Test, Head Thrust	4180186
979270	Tests, Head Heave	4180186
979270	Tests, Head Impulse	4180186
979270	Tests, Head Thrust	4180186
979271	Heavy Metal Poisonings	4180186
979271	Metal Poisoning, Heavy	4180186
979271	Metal Poisonings, Heavy	4180186
979271	Poisoning, Heavy Metal	4180186
979271	Poisonings, Heavy Metal	4180186
979272	Encephalitis, Nipah Virus	4180186
979272	Hendra Virus Infection	4180186
979272	Hendra Virus Infections	4180186
979272	Henipavirus Infection	4180186
979272	Infection, Hendra Virus	4180186
979272	Infection, Henipavirus	4180186
979272	Infection, Nipah Virus	4180186
979272	Infection, NiV	4180186
979272	Nipah Virus Encephalitis	4180186
979272	Nipah Virus Infection	4180186
979272	NiV Infection	4180186
979272	NiV Infections	4180186
979272	Virus Encephalitis, Nipah	4180186
979272	Virus Infection, Hendra	4180186
979272	Virus Infection, Nipah	4180186
979272	Virus Infections, Hendra	4180186
979273	HBOC Syndrome	4180186
979273	HBOC Syndromes	4180186
979273	Syndrome, HBOC	4180186
979273	Syndromes, HBOC	4180186
979274	HTLV-I Infection	4180186
979274	HTLV I Infections	4180186
979274	Human T lymphotropic Virus 1 Infection	4180186
979274	Human T-lymphotropic Virus 1 Infection	4180186
979274	Human T lymphotropic Virus 1 Infections	4180186
979274	Human T-lymphotropic Virus 1 Infections	4180186
979274	Infection, HTLV-I	4180186
979274	Infections, HTLV I	4180186
979274	Infections, HTLV-I	4180186
979278	AL Amyloidoses	4180186
979278	AL Amyloidosis	4180186
979278	Amyloidoses, Primary	4180186
979278	Amyloidoses, Primary Systemic	4180186
979278	Amyloidosis, Immunoglobulin Light chain	4180186
979278	Amyloidosis, Immunoglobulin Light-chain	4180186
979278	Amyloidosis, Primary	4180186
979278	Amyloidosis, Primary Systemic	4180186
979278	Immunoglobulin Light-chain Amyloidoses	4180186
979278	Immunoglobulin Light chain Amyloidosis	4180186
979278	Primary Amyloidoses	4180186
979278	Primary Amyloidosis	4180186
979278	Primary Systemic Amyloidoses	4180186
979278	Primary Systemic Amyloidosis	4180186
979278	Systemic Amyloidoses, Primary	4180186
979278	Systemic Amyloidosis, Primary	4180186
979279	Infusion Site Adverse Event	4180186
979279	Infusion Site Adverse Reaction	4180186
979279	Infusion Site Reaction	4180186
979279	Infusion Site Reactions	4180186
979279	Injection Site Adverse Event	4180186
979279	Injection Site Event	4180186
979279	Injection Site Events	4180186
979279	Injection Site Reactions	4180186
979283	Anti CTLA 4 MAb Ipilimumab	4180186
979283	Anti-CTLA-4 MAb Ipilimumab	4180186
979283	Ipilimumab, Anti-CTLA-4 MAb	4180186
979283	MDX010	4180186
979283	MDX 010	4180186
979283	MDX-010	4180186
979283	MDX CTLA 4	4180186
979283	MDX-CTLA-4	4180186
979283	Yervoy	4180186
979284	Keratectomies	4180186
979285	Infection, Klebsiella	4180186
979285	Infections, Klebsiella	4180186
979285	Klebsiella Infection	4180186
979288	Anal Sphincterotomy, Internal	4180186
979288	Internal Anal Sphincterotomies	4180186
979288	Internal Anal Sphincterotomy	4180186
979288	Internal Sphincterotomies	4180186
979288	Internal Sphincterotomy	4180186
979288	Lateral Internal Anal Sphincterotomy	4180186
979288	Lateral Internal Sphincterotomies	4180186
979288	Lateral Sphincterotomies	4180186
979288	Lateral Sphincterotomy	4180186
979288	Sphincterotomy, Internal	4180186
979288	Sphincterotomy, Lateral	4180186
979288	Sphincterotomy, Lateral Internal	4180186
979290	Malacoplakias	4180186
979290	Malakoplakia	4180186
979290	Malakoplakias	4180186
979294	Medically Unexplained Symptom	4180186
979294	Somatic Symptom	4180186
979294	Somatic Symptoms	4180186
979294	Symptom, Medically Unexplained	4180186
979294	Symptoms, Medically Unexplained	4180186
979294	Symptom, Somatic	4180186
979294	Symptoms, Somatic	4180186
979294	Unexplained Symptom, Medically	4180186
979294	Unexplained Symptoms, Medically	4180186
979295	Ayurvedic Medicine	4180186
979295	Hindu Medicine	4180186
979295	Medicine, Hindu	4180186
979295	Medicine, Siddha	4180186
979295	Siddha Medicine	4180186
979296	Chinese Medicine, Traditional	4180186
979296	Chinese Traditional Medicine	4180186
979296	Chung I Hsueh	4180186
979296	Hsueh, Chung I	4180186
979296	Tongue Assessment, Traditional	4180186
979296	Tongue Diagnoses, Traditional	4180186
979296	Tongue Diagnosis, Traditional	4180186
979296	Traditional Chinese Medicine	4180186
979296	Traditional Medicine, Chinese	4180186
979296	Traditional Tongue Assessment	4180186
979296	Traditional Tongue Assessments	4180186
979296	Traditional Tongue Diagnoses	4180186
979296	Traditional Tongue Diagnosis	4180186
979296	Zhong Yi Xue	4180186
979299	Carboxylase Deficiencies, Combined	4180186
979299	Carboxylase Deficiencies, Multiple	4180186
979299	Carboxylase Deficiency, Combined	4180186
979299	Carboxylase Deficiency, Multiple	4180186
979299	Combined Carboxylase Deficiencies	4180186
979299	Combined Carboxylase Deficiency	4180186
979299	Deficiencies, Combined Carboxylase	4180186
979299	Deficiencies, Multiple Carboxylase	4180186
979299	Deficiency, Combined Carboxylase	4180186
979299	Deficiency, Multiple Carboxylase	4180186
979299	Multiple Carboxylase Deficiencies	4180186
979303	Nephrolithotomies, Percutaneous	4180186
979303	Percutaneous Nephrolithotomies	4180186
979303	Percutaneous Nephrolithotomy	4180186
979304	Kidney Incision	4180186
979304	Kidney Incisions	4180186
979304	Nephrostomies	4180186
979304	Nephrostomy	4180186
979304	Nephrotomies	4180186
979304	Pyelostomies	4180186
979304	Pyelostomy	4180186
979304	Pyelotomies	4180186
979304	Pyelotomy	4180186
979305	Heminephroureterectomies	4180186
979305	Heminephroureterectomy	4180186
979305	Nephroureterectomies	4180186
979305	Nephro-ureterectomies	4180186
979305	Nephro ureterectomy	4180186
979305	Nephro-ureterectomy	4180186
979305	Ureteronephrectomies	4180186
979305	Ureteronephrectomy	4180186
979306	Chewing Gum, Nicotine	4180186
979306	Nicorette	4180186
979306	Nicotine Chewing Gums	4180186
979307	Discharge, Nipple	4180186
979307	Discharges, Nipple	4180186
979307	Nipple Discharges	4180186
979313	Arachis Oil	4180186
979313	Ground Nut Oil	4180186
979313	Nut Oil, Ground	4180186
979313	Oil, Arachis	4180186
979313	Oil, Ground Nut	4180186
979313	Oil, Peanut	4180186
979314	Sociophobias	4180186
979314	Sociophobia	4180186
979314	Social Evaluation Phobias	4180186
979314	Social Evaluation Phobia	4180186
979314	Social Evaluation Fear	4180186
979314	Phobia, Social Evaluation	4180186
979314	Fear of Social Evaluation	4180186
979314	Evaluation Fear, Social	4180186
979314	Anxiety Disorder, Social	4180186
979314	Disorder, Social Anxiety	4180186
979314	Social Anxiety Disorder	4180186
979314	Social Anxiety Disorders	4180186
979314	Social Phobia	4180186
979314	Social Phobias	4180186
979321	Preventive Surgical Procedure	4180186
979321	Preventive Surgical Procedures	4180186
979321	Procedure, Preventive Surgical	4180186
979321	Procedure, Prophylactic Surgical	4180186
979321	Procedures, Preventive Surgical	4180186
979321	Procedures, Prophylactic Surgical	4180186
979321	Prophylactic Surgical Procedure	4180186
979321	Surgical Procedure, Preventive	4180186
979321	Surgical Procedure, Prophylactic	4180186
979321	Surgical Procedures, Preventive	4180186
979321	Surgical Procedures, Prophylactic	4180186
979323	Ch'i Kung	4180186
979323	Qi Gong	4180186
979328	Bran Oil, Rice	4180186
979328	Oil, Rice Bran	4180186
979330	Infection, Roseolovirus	4180186
979330	Infections, Roseolovirus	4180186
979330	Roseolovirus Infection	4180186
979333	boulardii, Saccharomyces	4180186
979333	boulardius, Saccharomyces	4180186
979333	Saccharomyces boulardius	4180186
979334	Salmonella enterica serovar enteritidis	4180186
979337	Albumin Human	4180186
979337	Albumin, Human	4180186
979337	Albumin, Human Serum	4180186
979337	Human Albumin	4180186
979337	Human, Albumin	4180186
979337	Human Serum Albumin	4180186
979338	Injuries, Shoulder	4180186
979338	Injury, Shoulder	4180186
979338	Shoulder Injury	4180186
979338	SLAP Tear	4180186
979338	SLAP Tears	4180186
979338	Superior Labrum from Anterior to Posterior Injuries	4180186
979338	Tear, SLAP	4180186
979338	Tears, SLAP	4180186
979339	CT Scan, SPECT	4180186
979339	CT Scans, SPECT	4180186
979339	CT SPECT	4180186
979339	CT SPECTs	4180186
979339	CT SPECT Scan	4180186
979339	CT SPECT Scans	4180186
979339	Scan, CT SPECT	4180186
979339	Scans, CT SPECT	4180186
979339	Scan, SPECT CT	4180186
979339	Scans, SPECT CT	4180186
979339	SPECT CT	4180186
979339	SPECT, CT	4180186
979339	SPECT CT Scan	4180186
979339	SPECT CT Scans	4180186
979339	SPECT Scan, CT	4180186
979339	SPECT Scans, CT	4180186
979339	SPECTs, CT	4180186
979340	Examination, Slit Lamp	4180186
979340	Examinations, Slit Lamp	4180186
979340	Microscopy, Slit Lamp	4180186
979340	Slit Lamp Examination	4180186
979340	Slit Lamp Examinations	4180186
979343	beta-D-Galactopyranoside, (3beta)-solanid-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-	4180186
979344	TIBOLA	4180186
979344	African Tick Bite Fever	4180186
979344	African Tick-Bite Fever	4180186
979344	Far Eastern Spotted Fever	4180186
979344	Fever, African Tick-Bite	4180186
979344	Fever, Japanese Spotted	4180186
979344	Fevers, Japanese Spotted	4180186
979344	Fever, Spotted	4180186
979344	Fevers, Spotted	4180186
979344	Flinders Island Spotted Fever	4180186
979344	Infection, Rickettsia aeschlimannii	4180186
979344	Infection, Rickettsia africae	4180186
979344	Infection, Rickettsia akari	4180186
979344	Infection, Rickettsia australis	4180186
979344	Infection, Rickettsia slovaca	4180186
979344	Infections, Rickettsia aeschlimannii	4180186
979344	Infections, Rickettsia africae	4180186
979344	Infections, Rickettsia akari	4180186
979344	Infections, Rickettsia australis	4180186
979344	Infections, Rickettsia slovaca	4180186
979344	Japanese Spotted Fever	4180186
979344	Japanese Spotted Fevers	4180186
979344	Lymphadenopathies, Tick-Borne	4180186
979344	Lymphadenopathy, Tick-Borne	4180186
979344	North Asian Tick Typhus	4180186
979344	Queensland Tick Typhus	4180186
979344	Rickettsia aeschlimannii Infection	4180186
979344	Rickettsia aeschlimannii Infections	4180186
979344	Rickettsia africae Infection	4180186
979344	Rickettsia africae Infections	4180186
979344	Rickettsia akari Infection	4180186
979344	Rickettsia akari Infections	4180186
979344	Rickettsia australis Infection	4180186
979344	Rickettsia australis Infections	4180186
979344	Rickettsialpox	4180186
979344	Rickettsia slovaca Infection	4180186
979344	Rickettsia slovaca Infections	4180186
979344	Spotted Fever	4180186
979344	Spotted Fever Group Rickettsioses	4180186
979344	Spotted Fever, Japanese	4180186
979344	Spotted Fevers	4180186
979344	Tick-Bite Fever, African	4180186
979344	Tick-Borne Lymphadenopathies	4180186
979344	Tick Borne Lymphadenopathy	4180186
979344	Tick-Borne Lymphadenopathy	4180186
979344	Tick Typhus, Queensland	4180186
979344	Typhus, Queensland Tick	4180186
979346	Artery Stenoses, Pulmonary	4180186
979346	Artery Stenosis, Pulmonary	4180186
979346	Pulmonary Artery Stenoses	4180186
979346	Pulmonary Artery Stenosis	4180186
979346	Stenoses, Pulmonary Artery	4180186
979356	Clostridial Neurotoxin	4180186
979356	Clostridium tetani Toxin	4180186
979356	Neurotoxin, Clostridial	4180186
979356	Tetanus Toxins	4180186
979356	Toxin, Clostridium tetani	4180186
979356	Toxins, Tetanus	4180186
979356	Toxin, Tetanus	4180186
979357	Tetraploid	4180186
979357	Tetraploidies	4180186
979357	Tetraploids	4180186
979359	Transcatheter Aortic Valve Implantation	4180186
979361	Wolfram	4180186
979362	Doppler Ultrasonography	4180186
979362	Doppler Ultrasound	4180186
979362	Doppler Ultrasound Imaging	4180186
979362	Doppler Ultrasound Imagings	4180186
979362	Doppler Ultrasounds	4180186
979362	Imaging, Doppler Ultrasound	4180186
979362	Imagings, Doppler Ultrasound	4180186
979362	Ultrasound, Doppler	4180186
979362	Ultrasound Imaging, Doppler	4180186
979362	Ultrasound Imagings, Doppler	4180186
979362	Ultrasounds, Doppler	4180186
979365	Nitrate, Uranium	4180186
979365	Nitrate, Uranyl	4180186
979365	Uranium, bis(nitrato-O)dioxo-, (T-4)-	4180186
979365	Uranium Nitrate	4180186
979369	His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn	4180186
979369	Intestinal Peptide, Vasoactive	4180186
979369	Intestinal Polypeptide, Vasoactive	4180186
979369	Peptide, Vasoactive Intestinal	4180186
979369	Peptide, Vasointestinal	4180186
979369	Polypeptide, Vasoactive Intestinal	4180186
979369	Vasoactive Intestinal Polypeptide	4180186
979369	Vasointestinal Peptide	4180186
979369	VIP (Vasoactive Intestinal Peptide)	4180186
979374	1,1',1'',1'''-(ethylenedinitrilo)tetra-2-propanol monotosylate	4180186
979374	N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine	4180186
979374	Quadrol	4180186
979374	tetrahydroxypropyl ethylenediamine	4180186
979377	1,4-diphenyl-1,3-butadiene	4180186
979377	(E,E')-1,4-diphenyl-1,3-butadiene	4180186
979384	2,3-dihydroxybenzoate	4180186
979384	2,3-dihydroxy benzoic acid	4180186
979384	2-pyrocatechuic acid	4180186
979384	2-pyrocatechuic acid, sodium salt	4180186
979384	dihydroxybenzoic acid	4180186
979384	ferri-2,3-dihydroxybenzoic acid	4180186
979384	o-pyrocatechuic acid	4180186
979388	2-aminophenol, hydrochloride	4180186
979388	2-aminophenol, ion (1+)	4180186
979388	2-aminophenol, monopotassium salt	4180186
979388	2-aminophenol, monosodium salt	4180186
979388	o-aminophenol	4180186
979388	ortho-aminophenol	4180186
979390	boscalid	4180186
979391	2-fucosyllactose	4180186
979391	lactose, 2'-O-fucosyl-	4180186
979395	2-oxo-4-thiazolidine carboxylic acid	4180186
979395	2-oxothiazolidine-4-carboxylate	4180186
979395	2-oxothiazolidine-4-carboxylic acid, (R)-isomer	4180186
979395	2-oxothiazolidine-4-carboxylic acid, (S)-isomer	4180186
979395	4-Thiazolidinecarboxylic acid, 2-oxo-	4180186
979395	L-2-OTZD-4-CXA	4180186
979395	L-2-oxothiazolidine-4-carboxylate	4180186
979395	oxothiazolidinecarboxylic acid	4180186
979395	Procysteine	4180186
979398	CCC dysplasia	4180186
979398	Craniocerebellocardiac dysplasia	4180186
979398	Dandy-Walker-like malformation with atrioventricular septal defect	4180186
979398	Ritscher Schinzel syndrome	4180186
979398	Ritscher-Schinzel Syndrome	4180186
979399	phenylethyl resorcinol	4180186
979401	4-anisaldehyde, 1,2,3,4,5,6-(14)C6-labeled	4180186
979401	4-anisaldehyde, 18O-labeled	4180186
979401	4-anisaldehyde, formyl-(14)C-labeled	4180186
979401	4-methoxybenzaldehyde	4180186
979401	anisaldehyde	4180186
979401	benzaldehyde, 4-methoxy-	4180186
979401	p-anisaldehyde	4180186
979401	para-anisaldehyde	4180186
979401	p-methoxybenzaldehyde	4180186
979403	alpha-isobutylphenethyl alcohol	4180186
979403	benzylisobutylcarbinol	4180186
979403	COE 2031	4180186
979403	COE-2031	4180186
979403	FEMA 2208	4180186
979403	FEMA-2208	4180186
979406	7-ADCA	4180186
979406	7-aminodeacetoxycephalosporanic acid	4180186
979406	7-desacetoxyaminocephalosporanic acid	4180186
979410	Ablepharon-Macrostomia Syndrome	4180186
979412	Vici syndrome	4180186
979416	acetyl dipeptide-1 cetyl ester	4180186
979417	Achalasia microcephaly syndrome	4180186
979417	Achalasia-Microcephaly Syndrome	4180186
979420	Elejalde syndrome	4180186
979422	Palagonia type of acrofacial dysostosis	4180186
979428	Pseudopapilledema, Ocular Hypotelorism, Blepharophimosis, and Hand Anomalies	4180186
979430	ACRPV	4180186
979431	Acrorenal-Mandibular Syndrome	4180186
979431	Acro-renal-uterine-mandibular syndrome	4180186
979431	Acrorenal-Uterine-Mandibular Syndrome	4180186
979431	Split hand and split foot with mandibular hypoplasia	4180186
979431	Split-Hand And Split-Foot With Mandibular Hypoplasia	4180186
979434	Citrin deficiency	4180186
979434	Citrullinemia, Type II, Adult-Onset	4180186
979437	Al-Awadi-Raas-Rothschild Syndrome	4180186
979437	Al Awadi Rass Rothschild syndrome	4180186
979437	Limb-Pelvis Hypoplasia-Aplasia syndrome	4180186
979437	Limb-Pelvis-Hypoplasia-Aplasia Syndrome	4180186
979437	Schinzel phocomelia syndrome	4180186
979437	Ulna and fibula absence of with severe limb deficiency	4180186
979437	Ulna And Fibula, Absence Of, With Severe Limb Deficiency	4180186
979439	Albinism, Ocular, With Late-Onset Sensorineural Deafness	4180186
979439	Albinism, Ocular, With Sensorineural Deafness	4180186
979439	Deafness and ocular albinism	4180186
979439	Ocular albinism with sensorineural deafness	4180186
979439	Waardenburg Syndrome, Type Ii, With Ocular Albinism, Autosomal Recessive	4180186
979439	Ws2-Oa	4180186
979443	Alopecia, psychomotor epilepsy, pyorrhea, and mental subnormality	4180186
979443	Congenital universal alopecia, epilepsy, mental subnormality and pyorrhea	4180186
979443	Shokeir syndrome	4180186
979444	4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-3-buten-2-one	4180186
979444	alpha-ionone, (E)-isomer	4180186
979444	alpha-ionone, (E)-(+-)-isomer	4180186
979444	alpha-ionone, (+)-iosmer	4180186
979445	2 alpha ketoglutarate dehydrogenase deficiency	4180186
979445	2-Ketoglutarate Dehydrogenase Deficiency	4180186
979445	Oxoglutaricaciduria	4180186
979445	Oxoglutaric Aciduria	4180186
979447	AMME Complex	4180186
979454	Angel-shaped phalango-epiphyseal dysplasia	4180186
979454	Angel-Shaped Phalangoepiphyseal Dysplasia	4180186
979455	Ankyloblepharon Filiforme Adnatum and Cleft Palate	4180186
979455	Ankyloblepharon filiforme adnatum cleft palate	4180186
979455	Ankyloblepharon filiforme congenitum	4180186
979455	Congenital filiform fusion of the eyelids with cleft palate and-or cleft lip	4180186
979457	Anophthalmia-Plus Syndrome	4180186
979457	Fryns anophthalmia syndrome	4180186
979457	Fryns Microphthalmia Syndrome	4180186
979457	Microphthalmia with Facial Clefting	4180186
979459	AICC complex	4180186
979459	antiinhibitor coagulant complex	4180186
979459	anti-inhibitory coagulant complex	4180186
979459	factor eight inhibitor bypassing activity	4180186
979459	factor VIII inhibitor bypassing activity	4180186
979459	factor VIII inhibitor bypassing fraction	4180186
979459	Feiba	4180186
979459	FEIBA-VH	4180186
979462	Aplasia Cutis Congenita of Limbs, Recessive	4180186
979462	Congenital absence of skin on the upper or lower limbs	4180186
979462	Recessive aplasia cutis congenita of the limbs	4180186
979467	Aristada	4180186
979468	Grange Occlusive Arterial Syndrome	4180186
979470	Arthrogryposis, distal, type 6	4180186
979470	Familial hand abnormality and sensori-neural deafness	4180186
979471	AMCD1	4180186
979471	Arthrogryposis, distal, type 1	4180186
979471	Arthrogryposis Multiplex Congenita, Distal, Type I	4180186
979471	Distal arthrogryposis, type 1	4180186
979471	Distal Arthrogryposis Type 1	4180186
979473	AMC, neurogenic type	4180186
979473	Arthrogryposis Multiplex Congenita, Neurogenic Type	4180186
979473	Neurogenic type of AMC	4180186
979474	Arthrogryposis Multiplex Congenita With Whistling Face	4180186
979474	Illium syndrome	4180186
979474	Illum Syndrome	4180186
979474	Lethal autosomal recessive arthrogryposis multiplex congenita with whistling face and calcifications of the nervous system	4180186
979475	ARCS	4180186
979475	ARCS1	4180186
979475	ARC syndrome	4180186
979475	Arthrogryposis multiplex congenita, renal dysfunction, and cholestasis	4180186
979475	Arthrogryposis, Renal Dysfunction, And Cholestasis	4180186
979475	Arthrogryposis, renal dysfunction, and cholestasis 1	4180186
979477	Aoiii	4180186
979477	Atelosteogenesis Type Iii	4180186
979479	Athabaskan Brainstem Dysgenesis Syndrome	4180186
979479	Bosley-Salih-Alorainy Syndrome	4180186
979479	Navajo brainstem syndrome	4180186
979481	Alpha-Thalassemia-Mental Retardation Syndrome, Nondeletion Type	4180186
979481	Alpha thalassemia mental retardation syndrome, non deletion type, X-linked	4180186
979481	Alpha-Thalassemia-Mental Retardation Syndrome, Nondeletion Type, X-Linked	4180186
979481	Alpha Thalassemia-Mental Retardation, X-Linked	4180186
979481	Alpha Thalassemia X-Linked Intellectual Disability Syndrome	4180186
979481	Alpha-thalassemia X-linked mental retardation syndrome	4180186
979481	Alpha Thalassemia X-Linked Mental Retardation Syndrome	4180186
979481	ATR non deletion type	4180186
979481	ATR, Nondeletion Type	4180186
979481	ATRX Syndrome	4180186
979481	X-linked alpha thalassemia mental retardation syndrome	4180186
979481	X-Linked Alpha-Thalassemia Mental Retardation Syndrome	4180186
979481	XLMR-Hypotonic Face Syndrome	4180186
979483	Cleft lip with progressive retinopathy	4180186
979487	Bamforth-Lazarus syndrome	4180186
979487	Hypothyroidism, athyroidal, with spiky hair and cleft palate	4180186
979487	Hypothyroidism cleft palate	4180186
979487	Hypothyroidism, Thyroidal, With Spiky Hair And Cleft Palate	4180186
979490	HDR syndrome	4180186
979490	Hypoparathyroidism, Sensorineural Deafness, And Renal Disease	4180186
979490	Nephrosis, nerve deafness, and hypoparathyroidism	4180186
979491	BLS, Type I	4180186
979491	HLA Class I Deficiency	4180186
979494	2-(((4-dimethylamino)phenyl)azo)-1,3-dimethyl-1H-imidazolium chloride	4180186
979499	BIW-8405	4180186
979499	Fasenra	4180186
979499	MEDI 563	4180186
979499	MEDI-563	4180186
979502	Benign Congenital Muscular Dystrophy	4180186
979502	Benign Congenital Myopathy with Contractures	4180186
979502	Muscular dystrophy, benign congenital	4180186
979502	Myopathy, benign congenital, with contractures	4180186
979503	BEVYXXA	4180186
979503	N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide	4180186
979503	PRT054021	4180186
979507	cupric di(1,10-phenanthroline)	4180186
979507	(o-phenanthroline) cupric	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diacetate salt	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diacetate salt, (SP-4-1)-isomer	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, dinitrate	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, diperchlorate	4180186
979507	bis(1,10-phenanthroline)copper(2+) ion, sulfate (1:1)	4180186
979507	Cu(OP)2	4180186
979507	Cu(Phen)2	4180186
979515	Vasterbotten Dystrophy	4180186
979517	Brachydactylous dwarfs of Mseleni	4180186
979519	Brachydactyly, Farabee type	4180186
979519	Brachydactyly, Type A1	4180186
979519	Farabee-Type Brachydactyly	4180186
979520	Brachydactyly, Type A2	4180186
979520	Brachymesophalangy 2	4180186
979520	Brachymesophalangy Ii	4180186
979520	Mohr-Wriedt type brachydactyly	4180186
979521	Brachydactyly, Type A6	4180186
979521	Osebold-Remondini syndrome	4180186
979530	acid blue 9	4180186
979530	blue 4	4180186
979530	blue no. 1	4180186
979530	brilliant blue Al (3:1) salt	4180186
979530	brilliant blue, aluminium salt	4180186
979530	brilliant blue diammonium salt	4180186
979530	brilliant blue dipotassium salt	4180186
979530	brilliant blue, disodium salt	4180186
979530	brilliant blue FCF	4180186
979530	brilliant blue FCF, diammonium salt	4180186
979530	brilliant blue potassium, sodium salt	4180186
979530	caries check blue	4180186
979530	C.I. 42090	4180186
979530	CI 42090	4180186
979530	D & C blue no.4	4180186
979530	DC blue no. 4	4180186
979530	erioglaucine	4180186
979530	F D & C blue #1	4180186
979530	FD&C blue No.1	4180186
979530	food blue 2	4180186
979535	Bilateral choanal atresia, cardiac defects, deafness, and dysmorphic appearance	4180186
979536	2-(butylamino)propan-2-yl)phosphinic acid	4180186
979536	butaphosphan	4180186
979539	Campomelia, Cumming Type	4180186
979539	Cervical lymphocele with bowed long bones	4180186
979539	Cumming syndrome	4180186
979545	epsilon-caprolactone	4180186
979545	epsilon-captolactamium hydrogen sulfate	4180186
979548	Cardiomyopathy, Dilated, With Woolly Hair And Keratoderma	4180186
979548	Carvajal syndrome	4180186
979548	DCWHK	4180186
979548	Epidermolytic palmoplantar keratoderma, woolly hair, and dilated cardiomyopathy	4180186
979548	Palmoplantar keratoderma with left ventricular cardiomyopathy and woolly hair	4180186
979549	3-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea	4180186
979549	cariprazine HCl	4180186
979549	cariprazine hydrochloride	4180186
979549	N'-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimethylurea monohydrochloride	4180186
979549	RGH-188	4180186
979549	trans-4-(2-(4-(2,3-dichlorophenyl)piperazine-1-yl)-ethyl)-N,N-dimethylcarbamoyl-cyclohexyl-amine hydrochloride	4180186
979549	Vraylar	4180186
979551	Gastric Leiomyosarcoma, Pulmonary Chondroma, and Extraadrenal Paraganglioma	4180186
979555	Cataract-Microcornea Syndrome	4180186
979555	Microcornea cataract syndrome	4180186
979555	Microcornea-Cataract Syndrome	4180186
979557	8-epicedrol	4180186
979562	ceric oxide (Ce2O3)	4180186
979562	ceric oxide (CeO)	4180186
979562	cerium dioxide	4180186
979562	cerium oxide	4180186
979562	cerium oxide (CeO2)	4180186
979562	nanoceria	4180186
979563	Ceroid Lipofuscinosis, Neuronal, Cathepsin D-Deficient	4180186
979563	Neuronal Ceroid Lipofuscinosis, Congenital	4180186
979563	Neuronal Ceroid Lipofuscinosis Due To Cathepsin D Deficiency	4180186
979570	Charcot-Marie-Tooth Disease, Autosomal Dominant, Type 2B	4180186
979570	Charcot-Marie-Tooth disease, axonal, Type 2B	4180186
979570	Charcot-Marie-Tooth disease, neuronal, Type 2B	4180186
979570	Charcot-Marie-Tooth Neuropathy, Type 2B	4180186
979570	CMT2B	4180186
979570	CMT 2B	4180186
979570	Hereditary motor and sensory neuropathy 2 B (HMSN 2 B)	4180186
979570	Hereditary Motor And Sensory Neuropathy IIB	4180186
979570	HMSN2B	4180186
979570	HMSN IIB	4180186
979570	Peripheral sensory neuropathy, autosomal dominant (PSN)	4180186
979572	ARCMT2B	4180186
979572	Charcot-Marie-Tooth disease, axonal, autosomal recessive, B2	4180186
979572	Charcot-Marie-Tooth Disease, Axonal, Autosomal Recessive, Type B2	4180186
979572	Charcot-Marie-Tooth disease, axonal, Type 2B2	4180186
979572	Charcot-Marie-Tooth disease, neuronal, Type 2B2	4180186
979572	Charcot-Marie-Tooth Neuropathy, Type 2B2	4180186
979572	CMT2B2	4180186
979572	CMT 2B2	4180186
979575	Charcot-Marie-Tooth disease, demyelinating, autosomal recessive	4180186
979575	Charcot-Marie-Tooth Neuropathy, Type 4a	4180186
979575	CMT4A	4180186
979576	Charcot-Marie-Tooth Disease, Autosomal Recessive, With Focally Folded Myelin Sheaths, Autosomal Recessive, Type 4b1	4180186
979576	Charcot-Marie-Tooth disease, Type 4B	4180186
979576	Charcot-Marie-Tooth Neuropathy, Type 4B1	4180186
979576	CMT4B	4180186
979576	CMT4B1	4180186
979583	Brain-Lung-Thyroid Syndrome	4180186
979583	Choreoathetosis And Congenital Hypothyroidism	4180186
979589	17q21.31 Deletion Syndrome	4180186
979589	17q21.31 Microdeletion Syndrome	4180186
979589	Chromosome 17q21.31 Microdeletion Syndrome	4180186
979589	Koolen-De Vries Syndrome	4180186
979589	Koolen Syndrome	4180186
979589	Microdeletion 17q21.31 Syndrome	4180186
979589	Monosomy 17q21.31	4180186
979590	Duplication 17p	4180186
979590	Trisomy 17p	4180186
979591	Deletion 2q24	4180186
979591	Monosomy 2q24	4180186
979592	Deletion 3q13	4180186
979592	Monosomy 3q13	4180186
979593	Microdeletion 3q29 Syndrome	4180186
979595	Deletion 5q35	4180186
979595	Monosomy 5q35	4180186
979598	Chromosome 9, tetrasomy 9p mosaicism	4180186
979598	Mosaic tetrasomy 9p	4180186
979598	Tetrasomy 9p	4180186
979598	Tetrasomy, short arm of chromosome 9	4180186
979600	CJC1295	4180186
979600	CJC-1295	4180186
979601	Capillary Malformation Of The Lower Lip, Lymphatic Malformation Of Face And Neck, Asymmetry Of Face And Limbs, And Partial-Generalized Overgrowth	4180186
979601	Clapo	4180186
979601	Lopez-Gutierrez Syndrome	4180186
979603	2-Pyridinecarboxylic acid, 3,6-dichloro-	4180186
979603	3,6-dichloropicolinic acid	4180186
979603	clopyralide	4180186
979603	Dowco 290	4180186
979603	Lontrel	4180186
979604	Cerebellar vermis hypo-aplasia, Oligophrenia, Ataxia congenital, Coloboma, and Hepatic fibrosis	4180186
979604	Cerebellar Vermis Hypo-Aplasia, Oligophrenia, Congenital Ataxia, Ocular Coloboma, And Hepatic Fibrosis	4180186
979606	coco-betaine	4180186
979606	cocobetaine, sodium salt	4180186
979606	coconut betaine	4180186
979608	Cerebral, ocular, dental, auricular, and skeletal syndrome	4180186
979608	Cerebral, Ocular, Dental, Auricular, Skeletal Anomalies Syndrome	4180186
979610	Coloboma Of Macula With Type B Brachydactyly	4180186
979610	Sorsby syndrome	4180186
979612	Carbohydrate-deficient glycoprotein syndrome, type 4	4180186
979612	CDG1D	4180186
979612	Congenital Disorder Of Glycosylation, Type ID	4180186
979616	Congenital Disorder of Glycosylation, Type IJ	4180186
979617	Congenital Disorder Of Glycosylation, Type IK	4180186
979621	CDG2E	4180186
979621	CDGIIE	4180186
979621	CDG IIE	4180186
979621	Congenital Disorder Of Glycosylation, Type IIE	4180186
979622	CDG2G	4180186
979622	CDGIIG	4180186
979622	CDG IIG	4180186
979622	Congenital Disorder Of Glycosylation, Type IIG	4180186
979623	CDG2B	4180186
979623	CDGIIB	4180186
979623	CDG IIB	4180186
979623	Glucosidase I Deficiency	4180186
979628	acid blue 90	4180186
979628	brilliant blue G	4180186
979628	C.I. 42655	4180186
979628	coomassie blue G	4180186
979628	Coomassie brilliant blue G250	4180186
979628	Coomassie brilliant blue G 250	4180186
979628	serva blue G	4180186
979628	supranol cyanine G	4180186
979628	xylene brilliant cyanine G	4180186
979629	9-cordyceposidoadenine	4180186
979629	3'-deoxyadenosine	4180186
979629	cordycepene	4180186
979629	cordycepine	4180186
979631	Corneal-Cerebellar Syndrome	4180186
979631	Corneal dystrophy with spinocerebellar degeneration	4180186
979631	Der kaloustian Jarudi Khoury syndrome	4180186
979631	Spinocerebellar degeneration and corneal dystrophy	4180186
979634	Band-Shaped And Whorled Microcystic Corneal Epithelial Dystrophy	4180186
979634	Lisch Epithelial Corneal Dystrophy	4180186
979637	Toriello-Carey Syndrome	4180186
979638	Congenital shortness of the costocoracoid ligament	4180186
979638	Costocoracoid Ligament, Congenitally Short	4180186
979645	CDAGS syndrome	4180186
979647	Craniosynostosis, Boston-Type	4180186
979647	Warman Mulliken Hayward syndrome	4180186
979648	Complex of anomalies involving the cranium and brain	4180186
979650	Cryptomicrotia-Brachydactyly Syndrome	4180186
979650	Cryptomicrotia brachydactyly syndrome excess fingertip arch	4180186
979650	Tonoki Ohura Niikawa syndrome	4180186
979651	1-hydroxycyclopentyl-alpha- phenylacetic acid beta-dimethylaminoethyl ester	4180186
979651	Cyclopent	4180186
979651	G.T. 92	4180186
979653	1,2,3,4,5,6-hexahydro-1,5-methano-8H- pyrido(1,2-a)(1,5)diazocin-8-one	4180186
979653	3-hydroxy-11-norcytisine	4180186
979653	citizine	4180186
979653	cystisin	4180186
979653	cytisine dihydrochloride, trihydrate	4180186
979653	cytisine hydrochloride	4180186
979653	cytisine hydrochloride, hydrate	4180186
979653	cytisine tetrahydrochloride, trihydrate	4180186
979653	cytiton	4180186
979653	Tabex	4180186
979653	Tsitizin	4180186
979654	Czech Dysplasia	4180186
979654	Progressive Pseudorheumatoid Dysplasia with Hypoplastic Toes	4180186
979654	Pseudorheumatoid dysplasia, progressive, with hypoplastic toes	4180186
979654	Spondyloarthropathy with Short Third and Fourth Toes	4180186
979658	Goiter, Multinodular, Cystic Renal Disease, and Digital Anomalies	4180186
979658	Multinodular goiter, cystic renal disease, and digital anomalies	4180186
979658	Multinodular Goiter-Cystic Renal Disease-Digital Anomalies	4180186
979659	Darzalex	4180186
979659	humax-CD38	4180186
979659	humax-CD 38	4180186
979664	Autosomal recessive sensorineural hearing impairment, dizziness, and hypodontia	4180186
979664	Congenital profound sensorineural deafness and oligodontia	4180186
979664	Deafness-Oligodontia Syndrome	4180186
979669	Dermatoosteolysis, Kirghizian Type	4180186
979669	Kirghizian Dermatoosteolysis	4180186
979677	Dicarboxylic aminoaciduria	4180186
979677	Dicarboxylic amino aciduria	4180186
979677	Dicarboxylicamino Aciduria	4180186
979677	Glutamate and aspartate transport defect	4180186
979677	Glutamate-Aspartate Transport Defect	4180186
979677	Inborn error of glutamic and aspartate transport	4180186
979683	dimethyl p-phthalate	4180186
979683	dimethylterephthalate	4180186
979683	dimethyl terephthalate	4180186
979685	1-octadecanaminium, N,N-dimethyl-N-octadecyl-	4180186
979685	DDBAS compound	4180186
979685	dimethyl-dioctadecyl-ammonium bromide	4180186
979685	dimethyldioctadecylammonium bromide	4180186
979685	dimethyldioctadecylammonium chloride	4180186
979685	dimethyldioctadecylammonium methyl sulfate	4180186
979685	dimethyldioctadecylammonium sulfate	4180186
979685	dimethyldistearylammonium	4180186
979685	dimethyldistearylammonium bisulfate	4180186
979685	dimethyldistearylammonium bromide	4180186
979685	dioctadecyldimethylammonium	4180186
979685	dioctadecyl dimethylammonium bromide	4180186
979685	dioctadecyldimethylammonium chloride	4180186
979685	dioctadecyldimethylammonium ion	4180186
979685	distearyldimethylammonium	4180186
979685	distearyl dimethyl ammonium bromide	4180186
979685	distearyldimethylammonium bromide	4180186
979685	distearyldimonium	4180186
979685	distearyldimonium chloride	4180186
979685	DODAB	4180186
979685	DSDAC cpd	4180186
979686	dimethyldisulfide	4180186
979686	methyl disulfide	4180186
979691	Chromosome 10, distal trisomy 10q	4180186
979691	Chromosome 10, Partial Trisomy 10q24-qter	4180186
979691	Chromosome 10, Trisomy 10q2	4180186
979691	Distal Duplication 10q	4180186
979692	1,2-divinylbenzene	4180186
979692	divinylbenzene	4180186
979693	Phocomelia, Thrombocytopenia, Encephalocele, Urogenital Malformations	4180186
979693	Von Voss-Cherstvoy Syndrome	4180186
979696	Mexoryl XL	4180186
979696	Silatrizole	4180186
979699	DYT16	4180186
979700	Paroxysmal Exercise-Induced Dystonia	4180186
979700	Paroxysmal Exertion-Induced Dyskinesia	4180186
979701	Dopa-Responsive Dystonia	4180186
979701	Dopa-responsive dystonia, autosomal dominant	4180186
979701	Dystonia 5	4180186
979701	Dystonia, Dopa-responsive, autosomal dominant	4180186
979701	Dystonia-Parkinsonism with diurnal fluctuation	4180186
979701	Dystonia, progressive, with diurnal variation	4180186
979701	Hereditary Progressive Dystonia with Marked Diurnal Fluctuation	4180186
979701	Segawa syndrome, autosomal dominant	4180186
979702	Parkinson Disease 14, Autosomal Recessive	4180186
979703	Ectodermal Dysplasia-Ectrodactyly-Macular Dystrophy	4180186
979703	EEM Syndrome	4180186
979704	Ectodermal dysplasia- skin fragility syndrome	4180186
979704	Mcgrath syndrome	4180186
979712	ACE910	4180186
979712	ACE-910	4180186
979712	emicizumab-kxwh	4180186
979712	Hemlibra	4180186
979714	Epidermolysis Bullosa Simplex and Limb-Girdle Muscular Dystrophy	4180186
979714	Epidermolysis Bullosa Simplex with Muscular Dystrophy	4180186
979716	Ebs-Pa	4180186
979716	Ebs With Pyloric Atresia	4180186
979719	Ataxia, Periodic Vestibulocerebellar	4180186
979719	Periodic Vestibulocerebellar Ataxia	4180186
979723	Corneal Erosions, Recurring Hereditary	4180186
979724	Erythrokeratodermia Variabilis, Kamouraska Type	4180186
979725	Erythrokeratodermia ataxia	4180186
979725	Giroux Barbeau Syndrome	4180186
979732	Eastman Bixler syndrome	4180186
979733	Bindewald Ulmer Muller syndrome	4180186
979734	Familial cavernous hemangioma	4180186
979734	Familial cerebral cavernous angioma	4180186
979735	Factor V And Factor VIII, Combined Deficiency Of	4180186
979735	Factor V And Factor VIII, Combined Deficiency Of, With Normal Protein C And Protein C Inhibitor	4180186
979735	Multiple Coagulation Factor Deficiency I	4180186
979735	Combined Deficiency of Factor V and Factor VIII	4180186
979735	F5F8D	4180186
979735	MCFD1	4180186
979735	FMFD1	4180186
979735	FMFD I	4180186
979736	Osteochondritis Dissecans, Short Stature, and Early-Onset Osteoarthritis	4180186
979739	Femur, Unilateral Bifid, With Monodactylous Ectrodactyly	4180186
979739	Gollop-Wolfgang complex	4180186
979740	Bay 68138	4180186
979740	ethyl 4-(methylthio)m-tolyl isopropylphosphoroamidate	4180186
979740	Nemacur	4180186
979740	phenamiphos	4180186
979750	Anterior Opercular Syndrome	4180186
979750	Bilateral Anterior Opercular Syndrome	4180186
979750	Congenital Foix-Chavany-Marie syndrome	4180186
979750	Facio-Labio-Pharyngo-Glosso-Laryngo-Brachial Paralysis	4180186
979750	Facio-Pharyngo-Glossal Diplegia with Automatic-Voluntary Movement Dissociation	4180186
979750	Opercular Syndrome, Anterior	4180186
979750	Pseudobulbar Paralysis, Cortical Type	4180186
979752	Congenital heart disease, deafness, and skeletal malformations	4180186
979752	Mitral Regurgitation, Conductive Deafness, and Fusion of Cervical Vertebrae and of Carpal and Tarsal Bones	4180186
979753	Emend for injection	4180186
979753	fosaprepitant dimeglumine	4180186
979753	L 785,298	4180186
979753	L-785,298	4180186
979753	L785,298	4180186
979754	Mental retardation-deafnes, skeletal abnormalities, coarse face with full lips	4180186
979754	Mental Retardation, Sensorineural Deafness, Skeletal Abnormalities, And Coarse Face With Full Lips	4180186
979756	Macrocephaly with Spastic Paraplegia and Distinctive Craniofacial Appearance	4180186
979758	fumidil B	4180186
979766	2,6-Octadien-1-ol, 3,7-dimethyl-, acetate, (2E)-	4180186
979766	geraniol acetate	4180186
979766	geraniol acetate, (E)-isomer	4180186
979766	geraniol acetate, (Z)-isomer	4180186
979766	nerol acetate	4180186
979766	neryl acetate	4180186
979767	EGb761	4180186
979767	EGb 761	4180186
979767	EGb-761	4180186
979767	GBE 761	4180186
979767	GBE-761	4180186
979767	GBE 761 ONC	4180186
979767	Ginkgo biloba extract 761	4180186
979767	Ginkgo leaf extract	4180186
979767	Rokan	4180186
979767	Tanakan	4180186
979767	Tebofortran	4180186
979767	Tebokan	4180186
979767	Tebonin	4180186
979770	1,2,3,4,6-penta-O-acetyl-alpha-D-glucopyranoside	4180186
979770	beta-D-glucose pentaacetate	4180186
979770	glucose pentaacetate, (alpha-D)-isomer	4180186
979770	glucose pentaacetate, (beta-(D))-isomer	4180186
979770	glucose pentaacetate, (D)-isomer	4180186
979770	penta-O-acetyl-alpha-D-glucopyranose	4180186
979770	penta-O-acetylglucopyranose	4180186
979771	2,3-epoxypropyl methacrylate	4180186
979771	monomethacrylate propylene oxide	4180186
979771	Sta-Lock	4180186
979772	gE protein, VZV	4180186
979772	glycoprotein E, human herpesvirus 3	4180186
979772	glycoprotein E, VZV	4180186
979772	glycoprotein gE, VZV	4180186
979772	glycoprotein gp1, varicella-zoster virus	4180186
979772	glycoprotein I VZV	4180186
979772	gp1 VZV	4180186
979772	ORF68 protein, VZV	4180186
979772	varicella zoster virus glycoprotein E	4180186
979772	varicella-zoster virus glycoprotein gp1	4180186
979772	VZV gE	4180186
979772	VZV gp1	4180186
979775	Goldberg-Shprintzen syndrome	4180186
979779	Habrodysplasia	4180186
979779	Osteocraniosplenic syndrome	4180186
979779	Osteocraniostenosis	4180186
979779	Skeletal dysplasia, lethal, with gracile bones	4180186
979781	1-(2-(4-(2-ethyl-4,6-dimethylimidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-3-(4-methylphenyl)sulfonylurea	4180186
979783	Hoepffner dreyer reimers syndrome	4180186
979783	Insulin, Insulin-Like Growth Factor I, and Epidermal Growth Factor Deficiency	4180186
979783	Peptide growth factors deficiency	4180186
979783	Peptidic growth factors deficiency	4180186
979783	Werner-Like Syndrome due to Combined Growth Factor Deficiency	4180186
979786	CNTO 1959	4180186
979786	CNTO-1959	4180186
979786	Tremfya	4180186
979789	Hidrotic ectodermal dysplasia Halal type	4180186
979790	Microcephaly cleft palate autosomal dominant	4180186
979791	Cholestasis-pigmentary retinopathy-cleft palate syndrome	4180186
979792	Craniofacial digital genital anomalies	4180186
979792	Harrod syndrome	4180186
979794	Cardioskeletal syndrome, Kuwaiti type	4180186
979794	Congenital heart disease and skeletal malformations	4180186
979796	Brachydactyly and intraventricular conduction defect	4180186
979796	Upper limb malformations and congenital cardiac anomalies	4180186
979798	Hemochromatosis due to defect in transferrin receptor 2	4180186
979799	Hemochromatosis, autosomal dominant	4180186
979799	Hemochromatosis due to defect in ferroportin	4180186
979800	Coloboma of macula	4180186
979800	Agenesis of macula	4180186
979800	Macular coloboma	4180186
979803	ammonium hexafluorosilicate	4180186
979803	cesium hexafluosilicate	4180186
979803	hexafluorosilicate (2-)	4180186
979803	hexafluorosilicate, ammonium salt	4180186
979803	hexafluorosilicate, barium salt	4180186
979803	hexafluorosilicate, calcium salt	4180186
979803	hexafluorosilicate, magnesium salt	4180186
979803	hexafluorosilicate, magnesium salt, hydrate	4180186
979803	hexafluorosilicate, potassium salt	4180186
979803	hexafluorosilicate, sodium salt	4180186
979803	magnesium fluorosilicate	4180186
979803	magnesium hexafluorosilicate	4180186
979803	Na(2)SiF(6)	4180186
979803	sodium fluorosilicate	4180186
979803	sodium fluosilicate	4180186
979803	sodium hexafluorosilicate	4180186
979807	Astragali radix (Astragalus membranaceus)	4180186
979807	Astragalus membranaceus root	4180186
979807	Astragalus membranaceus root extract	4180186
979807	Astragalus membranaceus root powder	4180186
979807	Astragalus propinquus root	4180186
979807	Astragalus root (Astragalus propinquus)	4180186
979807	Huang Qi (Astragalus mongholicus Bunge)	4180186
979807	Huang Qi (Astragalus propinquus)	4180186
979807	membranous milkvetch root	4180186
979807	Mo Jia Huang Qi	4180186
979807	Phaca membranacea root	4180186
979807	Radix Astragali	4180186
979807	Radix Astragali seu Hedysari	4180186
979807	RAH extract	4180186
979810	Communicating hydrocephalus, endocardial fibroelastosis (EFE) and congenital cataracts	4180186
979815	Hyperinsulinism-hyperammonemia syndrome	4180186
979816	Deficiency of Methionine Adenosyltransferase	4180186
979816	Glycine N-Methyltransferase Deficiency	4180186
979816	GNMT Deficiency	4180186
979816	Hepatic Methionine Adenosyltransferase Deficiency	4180186
979816	Hypermethioninemia, Isolated Persistent	4180186
979816	Hypermethioninemia with Deficiency of S-Adenosylhomocysteine Hydrolase	4180186
979816	Methionine Adenosyltransferase Deficiency	4180186
979816	Methioninemia	4180186
979816	S-Adenosylhomocysteine Hydrolase Deficiency	4180186
979822	Hypomagnesemia, Familial, with Hypercalciuria, Nephrocalcinosis, and Severe Ocular Involvement	4180186
979822	Hypomagnesemia, Renal, with Ocular Involvement	4180186
979822	Macular Coloboma, Bilateral, with Hypercalciuria	4180186
979827	Hereditary hypotrichosis simplex	4180186
979829	3-((6-deoxymannopyranosyl)oxy)-7-(glucopyranosyloxy)-5-hydroxy-2-(4-methoxyphenyl)-8-(3-methyl-2-butenyl)-4H-1-benzopyran-4-one	4180186
979831	Epidermolytic Ichthyosis, Annular	4180186
979840	IGF-I Resistance	4180186
979840	Somatomedin C, Resistance To	4180186
979840	Somatomedin, End-Organ Insensitivity To	4180186
979842	125I radioisotope	4180186
979842	I-125 radioisotope	4180186
979845	Coxopodopatellar Syndrome	4180186
979845	Scott-Taor syndrome	4180186
979845	Small patella syndrome	4180186
979847	Duplication-Inversion 15q11	4180186
979847	Idic(15)	4180186
979847	Inv Dup(15)	4180186
979847	Inverted Duplication 15	4180186
979847	Isodicentric Chromosome 15	4180186
979847	Non-Distal Tetrasomy 15q	4180186
979855	Fibromatosis gingival progressive deafness	4180186
979855	Fibromatosis, Gingival, With Progressive Deafness	4180186
979855	Gingival fibromatosis with progressive deafness	4180186
979855	Gingival fibromatosis with sensorineural hearing loss	4180186
979856	Cleft Lip-Palate With Abnormal Thumbs And Microcephaly	4180186
979856	Juberg-Hayward Syndrome	4180186
979856	OFDS VIII	4180186
979856	Oral-Facial-Digital Syndrome, Type VIII	4180186
979856	Oral-Facial-Digital Syndrome with Hypoplastic Epiglottis	4180186
979856	Orocraniodigital syndrome	4180186
979857	Osteopenia and sparse hair	4180186
979857	Osteopenia mental retardation sparse hair	4180186
979860	Cleft lip palate, facial, eye, heart and intestinal anomalies	4180186
979860	Long columella with cleft lip-palate and eye, heart, and intestinal anomalies	4180186
979861	Cataract mental retardation anal atresia urinary defects	4180186
979861	Congenital cataract with multiple congenital anomalies in a sibship	4180186
979864	Epithelioma, self-healing squamous, 1	4180186
979864	Ferguson-Smith Type epithelioma	4180186
979864	Multiple self-healing squamous epithelioma	4180186
979866	Cochin Jewish disorder	4180186
979866	Haim-Munk syndrome	4180186
979867	Pulmonic stenosis, brachytelephalangism, and calcification of cartilages	4180186
979871	Telecanthus, hypertelorism, strabismus, and pes cavus syndrome	4180186
979872	KRPPD Kufor Rakeb pallidopyramidal degeneration with supranuclear upgaze paresis and dementia	4180186
979872	Pallidopyramidal Degeneration with Supranuclear Upgaze Paresis and Dementia	4180186
979872	Parkinson disease 9	4180186
979878	Retinal Degeneration, Late-Onset, Autosomal Dominant	4180186
979879	3-beta-hydroxysteroid-delta(5)-desaturase deficiency	4180186
979879	Deficiency of 3-beta-hydroxysteroid-delta(5)-desaturase	4180186
979879	Sterol C5-Desaturase Deficiency	4180186
979881	Cox deficiency, French Canadian type	4180186
979881	Cox Deficiency, French-Canadian Type	4180186
979881	Cox deficiency, Saguenay Lac saint Jean type	4180186
979881	Cox Deficiency, Saguenay-Lac Saint-Jean Type	4180186
979881	Cytochrome c oxidase deficiency, French Canadian type	4180186
979881	Cytochrome C Oxidase Deficiency, French-Canadian Type	4180186
979881	Leigh Syndrome, French-Canadian Type	4180186
979881	Leigh syndrome, Saguenay Lac saint Jean type	4180186
979881	Leigh Syndrome, Saguenay-Lac Saint-Jean Type	4180186
979882	Ectodermal Dysplasia, Hypohidrotic, with Acanthosis Nigricans	4180186
979886	Lethal autosomal recessive syndrome of multiple congenital contractures	4180186
979886	Multiple contracture syndrome, Finnish type	4180186
979887	Erythroderma lethal congenital	4180186
979887	Erythroderma, Lethal Congenital	4180186
979888	Dentoleukoencephalopathy	4180186
979889	Leukodystrophy, Hypomyelinating, With Atrophy Of The Basal Ganglia And Cerebellum	4180186
979896	Mammary hypoplasia, ectrodactyly, and other hand-foot anomalies	4180186
979901	Short tarsus absence of lower eyelashes	4180186
979901	Short Tarsus with Absence of Lower Eyelashes	4180186
979902	Lowry-Maclean Syndrome	4180186
979902	Mental retardation, cleft palate, eventration of diaphragm, congenital heart defect, glaucoma, craniosynostosis, and growth failure	4180186
979903	Epiphyseal dysplasia, microcephaly and nystagmus	4180186
979903	Epiphyseal Dysplasia, Microcephaly, And Nystagmus	4180186
979903	Lowry-Wood Syndrome	4180186
979905	Cataracts and testicular failure	4180186
979905	Hypogonadism-Cataract Syndrome	4180186
979908	Steroid dehydrogenase deficiency dental anomalies	4180186
979910	MacDermot-Winter syndrome	4180186
979910	Prominent glabella microcephaly hypogenitalism	4180186
979912	AEZS-130	4180186
979912	Aib-DTrp-DgTrp-CHO	4180186
979912	Aib-Trp-gTrp-CHO	4180186
979912	aminoisobutyryl-tryptophyl-tryptophanamine-formyl	4180186
979912	ARD-07	4180186
979912	EP1572	4180186
979912	EP 1572	4180186
979912	EP-1572	4180186
979912	JMV1843	4180186
979912	JMV 1843	4180186
979912	JMV-1843	4180186
979912	macimorelin acetate	4180186
979912	Macrilen	4180186
979914	MACS Syndrome	4180186
979918	hausmannite	4180186
979918	manganese monoxide	4180186
979918	manganese oxide, hydrate	4180186
979918	manganomanganic oxide	4180186
979918	manganous-manganic oxide	4180186
979918	Mn3O4	4180186
979920	Blepharophimosis, arachnodactyly, and congenital contractures	4180186
979920	Marden Walker like syndrome without psychomotor retardation	4180186
979920	Marden-Walker-Like Syndrome Without Psychomotor Retardation	4180186
979920	Van den Ende Gupta syndrome	4180186
979920	Van Den Ende-Gupta Syndrome	4180186
979920	VDEGS	4180186
979921	heptadecanoic acid	4180186
979921	margaric acid, 1-(11)C-labeled	4180186
979921	margaric acid, nickel (2+) salt	4180186
979921	margaric acid, potassium salt	4180186
979921	margaric acid, sodium salt	4180186
979921	omega I-123 heptadecanoic acid	4180186
979923	Adducted thumb with mental retardation	4180186
979923	Clasped thumb and mental retardation	4180186
979923	Crash syndrome	4180186
979923	Gareis-Mason syndrome	4180186
979923	Genetic Diseases, X-Linkeds	4180186
979923	L1 Syndrome	4180186
979923	Masa Syndrome	4180186
979923	Mental Retardation, Aphasia, Shuffling Gait, Adducted Thumbs (MASA)	4180186
979923	Mental Retardation, Aphasia, Shuffling Gait, And Adducted Thumbs	4180186
979923	Spastic paraplegia, type 1	4180186
979923	Spg1	4180186
979923	Thumb, congenital clasped, with mental retardation	4180186
979923	X-Linked Complicated Hereditary Spastic Paraplegia Type 1	4180186
979923	X-Linked Corpus Callosum Agenesis	4180186
979923	X-Linked Hydrocephalus with Stenosis of the Aqueduct of Sylvius (Hsas)	4180186
979924	Leigh disease, maternally inherited	4180186
979924	Subacute necrotizing encephalomyelopathy maternally inherited	4180186
979926	Mental retardation, peculiar facies, kyphoscoliosis, diastasis recti, cryptorchidism, and congenital heart defect	4180186
979929	Cleft, median, of upper lip with polyps of facial skin and nasal mucosa	4180186
979929	Pai Levkoff syndrome	4180186
979929	Pai syndrome	4180186
979932	Cutaneous malignant melanoma and cerebral astrocytoma	4180186
979932	Melanoma and neural system tumor syndrome	4180186
979932	Melanoma-Astrocytoma Syndrome	4180186
979936	Carpenter-Waziri syndrome	4180186
979936	Chudley Lowry Hoar syndrome	4180186
979936	Chudley-Lowry Syndrome	4180186
979936	Chudley mental retardation syndrome	4180186
979936	Chudley syndrome 1	4180186
979936	Holmes-Gang syndrome	4180186
979936	Juberg-Marsidi Mental Retardation Syndrome	4180186
979936	Juberg Marsidi syndrome	4180186
979936	Juberg-Marsidi syndrome	4180186
979936	Mental retardation, x-linked, with growth retardation, deafness, and microgenitalism	4180186
979936	Mental Retradation, X-linked with Growth Delay, Deafness, Microgenitalism	4180186
979936	MRXHF1	4180186
979936	Smith-fineman-myers syndrome 1	4180186
979936	X-linked hypogonadism gynecomastia mental retardation	4180186
979936	X-Linked Mental Retardation-Hypotonic Facies Syndrome	4180186
979941	17beta-Hydroxysteroid Dehydrogenase Type 10 Deficiency	4180186
979941	17-Beta-Hydroxysteroid Dehydrogenase X Deficiency	4180186
979941	2-Methyl-3-Hydroxybutyric Aciduria	4180186
979941	2-Methyl-3-Hydroxybutyryl-CoA Dehydrogenase Deficiency	4180186
979941	3-Hydroxy-2-Methylbutyryl-CoA Dehydrogenase Deficiency	4180186
979941	3-Hydroxyacyl-CoA Dehydrogenase II Deficiency	4180186
979941	3-Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency	4180186
979941	Chorioathetosis With Mental Retardation And Abnormal Behavior	4180186
979941	HSD17B10 Deficiency	4180186
979941	Hydroxyacyl-CoA Dehydrogenase II Deficiency	4180186
979941	Hydroxyacyl-CoA Dehydrogenase, Type 2, Deficiency	4180186
979941	Mental Retardation With Chorioathetosis And Abnormal Behavior	4180186
979941	MRXS10	4180186
979942	Dandy-Walker malformation with mental retardation, basal ganglia disease, and seizures	4180186
979942	Mental retardation, X-linked, with Dandy-Walker malformation, basal ganglia disease, and seizures	4180186
979942	Pettigrew syndrome	4180186
979943	Cabezas Syndrome	4180186
979943	Cabezas X-Linked Mental Retardation Syndrome	4180186
979943	Mental Retardation, X-Linked, Syndromic 15	4180186
979943	Mental Retardation, X-Linked, With Short Stature, Small Testes, Muscle Wasting, And Tremor	4180186
979943	MRXS15	4180186
979944	Bosatria	4180186
979944	Nucala	4180186
979944	SB240563	4180186
979944	SB-240563	4180186
979945	Mesomelia synostoses	4180186
979945	Verloes-David syndrome	4180186
979953	9-octadecenoic acid, methyl ester, (9E)-	4180186
979953	9-octadecenoic acid (Z)-, methyl ester	4180186
979953	methyl elaidate	4180186
979953	methyl oleate, (E)-isomer	4180186
979953	oleic acid methyl ester	4180186
979954	dimethyl 4-nitrophenyl phosphate	4180186
979954	dimethyl p-nitrophenyl phosphate	4180186
979954	MEE 600	4180186
979954	methyl paraoxon	4180186
979955	Microcephalic primordial dwarfism and cataracts	4180186
979955	Microcephalic Primordial Dwarfism, Toriello Type	4180186
979956	Albinism-Microcephaly digital anomalies syndrome	4180186
979956	Albinism-Microcephaly-Digital Anomalies Syndrome	4180186
979956	Microcephaly-Albinism-Digital Anomalies Syndrome	4180186
979957	Microcephaly, mild mental retardation, short stature, and skeletal anomalies	4180186
979957	Microcephaly with Cervical Spine Fusion Anomalies	4180186
979961	benzamide, N-(2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-1-oxo-8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-10-yl)-N-methyl-, (8alpha,9beta,10beta,12alpha)-	4180186
979961	4'-N-benzoylstaurosporine	4180186
979961	4'-N-benzoyl staurosporine	4180186
979961	benzoylstaurosporine	4180186
979961	CGP 41251	4180186
979961	CGP 41 251	4180186
979961	CGP-41251	4180186
979961	N-((9S,10R,11R,13R)-10-methoxy-9-methyl-1-oxo-2,3,10,11,12,13-hexahydro-9,13-epoxy-1H,9H-diindolo(1,2,3-GH:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-n-methylbenzamide	4180186
979961	PKC412	4180186
979961	PKC 412	4180186
979961	PKC-412	4180186
979961	Rydapt	4180186
979965	99Mo radioisotope	4180186
979965	Mo-99 radioisotope	4180186
979966	1-amino-2-propanol	4180186
979966	isopropanolamine	4180186
979969	Hydronephrosis Due To Pujo	4180186
979969	Pelvi-ureteric junction obstruction	4180186
979969	Pelviureteric Junction Obstruction	4180186
979972	2,4,6-trinitro-1,3-dimethyl-5-tert-butylbenzene	4180186
979972	2,4,6-trinitro-3,5-dimethyl-tert-butylbenzene	4180186
979972	5-tert-butyl-2,4,6-trinitroxylene	4180186
979972	musk xylol	4180186
979978	CL 1700	4180186
979978	N-acetylcarnosine, (DL)-isomer	4180186
979978	N-acetyl-L-carnosine aluminum	4180186
979981	Spastic paraplegia, mental retardation and thin corpus callosum	4180186
979983	2-(2'-hydroxyoctadecanoylamino)-1,3,4-octadecanetriol	4180186
979983	ceramide 6	4180186
979983	ceramide AP	4180186
979983	DL-CER6	4180186
979984	benzin	4180186
979984	benzine	4180186
979984	petroleum ether	4180186
979986	Nasopalpebral Lipoma-Coloboma Syndrome	4180186
979986	Palpebral coloboma lipoma Syndrome	4180186
979986	Palpebral Coloboma-Lipoma Syndrome	4180186
979988	Congenital myopathy cleft palate and malignant hyperthermia	4180186
979988	Myopathy, Congenital, With Cleft Palate And Malignant Hyperthermia	4180186
979989	Keratosis palmoplantaris with arrhythmogenic cardiomyopathy	4180186
979989	Mal de Naxos	4180186
979989	Palmoplantar keratoderma with arrhythmogenic right ventricular cardiomyopathy and woolly hair	4180186
979989	Woolly hair, palmoplantar keratoderma, and cardiac abnormalities	4180186
979990	N-cyclohexyl-N'-phenylparaphenylenediamine	4180186
979991	11F8	4180186
979991	IMC-11F8	4180186
979991	IMC-11F8 monoclonal antibody	4180186
979991	Portrazza	4180186
979995	Freire-Maia Pinheiro Opitz syndrome	4180186
980004	n-hexane, 1-(13)C-labeled cpd	4180186
980004	n-hexane, 2-(13)C-labeled cpd	4180186
980004	n-hexane, 3-(13)C-labeled cpd	4180186
980005	nicotinuric acid, monosodium salt	4180186
980007	Chondrodysplasia pseudohermaphrodism syndrome	4180186
980007	Chondrodysplasia-pseudohermaphroditism syndrome	4180186
980007	Pseudohermaphrodism and chondrodysplasia	4180186
980008	lauroyl proline	4180186
980009	1-methyl-2-pyrrolidinone	4180186
980009	1-methyl-2-pyrrolidinone, 1-methyl-(14)C-labeled	4180186
980009	1-methyl-2-pyrrolidinone, 2,3,4,5-(14)C-labeled	4180186
980009	methyl pyrrolidone	4180186
980009	N-methyl-2-pyrrolidinone	4180186
980009	N-methyl-2-pyrrolidone	4180186
980009	N-methylpyrrolidinone	4180186
980009	pharmasolve	4180186
980012	Lissencephaly 2	4180186
980012	Lissencephaly syndrome, Norman-Roberts type	4180186
980017	Anthim	4180186
980017	ETI-204	4180186
980019	octadecane, 1-(14)C-labeled cpd	4180186
980019	octadecane, 14C-labeled cpd	4180186
980025	Boder syndrome	4180186
980025	Odontoma-Dysphagia Syndrome	4180186
980025	Odontomatosis (multiple odontomas) with dysphagia	4180186
980028	Congenital trichomegaly, pigmentary retinal degeneration, and short stature	4180186
980028	Eyelashes long mental retardation	4180186
980028	Oliver McFarlane syndrome	4180186
980028	Trichomegaly retina pigmentary degeneration dwarfism	4180186
980031	OMOD2	4180186
980031	Omodysplasia, Autosomal Dominant	4180186
980036	Opa3, Autosomal Dominant	4180186
980036	Optic Atrophy 3, Autosomal Dominant	4180186
980036	Optic atrophy, cataract, and neurologic disorder	4180186
980037	Optic atrophy 2	4180186
980037	Optic atrophy, non-Leber type, with early onset	4180186
980040	OFD9	4180186
980040	OFDS IX	4180186
980040	Oral-facial-digital syndrome 9	4180186
980040	Oral Facial Digital Syndrome, Type IX	4180186
980040	Oral-facial-digital syndrome with retinal abnormalities	4180186
980040	Orofaciodigital syndrome IX	4180186
980040	Orofaciodigital Syndrome, Type 9	4180186
980040	Orofaciodigital syndrome with retinal abnormalities	4180186
980041	Oral-Facial-Digital Syndrome, Type X	4180186
980041	Oral-Facial-Digital Syndrome with Fibular Aplasia	4180186
980041	Orofaciodigital Syndrome with Fibular Aplasia	4180186
980045	Dacryocystitis osteopoikilosis	4180186
980045	Gunal Seber Basaran syndrome	4180186
980047	1-cyclopropyl-8-methyl-7-(5-methyl-6-(methylamino)-3-pyridinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid	4180186
980047	xepi	4180186
980047	ozanex	4180186
980049	Median cleft upper lip, mental retardation and pugilistic facies	4180186
980049	W syndrome	4180186
980051	Diffuse palmoplantar keratoderma with deafness	4180186
980051	Focal palmoplantar keratoderma with sensorineural deafness	4180186
980051	Hereditary palmoplantar keratoderma with deafness	4180186
980051	Keratoderma palmoplantar deafness	4180186
980051	Keratoderma palmoplantar, with deafness	4180186
980051	Keratoderma, Palmoplantar, With Deafness	4180186
980051	Palmoplantar Hyperkeratosis-Deafness Syndrome	4180186
980051	Palmoplantar Hyperkeratosis-Hearing Loss Syndrome	4180186
980051	Palmoplantar keratoderma and sensorineural deafness	4180186
980051	Palmoplantar Keratoderma-Deafness Syndrome	4180186
980051	Palmoplantar Keratoderma-Hearing Loss Syndrome	4180186
980051	Ppk-Deafness Syndrome	4180186
980051	Ppk with Deafness	4180186
980056	Blepharonasofacial malformation syndrome	4180186
980057	RLY5016	4180186
980057	RLY 5016	4180186
980057	RLY-5016	4180186
980057	Veltassa	4180186
980059	3beta, 20-dihydroxy-5alpha-cevan-6-one	4180186
980059	fritillarine	4180186
980059	imperialine	4180186
980059	peiminine, (3beta,5alpha,17beta)-isomer	4180186
980059	peiminine, (3beta,5alpha,25alpha)-isomer	4180186
980059	peiminine hydrochloride, (3beta,5alpha,17beta)-isomer	4180186
980059	peiminine nitrate salt, (3beta,5alpha,17beta)-isomer	4180186
980059	sipeimine	4180186
980059	zhebeinone	4180186
980060	Cousin Syndrome	4180186
980060	Craniofacial Dysmorphism, Hypoplasia of Scapula and Pelvis, and Short Stature	4180186
980060	Pelvic shoulder dysplasia	4180186
980063	COVERNOX	4180186
980069	Short stature, mental retardation and multiple dysmorphisms	4180186
980071	Pfeiffer-Palm-Teller Syndrome	4180186
980073	1-phenyl-3-methyl-5-pyrazolone	4180186
980073	3H-pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-	4180186
980073	3-methyl-1-phenyl-2-pyrazolin-5-one	4180186
980073	edarabone	4180186
980073	edaravone	4180186
980073	MCI 186	4180186
980073	MCI-186	4180186
980073	norantipyrine	4180186
980073	norphenazone	4180186
980073	Radicava	4180186
980074	FVAPFP	4180186
980074	hexapeptide-11	4180186
980077	PSAT Deficiency	4180186
980078	dimethyl N,N'-(((2R,5R)-1-(3,5-difluoro-4-(4-(4-fluorophenyl)piperidin-1-yl)phenyl)pyrrolidine-2,5-diyl)bis((6-fluoro-1h-benzimidazole-5,2-diyl)((2S)-pyrrolidine-2,1-diyl)((2S,3R)-3-methoxy-1-oxobutane-1,2-diyl)))biscarbamate	4180186
980078	ABT-530	4180186
980078	A-1325912.0	4180186
980080	Chitayat Meunier Hodgkinson syndrome	4180186
980080	Robin sequence with facial and digital anomalies	4180186
980081	Microcoria and congenital nephrotic syndrome	4180186
980081	Microcoria-Congenital Nephrotic Syndrome	4180186
980081	Nephrotic Syndrome, Congenital, With Ocular Abnormalities And Congenital Myasthenic Syndrome	4180186
980083	ACP103	4180186
980083	ACP 103	4180186
980083	ACP-103	4180186
980083	bis(1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate	4180186
980083	N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide	4180186
980083	Nuplazid	4180186
980083	pimavanserin tartrate	4180186
980083	urea, n-((4-fluorophenyl)methyl)-n-(1-methyl-4-piperidinyl)-n'-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)	4180186
980087	L-leucine, L-asparaginyl-L-alpha-aspartyl-L-alpha-glutamyl-L-cysteinyl-L-alpha-glutamyl-L-leucyl-L-cysteinyl-L-valyl-L-asparaginyl-L-valyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (4-12),(7-15)-bis(disulfide)	4180186
980087	SP-304	4180186
980087	Trulance	4180186
980088	PSP	4180186
980090	Czeizel Brooser syndrome	4180186
980090	Polydactyly-Myopia Syndrome	4180186
980090	Polydactyly, Postaxial, With Progressive Myopia	4180186
980090	Postaxial polydactyly-progressive myopia syndrome	4180186
980090	Postaxial Polydactyly with progressive myopia	4180186
980095	Pontocerebellar Hypoplasia, Type 1a	4180186
980095	Pontocerebellar Hypoplasia With Anterior Horn Cell Disease	4180186
980095	Pontocerebellar Hypoplasia With Infantile Spinal Muscular Atrophy	4180186
980101	potassium tellurite	4180186
980102	Chromosome 17p11.2 Duplication Syndrome	4180186
980102	Chromosome 17, trisomy 17p11 2	4180186
980102	Duplication 17p11 2	4180186
980102	Duplication 17p11.2 syndrome	4180186
980102	Potocki-Lupski syndrome (dup(17)(p11.2p11.2))	4180186
980102	Trisomy 17p11 2	4180186
980104	Urban Rogers Meyer syndrome	4180186
980104	Urban-Rogers-Meyer Syndrome	4180186
980106	Juvenile Primary Lateral Sclerosis	4180186
980106	Primary Lateral Sclerosis, Juvenile	4180186
980107	Orthostatic tremor, primary	4180186
980107	Shaky leg syndrome	4180186
980111	Aminopterin syndrome sine aminopterin	4180186
980113	Holoprosencephaly polydactyly syndrome	4180186
980113	Holoprosencephaly-Polydactyly Syndrome	4180186
980113	Pseudo trisomy 13 syndrome	4180186
980114	Khalifa Graham syndrome	4180186
980114	Pterygium colli and mental retardation with facial and digital anomalies	4180186
980117	Familial recurrent arthritis	4180186
980117	PAPA syndrome	4180186
980117	Pyogenic arthritis, pyoderma gangrenosum, and severe cystic acne	4180186
980117	Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne	4180186
980118	1-hydroxypyrene-3,6,8-trisulfonic acid	4180186
980118	8-hydroxy-1,3,6-pyrenetrisulfonic acid trisodium salt	4180186
980118	8-hydroxypyrene-1,3,6-trisulfonate	4180186
980118	8-hydroxypyrene-1,3,6-trisulfonic acid	4180186
980118	C.I. 59040	4180186
980118	CI 59040	4180186
980118	D.C. Green No. 8	4180186
980118	D&C Green No. 8	4180186
980118	D&C Green No. 8 free acid	4180186
980118	Green 8	4180186
980118	pyranine free acid	4180186
980119	1-phenyl-4-amino-5-chloropyridazin-6-one	4180186
980119	chlordiazon	4180186
980119	chloridazon	4180186
980119	PAC herbicide	4180186
980119	phenazon	4180186
980119	Pyramin	4180186
980120	Epileptic Encephalopathy, Neonatal, PNPO-Related	4180186
980120	PNPO Deficiency	4180186
980120	PNPO-Related Neonatal Epileptic Encephalopathy	4180186
980120	Pyridoxal 5'-Phosphate-Dependent Epilepsy	4180186
980120	Pyridoxine-5'-Phosphate Oxidase Deficiency	4180186
980120	Seizures, Pyridoxine-Resistant, PLP-Sensitive	4180186
980125	Ramos Arroyo Syndrome	4180186
980126	4-(4-hydroxyphenyl)butan-2-one	4180186
980126	4-hydroxybenzylacetone	4180186
980126	4-(p-hydroxyphenyl)-2-butanone	4180186
980126	betuligenol	4180186
980126	oxyphenalon	4180186
980126	p-hydroxybenzylacetone	4180186
980128	Rec(8) Syndrome	4180186
980128	Recombinant 8 Syndrome	4180186
980128	San Luis Valley recombinant chromosome 8 syndrome	4180186
980128	San Luis Valley syndrome	4180186
980134	Giant pelvic retroperitoneal liposarcoma	4180186
980134	Pelvic retroperitoneal liposarcoma	4180186
980136	Exudative retinopathy with bone marrow failure	4180186
980136	Revesz Syndrome	4180186
980137	Patterson-Lowry rhizomelic dysplasia	4180186
980137	Patterson Lowry syndrome	4180186
980137	Rhizomelic Dysplasia, Patterson-Lowry Type	4180186
980141	Richieri-Costa and Pereira form of acrofacial dysostosis	4180186
980141	Richieri-Costa-Pereira Syndrome	4180186
980141	Robin sequence with cleft mandible and limb anomalies	4180186
980145	Camptodactyly, joint contractures, facial skeletal defects	4180186
980145	Camptodactyly, myopia, and fibrosis of the medial rectus muscle of eye	4180186
980146	AG014699	4180186
980146	AG 014699	4180186
980146	AG-014699	4180186
980146	PF-01367338	4180186
980146	Rubraca	4180186
980147	Caudal dysgenesis familial type	4180186
980147	Familial caudal dysgenesis	4180186
980150	Fibuloulnar aplasia or hypoplasia with renal abnormalities	4180186
980150	Fibulo ulnar hypoplasia renal anomalies	4180186
980152	Hirschsprung disease, deafness and polydactyly	4180186
980154	Simparica	4180186
980155	bis-acetatoamminedichlorocyclohexylamine platinum(IV)	4180186
980155	JM216	4180186
980155	JM 216	4180186
980155	JM-216	4180186
980155	Platinum, bis(acetato-O)amminedichloro(cyclohexanamine)-, (OC-6-43)-	4180186
980155	trans,cis,cis-bis(acetato)amminecyclohexylaminedichloroplatinum(IV)	4180186
980156	Microcephaly hypogammaglobulinemia abnormal immunity	4180186
980159	Finlay-Marks Syndrome	4180186
980159	Hereditary syndrome of lumpy scalp, odd ears and rudimentary nipples	4180186
980159	Scalp-Ear-Nipple Syndrome	4180186
980160	Skeletal Abnormalities, Cutis Laxa, Craniostenosis, Ambiguous Genitalia, Retardation, And Facial Abnormalities	4180186
980162	Blepharofacioskeletal Syndrome	4180186
980162	Cleft Palate, Hypotelorism, and Hypospadias	4180186
980162	Ocular Hypotelorism, Submucosal Cleft Palate, and Hypospadias	4180186
980164	Midline development field defects	4180186
980170	Microcephaly microcornea syndrome Seemanova type	4180186
980174	rybelsus	4180186
980174	Ozempic	4180186
980175	EAST syndrome	4180186
980175	Epilepsy, ataxia, sensorineural deafness and tubulopathy	4180186
980175	Epilepsy, Ataxia, Sensorineural Deafness, And Tubulopathy	4180186
980175	Seizures, sensorineural deafness, ataxia, mental retardation and electrolyte imbalance	4180186
980175	Seizures, Sensorineural Deafness, Ataxia, Mental Retardation, And Electrolyte Imbalance	4180186
980176	SERKAL	4180186
980176	SERKAL Syndrome	4180186
980177	Mievis Verellen-Dumoulin syndrome	4180186
980178	Laryngeal and pharyngeal hypoplasia with omphalocele	4180186
980178	Pharynx and larynx hypoplasia with omphalocele	4180186
980178	Shprintzen-Goldberg omphalocele syndrome	4180186
980185	Congenital testicular deficiency	4180186
980188	Hereditary Spastic Paraplegia, Paraplegin Type	4180186
980188	Spastic Paraplegia 7	4180186
980190	SCA20 Spinocerebellar ataxia 20	4180186
980190	Spinocerebellar ataxia type 20	4180186
980190	Spinocerebellar Ataxia With Dysphonia	4180186
980190	Spinocerebellar Ataxia With Spasmodic Cough	4180186
980191	SCA25 Spinocerebellar ataxia 25	4180186
980191	Spinocerebellar ataxia type 25	4180186
980192	SCA26 Spinocerebellar ataxia 26	4180186
980192	Spinocerebellar ataxia type 26	4180186
980193	Ataxia-ocular apraxia 2	4180186
980193	Ataxia-oculomotor apraxia 2	4180186
980193	Ataxia with Oculomotor Apraxia	4180186
980193	SCAN2	4180186
980193	SCAR1	4180186
980193	Spinocerebellar Ataxia, Recessive, Non-Friedreich Type 1	4180186
980193	Spinocerebellar Ataxia with Axonal Neuropathy Type 2	4180186
980194	Cerebellar Granular Cell Hypoplasia and Mental Retardation, Congenital	4180186
980194	Cerebellar Hypoplasia, Nonprogressive Norman Type	4180186
980194	Cerebelloparenchymal Disorder III	4180186
980194	CPD3	4180186
980194	CPD III	4180186
980194	SCAR2	4180186
980194	Spinocerebellar Ataxia Autosomal Recessive 2	4180186
980195	Ataxia-deafness syndrome X-linked	4180186
980195	Ataxia-deafness syndrome, X-linked	4180186
980195	Schmidley syndrome	4180186
980195	Spinocerebellar Ataxia, X-Linked 3	4180186
980198	Aplasia of tibia with ectrodactyly	4180186
980198	Cleft hand absent tibia	4180186
980198	Cleft Hand And Absent Tibia	4180186
980198	Ectrodactyly with aplasia of long bones	4180186
980198	Split-Hand-Foot Malformation With Long Bone Deficiency 1	4180186
980198	Tibial aplasia with split-hand-split-foot deformity	4180186
980199	Deafness, Congenital, And Split Hands And Feet	4180186
980199	SHFM1D	4180186
980202	SEMD, Aggrecan Type	4180186
980205	SEMD, Shohat Type	4180186
980210	Odontochondrodysplasia	4180186
980214	Multiple non-erupting teeth, maxillo-zygomatical hypoplasia and other congenital defects	4180186
980214	Non erupted teeth with maxillary hypoplasia and genu valgum	4180186
980215	Facioauriculoradial dysplasia	4180186
980215	Phocomelia-ectrodactyly, ear malformation, deafness, and sinus arrhythmia	4180186
980216	Overhydrated Hereditary Stomatocytosis	4180186
980216	Potassium-Sodium Disorder Of Erythrocyte	4180186
980217	Bilateral Striatal Necrosis, Infantile	4180186
980217	Infantile bilateral striatal necrosis	4180186
980217	Striatal degeneration familial	4180186
980217	Striatal Degeneration, Familial	4180186
980217	Striatonigral Degeneration, Infantile	4180186
980218	82Sr radioisotope	4180186
980218	Sr-82 radioisotope	4180186
980219	85Sr radioisotope	4180186
980219	Sr-85 radioisotope	4180186
980221	sucrose palmitate	4180186
980222	6-perdeoxy-6-per(2-carboxyethyl)thio-gamma-cyclodextrin sodium salt	4180186
980222	Bridion	4180186
980222	Org 25969	4180186
980222	Sugammadex sodium	4180186
980223	Atrophia Areata	4180186
980223	Helicoidal Peripapillary Chorioretinal Degeneration	4180186
980223	Peripapillary Chorioretinal Degeneration, Icelandic Type	4180186
980225	Cenani-Lenz Syndactyly	4180186
980225	Cenani-Lenz type syndactyly	4180186
980225	Cenani syndactylism	4180186
980225	Syndactyly type 7	4180186
980225	Syndactyly, Type VII	4180186
980226	Syndactyly, Malik-Percin Type	4180186
980226	Syndactyly, Type IX	4180186
980230	Syndactyly type 5	4180186
980230	Syndactyly with metacarpal and metatarsal fusion	4180186
980231	Heart-hand syndrome 2	4180186
980237	Brachycephalofrontonasal dysplasia	4180186
980237	Hypertelorism, Teebi type	4180186
980237	Teebi hypertelorism syndrome	4180186
980239	22q13.3 Deletion Syndrome	4180186
980239	22q13 Deletion Syndrome	4180186
980239	Chromosome 22q13.3 Deletion Syndrome	4180186
980239	Deletion 22q13.3 Syndrome	4180186
980239	Deletion 22q13 Syndrome	4180186
980239	Monosomy 22q13	4180186
980239	Phelan-McDermid Syndrome	4180186
980242	Mental Retardation, Severe, And Absent Nails Of Hallux And Pollex	4180186
980243	Craniofacial dysmorphism with ocular coloboma absent corpus callosum and aortic dilatation	4180186
980243	Craniofacial Dysmorphism With Ocular Coloboma, Absent Corpus Callosum, And Aortic Dilatation	4180186
980243	Dysmorphism, corpus callosum agenesis and colobomas	4180186
980245	Zimmer phocomelia	4180186
980245	Zimmer Taub Sova syndrome	4180186
980246	1,7-bis(4-hydroxy-3-methoxyphenyl)-3,5-heptanedione	4180186
980247	VX-661	4180186
980249	Autosomal dominant thoracolaryngopelvic dysplasia	4180186
980249	Barnes syndrome	4180186
980253	5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione	4180186
980254	STAR Syndrome	4180186
980254	Syndactyly with Renal and Anogenital Malformations	4180186
980257	Mental retardation X-linked, Tranebjaerg type seizures and psoriasis	4180186
980257	X-linked mental retardation associated with psoriasis	4180186
980258	Dystrophic Epidermolysis Bullosa, Dominant Neonatal	4180186
980258	Epidermolysis bullosa dystrophica, dominant neonatal form	4180186
980259	Hostaphat KW 340N	4180186
980260	4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-	4180186
980260	5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one	4180186
980261	n-tridecane	4180186
980266	Hereditary bone dysplasia with characteristic bowing and thickening of the distal ulna	4180186
980266	Metaphyseal Chondrodysplasia, Rosenberg Type	4180186
980266	Metaphyseal chondroplasia Rosenberg type	4180186
980266	Rosenberg Lohr syndrome	4180186
980267	40-O-(2-ethoxyethyl)rapamycin	4180186
980267	42-O-(2-ethoxyethyl) rapamycin	4180186
980267	Biolimus A9	4180186
980267	rapamycin, 42-O-(2-ethoxyethyl)-	4180186
980267	TRM-986	4180186
980270	2',3',5'-tri-O-acetyluridine	4180186
980270	PN401	4180186
980270	PN 401	4180186
980270	PN-401	4180186
980270	RG2133	4180186
980270	RG-2133	4180186
980270	triacetyluridine	4180186
980270	Xuriden	4180186
980271	(2R,3R,11BR)-9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H- benzo(a)quinolizin-2-yl l-valinate	4180186
980271	Ingrezza	4180186
980271	NBI-98854	4180186
980271	valine 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo(a)quinolizin-2-yl ester	4180186
980274	RG-7601	4180186
980274	4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide	4180186
980274	ABT-199	4180186
980274	benzamide, 4-(4-((2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-n-((3-nitro-4-(((tetrahydro-2h-pyran-4-yl)methyl)amino)phenyl)sulfonyl)-2-(1h-pyrrolo(2,3-b)pyridin-5-yloxy)-	4180186
980274	GDC-0199	4180186
980274	RG7601	4180186
980274	Venclexta	4180186
980275	Platyspondyly with amelogenesis imperfecta	4180186
980275	Skeletal dysplasia with amelogenesis imperfecta and platyspondyly	4180186
980276	Cerebro-Acro-Visceral Early lethality multiplex syndrome	4180186
980280	GS-9857	4180186
980282	Hirschsprung disease with pigmentary anomaly	4180186
980282	Shah-Waardenburg syndrome	4180186
980282	Waardenburg-Hirschsprung disease	4180186
980282	Waardenburg-Shah syndrome	4180186
980282	Waardenburg Syndrome, Type 4a	4180186
980282	Waardenburg Syndrome, Type Iva	4180186
980282	Waardenburg Syndrome With Hirschsprung Disease, Type 4a	4180186
980284	Anterior bowing of legs with dwarfism	4180186
980284	Bowing of legs, anterior, with dwarfism	4180186
980284	Toxopachyosteose diaphysaire tibio-peroniere	4180186
980284	Toxopachyosteosis	4180186
980284	Toxopachyoteose diaphysaire tibio peroniere	4180186
980284	Weismann Netter Stuhl syndrome	4180186
980284	Weismann-Netter Syndrome	4180186
980291	Craniofacial malformations, asymmetric, with polysyndactyly and abnormal skin and gut development	4180186
980291	Curry Jones syndrome	4180186
980291	Curry-Jones Syndrome	4180186
980292	Immunoneurologic Disorder, X-Linked	4180186
980292	Neonatal death immune deficiency	4180186
980292	Woods-Black-Norbury Syndrome	4180186
980292	X-linked immunoneurological disorder	4180186
980294	Radial-ulnar hypoplasia with bone marrow failure and-or leukemia	4180186
980294	WT Limb-Blood Syndrome	4180186
980295	133Xe radioisotope	4180186
980295	Xe-133 radioisotope	4180186
980296	1-((2-methylphenyl)azo)-2-naphthylamine	4180186
980298	Pancreatic hypoplasia diabetes heart disease	4180186
980299	Encephalopathy, fatal infantile, with olivopontocerebellar hypoplasia	4180186
980299	Olivopontocerebellar hypoplasia lethal type	4180186
980299	Pontocerebellar Hypoplasia Type 4	4180186
980300	169Yb radioisotope	4180186
980300	Yb-169 radioisotope	4180186
980301	Selective T-Cell Defect	4180186
980301	Zap70-Related Scid	4180186
980301	Zap70-Related Severe Combined Immunodeficiency	4180186
980301	Zeta-associated-protein 70 deficiency	4180186
980301	Zeta-Associated Protein 70 Deficiency	4180186
980304	sphalerite	4180186
980305	CLPED1	4180186
980305	Autosomal recessive ectodermal dysplasia	4180186
980305	Bustos Simosa Pinto Cisternas syndrome	4180186
980305	Cleft lip-palate-ectodermal dysplasia syndrome	4180186
980305	Ectodermal dysplasia, cleft lip and palate, mental retardation, and syndactyly	4180186
980305	Ectodermal dysplasia Margarita island type	4180186
980305	Ectodermal Dysplasia, Margarita Island Type	4180186
980305	Ectodermal dysplasia type 4	4180186
980305	Ectodermal Dysplasia, Type 4	4180186
980306	CHIME syndrome	4180186
1001444	Carolina Breast Cancer Study	4180186
1001449	Perceived Stress Scale-10	4180186
1001475	Ear.external	4180186
1001484	1-beta-D-galactosphingosine; Chemistry; Erythrocytes; Galactosylsphingosine; Globoid Cell Leukodystrophies; Globoid Cell Leukodystrophy; Krabbe disease; Leukodystrophy, Krabbe; Point in time; PSY; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; Sphingosine galactoside; Substance content	4180186
1001484	Psychosine RBC-sCnt	4180186
1001484	神经鞘氨醇半乳糖苷:物质的量含量:时间点:红细胞:定量型	4182948
1001485	MR T+L-Spine WO+W contr	4180186
1001485	多层^不采用 & 采用对比剂:发现:时间点:胸部>脊椎.胸段 & 腹部>脊椎.腰段:文档型:MR	4182948
1001485	Abd; Abdo; Abdomen+; Abdominal; c; Contr; Contra; Contrst; Document; Dorsal spine; Finding; Findings; Imaging; L/sp; L-spine; Lumbar; Lumbo; Mitral regurgitation maximum velocity; MRI; Point in time; Radiology; Random; Spinal; Spinal Cord; T Spine+Ab; T+L-Spine; Th/sp; Thorax; T-spine; WC; WO & WC; WO+W contr; WWO	4180186
1001488	Variant unknown sig Bld/T	4180186
1001488	Blood; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; Variant unknown sig; WB; Whole blood; Whole blood or Tissue	4180186
1001488	意义未知的变异:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001489	Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; MEDS; Narrative; Point in time; Random; Report	4180186
1001489	药物建议:印象:时间点:^患者:叙述型	4182948
1001491	Bld flow; Bld flow vel; Bld flow.velocity; Blood flow vel.S1 wave; CARD.US; Cardiology; DOP; DOP.PW; DUPLEX; Dynamic; Echography; Point in time; Pulm v; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity; Ven; Venous	4180186
1001491	Pulm v Blood flow vel.S1 wave DOP.PW	4180186
1001491	血流速度.S1 波:速度:时间点:肺静脉:定量型:超声.多普勒.PW	4182948
1001495	4OHGlu/Creat Ur-sRto	4180186
1001495	4OHGlu; Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001495	4-羟基谷氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001498	little cE Ag RBC Ql	4180186
1001498	Antigen; Antigens; BLOOD BANK; c; Erythrocytes; little cE; little cE Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Rh27; Screen	4180186
1001498	cE 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001508	Finding; Findings; Gestation; Gestations; Gravida; Nominal; Point in time; Pregnancies; Random; Survey; SURVEY.MTLHLTH; Sx	4180186
1001509	Gas + CO + Electrolytes Pnl BldA	4180186
1001509	ABG; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Elect; Electr; Electrolyte; Gas + CO + electrolytes Pnl; Gases; Lytes; Lytes Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001509	气体与一氧化碳与电解质组套:-:时间点:动脉全血:定量型	4182948
1001510	Busulfan AUC Pnl Plas	4180186
1001510	Busulfan AUC Pnl; DRUG/TOXICOLOGY; Drugs; Myleran; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies	4180186
1001510	白消安曲线下面积组套:-:检查过程持续时间:血浆:定量型	4182948
1001511	Avail tx for variant but not dx; Blood; Dx; Genetics; Genomic; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; Tx; Unrelated therapy; WB; Whole blood; Whole blood or Tissue	4180186
1001511	Avail tx for variant but not dx Bld/T	4180186
1001511	与遗传变异相关但与患者诊断并不相关的可用治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001512	Clobazam metabolite; Desmeth; Desmethylclobazam; DRUG/TOXICOLOGY; Drugs; N-desmethylclobazam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001512	Norclobazam Ur Ql Scn	4180186
1001512	去甲基氯巴詹:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001513	R eye Dark rod adaptation tm	4180186
1001513	Dark rod adaptation tm; EYE.PX; Eyeball; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; R; R eye; Random; Rod intercept (TM); RT; Vision; Visual	4180186
1001513	黑暗介导的视杆细胞适应时间:时间:时间点:眼睛.右侧:定量型	4182948
1001515	LV ES vol A2C SP A-L	4180186
1001515	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001515	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1001517	1 month; 1 month (30 days); 30 days; Durat; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001518	Pulm valve Regurg vel.early dia DOP.PW	4180186
1001518	Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; Cardiology; Dias; Diast; Diastoli; DOP; DOP.PW; DUPLEX; Dynamic; Echography; Point in time; Pulm valve; Pulmonic valvular; QNT; Quan; Quant; Quantitative; Random; Regurg bld flow vel; Regurg vel.early dia; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity	4180186
1001518	反流血流速度.舒张早期:速度:时间点:肺动脉瓣:定量型:超声.多普勒.PW	4182948
1001519	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001523	Cnt; Count; No; Num; Number; Past; QNT; Quan; Quant; Quantitative; Survey	4180186
1001524	K Ag RBCCo Ql	4180186
1001524	Antigen; Antigens; BLOOD BANK; KEL1; Kell Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Screen	4180186
1001524	K 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1001529	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001530	Chemistry; Inflammatory Bowel Disease; Joint aspirate; Joint fld; Joint flu; Joint fluid; Level; Mass concentration; MRP8/14; Point in time; QNT; Quan; Quant; Quantitative; Random; Rheumatoid arthritis; S100A8/A9; SF; SNV; Syn; Syn fl; Synov; Synovial fluid	4180186
1001530	Calprotectin Snv-mCnc	4180186
1001530	钙卫蛋白:质量浓度:时间点:滑液:定量型	4182948
1001533	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001534	ABO Group infant Bld	4180186
1001534	ABO Gp^infant; Blood; BLOOD BANK; infant; Nominal; Point in time; Random; Typ; WB; Whole blood	4180186
1001534	ABO 血型^婴儿期期间:类型:时间点:全血:名义型	4182948
1001537	A baumannii DNA Bld Pos Ql NAA+probe	4180186
1001537	3 Self-Sustaining Sequence Replication; 3SR SR; A baumannii; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001537	鲍曼不动杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001538	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001543	CLIN; CLIN.VET; Gases; O2; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Totl; Vet cage; Volfr; Volume fraction	4180186
1001543	O2/Gas.total VFr Vet cage	4180186
1001543	氧/气体.总计:体积分数:时间点:兽医用病畜隔离笼:定量型	4182948
1001544	17-Hydroxycorticosterone; 2M p 1 ug/kg CRH IV; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001544	Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc	4180186
1001544	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后2分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001545	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1001546	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Psychiatric; Random; Study report; Visit note	4180186
1001546	Psychiatric Diag study note	4180186
1001546	诊断性检查记录:发现:时间点:{环境}:文档型:精神病学	4182948
1001548	GCA SerPl-sCnc	4180186
1001548	Chemistry; GCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001548	甘氨胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001549	H seoul IgM SerPl Ql Line blot	4180186
1001549	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR	4180186
1001549	汉坦病毒 汉城型 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:线点印迹法	4182948
1001551	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1001552	DRUG/TOXICOLOGY; Drugs; Niravam; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn; Xanax	4180186
1001552	Alpraz Ur Ql Scn	4180186
1001552	阿普唑仑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001553	Clot; Clottable; COAGULATION; Coagulation assay; Pan; PANEL.COAGULATION; Panl; Plas; Platelet poor plasma; Pnl; Point in time; PT mix Pnl; QNT; Quan; Quant; Quantitative; Random; Study report; Tilt tube	4180186
1001553	PT mix Pnl PPP	4180186
1001553	凝血酶原时间混合检查组套:-:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001556	Arm; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; Tot; Total maturity score; Totl; UE; Up; Upper extremity; Upper extremity joint; Xray; X-ray	4180186
1001556	XR Wrist+Hand Total maturity score	4180186
1001556	骨骼成熟度总评分:评分:时间点:上肢>腕部+手部:定量型:X射线摄影术	4182948
1001557	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Opioids Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; Synth Opioids; Synthetic opioid; Synthetic opioids pnl; UA; UR; Urn	4180186
1001557	Synthetic opioids pnl Ur Cfm	4180186
1001557	合成阿片类药物组套:-:时间点:尿液:-:毒理学确认试验	4182948
1001558	Preferred lang + interp need	4180186
1001558	ADMIN; Pan; Panel; PANEL.ADMIN; Panl; Pnl; Point in time; Preferred lang + interp need; Random; Translator	4180186
1001558	首选语言和口译员需求:-:时间点:^患者:-	4182948
1001559	Activities of Daily Living; Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1001560	tr-Cinnamoylgly/Creat Ur-sRto	4180186
1001560	Chemistry; CR; Crea; Creat; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; tr-Cinnamoylgly; UA; UCr; UR; Urn	4180186
1001560	反-肉桂酰甘氨酸/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001562	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; Creat Pnl; Pan; PANEL.CHEMISTRY; Panl; Pnl; UA; UCr; UR; Urn	4180186
1001562	Creat Pnl Ur	4180186
1001562	肌酐组套:-:5小时:尿液:-	4182948
1001564	ICS IgG Ser Ql IF	4180186
1001564	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cell surface; FA; Fluorescent antibody; Fluoresent; ICS; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Intercellular structure; Ordinal; Paraneoplastic pemphigus; Pemphigus; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR; Subs; Time Resolved Fluorescence; TRF	4180186
1001564	细胞间质 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫荧光法	4182948
1001565	NOP56 GGCCTG Rpt Bld/T Ql	4180186
1001565	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.NUCREPEAT; NOP56 GGCCTG Rpt; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Repeat; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001565	NOP56 基因.GGCCTG 重复序列:存在情况或阈值:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001566	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001572	2-Octenoate/Creat Ur-sRto	4180186
1001572	2-Octenoic acid; Chemistry; CR; Crea; Creat; II; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001572	2-辛烯酸酯/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001575	Calc; Calculation; Chemistry; HUM; Humulin; IH7; Ins Sens Index; Insul; Lente; NPH; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Ultralente	4180186
1001575	Ins Sens Index SerPl Calc-Rto	4180186
1001575	胰岛素敏感性指数:比率:时间点:血清/血浆:定量型:计算法	4182948
1001578	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP	4180186
1001578	Osmolality 2h p Vaso Ur	4180186
1001578	渗透压^在给予剂量后叶加压素之后2小时:渗透压:时间点:尿液:定量型	4182948
1001579	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TDCA	4180186
1001579	TDCA SerPl-sCnc	4180186
1001579	牛磺去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001581	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1001581	XR Trapezoid Bone dev stage	4180186
1001581	骨骼发育阶段:评分:时间点:上肢>腕部.小多角骨:定量型:X射线摄影术	4182948
1001583	HEDIS 2020 Urine Prot Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; PR; Prot; Random	4180186
1001583	HEDIS 2020 Urine Prot Tests	4180186
1001583	HEDIS 2020 取值集合 - 尿液蛋白检验项目:-:时间点:^患者:-	4182948
1001585	Centers for Medicare and Medicaid Assessment; Form version; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001586	Calc; Calculation; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale	4180186
1001586	Ceramide risk score Plas Calc	4180186
1001586	神经酰胺风险评分:评分:时间点:血浆:定量型:计算法	4182948
1001587	Activ; Actvty; Blood; Drug metabolism; Gene prod met act imp; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; NUDT15 gene prod met act imp; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001587	NUDT15 gene prod met act imp Bld/T-Imp	4180186
1001587	NUDT15 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001589	Blood; Gene studied w no variant found; Identity or presence; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001589	Gene studied w no variant found Bld/T	4180186
1001589	经检查但未发现变异的基因:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1001594	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; EBV; Epstn; HHV-4; human herpesvirus 4; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Log ACNC; Log IU; Microbiology; Mono; Mononucleosis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Viral load; WB; Whole blood	4180186
1001594	EBV DNA Bld NAA+probe-Log IU	4180186
1001594	Epstein Barr 病毒 DNA:对数型任意浓度:时间点:全血:定量型:探针法.基因扩增.靶向	4182948
1001596	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Sal; Salmonel; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001596	Salmonella DNA Bld Pos Ql NAA+probe	4180186
1001596	沙门菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001599	Contraindicated vaccine	4180186
1001599	Ident; Identifier; Nominal; Point in time; Random	4180186
1001599	禁忌疫苗类型:标识符:时间点:^患者:名义型	4182948
1001600	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1001600	Coccidioides IgG SerPl IA-aCnc	4180186
1001600	球孢子菌属单个未知种 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001602	Ortho surg Team Conf eval note	4180186
1001602	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Ortho surg Team; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Visit note	4180186
1001602	会议记录:发现:时间点:{环境}:文档型:矫形外科学.团队	4182948
1001603	Prim Med Lg B-cell lymph Tiss	4180186
1001603	原发性纵隔大B细胞淋巴瘤:似然性:时间点:组织与涂片:定量型	4182948
1001603	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; PATHOLOGY; PMBCL; Point in time; Prim Med Lg B-cell lymph; QNT; Quan; Quant; Quantitative; Random; Risk; Tissue; Tissue, unspecified	4180186
1001605	Bacterial rpoB drug res mut Islt/Spm	4180186
1001605	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial rpoB drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001605	细菌 rpoB 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001606	ABO + Rh; ABO + Rh Pnl p transf rx; ABO group and Rh type; ABO+Rh Gp; After; Blood; BLOOD BANK; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; React; Rh phenotyping; Rh typing; Rxn; Transf React; Transf React Pnl; Tx; WB; Whole blood	4180186
1001606	ABO + Rh Pnl p transf rx Bld	4180186
1001606	输血反应后ABO与Rh血型组套:-:时间点:全血:-	4182948
1001607	Finding; Findings; Ordinal; Othr; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1001608	Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Mec; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tramal; Ultram	4180186
1001608	traMADol Mec Ql Scn	4180186
1001608	曲马多:存在情况或阈值:时间点:胎便:序数型:毒理学筛查试验	4182948
1001610	Centers for Medicare and Medicaid Assessment; Drugs; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1001613	GFAP alpha IgG Titr CSF IF	4180186
1001613	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1001613	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr	4180186
1001614	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fentanyl metabolite; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001614	Acetyl norfentanyl Ur Cfm-mCnc	4180186
1001614	乙酰基去甲基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001615	Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1001615	Observation Imp	4180186
1001615	观察结果解释:印象:时间点:XXX:名义型	4182948
1001616	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Level; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; VP	4180186
1001616	Creat 2h p Vaso SerPl-mCnc	4180186
1001616	肌酐^在给予剂量后叶加压素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1001617	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001618	Blastomyces Ag Ur IA-mCnc	4180186
1001618	Antigen; Antigens; Blasto; Blastomycosis; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS; UA; UR; Urn	4180186
1001618	芽生菌属单个未知种 抗原:质量浓度:时间点:尿液:定量型:免疫测定法	4182948
1001619	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1001619	Validation error details Doc	4180186
1001619	验证错误详情:发现:时间点:文档:文档型	4182948
1001620	Blood; HEMATOLOGY/CELL COUNTS; LM; Lymp; Lymph; Lymph Villous; Lympho; Lymphocyte; Lymphs; Lymphs%; Micro; Micros; Microscopic; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1001620	Lymph Villous Bld Ql Smear	4180186
1001620	淋巴细胞.绒毛:存在情况或阈值:时间点:全血:序数型:显微镜检查.光学	4182948
1001621	Validation error summary Doc	4180186
1001621	ADMIN; DOC.ADMIN; Document; Finding; Findings; Point in time; Random	4180186
1001621	验证错误摘要:发现:时间点:文档:文档型	4182948
1001622	Antigen; Antigens; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1001622	Coccidioides Ag SerPl IA-mCnc	4180186
1001622	球孢子菌属单个未知种 抗原:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1001624	Platelet GP disorder Bld FC-Imp	4180186
1001624	Blood; CELL MARKERS; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; Pl; Plat Gp; Platelet GP disorder; Platelets; Platelt; Plt; Point in time; Random; Report; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001624	血小板糖蛋白疾病:印象:时间点:全血:叙述型:流式细胞测量术	4182948
1001627	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001628	EWSR1 gene Rear Tiss FISH	4180186
1001628	22q12 rearrangement; Document; Ewing Sarcoma; Ewing sarcoma breakpoint region 1; EWS; EWSCR; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; Point in time; Primitive Neuroectodermal Tumor; Primitive Neuroectodermal Tumors; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified	4180186
1001628	EWSR1 基因重排:发现:时间点:组织与涂片:文档型:FISH	4182948
1001629	D Ag infant RBC Ql	4180186
1001629	Antigen; Antigens; BLOOD BANK; D Ag^infant; Dextro; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rhesus; Screen	4180186
1001629	D 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001630	Consult note; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note; WOC	4180186
1001630	WOC Consult note	4180186
1001630	会诊记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
1001632	Document; DOP; DUPLEX; Echography; Finding; Findings; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; Sonogram; Sonograph; Sonography; Spec; To be specified in another part of the message; ULS; Ultrasound; Unspecified	4180186
1001632	DOP Unsp region	4180186
1001632	多层:发现:时间点:XXX:文档型:超声.多普勒	4182948
1001633	After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001633	Breath methane p carb	4180186
1001633	甲烷/已呼出的气体^在给予剂量碳水化合物之后:体积分数:时间点:呼出的气体:定量型	4182948
1001634	4-MetPhenEthAcetFentanyl; Acetylfentanyl-4-methylphenethyl; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001634	4-MetPhenEthAcetFentanyl Ur Cfm-mCnc	4180186
1001634	4-甲基苯乙基乙酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001639	After; DRUG/TOXICOLOGY; Drugs; immed p busulfan; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1001639	Busulfan immed p busulfan Plas-mCnc	4180186
1001639	白消安^紧接着在完成白消安输注之后:质量浓度:时间点:血浆:定量型	4182948
1001642	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001647	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001648	Addiction; C16H22N2O3; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; methyl 4-(N-propanoylanilino)piperidine-4-carboxylate; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001648	Norcarfentanil Ur Cfm-mCnc	4180186
1001648	4-(苯基丙酰氨基)哌啶-4-羧酸甲酯:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001650	SSD screen report	4180186
1001650	Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; SSD screen report; Sx	4180186
1001650	躯体症状障碍筛查报告:发现:时间点:^患者:文档型	4182948
1001651	Rh Ags+K Ag Pnl Bld	4180186
1001651	Blood; BLOOD BANK; D phenotyping; D typing; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1001651	Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1001654	Code Purple Recording Sheet; DOC.ONT; Document; Emerg procedure note; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OB; Obstetric; Obstetrical emergency recording from; Point in time; Prenatal; Random; Visit note	4180186
1001654	OB Emerg procedure note	4180186
1001654	急诊操作记录:发现:时间点:{环境}:文档型:产科学	4182948
1001660	Centers for Medicare and Medicaid Assessment; Deglutition; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
1001661	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Othr; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001664	Pan; Panel; Panl; Pnl; Point in time; Random; Survey	4180186
1001666	Adrenalin; Adrenaline; Adreneline; Agg; Aggr; COAGULATION; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Left; Levo; PA; PA Epineph; Pl; Platelet rich plasma; Platelets; Platelt; Plt; Point in time; QNT; Quan; Quant; Quantitative; Random; RlACnc; Thrombocyte; Thrombocytes	4180186
1001666	PA Epineph 5 umol/L PRP	4180186
1001666	血小板聚集.肾上腺素诱导型^5 微摩尔/升:相对任意型浓度:时间点:富血小板血浆:定量型	4182948
1001671	Bipolar type	4180186
1001671	Bipolar type; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1001671	双相障碍类型:类型:时间点:^患者:名义型	4182948
1001674	3 months; Cnt; Count; Number; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001675	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001676	CARD.US; Cardiac; Cardiology; DOP; DUPLEX; Echography; Hrt; Hrt ventr; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; Sys time; ULS; Ultrasound; Ventricular	4180186
1001676	RV Sys time DOP	4180186
1001676	心脏收缩时间:时间:时间点:心脏.心室.右侧:定量型:超声.多普勒	4182948
1001678	F tular; F tularensis; F. tularensis IgG + IgM; F. tularensis IgG+ IgM Pnl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; Tularemia	4180186
1001678	F. tularensis IgG+ IgM Pnl Ser	4180186
1001678	土拉弗朗西斯菌抗体.IgG 与 IgM 组套:-:时间点:血清:-	4182948
1001679	4-Fluorofentanyl; Addiction; C22H27FN2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(4-fluorophenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide; parafluorofentanyl; p-Fluorofentanyl; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001679	4-Fluorofentanyl Ur Cfm-mCnc	4180186
1001679	4-氟芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001680	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001681	Blood; Document; Finding; Findings; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001681	PROC Full Mut Anl Bld/T Seq	4180186
1001681	PROC 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1001682	(8;8)(HEY1,NCOA2); DNA; gene fusion; gene translocation; Molecular genetics; Molecular pathology; MOLPATH; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; RNA; Screen; Tissue; Tissue, unspecified; translocation	4180186
1001682	(8;8)(HEY1,NCOA2) Tiss Ql	4180186
1001682	(8;8)(q13;q21)(HEY1,NCOA2) 融合转录物:存在情况或阈值:时间点:组织与涂片:序数型:分子遗传学类实验室方法	4182948
1001683	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001683	自杀意图:发现:时间点:^患者:序数型	4182948
1001684	LV Max circ strain rate sys 3D US	4180186
1001684	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max circ strain rate sys; Max strain rate sys; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; ULS; Ultrasound; Ventricular	4180186
1001684	环向应变速率.收缩期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1001685	Chr 2 copy num; Chromosom; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; II; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001685	Chr 2 copy num/nucleus EntNum Tiss FISH	4180186
1001685	染色体 2 拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1001688	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001691	Aryl sulfatase B; Arylsulfatase B; Catalytic Concentration Ratio; Catalytic Ratio; CCrto; Chemistry; Chondroitin sulfatase; Chondroitinase; Enzymatic activity ratio; Galactose-6-sulfate sulfatase; GalN6S; GalNAc6S sulfatase; GALNS; Maroteaux-Lamy disease; Morquio disease, type A; MPS VI; MPS VI A; Point in time; QNT; Quan; Quant; Quantitative; Random; rh4S; rhASB; UA; UR; Urn	4180186
1001691	Arylsulfatase B/GALNS Ur-cRto	4180186
1001691	N-乙酰半乳糖胺-4-硫酸酯酶/N-乙酰基半乳糖胺-6-硫酸酯酶:催化比率:时间点:尿液:定量型	4182948
1001692	Med records p auth denial	4180186
1001692	ADMIN; DOC.ADMIN; Document; Finding; Findings; Med records p auth denial; Point in time; Random	4180186
1001692	针对拒绝授权的医疗记录:发现:时间点:^患者:文档型	4182948
1001700	Antigen; Antigens; Blasto; Blastomycosis; Bronchial alveolar lavage; Bronchoalveolar lavage; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; spp; SUDS	4180186
1001700	Blastomyces Ag BAL IA-mCnc	4180186
1001700	芽生菌属单个未知种 抗原:质量浓度:时间点:支气管肺泡灌洗液:定量型:免疫测定法	4182948
1001701	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001702	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K oxytoca; K oxytoca DNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001702	K oxytoca DNA Bld Pos Ql NAA+probe	4180186
1001702	产酸克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001703	CLIN; Home accessibility mod panel; Pan; PANEL.CLINICAL; Panl; Pnl; Point in time; Random	4180186
1001703	Home accessibility mod panel	4180186
1001703	住宅无障碍改造组套:-:时间点:^患者:-	4182948
1001704	AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Arbitrary concentration; Chromogenic assay; Circulating anticoagulant; Coag; ENZY; Enzymatic assay; F8; Fac; Fact; Fact VIII; Fact VIII Inhib; Factor 8; Factor VIII clotting activity; FVIII; Inhib; Inhibit; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Thrombocyte cofactor A; VIII:C	4180186
1001704	Fact VIII Inhib PPP Chro-aCnc	4180186
1001704	凝血因子 VIII 抑制剂:任意型浓度:时间点:贫血小板血浆:定量型:凝血因子酶学测定法	4182948
1001705	3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide; Addiction; C16H22Cl2N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pink; Pinky; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; U4; UA; UR; Urn	4180186
1001705	U-47700 Ur Cfm-mCnc	4180186
1001705	U-47700:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001706	Microbiology; Misc; Miscellaneous; MuV; MuV RNA and N gene Pnl; Other; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Ribonucleic acid; Spec; To be specified in another part of the message; Unspecified	4180186
1001706	MuV RNA and N gene Pnl Spec	4180186
1001706	流行性腮腺炎病毒 RNA & N 基因组套:-:时间点:XXX:-	4182948
1001707	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; ANTIBIOTIC SUSCEPTIBILITIES; Compx; Islt; Islt/Spm; Isol; M tb; M TB Cmplx; M tuberculosis; Molecular genetics; Mtb; MTB cmplx resist Pnl; Myco; Mycobact; Mycobacterium tuberculosum; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec; TB; Tuberculosis	4180186
1001707	MTB cmplx resist Pnl Islt/Spm	4180186
1001707	结核分枝杆菌复合菌群耐药性组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
1001710	Blood; Document; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001710	SLCO1B1 Mut Anl Bld/T	4180186
1001710	SLCO1B1 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001711	Red cabbage IgE Qn	4180186
1001711	紫甘蓝 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1001711	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Brassica aleraceae; Brassica oleracea capitata; Brassica rubra; Cabbage; f216; Immune globulin E; Immunoglobulin E; Point in time; QNT; Quan; Quant; Quantitative; Random; Red cabbage; Red cabbage Ab; Red cabbage IgE; Serum; SR	4180186
1001713	Breath methane 45M p carb	4180186
1001713	45M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1001713	甲烷/已呼出的气体^在给予剂量碳水化合物之后45分钟:体积分数:时间点:呼出的气体:定量型	4182948
1001715	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001718	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001720	4-Methbutfentanyl; 4-Methoxybutyrfentanyl; 4-methoxy-Butyryl fentanyl; Addiction; C24H32N2O2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-(4-methoxyphenyl)-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001720	4-Methbutfentanyl Ur Cfm-mCnc	4180186
1001720	4-甲氧基丁酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001722	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001723	HF+TC Letter	4180186
1001723	DOC.ONT; Document; Finding; Findings; Heart function; HF+TC; Point in time; Random; TC	4180186
1001723	信函:发现:时间点:{环境}:文档型:心力衰竭+移植心脏病学	4182948
1001724	ANTIBIOTIC SUSCEPTIBILITIES; AST; Islt; Isol; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1001724	Pretomanid Susc Islt	4180186
1001724	培托马尼:抗生素敏感性:时间点:分离株:定量型或序数型	4182948
1001727	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001732	Chemistry; GLCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001732	GLCA SerPl-sCnc	4180186
1001732	甘氨石胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001734	C24:1 ceramide/C24 ceramide Plas-sRto	4180186
1001734	C24 ceramide; C24:1 ceramide; Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio	4180186
1001734	N-神经酰基神经鞘氨醇/N-二十四烷酰基神经鞘氨醇:物质的量比率:时间点:血浆:定量型	4182948
1001736	出院摘要记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
1001736	Navigator D/C sum	4180186
1001736	D/C sum; Disch; Discharge summary; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001737	COAGULATION; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Mon; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; SUDS	4180186
1001737	Fibrin Monomer PPP IA-mCnc	4180186
1001737	纤维蛋白单体:质量浓度:时间点:贫血小板血浆:定量型:免疫测定法	4182948
1001738	AV Regurg fraction PISA	4180186
1001738	AO; AoV; AV; Calc; Calculation; CARD.US; Cardiology; DOP; DUPLEX; Echography; Frac; Fract; Fractionation; Fractions; Percent; Point in time; Proximal Isovelocity Surface Area; QNT; Quan; Quant; Quantitative; Random; Regurg fraction; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Volfr; Volume fraction	4180186
1001738	反流分数:体积分数:时间点:主动脉瓣:定量型:超声.多普勒+近端等速表面积计算法	4182948
1001742	AMPAR2 IgG Titr SerPl IF	4180186
1001742	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
1001742	ABS; Aby; ACIF; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GluA2; GluR2; GluR-B; Hydrox; IFA; II; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalitis; OH; Pl; Plasma; Plsm; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1001743	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001745	XR Finger.5th.distl phlnx Bone dev stage	4180186
1001745	5th; 5th finger; Arm; Bone dev stage; EXT; Finger.5th; Finger.5th.distl phlnx; Imaging; little finger; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001745	骨骼发育阶段:评分:时间点:上肢>手指.第五.远节指骨:定量型:X射线摄影术	4182948
1001746	AmpC blaCMY-2 gene Islt/Spm Ql	4180186
1001746	ANTIBIOTIC SUSCEPTIBILITIES; B; Bact; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1001746	细菌 beta-内酰胺耐药 AmpC blaCMY-2 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1001747	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001748	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1001750	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001751	Blastomyces Ag CSF IA-mCnc	4180186
1001751	Antigen; Antigens; Blasto; Blastomycosis; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS	4180186
1001751	芽生菌属单个未知种 抗原:质量浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1001752	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001754	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001755	RFA Ext ves-Ul Views W contr IV	4180186
1001755	c; Contr; Contra; Contrst; Document; EXT; Ext ves-Ul; Extr ves; Extr-Ul; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; Point in time; Radiology; Random; RFA; Vesl; Vessels.XXX; View; VWS; W contr IV; WC	4180186
1001755	多重视图^采用静脉注射对比剂:发现:时间点:肢体.单侧>肢体血管类:文档型:放射荧光透视法.血管造影术	4182948
1001757	4 weeks; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1001758	11OH-Testost; Chemistry; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001758	11OH-Testost SerPl-mCnc	4180186
1001758	11-羟基睾酮:质量浓度:时间点:血清/血浆:定量型	4182948
1001759	S marcescens DNA Bld Pos Ql NAA+probe	4180186
1001759	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S marcescens; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001759	粘质沙雷氏菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001760	Centers for Medicare and Medicaid Assessment; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001762	Liver steatosis grade SerPl Ql	4180186
1001762	Chemistry; Finding; Findings; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001762	肝脂肪变性分级:发现:时间点:血清/血浆:序数型	4182948
1001763	ABO + Rh; ABO + Rh Pnl; ABO group and Rh type; ABO+Rh Gp; Blood - (umbilical) cord; BLOOD BANK; Cord (umbilical) blood; Cord bld; Cord blood; D phenotyping; D typing; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh phenotyping; Rh typing	4180186
1001763	ABO + Rh Pnl BldCo	4180186
1001763	ABO与Rh血型组套:-:时间点:脐带全血:-	4182948
1001764	PDX1 Full Mut Anl Bld/T Seq	4180186
1001764	Blood; full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Identity or presence; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001764	PDX1 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
1001769	CLIN; CLIN.VET; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temperature; Vet cage	4180186
1001769	Temp Vet cage	4180186
1001769	温度:温度:时间点:兽医用病畜隔离笼:定量型	4182948
1001771	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001771	轻度睡眠持续时间:时间:时间点:^患者:定量型	4182948
1001772	Integrative medicine Diag study note	4180186
1001772	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Integrated medicine; notes; Point in time; Random; Study report; Visit note	4180186
1001772	诊断性检查记录:发现:时间点:{环境}:文档型:整合医学	4182948
1001774	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001775	BP; Dias; Diast; Diastoli; HEDIS 2020 Diastolic BP; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1001775	HEDIS 2020 Diastolic BP	4180186
1001775	HEDIS 2020 取值集合 - 舒张压:-:时间点:^患者:-	4182948
1001776	Blood; CHD Multigene Anl; Dis; Diseases; Document; Dz; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001776	CHD Multigene Anl Bld/T	4180186
1001776	冠心病多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001777	Arterial Stenosis; BP; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001779	Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Herpes zoster; HHV-3; Human herpesvirus 3; Immune globulin M; Immunoglobulin M; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Tot; Totl; VZ; VZV; VZV Ab.IgM+total; Zoster	4180186
1001779	VZV Ab.IgM+total CSF Ql	4180186
1001779	水痘带状疱疹病毒抗体.IgM+总计:存在情况或阈值:时间点:脑脊液:序数型	4182948
1001780	Centers for Medicare and Medicaid Assessment; Deglutition; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey; Swallowing/nutritional status	4180186
1001781	Admin info; Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001783	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001784	Zolpidem phenyl-4-carb Ur Ql Scn	4180186
1001784	Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Edluar; Hypnogen; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
1001784	唑吡坦 苯基-4-羧酸酯:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001785	Bacterial ahpC drug res mut Islt/Spm	4180186
1001785	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial ahpC drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001785	细菌 ahpC 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001786	Calories burned dur activity ?Tm	4180186
1001786	?Tm; Activ; Actvty; CLIN; dur activity; Energy/time; Movements; Power; QNT; Quan; Quant; Quantitative	4180186
1001786	已消耗的热量^在活动的过程中:功率:XXX:^患者:定量型	4182948
1001788	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001790	Cortisol p CRH stimulation Pnl SerPl	4180186
1001790	17-Hydroxycorticosterone; ACTH; ACTH RH; Adrenocorticotrophic hormone; Adrenocorticotropin; After; c206; c74; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; Corticotropin Releasing Factor; Cortisol p CRH stimulation Pnl; Cortrosyn; CRF; CRH; F; Horm; hydrocortisone; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rc206; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Stim; Tumor marker	4180186
1001790	促肾上腺皮质激素释放激素刺激后皮质醇组套:-:时间点:血清/血浆:定量型	4182948
1001792	Burn Procedure note	4180186
1001792	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001792	操作记录:发现:时间点:{环境}:文档型:烧伤管理	4182948
1001793	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1001795	Chemistry; GDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1001795	GDCA SerPl-sCnc	4180186
1001795	甘氨去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001797	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1001797	Navigator Phone Note	4180186
1001797	记录:发现:时间点:电话就医:文档型:医疗保健服务导航员	4182948
1001800	After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Neut; Neutr; p hep neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1001800	dRVVT confirm p hep neut PPP	4180186
1001800	稀释蝰蛇毒诱导型凝血过程.过量磷脂^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001801	Dark rod adaptation tm; EYE.PX; Eyeball; L; L eye; LT; Occular; Oculis; Ophthalmologic; Optic globe; Point in time; QNT; Quan; Quant; Quantitative; Random; Rod intercept (TM); Vision; Visual	4180186
1001801	L eye Dark rod adaptation tm	4180186
1001801	黑暗介导的视杆细胞适应时间:时间:时间点:眼睛.左侧:定量型	4182948
1001806	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001808	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001815	CR; Crea; Creat; DRUG/TOXICOLOGY; Drugs; GADO; Gadolium; Gd; Mass concentration ratio; Mass ratio; MCRto; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UCr; UR; Urn	4180186
1001815	Gadolinium/Creat Ur	4180186
1001815	钆/肌酐:质量比率:时间点:尿液:定量型	4182948
1001816	Elevation climbed 24h lRate	4180186
1001816	1 day; 24 hours; 24HR; Elevation gain; Elevation gained; H+P; H+P.HX; lRate; P prime; QNT; Quan; Quant; Quantitative	4180186
1001816	攀登高度:长度速率:24小时:^患者:定量型	4182948
1001817	DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random	4180186
1001817	分项账单:发现:时间点:^患者:文档型	4182948
1001818	Antigen; Antigens; BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1001818	VS Ag RBC Ql	4180186
1001818	VS 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001820	Blood; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NC_000010.10:g.96405502G&gt;A; NC_000010.11:g.94645745G&gt;A; Nominal; PCR; Point in time; Random; rs12777823; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001820	10q23 g.94645745G>A Geno Bld/T	4180186
1001820	10q23 g.94645745G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1001824	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Nominal; Report period; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
1001826	Lg B-cell Lymph Pnl Tiss	4180186
1001826	大B细胞淋巴瘤分类组套:-:时间点:组织与涂片:-	4182948
1001826	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; DLBCL; Lg B-cell lymph; Lg B-cell Lymph Pnl; Pan; PANEL.PATH; Panl; Pathology; PMBCL; Pnl; Point in time; Random; Tissue; Tissue, unspecified	4180186
1001827	GN resist Pnl Islt/Spm	4180186
1001827	ANTIBIOTIC SUSCEPTIBILITIES; Bact; GN resist Pnl; Islt; Islt/Spm; Isol; Molecular genetics; NEG; Pan; PANEL.ANTIBIOTIC SUSCEPTIBILITIES; Panl; PCR; Pnl; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001827	革兰氏阴性细菌耐药性组套:-:时间点:分离株/标本:-:分子遗传学类实验室方法	4182948
1001828	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; D immitis; EIA; ELFA; ELISA; Enzyme immunoassay; Filariasis; Heartworm; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1001828	D immitis IgG Ser Ql IA	4180186
1001828	犬恶丝虫 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1001830	1,3-Beta-D-Glucan; B; Beta glucan; i; III; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR	4180186
1001830	1,3 beta glucan Ser Ql	4180186
1001830	1,3 Beta 葡聚糖:存在情况或阈值:时间点:血清:序数型	4182948
1001834	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Subs; SUD consistency score	4180186
1001834	SUD consistency score	4180186
1001834	物质使用障碍问题一致性评分:评分:时间点:^患者:定量型	4182948
1001837	CHIKV IgG+IgM Pnl SerPl	4180186
1001837	CHIKV; CHIKV IgG+IgM Pnl; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001837	基孔肯亚病毒抗体.IgM 与 IgG 组套:-:时间点:血清/血浆:-	4182948
1001840	DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV6; HPV6+11; HPV6+11 E6+E7 mRNA; Human papillomavirus; Microbiology; Ordinal; Papilloma virus low risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1001840	HPV6+11 E6+E7 mRNA Tiss Ql Probe	4180186
1001840	人乳头瘤病毒 6+11 E6+E7 mRNA:存在情况或阈值:时间点:组织与涂片:序数型:DNA探针	4182948
1001842	c; Cath; Contr; Contra; Contrst; Document; Films; Finding; Findings; Fluor; Fluoro; Fluoroscopy; Imaging; LMTED; LTD; LVs thpy or emb or inf^W c v ex cath; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; View; Views Ltd; Vs Ltd; VWS; W contr via exist cath; WC	4180186
1001842	RFA Vs Ltd W contr via exist cath	4180186
1001842	针对治疗或栓塞术或输注的局部多重视图^采用经已有导管的对比剂:发现:时间点:XXX:文档型:放射荧光透视法.血管造影术	4182948
1001843	Chloride 2h p Vaso SerPl-sCnc	4180186
1001843	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1001843	氯^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001844	ABO Gp^p stem trnsplt; After; Blood; BLOOD BANK; Nominal; p HSCT; Point in time; PST; Random; Typ; WB; Whole blood	4180186
1001844	ABO Group p HSCT Bld	4180186
1001844	ABO 血型^在造血干细胞移植之后:类型:时间点:全血:名义型	4182948
1001845	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Special Txs, procedures and programs; Survey; Tx; Txs	4180186
1001847	Blood; Document; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; PH Multigene Anl; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001847	PH Multigene Anl Bld/T	4180186
1001847	原发性高草酸尿症多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001848	GABABR IgG Titr CSF IF	4180186
1001848	Gamma 氨基丁酸 B 受体 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1001848	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; ACIF; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Piperidic acid; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1001849	Imi+Rel Islt Grad strip	4180186
1001849	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; Imi+Rel; Imipeneum; Imp; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Primaxin; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1001849	亚胺培南+瑞雷巴坦:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1001851	Nortrip Ur Ql Scn	4180186
1001851	Amitriptyline metabolite; Aventyl; DRUG/TOXICOLOGY; Drugs; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1001851	去甲阿米替林:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1001852	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1001854	E Ag infant RBC Ql	4180186
1001854	Antigen; Antigens; BLOOD BANK; E Ag^infant; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1001854	E 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001857	XR Thumb.prox phlnx Bone dev stage	4180186
1001857	1st metacarpal; Arm; Bone dev stage; EXT; First finger; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; Thumb.prox phlnx; UE; Up; Xray; X-ray	4180186
1001857	骨骼发育阶段:评分:时间点:上肢>拇指.近节指骨:定量型:X射线摄影术	4182948
1001859	A1AT Cl Pnl SerPl+Stl	4180186
1001859	A1; A1A; A1AT; A-1-AT; A1-AT; A1AT Cl Pnl; AAT; Alfa; Alpha-1-antitrypsin.total; Alpha-1-protease inhibitor; Alpha-1-proteinase inhibitor; Alpha-1-trypsin inhibitor; Bowel movement; Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Faecal; Faeces; Fecal; Feces; i; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPl+Stl; SerPlas; Serum; Serum or plasma; Serum or plasma and stool; SR; Stl; Stool = Fecal	4180186
1001859	Alpha 1 抗胰蛋白酶粪便清除组套:-:时间点:血清/血浆+便:定量型	4182948
1001863	HPV16+18 E6+E7 mRNA Tiss Ql Probe	4180186
1001863	DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; HPV; HPV16; HPV16 and 18; HPV16+18; HPV16+18 E6+E7; HPV16+18 E6+E7 mRNA; Human papillomavirus; Microbiology; Ordinal; Papilloma virus high risk; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified	4180186
1001863	人乳头瘤病毒 16+18 E6+E7 mRNA:存在情况或阈值:时间点:组织与涂片:序数型:DNA探针	4182948
1001864	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001864	LV ED vol A4C SP A-L	4180186
1001864	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1001867	Jk3 Ag RBC Ql	4180186
1001867	Antigen; Antigens; BLOOD BANK; Erythrocytes; Jk3; Jk3 Ag; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001867	Jk3 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1001868	Moxifloxacin 3 ug/mL Islt SlowMyco	4180186
1001868	3 ug/mL; AFB; ANTIBIOTIC SUSCEPTIBILITIES; AST; Avelox; Islt; Isol; mcg; Myco; Mycobacteria susceptibility; Mycobacterial susceptibility; Point in time; Random; SlowMyco; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; TB; Tuberculosis	4180186
1001868	莫西沙星 3.0 微克/毫升:抗生素敏感性:时间点:分离株:定量型或序数型:针对慢长型分枝杆菌的方法	4182948
1001870	PPT1 + TPP1 Pnl Fib	4180186
1001870	Chemistry; Fib; Fibr; i; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; PPT; PPT1 + TPP1 Pnl; PR; Prot; Random	4180186
1001870	棕榈酰蛋白硫酯酶 1 与三肽基肽酶 1 组套:-:时间点:成纤维细胞:-	4182948
1001871	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TLCA	4180186
1001871	TLCA SerPl-sCnc	4180186
1001871	牛磺石胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001873	DPYD gene Mut Anl Bld/T	4180186
1001873	Blood; DHP; DHPDHase; dihydropyrimidine dehydrogenase; Dihydropyrimidine dehydrogenase gene; Dihydrothymine dehydrogenase gene; Dihydrouracil dehydrogenase gene; Document; DPD; Finding; Findings; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mut Anl; Mutations; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001873	DPYD 基因 突变分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001874	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1001874	今天已上学:发现:时间点:^患者:序数型	4182948
1001876	Color Me Healthy panel	4180186
1001876	Appearance; Color Me Healthy panel; Colour; H+P; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; S prime; Sx	4180186
1001878	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1001879	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1001879	GABABR IgG CSF Ql CBA IFA	4180186
1001879	Gamma 氨基丁酸 B 受体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1001881	10M p 1 ug/kg CRH IV; 17-Hydroxycorticosterone; After; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001881	Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc	4180186
1001881	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之后10分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001882	Pref vaccine	4180186
1001882	Ident; Identifier; Nominal; Point in time; Pref vaccine; Random	4180186
1001882	首选疫苗类型:标识符:时间点:^患者:名义型	4182948
1001884	Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1001886	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; FA; Fluorescent antibody; Fluoresent; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR; Time Resolved Fluorescence; TRF	4180186
1001886	Hantavirus IgM SerPl Ql IF	4180186
1001886	汉坦病毒 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫荧光法	4182948
1001887	3 days; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Survey; Sx	4180186
1001890	Antigen; Antigens; BLOOD BANK; C Ag^infant; Erythrocytes; infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1001890	C Ag infant RBC Ql	4180186
1001890	C 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1001891	H+P; H+P.HX; Nominal; P prime; Point in time; Random; Typ	4180186
1001891	注意力缺陷多动障碍类型:类型:时间点:^患者:名义型	4182948
1001892	acryloylfentanyl; Addiction; C22H26N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Egyptenyl; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]prop-2-enamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001892	Acrylfentanyl Ur Cfm-mCnc	4180186
1001892	丙烯酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001893	Plt CD42b Act/Nor Bld FC	4180186
1001893	Act/Nor; Blood; CELL MARKERS; Control; Dynamic; FC; Glycocalicin; Glycoprotein Ib alpha; GPIba; GPIbalpha; Pl; Platelets; Platelt; Plt; Plt CD42b; Plt CD42b Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1001893	血小板 CD42b 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1001894	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial inhA drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1001894	Bacterial inhA drug res mut Islt/Spm	4180186
1001894	细菌 inhA 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1001896	Addiction; B; Beta hydroxy thiofentanyl; B-OH thiofentanyl; C20H26N2O2S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-[1-(2-hydroxy-2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001896	B-OH thiofentanyl Ur Cfm-mCnc	4180186
1001896	Beta 羟基硫代芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001898	P aeruginosa DNA Bld Pos Ql NAA+probe	4180186
1001898	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P aeruginosa; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001898	铜绿假单胞菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001899	Durat; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001900	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001902	Blood; Document; EDS Multigene Anl; Finding; Findings; Gene; Gene panel; Molecular genetics; Molecular pathology; MOLPATH; Multi-gene study; Multiple-gene panel test; PCR; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001902	EDS Multigene Anl Bld/T	4180186
1001902	埃勒斯-当洛斯综合征多基因分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1001903	Temp setting Vet cage	4180186
1001903	CLIN; CLIN.VET; Point in time; QNT; Quan; Quant; Quantitative; Random; Temp; Temp setting; Temperature; Vet cage	4180186
1001903	温度设置:温度:时间点:兽医用病畜隔离笼:定量型	4182948
1001906	CYP4F2 c.1297G>A Geno Bld/T	4180186
1001906	Blood; CYP4F2 c.1297G&gt;A; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; NC_000019.10:g.15879621C&gt;T; NC_000019.9:g.15990431C&gt;T; NG_007971.2:g.23454G&gt;A; NM_001082.4:c.1297G&gt;A; Nominal; NP_001073.3:p.Val433Met; p.V433M; PCR; Point in time; Random; rs2108622; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001906	CYP4F2 基因.c.1297G>A:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1001907	Compare; Compare prior test exam; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Prev; Random	4180186
1001907	与既往结果之间的比较:发现:时间点:^患者:文档型	4182948
1001908	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001909	Chemistry; CR; Crea; Creat; Hepacarboxyporph; Heptacarbox; Heptacarboxyl porphyrin; Heptacarboxylate porphyrin; Heptacarboxylporphyrins; Heptacarboxyporph; Heptacarboxyporphyrin; Hepta-CP; Hepta-CP I; Heptaporphyrin; Heptaporphyrine I; Hexacarboxyl porphyrin; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn	4180186
1001909	Hepta-CP I/Creat Ur-sRto	4180186
1001909	七羧基卟啉 I/肌酐:物质的量比率:时间点:尿液:定量型	4182948
1001910	Finding; Findings; Occupation; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; Work	4180186
1001911	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; GCMS; Mass content; Mec; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite	4180186
1001911	N-nortramadol Mec Cfm-mCnt	4180186
1001911	N-去甲基曲吗多:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
1001912	Chr 12 copy num/nucleus EntNum Tiss FISH	4180186
1001912	Chr 12 copy num; Chromosom; Chromosomes; Entitic; Entitic number; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001912	染色体 12 拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1001917	LV ED vol A2C SP A-L	4180186
1001917	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1001917	心脏舒张末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1001918	Insulin p meal SerPl-sCnc	4180186
1001918	After; Chemistry; HUM; Humulin; IH7; Insul; Lente; Level; NPH; p meal; PC; Pl; Plasma; Plsm; Point in time; Post Pran; Post prandial; PP; PST; QNT; Quan; Quant; Quantitative; Random; Semilente; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sliding; SR; Substance concentration; Ultralente	4180186
1001918	胰岛素^在进餐之后:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001922	Cl; Clear; Clearanc; Clearances; Clr; DRUG/TOXICOLOGY; Drugs; Myleran; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies; Volume rate content	4180186
1001922	Busulfan Cl from Plas	4180186
1001922	白消安 清除:体积速率含量:检查过程持续时间:血浆:定量型	4182948
1001925	Alc; alcoholic; Drug; Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.MTLHLTH	4180186
1001927	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1001927	XR Capitate Bone dev stage	4180186
1001927	骨骼发育阶段:评分:时间点:上肢>腕部.头状骨:定量型:X射线摄影术	4182948
1001929	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1001930	FLUAV PB2 gene Islt-Seq	4180186
1001930	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV PB2 gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1001930	流感病毒 A PB2 基因:序列:时间点:分离株:名义型:序列测定	4182948
1001932	Durat; H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1001932	深度睡眠持续时间:时间:时间点:^患者:定量型	4182948
1001933	FLUAV PA gene Islt-Seq	4180186
1001933	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV PA gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Postero-Anterior; Random	4180186
1001933	流感病毒 A PA 基因:序列:时间点:分离株:名义型:序列测定	4182948
1001935	LA ES vol A4C SP A-L	4180186
1001935	2D US; A4C SP A-L; Atrial; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume	4180186
1001935	心脏收缩末期容积:体积型属性:时间点:心脏.心房.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1001937	Anxiety screen report	4180186
1001937	Anxiety screen report; Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn	4180186
1001937	焦虑筛查报告:发现:时间点:^患者:文档型	4182948
1001939	CLIN; Finding; Findings; Nominal; Point in time; Random	4180186
1001939	自我照顾能力:发现:时间点:^患者:名义型	4182948
1001941	Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc	4180186
1001941	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1001941	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前5分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1001943	PHH3 Tiss Ql ImStn	4180186
1001943	IHC; Imm; Immunohistochemical stain; Immunostain; ImStn; Imun; Imune; Ordinal; PATHOLOGY; PHH3; Point in time; PR; QL; Qual; Qualitative; Random; Screen; St; Stains; Stn; Tissue; Tissue, unspecified	4180186
1001943	磷酸化组蛋白 H3:存在情况或阈值:时间点:组织与涂片:序数型:免疫染色法	4182948
1001944	LV ED sphericity index US	4180186
1001944	CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; ED; ED sphericity index; Hrt; Hrt ventr; L; Length Ratio; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1001944	球形指数.舒张末期:长度比率:时间点:心脏.心室.左侧:定量型:超声	4182948
1001946	5th; 5th finger; Arm; Bone dev stage; EXT; Finger.5th; Finger.5th.prox phlnx; Imaging; little finger; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001946	XR Finger.5th.prox phlnx Bone dev stage	4180186
1001946	骨骼发育阶段:评分:时间点:上肢>手指.第五.近节指骨:定量型:X射线摄影术	4182948
1001948	FOXO1 gene Rear Tiss FISH	4180186
1001948	13q14.1; Document; Finding; Findings; FKH; FKH1; FKHR; Fluorescent in situ hybridization; Forkhead box O1A; Forkhead in rhabdomyosarcoma; FOXO1A; Molecular pathology; MOLPATH; Point in time; Random; Rearr; Rearrangement; Tissue; Tissue, unspecified	4180186
1001948	FOXO1 基因重排:发现:时间点:组织与涂片:文档型:FISH	4182948
1001953	Activ; Actvty; Blood; Catechol-O-Methyltransferase; COMT gene prod met activ imp; Drug metabolism; Gene prod met act imp; HEL-S-98n; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Movements; Ordinal; PCR; Phenotype; Point in time; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1001953	COMT gene prod met activ Bld/T-Imp	4180186
1001953	COMT 基因产物新陈代谢活性解释:印象:时间点:全血/组织:序数型:分子遗传学类实验室方法	4182948
1001955	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CSSRS	4180186
1001956	XR Finger.3rd.mid phlnx Bone dev stage	4180186
1001956	3rd; 3rd finger; Arm; Bone dev stage; EXT; Finger.3rd; Finger.3rd.mid phlnx; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1001956	骨骼发育阶段:评分:时间点:上肢>手指.第三.中节指骨:定量型:X射线摄影术	4182948
1001957	M. morganii DNA Bld Pos Ql NAA+probe	4180186
1001957	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enterobacteriaceae; Gram Negative Bacteria; Gram-Negative Bacterial Infection; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M. morganii; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1001957	摩根摩根菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1001958	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TCA	4180186
1001958	TCA SerPl-sCnc	4180186
1001958	牛磺胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001961	dRVVT confirm Act/Nor p hep neut PPP	4180186
1001961	Act/Nor; After; Clot; Clottable; Coag; Coagulation assay; Coagulation dilute Russell viper venom induced confirmatory test; Control; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; dRVVT confirm; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Neut; Neutr; p hep neut; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; RlTm; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1001961	稀释蝰蛇毒诱导型凝血过程.过量磷脂 实际的/正常的^在肝素中和之后:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1001962	4 weeks; Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1001963	4-chloro-N-[[1-(dimethylamino)cyclohexyl]methyl]-benzamide; Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001963	AH-8529 Ur Cfm-mCnc	4180186
1001963	AH-8529:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001965	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1001968	Copper Dial fld-sCnc	4180186
1001968	Chemistry; Cu; Diaf; Dialysate; Dialysis fluid; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1001968	铜:物质的量浓度:时间点:透析液:定量型	4182948
1001969	M hyorhinis IgG/Pos cntrl Ser IA	4180186
1001969	猪鼻支原体 抗体.IgG/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
1001969	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; M hyorhinis; M hyorhinis Ab.IgG; MEIA; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS; Vet; Veterinary	4180186
1001972	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1001973	RV Major axis dias A4C	4180186
1001973	2D US; CARD.US; Cardiac; Cardiology; Dias; Diast; Diastoli; Echography; Hrt; Hrt ventr; LAX; Length; Long axis; Major axis dias; Point in time; QNT; Quan; Quant; Quantitative; R; Random; RT; RV; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular	4180186
1001973	主轴.舒张期:长度:时间点:心脏.心室.右侧:定量型:超声.2D.A4C	4182948
1001978	4-Chloro-N-(1-(4-nitrophenethyl)piperidin-2-ylidene)benzenesulfonamide; Addiction; C19H20ClN3O4S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1001978	W-18 Ur Cfm-mCnc	4180186
1001978	W-18:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1001979	Personnel Funeral service licensee	4180186
1001979	ADMIN; bod; Bodies; Nominal; Othr; Person name; Point in time; Random	4180186
1001979	丧葬服务持照方或者其他负责保管逝者遗体的机构:人员姓名:时间点:工作人员:名义型	4182948
1001981	HTLV I+II IgG Pnl CSF	4180186
1001981	2; Cerebral spinal fluid; Cerebrospinal Fl; HTLV I+II; HTLV I+II IgG Pnl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1001981	HTLV I & II 抗体.IgG 组套:-:时间点:脑脊液:-	4182948
1001984	After; Antigen; Antigens; BLOOD BANK; Erythrocytes; K Ag^p stem trnsplt; KEL1; Kell Blood Group System; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1001984	K Ag p HSCT RBC Ql	4180186
1001984	K 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1001987	dPAP by Cardiac cath	4180186
1001987	Art; Blood pressure; Blood pressure diastolic; BLOOD PRESSURE MEASUREMENTS.CENTRAL.MOLEC; BP; BP diastolic; BP end dias; DBP; Dias; Dias BP; Diast; Diastoli; ED; Intravenous; IV; PA; PAP; Point in time; Pressure; QNT; Quan; Quant; Quantitative; Random	4180186
1001987	血管内心脏舒张期末期:压力或压强:时间点:肺动脉:定量型:心导管插入术	4182948
1001991	SUD screen report	4180186
1001991	Asympt; Asymptomatic; DOC.MISC; Document; Finding; Findings; MISC; Point in time; Random; Scn; Subs; SUD screen report	4180186
1001991	物质使用障碍筛查报告:发现:时间点:^患者:文档型	4182948
1001993	THDCA SerPl-sCnc	4180186
1001993	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; THDCA	4180186
1001993	牛磺猪去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1001994	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Colistin res mcr-2; Colmycin; Colymycin; II; Islt; Islt/Spm; Isol; Molecular genetics; Ordinal; PCR; Point in time; PR; QL; Qual; Qualitative; Random; Resist; Resistanc; Resistant; Resistent; Screen; Spec	4180186
1001994	Colistin res mcr-2 Islt/Spm Ql	4180186
1001994	细菌粘菌素耐药 mcr-2 基因:存在情况或阈值:时间点:分离株/标本:序数型:分子遗传学类实验室方法	4182948
1001996	MYCN copy num/Chr 2 copy num Tiss FISH	4180186
1001996	Chr 2 copy num; Chromosom; Chromosomes; Fluorescent in situ hybridization; II; Molecular pathology; MOLPATH; MYCN copy num; No; Num; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1001996	MYCN 基因拷贝数/染色体 2 拷贝数:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1001997	Calc; Calculation; CARD.US; Cardiology; DOP; DUPLEX; Echography; Point in time; Proximal Isovelocity Surface Area; QNT; Quan; Quant; Quantitative; Random; Reg vol; Sonogram; Sonograph; Sonography; TV; ULS; Ultrasound; Vol; Volume	4180186
1001997	TV Reg vol PISA	4180186
1001997	反流体积:体积型属性:时间点:三尖瓣:定量型:超声.多普勒+近端等速表面积计算法	4182948
1001999	RFA Vs for dial fistula W contr IA	4180186
1001999	Arteriogram; c; Contr; Contra; Contrst; Dialy; Document; Films; Finding; Findings; Fistulogram; Fluor; Fluoro; Fluoroscopy; Imaging; Misc; Miscellaneous; Other; Point in time; Radiology; Random; RFA; Spec; To be specified in another part of the message; Unspecified; Vesl; Vessels.XXX; View; Vs dial fistula^W cont IA; Vs for dial fistula; VWS; W contr IA; WC	4180186
1001999	针对透析瘘管的多重视图^采用动脉注射对比剂:发现:时间点:XXX>血管类:文档型:放射荧光透视法.血管造影术	4182948
1002000	2D US; A2C MOD; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002000	LV Output A2C MOD	4180186
1002000	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002003	Blood; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; Variant interaction summary; WB; Whole blood; Whole blood or Tissue	4180186
1002003	Variant interaction summary Bld/T-Imp	4180186
1002003	遗传变异相互作用摘要:印象:时间点:全血/组织:叙述型	4182948
1002007	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002009	After; Antigen; Antigens; BLOOD BANK; c; C Ag^p stem trnsplt; Erythrocytes; little c Ag^p stem trnsplt; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1002009	little c Ag p HSCT RBC Ql	4180186
1002009	c 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002017	Act/Nor; Blood; CELL MARKERS; Control; Dynamic; FC; gG; Glycoprot; Glycoproteins; GP; GPVI; Pl; Plat Gp; Platelet glycoprotein VI; Platelet GPVI Act/Nor; Platelets; Platelt; Plt; Plt GPVI; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002017	Plt GPVI Act/Nor Bld FC	4180186
1002017	血小板糖蛋白 VI 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002018	After; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p 4h FFST; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002018	Osmolality p 4h FFST SerPl	4180186
1002018	渗透压^在液体型禁食之后4小时:渗透压:时间点:血清/血浆:定量型	4182948
1002019	Eravacycline Islt Grad strip	4180186
1002019	ANTIBIOTIC SUSCEPTIBILITIES; AST; Epsilometer; Estrip; E-strip; Grad strip; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1002019	厄伐环素:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1002020	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002020	LV Output Biplane area-length	4180186
1002020	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1002025	Diff Lg B-cell lymph COO Tiss	4180186
1002025	弥漫性大B细胞淋巴瘤细胞起源:类型:时间点:组织与涂片:名义型	4182948
1002025	ABC; B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; COO; Diff Lg B-cell lymph; Diff Lg B-cell lymph COO; DLBCL; GCB; Lg B-cell lymph; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002026	Heparan sulfate SerPl-mCnc	4180186
1002026	Chemistry; HS; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SO4; SO4-2; SR; Sulf	4180186
1002026	硫酸类肝素:质量浓度:时间点:血清/血浆:定量型	4182948
1002027	Blood; Cell; Cells w cytogenetic abnl; Cellularity; Cnt; Count; Molecular genetics; Molecular pathology; MOLPATH; Number; PCR; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002027	Cells w cytogenetic abnl Bld/T	4180186
1002027	细胞.细胞遗传学异常:数量(计数):时间点:全血/组织:定量型:分子遗传学类实验室方法	4182948
1002029	Residual vol/Predicted Plethysmograph	4180186
1002029	bod; Bodies; Breathing; Lungs; Percent; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Residual vol; RS; RV; V Res/Predicted; Vol; Volfr; Volume fraction	4180186
1002029	体积.残余/预计法:体积分数:时间点:呼吸系统:定量型:体积描记器.体箱计	4182948
1002031	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1002031	病程记录:发现:时间点:{环境}:文档型:医疗保健服务导航员	4182948
1002031	Navigator Prog note	4180186
1002032	Addiction; Adormix; Ambien; Ambien CR; Damixan; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Edluar; Hypnogen; Illicit; Ivedal; Lioran; Myslee; Nasen; Nytamel; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Sanval; Scn; Scr; Screen; Scrn; Somidem; Stilnoct; Stilnox; Stilnox CR; Sucedal; UA; UR; Urn; Zoldem; Zolpihexal; Zolpimist	4180186
1002032	Zolpidem Ur Ql Scn	4180186
1002032	唑吡坦:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002033	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; spp; SUDS; Valley fever	4180186
1002033	Coccidioides IgM CSF IA-aCnc	4180186
1002033	球孢子菌属单个未知种 抗体.IgM:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002034	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; Blood urea nitrogen; BUN; CHEMISTRY.CHALLENGE TESTING; Level; Mass concentration; N; N2; Nit; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UN; VP	4180186
1002034	BUN 2h p Vaso SerPl-mCnc	4180186
1002034	尿素氮^在给予剂量后叶加压素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1002035	Antigen; Antigens; BLOOD BANK; Erythrocytes; infant; K Ag^infant; KEL1; Kell Blood Group System; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1002035	K Ag infant RBC Ql	4180186
1002035	K 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1002037	Addiction; Drugs; Drugs of abuse; Illicit; Nominal; Point in time; PotentialForAbuse; Random; Survey; Typ	4180186
1002043	ADHD hyperactive severity; H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Sx	4180186
1002043	ADHD hyperactive severity	4180186
1002043	注意力缺陷多动障碍极度活跃症状严重程度:印象:时间点:^患者:序数型	4182948
1002045	little c Ag RBCCo Ql	4180186
1002045	Antigen; Antigens; BLOOD BANK; c; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells cord; Rh; Rh Blood Group System; Screen	4180186
1002045	c 抗原:存在情况或阈值:时间点:脐带血红细胞:序数型	4182948
1002047	Addiction; Butyrfentanyl; Butyr-fentanyl; Butyryl fentanyl; C23H30N2O; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]butanamide; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002047	Butyrylfentanyl Ur Cfm-mCnc	4180186
1002047	丁酰基芬太尼:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002048	4 weeks; Job; Occupation; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Survey; SURVEY.GNHLTH	4180186
1002056	After; Clot; Clottable; Coag; Coagulation assay; DDRVTVT; Dil; Dil Russell Vip Ven; Dilut; dRVV; dRVVT; Hep; Hepar; Heparin Nt; Heparn; Neut; Neutr; p hep neut; Plas; Platelet poor plasma; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Rus; RVV; Screening test for lupus anticoagulant; Tilt tube	4180186
1002056	dRVVT p hep neut PPP	4180186
1002056	稀释蝰蛇毒诱导型凝血过程^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002058	mGluR1 IgG CSF Ql CBA IFA	4180186
1002058	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; Glu; Glutamic acid; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; mGluR1; mGluR1 Ab; mGluR1 IgG; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002058	代谢型谷氨酸受体 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1002059	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002061	HAdV A+B+C+D+E DNA Resp Ql NAA+probe	4180186
1002061	腺病毒 A+B+C+D+E DNA:存在情况或阈值:时间点:呼吸道:序数型:探针法.基因扩增.靶向	4182948
1002061	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Adeno virus; Amplif; Amplification; Amplified; Breathing; Deoxyribonucleic acid; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; HAdV; HAdV A+B+C+D+E; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lungs; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; RS; Screen; SDA; Spec; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1002063	Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Point in time; Random; Survey	4180186
1002065	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note	4180186
1002065	Eating disorders Diag study note	4180186
1002065	诊断性检查记录:发现:时间点:{环境}:文档型:进食障碍	4182948
1002067	O2/Total gas setting VFr Vet cage	4180186
1002067	CLIN; CLIN.VET; Gases; O2; O2/gas .tot set; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; tO2; Tot; Total gas setting; Totl; Vet cage; Volfr; Volume fraction	4180186
1002067	氧/气体.总计设置:体积分数:时间点:兽医用病畜隔离笼:定量型	4182948
1002071	Finding; Findings; Mult; Multi; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002072	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SSD score; Sx	4180186
1002072	SSD score	4180186
1002072	躯体症状障碍评分:评分:时间点:^患者:定量型	4182948
1002073	Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002078	Continuity assessment record and evaluation; Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Visit note; WOC	4180186
1002078	WOC Diag study note	4180186
1002078	诊断性检查记录:发现:时间点:{环境}:文档型:伤口、造口和大小便节制照护服务	4182948
1002088	DRUG/TOXICOLOGY; Drugs; Horizant; Neurontin; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1002088	Gabapentin Tiss Ql Scn	4180186
1002088	加巴喷丁:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验	4182948
1002089	Date and time; Date+time; Date+time OB delivery; OB; OBGYN; Obstetrical; Obstetrics; Point in time; Pregnancy; Prenatal; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1002089	Date+time OB delivery	4180186
1002089	产科分娩日期和时间:时间戳:时间点:^患者:定量型	4182948
1002091	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002093	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002093	Haem influ DNA Bld Pos Ql NAA+probe	4180186
1002093	流感嗜血杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002101	little e Ag p HSCT RBC Ql	4180186
1002101	After; Antigen; Antigens; BLOOD BANK; e; E Ag^p stem trnsplt; Erythrocytes; little e Ag^p stem trnsplt; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh Blood Group System; Screen	4180186
1002101	e 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002102	B; CG; Chemistry; Choriogonadotropins total; Chorionic gonadotropin; Chorionic gonadotropin.intact; HCG; HCG Intact; HCG Intact+B; Human chorionic gonadotropin; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002102	HCG Intact+B SerPl-mCnc	4180186
1002102	绒毛膜促性腺激素.完整型+Beta 亚单位:质量浓度:时间点:血清/血浆:定量型	4182948
1002106	T gondii IgG pnl Ser Donr	4180186
1002106	Donr; Immune globulin G; Immunoglobulin G; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Serum; SR; T gondii; T gondii IgG pnl; Toxo; Toxoplasmosis	4180186
1002106	刚地弓形虫抗体.IgG 组套:-:时间点:血清^供体:-	4182948
1002108	Antigen; Antigens; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Level; Mass concentration; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; species; spp; SUDS; UA; UR; Urn; Valley fever	4180186
1002108	Coccidioides Ag Ur IA-mCnc	4180186
1002108	球孢子菌属单个未知种 抗原:质量浓度:时间点:尿液:定量型:免疫测定法	4182948
1002112	GFAP alpha IgG Titr Ser IF	4180186
1002112	神经胶质纤维酸性蛋白.alpha 亚单位 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
1002112	ABS; Aby; ACIF; Alfa; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GFAP; GFAP alpha; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Pituitary glycoproteins; Point in time; PR; Prot; Random; Serology; Serum; SmQn; SR; Stroke; TBI (Traumatic Brain Injury); Time Resolved Fluorescence; Titer; Titered; Titre; Traumatic Brain Injuries; TRF; Ttr	4180186
1002117	Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Persons; Pnl; Point in time; Random; SDOH; Survey; SURVEY.GNHLTH	4180186
1002119	Blood; CELL MARKERS; Dynamic; FC; Fc gamma receptor I; Fc gamma RI; FC gammaRI; FCR I; Neut; Neut.CD64; Neut.CD64/100 Neut; Neutr; Neutrophil; Number fraction; Percent; PMN; PNM; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood	4180186
1002119	Neut.CD64/100 Neut NFr Bld FC	4180186
1002119	嗜中性粒细胞.CD64/100 个嗜中性粒细胞:计数型分数:时间点:全血:定量型:流式细胞测量术	4182948
1002122	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; DFS70; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin G; Immunoglobulin G; MEIA; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1002122	DFS70 IgG SerPl Ql IA	4180186
1002122	致密细斑 70 蛋白 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
1002124	Centers for Medicare and Medicaid Assessment; Finding; Findings; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
1002127	3D US; Arbitrary rate; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; LT; LV; Max long strain rate sys; Max strain rate sys; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Sys; Sys.max; Syst; ULS; Ultrasound; Ventricular	4180186
1002127	LV Max long strain rate sys 3D US	4180186
1002127	纵向应变速率.收缩期.最大值:任意型速率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002130	Finding; Findings; Nominal; Survey; SURVEY.CSSRS	4180186
1002135	Blood; Drugs; Finding; Findings; Genetics; Genomic; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; Variant drug sens effect; WB; Whole blood; Whole blood or Tissue	4180186
1002135	Variant drug sens effect Nar	4180186
1002135	遗传变异对药物敏感性的影响:发现:时间点:全血/组织:叙述型	4182948
1002136	Pulm valve Regurg PHT DOP	4180186
1002136	Bld flow; CARD.US; Cardiology; DOP; DUPLEX; Dynamic; Echography; P1/2T; PHT; Point in time; Pulm valve; Pulmonic valvular; QNT; Quan; Quant; Quantitative; Random; Regurg PHT; Sonogram; Sonograph; Sonography; T1/2; ULS; Ultrasound	4180186
1002136	反流血流压力减半时间:时间:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
1002140	Home access mod responsible party	4180186
1002140	CLIN; Finding; Findings; Home access mod responsible party; Nominal; Point in time; Random	4180186
1002140	住宅无障碍改造责任方:发现:时间点:^患者:名义型	4182948
1002141	Centers for Medicare and Medicaid Assessment; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1002143	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart function; HF+TC; notes; Point in time; Random; Study report; TC; Visit note	4180186
1002143	HF+TC Diag study note	4180186
1002143	诊断性检查记录:发现:时间点:{环境}:文档型:心力衰竭+移植心脏病学	4182948
1002144	ABG; Amm; Ammon; Amon; ART; Art bld; Art blood; Arterial; Arterial blood; Blood arterial; Chemistry; Level; NH3; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002144	Ammonia BldA-sCnc	4180186
1002144	氨:物质的量浓度:时间点:动脉全血:定量型	4182948
1002147	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002150	Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CSSRS	4180186
1002151	C16 ceramide; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002151	C16 ceramide Plas-sCnc	4180186
1002151	N-棕榈酰基神经鞘氨醇:物质的量浓度:时间点:血浆:定量型	4182948
1002152	H capsul IgG CSF IA-aCnc	4180186
1002152	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; EIA; ELFA; ELISA; Enzyme immunoassay; H capsul; H capsulatum; H farciminosum; Histo; Histopl; Histoplasma farciminosum; Histoplasmos; Histoplasmosis; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS	4180186
1002152	荚膜组织胞浆菌 抗体.IgG:任意型浓度:时间点:脑脊液:定量型:免疫测定法	4182948
1002154	Act/Nor; Antigen, CD42a; Blood; CD42a Antigen; CELL MARKERS; Control; Dynamic; FC; GPIX; Pl; Platelet Glycoprotein IX; Platelets; Platelt; Plt; Plt CD42a; Plt CD42a Act/Nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002154	Plt CD42a Act/Nor Bld FC	4180186
1002154	血小板 CD42a 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002156	2-OH-Ethylfluraz Ur Ql Scn	4180186
1002156	2-OH-Ethylfluraz; DRUG/TOXICOLOGY; Drugs; Flurazepam metabolite; Hydroxy ethylflurazepam; II; OH-Ethylfluraz; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002156	2-羟乙基氟西泮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002157	Lg B-cell lymph Tiss	4180186
1002157	大B细胞淋巴瘤:类型:时间点:组织与涂片:名义型	4182948
1002157	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002158	Advanced; CLIN; directives; Finding; Findings; Nominal; Point in time; Random	4180186
1002158	事前指示文档格式:发现:时间点:^患者:名义型	4182948
1002159	D Ag p HSCT RBC Ql	4180186
1002159	After; Antigen; Antigens; BLOOD BANK; D Ag^p stem trnsplt; Dextro; Erythrocytes; Ordinal; p HSCT; Point in time; PR; PST; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rhesus; Screen	4180186
1002159	D 抗原^在造血干细胞移植之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1002161	BM; BON; Bone marrow; Deoxyribonucleic acid; DNA content; Dynamic; FC; MAR; Marrow (bone); minimal angle of resolution; Minimum angle of resolution; Molecular pathology; MOLPATH; Monotypic PC DNA ploidy; Nominal; Point in time; Random; Typ	4180186
1002161	Monotypic PC DNA ploidy Mar FC	4180186
1002161	单型浆细胞 DNA 倍性:类型:时间点:骨髓:名义型:流式细胞测量术	4182948
1002162	HMGCR IgG Ser IA-aCnc	4180186
1002162	3-羟基-3-甲基戊二酰-辅酶 A 还原酶 抗体.IgG:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
1002162	3-OH-3-Methylglutaryl-coA reductase Ab; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; HMGCR; Hydrox; IAA; III; Immune globulin G; Immunoglobulin G; MEIA; NAM; Necrotizing autoimmune myopathy; OH; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; SUDS	4180186
1002163	Blood; Document; Finding; Findings; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MYCN amplification; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002163	MYCN amplification Bld/T FISH	4180186
1002163	MYCN 基因扩增:发现:时间点:全血/组织:文档型:FISH	4182948
1002165	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Osmo; Osmol; Osmolality; osmolarity; p dose; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VP	4180186
1002165	Osmolality 1h p Vaso Ur	4180186
1002165	渗透压^在给予剂量后叶加压素之后1小时:渗透压:时间点:尿液:定量型	4182948
1002166	Bacterial gyrA drug res mut Islt/Spm	4180186
1002166	ANTIBIOTIC SUSCEPTIBILITIES; Bact; Bacterial gyrA drug res mut; Drugs; Identity or presence; Islt; Islt/Spm; Isol; Molecular genetics; Mut; Mutations; Nominal; PCR; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Spec	4180186
1002166	细菌 gyrA 基因耐药性突变:存在与否或特征标识:时间点:分离株/标本:名义型:分子遗传学类实验室方法	4182948
1002167	Citrobac sp DNA Bld Pos Ql NAA+probe	4180186
1002167	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Citrobac sp; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002167	柠檬酸杆菌属单个未知种 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002168	N men DNA Bld Pos Ql NAA+probe	4180186
1002168	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002168	脑膜炎奈瑟菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002169	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Substance abuse; Visit note	4180186
1002169	Addiction med Prog note	4180186
1002169	病程记录:发现:时间点:{环境}:文档型:成瘾医学	4182948
1002173	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002174	H+P; H+P.PX; Nominal; P prime; Point in time; Random; Wnd; Wnd shape	4180186
1002174	Wnd shape	4180186
1002174	伤口形状:形状:时间点:伤口:名义型	4182948
1002177	Blood; ECGF1; Endothelial cell growth factor 1 (platelet-derived); full gene sequencing; Full Mut Anl; high-throughput sequencing; HTS; Identity or presence; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; Nominal; Point in time; Random; sequencing of entire coding region; Thymidine phosphorylase; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002177	TYMP Full Mut Anl Bld/T Seq	4180186
1002177	TYMP 基因 全面突变分析:存在与否或特征标识:时间点:全血/组织:名义型:序列测定	4182948
1002180	mGluR1 IgG Titr CSF IF	4180186
1002180	代谢型谷氨酸受体 1 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1002180	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; c707; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; Glu; Glutamic acid; i; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; mGluR1; mGluR1 Ab; mGluR1 IgG; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002182	Admin info; Centers for Medicare and Medicaid Assessment; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002183	BM; BON; Bone marrow; Cell; Cellularity; Dynamic; FC; HEMATOLOGY/CELL COUNTS; Identity or presence; Leukemia; MAR; Marrow (bone); MGUS; minimal angle of resolution; Minimum angle of resolution; Monoclonal; Monotypic plasma cells; Multiple myeloma; Myeloma cells; Nominal; Plasma cell myeloma; Plasmacyte; Plasmacytes; Point in time; Random	4180186
1002183	Monotypic plasma cells Mar FC	4180186
1002183	浆细胞.单型群:存在与否或特征标识:时间点:骨髓:名义型:流式细胞测量术	4182948
1002184	1 month; 1 month (30 days); 30 days; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002185	Exercise distance 24h	4180186
1002185	1 day; 24 hours; 24HR; CLIN; EXCZ; Length; QNT; Quan; Quant; Quantitative	4180186
1002185	运动距离:长度:24小时:^患者:定量型	4182948
1002186	120 min; 120 minutes; 120min; 2 hours; 2h p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002186	Breath H2 2h p carb	4180186
1002186	氢/已呼出的气体^在给予剂量碳水化合物之后2小时:体积分数:时间点:呼出的气体:定量型	4182948
1002190	GN Bld Culture Pnl Bld Pos NAA+probe	4180186
1002190	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; DNA NUCLEIC ACID PROBE; DNA probe; GN Bld Culture Pnl; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; NEG; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002190	革兰氏阴性细菌血液培养组套:-:时间点:血液.生长阳性:-:探针法.基因扩增.靶向	4182948
1002195	Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Vomitus	4180186
1002195	已发生的呕吐:发现:时间点:^患者:序数型	4182948
1002196	Gyn Onc Phone Note	4180186
1002196	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Point in time; Random; Visit note	4180186
1002196	记录:发现:时间点:电话就医:文档型:妇科肿瘤学	4182948
1002197	GABABR Ab Ser Ql CBA IFA	4180186
1002197	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002197	Gamma 氨基丁酸 B 受体 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002200	After; Blood; BLOOD BANK; D phenotyping; D typing; K Ag^p stem trnsplt; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; PST; Random; Rh Ags+K Ag Pnl p stem trnsplt; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002200	Rh Ags+K Ag Pnl p stem trnsplt Bld	4180186
1002200	造血干细胞移植后Rh抗原与K抗原组套:-:时间点:全血:-	4182948
1002201	GABABR IgG Titr SerPl IF	4180186
1002201	Gamma 氨基丁酸 B 受体 抗体.IgG:滴定度:时间点:血清/血浆:定量型:免疫荧光法	4182948
1002201	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; ACIF; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Piperidic acid; Pl; Plasma; Plsm; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002202	H+P; H+P.HX; P prime; Point in time; QNT; Quan; Quant; Quantitative; Random; Vol; Volume; Wnd	4180186
1002202	Wound vol	4180186
1002202	伤口体积:体积型属性:时间点:伤口:定量型	4182948
1002204	Blood; Genetic variant diag sig; Genetics; Genomic; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; Narrative; Point in time; Random; Report; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002204	Genetic variant diag sig Bld/T-Imp	4180186
1002204	遗传变异诊断意义:印象:时间点:全血/组织:叙述型	4182948
1002205	LA ES vol/BSA A2C MOD	4180186
1002205	2D US; A2C MOD; Atrial; Bdy surface; bod; Bodies; BSA; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; L; LA; LAA; LAVI; Left Atrial Volume Index; LT; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; Surf; ULS; Ultrasound; Ultrasound - 2-dimensional; Vol; Volume/area	4180186
1002205	心脏收缩末期容积/体表面积:体积/面积:时间点:心脏.心房.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002206	Plt CD61 Act/Nor Bld FC	4180186
1002206	Act/Nor; Beta 3; Beta 3 integrin chain; Beta3; Beta-3 integrin; Blood; CD61 Antigen; CD61A; CELL MARKERS; Control; Dynamic; FC; GPIIb/IIIa; GPIIIa; Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61); Pl; Platelet Glycoprotein IIIa; Platelet GPIIIa; Platelets; Platelt; Plt; Plt CD61; Plt CD61 act/nor; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1002206	血小板 CD61 实际的/正常的:相对比率:时间点:全血:定量型:流式细胞测量术	4182948
1002209	Arterial Stenosis; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1002210	Centers for Medicare and Medicaid Assessment; Finding; Findings; LMTED; LTD; Ordinal; Ql; Qual; Qualitative; Report period; Screen; Survey	4180186
1002211	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002212	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Spec; Survey; SURVEY.CSSRS	4180186
1002221	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Othr; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002222	CT Head+C-spine WO+W contr IV	4180186
1002222	Brain; c; C/sp; CAT scan; Cerv; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; C-spine; CT scan; Document; Finding; Findings; Head+C-spine; Head+Neck; Imaging; Intracranial; Point in time; Radiology; Random; Skull; Spinal; Spinal Cord; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1002222	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部 & 颈部>脊椎.颈段:文档型:CT	4182948
1002225	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1002226	Chemistry; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; NASH interpretation; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002226	NASH interpretation SerPl-Imp	4180186
1002226	非酒精性脂肪变性肝炎解释:印象:时间点:血清/血浆:序数型	4182948
1002229	XR Finger.3rd.distl phlnx Bone dev stage	4180186
1002229	3rd; 3rd finger; Arm; Bone dev stage; EXT; Finger.3rd; Finger.3rd.distl phlnx; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Xray; X-ray	4180186
1002229	骨骼发育阶段:评分:时间点:上肢>手指.第三.远节指骨:定量型:X射线摄影术	4182948
1002230	Glucose Mean SerPl-mCnc	4180186
1002230	Average; Avg; Chemistry; Glu; Gluc; Glucoseur; Level; Mass concentration; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Studies; Study; Sutdies	4180186
1002230	葡萄糖:质量浓度:检查过程持续时间^平均值:血清/血浆:定量型	4182948
1002231	Liver steatosis score SerPl	4180186
1002231	Chemistry; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002231	肝脂肪变性评分:评分:时间点:血清/血浆:定量型	4182948
1002232	2; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002232	HTLV I+II IgG CSF Ql Line blot	4180186
1002232	HTLV I+II 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:线点印迹法	4182948
1002236	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002238	5th; Arm; Bone dev stage; EXT; Imaging; Metacarpal.5th; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002238	XR Metacarpal.5th Bone dev stage	4180186
1002238	骨骼发育阶段:评分:时间点:上肢>手.掌骨.第五:定量型:X射线摄影术	4182948
1002239	Entitic; Entitic number; Fluorescent in situ hybridization; Molecular pathology; MOLPATH; MYCN copy num; No; Num; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1002239	MYCN copy num/nucleus EntNum Tiss FISH	4180186
1002239	MYCN 基因拷贝数/核:实体数量:时间点:组织与涂片:定量型:FISH	4182948
1002240	ABO + Rh infant Bld	4180186
1002240	ABO + Rh; ABO group and Rh type; ABO+Rh Gp; ABO+Rh Gp^infant; Blood; BLOOD BANK; D phenotyping; D typing; infant; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood	4180186
1002240	ABO与Rh血型^婴儿期期间:类型:时间点:全血:名义型	4182948
1002242	Centers for Medicare and Medicaid Assessment; Disch; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey	4180186
1002246	Bdy weight; bod; Bodies; BW; EXCZ; O2; O2 consumption; O2 consumption/BW; peak W exer; Point in time; Post; Postdose; Post-dose; PULMONARY; QNT; Quan; Quant; Quantitative; Random; tO2; Volume rate content; W exercise; Wt	4180186
1002246	VO2/BW max dur exercise	4180186
1002246	氧消耗/体重^运动过程中的峰值:体积速率含量:时间点:^患者:定量型	4182948
1002247	Anaerobic Thresholds; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; Threshold, Anaerobic; Volume rate content	4180186
1002247	Ventilatory threshold	4180186
1002247	通气阈值:体积速率含量:时间点:^患者:定量型	4182948
1002248	AMPAR2 Ab Ser Ql CBA IFA	4180186
1002248	ABS; Aby; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GluA2; GluR2; GluR-B; Hydrox; II; III; Indirect Fluorescence Antibody; Limbic encephalitis; OH; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Serum; SR	4180186
1002248	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体:存在情况或阈值:时间点:血清:序数型:CBA IFA	4182948
1002249	B miyamotoi IgG+IgM SerPl-Imp	4180186
1002249	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B miyamotoi; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Microbiology; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; TBRF; Tick Borne Diseases; tick-borne relapsing fever	4180186
1002249	宫本疏螺旋体 抗体.IgG+IgM:印象:时间点:血清/血浆:名义型	4182948
1002250	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002251	SSD severity	4180186
1002251	H+P; H+P.HX; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; SSD severity; Sx	4180186
1002251	躯体症状障碍严重程度:印象:时间点:^患者:序数型	4182948
1002252	LV Max circ atrial contract st rt 3D US	4180186
1002252	3D US; CARD.US; Cardiac; Cardiology; Echography; Hrt; Hrt ventr; L; Largest; Length Ratio; LT; LV; Max circ atrial contract st rt; Maximal; Maximum; Peak; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ventricular	4180186
1002252	心房收缩应变速率.周向.最大值:长度比率:时间点:心脏.心室.左侧:定量型:超声.3D	4182948
1002261	Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002263	1 hour; 1.0Hr; 1h p Vaso; 60 min; 60 minutes; 60M; 60min; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Cl; Cl-; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002263	Chloride 1h p Vaso SerPl-sCnc	4180186
1002263	氯^在给予剂量后叶加压素之后1小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002264	After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002264	Breath H2 p carb	4180186
1002264	氢/已呼出的气体^在给予剂量碳水化合物之后:体积分数:时间点:呼出的气体:定量型	4182948
1002265	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; P mirabilis; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002265	P mirabilis DNA Bld Pos Ql NAA+probe	4180186
1002265	奇异变形杆菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002267	GRS for CHD	4180186
1002267	CLIN; CLIN.RISK; Coronary Artery Diseases; Dis; Disease, Coronary Artery; Diseases; Dz; Genetics; Genomic; Genomic risk score; GRS for CHD; Polygenic risk score; QNT; Quan; Quant; Quantitative; Scale	4180186
1002267	冠心病遗传风险评分:评分:一生:^患者:定量型	4182948
1002268	CARD.US; Cardiology; Dias; Dias.max; Diast; Diastoli; DOP; DUPLEX; Echography; Grad; Largest; Maximal; Maximum; Peak; Point in time; Pres grad.early dias.max; Press grad; PV; PVG; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound	4180186
1002268	PV Pres grad.early dias.max DOP	4180186
1002268	压力梯度.舒张早期.最大值:压差:时间点:肺动脉瓣:定量型:超声.多普勒	4182948
1002269	Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; Clot; Clottable; Coag; Coagulation assay; Hep; Hepar; Heparin Nt; Heparn; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1002269	aPTT-LA p hep neut PPP	4180186
1002269	表面诱导型凝血过程.狼疮敏感性^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002271	Appt legal guardian	4180186
1002271	ADMIN; ADMIN.PATIENT; Appt legal guardian; Finding; Findings; Nominal; Point in time; Random	4180186
1002271	法定监护人委任情况:发现:时间点:^患者:名义型	4182948
1002273	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F tular; F tularensis; IAA; Immune globulin G; Immunoglobulin G; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Tularemia	4180186
1002273	F tular IgG Ser Ql IA	4180186
1002273	土拉弗朗西斯菌 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1002276	XR Triquetrum Bone dev stage	4180186
1002276	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002276	骨骼发育阶段:评分:时间点:上肢>腕部.三角骨:定量型:X射线摄影术	4182948
1002280	FDA label Index - drug interactions	4180186
1002280	DOCUMENT.REGULATORY; Drugs; FDA label; Index - drug interactions; Narrative; Report	4180186
1002280	索引 - 药物相互作用:-:-:^FDA 产品标签:叙述型	4182948
1002282	Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc	4180186
1002282	17-Hydroxycorticosterone; Before; CHEMISTRY.CHALLENGE TESTING; Compound F; Coritsol; Cort; F; hydrocortisone; i; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002282	皮质醇^在静脉注射1 ug/kg促肾上腺皮质激素释放激素之前1分钟:质量浓度:时间点:血清/血浆:定量型	4182948
1002283	Adverse drug seq var interp Bld/T-Imp	4180186
1002283	Adverse drug rxn; Adverse drug seq var interp; Blood; Drugs; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Narrative; Point in time; Random; React; Report; Rxn; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002283	药物不良反应序列变异风险解释:印象:时间点:全血/组织:叙述型	4182948
1002284	K pneumon DNA Bld Pos Ql NAA+probe	4180186
1002284	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bld Pos; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; K pneumon; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002284	肺炎克雷伯菌 DNA:存在情况或阈值:时间点:血液.生长阳性:序数型:探针法.基因扩增.靶向	4182948
1002286	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.MTLHLTH; Tot; Totl	4180186
1002288	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Gestation; Gestations; Gravida; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Pregnancies; Random; Study report; Survey; SURVEY.MTLHLTH	4180186
1002289	Metamyelocytes.neut/leuk NFr Mar Manual	4180186
1002289	100WBC; BM; BON; Bone marrow; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; MAR; Marrow (bone); Meta; Metamyelo; Metamyelocyte; Metamyelocyte%; Metas; minimal angle of resolution; Minimum angle of resolution; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells	4180186
1002289	晚幼粒细胞.嗜中性/100 个白细胞:计数型分数:时间点:骨髓:定量型:手工计数方法	4182948
1002291	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Astro virus; DNA NUCLEIC ACID PROBE; DNA probe; HAstV; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; PoAstV3; Point in time; Polymerase chain reaction; Pork; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002291	PoAstV3 RNA Ct Spec Qn NAA+probe	4180186
1002291	猪星状病毒 3 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002293	3-alpha,6-alpha-dihydroxy-5-beta-cholan-24-oate; 6alpha-Hydroxylithocholate; Chemistry; HDCA; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1002293	HDCA SerPl-sCnc	4180186
1002293	猪去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002294	Breath H2 45M p carb	4180186
1002294	45M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002294	氢/已呼出的气体^在给予剂量碳水化合物之后45分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002296	HEDIS 2020 Mammography	4180186
1002296	HEDIS 2020 Mammography; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002296	HEDIS 2020 取值集合 - 乳房X线照相术:-:时间点:^患者:-	4182948
1002298	C18 Cer; C18 ceramide; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration	4180186
1002298	C18 ceramide Plas-sCnc	4180186
1002298	N-硬脂酰基神经鞘氨醇:物质的量浓度:时间点:血浆:定量型	4182948
1002299	Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002300	Chemistry; Frac; Fract; Fraction; Fractionated; Fractionation; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Porphyrin Fract Pnl; Random; UA; UR; Urn	4180186
1002300	Porphyrin Fract Pnl Ur	4180186
1002300	卟啉类成分组套:-:时间点:尿液:-	4182948
1002303	ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; PST; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Vasopressin chal p H2O deprivation Pnl; VP	4180186
1002303	Vasopressin chal p H2O depr Pnl U+SerPl	4180186
1002303	限制饮水之后后叶加压素刺激组套:-:时间点:尿液+血清/血浆:-	4182948
1002311	Document; Finding; Findings; Fluorescent in situ hybridization; MDM2 amplification; Molecular pathology; MOLPATH; Point in time; Random; Tissue; Tissue, unspecified	4180186
1002311	MDM2 amplification Tiss FISH	4180186
1002311	MDM2 基因扩增:发现:时间点:组织与涂片:文档型:FISH	4182948
1002313	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; EMCV; EMCV RNA; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002313	EMCV RNA Ct Spec Qn NAA+probe	4180186
1002313	脑心肌炎病毒 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1002315	Finding; Findings; Last; Ordinal; Ql; Qual; Qualitative; Screen; SDOH; Survey; T prime	4180186
1002316	Centers for Medicare and Medicaid Assessment; Form version; Othr; Outcome and assessment information set; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002317	4h p busulfan; After; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1002317	Busulfan 4h p busulfan Plas-mCnc	4180186
1002317	白消安^在完成白消安输注之后4小时:质量浓度:时间点:血浆:定量型	4182948
1002318	AMPAR2 IgG Titr CSF IF	4180186
1002318	Alpha-氨基-3-羟基-5-甲基-4-异噁唑丙酸受体 2 抗体.IgG:滴定度:时间点:脑脊液:定量型:免疫荧光法	4182948
1002318	ABS; Aby; ACIF; Alfa; AMPA Receptor; AMPAR2; AMPAR2 Ab; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; GluA2; GluR2; GluR-B; Hydrox; IFA; II; III; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Limbic encephalitis; OH; Point in time; Random; Rec; Recept; Receptors; Recp; Recptr; Serology; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002320	Home access mod date	4180186
1002320	CLIN; Home access mod date; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1002320	住宅无障碍改造日期:日期:时间点:^患者:定量型	4182948
1002321	120 min; 120 minutes; 120min; 2 hours; 2h p busulfan; After; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Myleran; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random	4180186
1002321	Busulfan 2h p busulfan Plas-mCnc	4180186
1002321	白消安^在完成白消安输注之后2小时:质量浓度:时间点:血浆:定量型	4182948
1002322	Clarmyl; Clopax; DRUG/TOXICOLOGY; Drugs; Frisium; Noiafren; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sederlona; UA; UR; Urbadan; Urbanol; Urbanyl; Urn	4180186
1002322	cloBAZam Ur Ql Scn	4180186
1002322	氯巴詹:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002323	3 days; Centers for Medicare and Medicaid Assessment; Finding; Findings; Nominal; Past; Survey	4180186
1002324	Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Desmeth; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Mass Content; Mec; N-desmethyltramadol; NDT; Notramadol; O-desmethyltramadol; ODT; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Tramadol metabolite	4180186
1002324	O-nortramadol Mec Cfm-mCnt	4180186
1002324	O-去甲基曲马多:质量含量:时间点:胎便:定量型:毒理学确认试验	4182948
1002325	Bld flow; Bld flow vel; Bld flow.velocity; CARD.US; Cardiac; Cardiology; DOP; DUPLEX; Dynamic; Echography; Hrt; L; Largest; LT; LVOT; LVOT/AV Vmax; Maximal; Maximum; Peak; Peak velocity; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Vel; Velocity ratio; Vmax	4180186
1002325	Hrt LVOT/Aortic valve DOP	4180186
1002325	血流速度.最大值.左心室流出道/血流.最大值.主动脉瓣:速度比率:时间点:心脏:定量型:超声.多普勒	4182948
1002327	4-Hydroxycoumarin; Blood; Coumadin; Coumarin; Coumarins; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Pan; Panel.molpath; Panel.molpath.pharmg; Panl; Panwarfin; PCR; Pnl; Point in time; Random; Sofarin; Tissue; Tissue, unspecified; Warfarin genotype pnl; WB; Whole blood; Whole blood or Tissue	4180186
1002327	Warfarin genotype pnl Bld/T	4180186
1002327	华法林反应基因型组套:-:时间点:全血/组织:-:分子遗传学类实验室方法	4182948
1002328	B duncani IgG Titr Ser IF	4180186
1002328	邓肯巴贝斯虫 抗体.IgG:滴定度:时间点:血清:定量型:免疫荧光法	4182948
1002328	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; B duncani; Babesia WA1; Babesiosis; Dilution factor; Dilution Factor (Titer); FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Microbiology; Piroplasmosis; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr	4180186
1002329	Centers for Medicare and Medicaid Assessment; Drugs; Nominal; Point in time; Random; Survey; Typ	4180186
1002332	Flights climbed 24h nRate	4180186
1002332	1 day; 24 hours; 24HR; Count/time; H+P; H+P.HX; nRate; Number rate; Number Rate = Count/Time; P prime; QNT; Quan; Quant; Quantitative	4180186
1002332	攀登楼层数:计数型速率:24小时:^患者:定量型	4182948
1002333	Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; TUDCA	4180186
1002333	TUDCA SerPl-sCnc	4180186
1002333	牛磺熊去氧胆酸:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002335	Breath H2 15M p carb	4180186
1002335	15M p carb; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; H2; Hyd; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002335	氢/已呼出的气体^在给予剂量碳水化合物之后15分钟:体积分数:时间点:呼出的气体:定量型	4182948
1002336	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002343	LV SV A4C SP A-L	4180186
1002343	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002343	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002344	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Coccidiodes; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; San Joaquin Valley fever; SerP; SerPl; SerPlas; Serum; Serum or plasma; species; spp; SR; SUDS; Valley fever	4180186
1002344	Coccidioides IgM SerPl IA-aCnc	4180186
1002344	球孢子菌属单个未知种 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1002346	1-cyclohexyl-4-(1,2-diphenylethyl)piperazine; Addiction; C24H32N2; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002346	MT-45 Ur Cfm-mCnc	4180186
1002346	MT-45:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002348	Radiology Team Conf eval note	4180186
1002348	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Radiology Team; Random; Visit note	4180186
1002348	会议记录:发现:时间点:{环境}:文档型:放射医学.团队	4182948
1002350	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Ag; AnGAP; Anion Gap3; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; III; Level; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002350	Anion Gap3 2h p Vaso SerPl-sCnc	4180186
1002350	阴离子间隙 3^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002354	2; Bands; bnd; Cerebral spinal fluid; Cerebrospinal Fl; HTLV I + II ab band; HTLV I+II; HTLV type 1+2; HTLV type I+II; Human T-cell Leukemia Virus; Human T-cell Lymphotrophic Virus; Immune globulin G; Immunoglobulin G; Microbiology; Nominal; Point in time; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Typ	4180186
1002354	HTLV I + II ab band CSF Line blot	4180186
1002354	HTLV I & II 抗体.IgG 条带:类型:时间点:脑脊液:名义型:线点印迹法	4182948
1002355	XR Radius Bone dev stage	4180186
1002355	Arm; Bone dev stage; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002355	骨骼发育阶段:评分:时间点:上肢>桡骨:定量型:X射线摄影术	4182948
1002356	Assessment; Centers for Medicare and Medicaid Assessment; Disch; Eval; H&P; History and physical; Hosp; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Point in time; Random; Survey	4180186
1002359	Busulfan Plas-AUC	4180186
1002359	AUC; DRUG/TOXICOLOGY; Drugs; Myleran; Pl; Plasma; Plsm; QNT; Quan; Quant; Quantitative; Studies; Study; Sutdies	4180186
1002359	白消安:曲线下面积:检查过程持续时间:血浆:定量型	4182948
1002360	Arm; Bone dev stage; EXT; Imaging; Metacarpal.1st; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity; Xray; X-ray	4180186
1002360	XR Metacarpal.1st Bone dev stage	4180186
1002360	骨骼发育阶段:评分:时间点:上肢>手.掌骨.第一:定量型:X射线摄影术	4182948
1002370	HTR2C c.551-3008C>G Geno Bld/T	4180186
1002370	5-HT1C; 5HT-1C; 5-HT2C; 5-HT-2C; 5HTR2C; 5-HTR2C; 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled; 5-hydroxytryptamine receptor 2C gene; Blood; HTR1C; HTR2C c.551-3008C&gt;G; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Point in time; Random; rs1414334; serotonin receptor 2C gene; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002370	HTR2C 基因.c.551-3008C>G:基因型:时间点:全血/组织:名义型:分子遗传学类实验室方法	4182948
1002371	Plastic surgery Diag study note	4180186
1002371	Diag study note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Study report; Surg; Visit note	4180186
1002371	诊断性检查记录:发现:时间点:{环境}:文档型:成形外科学	4182948
1002374	NuPDQ Concurrent SA Version; Pan; Panel; PANEL.SURVEY.MTLHLTH; Panl; Pnl; Point in time; Pregnancy distressed questionnaire; Random; Survey; SURVEY.MTLHLTH	4180186
1002375	2D US; Calc; Calculation; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002375	LV SV Biplane area-length	4180186
1002375	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D+双平面面积-长度计算法	4182948
1002376	aPTT-LA confirm Act/Nor p hep neut PPP	4180186
1002376	Act/Nor; Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; aPTT-LA confirm; aPTT-LA confirm actual; Clot; Clottable; Coag; Coagulation assay; Control; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; RlTm; Surf; Tilt tube	4180186
1002376	表面诱导型凝血过程.狼疮敏感性.过量磷脂 实际的/正常的^在肝素中和之后:相对时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002380	UGT1A1 gene Full Mut Anl Bld/T Seq	4180186
1002380	BILIQTL1; Blood; Crigler-Najjar syndrome, type I; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gilbert Syndrome; GNT1; high-throughput sequencing; HTS; HUG-BR1; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Mut; Mutations; Next generation sequencing; NGS; Point in time; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; UDP glucuronosyltransferase 1 family, polypeptide A1; UDP glycosyltransferase 1 family, polypeptide A1 gene; UDPGT; UDPGT 1-1; UGT1; UGT1A; UGT1A5; WB; Whole blood; Whole blood or Tissue	4180186
1002380	UGT1A1 基因 全面突变分析:发现:时间点:全血/组织:文档型:序列测定	4182948
1002382	Exchange; Finding; Findings; Nominal; Persons; Point in time; Random; Replace; Survey; SURVEY.MTLHLTH; World Heatlth Organization	4180186
1002384	Antigen; Antigens; BLOOD BANK; c; C Ag^infant; Erythrocytes; infant; little c Ag^infant; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Rh; Rh Blood Group System; Screen	4180186
1002384	little c Ag infant RBC Ql	4180186
1002384	c 抗原^婴儿期期间:存在情况或阈值:时间点:红细胞:序数型	4182948
1002385	2D US; A2C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; CO; Echography; Flow; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volume rate; vRate	4180186
1002385	LV Output A2C SP A-L	4180186
1002385	心输出量:体积速率:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+单平面面积-长度计算法	4182948
1002386	Arbitrary concentration; Beta 1 E-globulin; Comp; Complmt; HEMATOLOGY/CELL COUNTS; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002386	C4.functional SerPl-aCnc	4180186
1002386	补体 C4.功能性:任意型浓度:时间点:血清/血浆:定量型	4182948
1002389	Alc; alcoholic; Drug; Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey	4180186
1002390	Breath methane 1.5h p carb	4180186
1002390	1 1/2 hours; 1 1/2 HR; 1.5h p carb; 1.5Hr; 90 min; 90 minutes; 90M; 90min; After; Breath; CHEMISTRY.CHALLENGE TESTING; ExG; Exhaled gas; Exhaled gas (=breath); Gases; p carb; p dose; Percent; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Volfr; Volume fraction	4180186
1002390	甲烷/已呼出的气体^在给予剂量碳水化合物之后1.5小时:体积分数:时间点:呼出的气体:定量型	4182948
1002391	Lu 20 Ag RBC Ql	4180186
1002391	Antigen; Antigens; BLOOD BANK; Erythrocytes; Left; Levo; Lu 20; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen	4180186
1002391	Lu 20 抗原:存在情况或阈值:时间点:红细胞:序数型	4182948
1002392	3 months; Cnt; Count; Number; QNT; Quan; Quant; Quantitative; Survey; SURVEY.CSSRS	4180186
1002393	TMB Tumor-Imp	4180186
1002393	Cancer; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; TMB; Tumor mutational load; tumors; tumour; tumours	4180186
1002393	肿瘤突变负荷:印象:时间点:肿瘤:序数型	4182948
1002396	Busulfan Gvn ?Tm Dose	4180186
1002396	?Tm; Dose med or substance; DRUG DOSES; Gvn; Myleran; QNT; Quan; Quant; Quantitative	4180186
1002396	白消安 给予的:质量:XXX:剂量药物或剂量物质:定量型	4182948
1002397	FLUAV NS1 gene Islt-Seq	4180186
1002397	Avian influenza; Bird flu; FLUA; FLUAV; FLUAV NS1 gene; FLUV; Fowl plague; high-throughput sequencing; HTS; Influ; Influenza A; Influenza A virus; Islt; Isol; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random	4180186
1002397	流感病毒 A NS1 基因:序列:时间点:分离株:名义型:序列测定	4182948
1002399	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002400	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002400	HSV2 DNA Bld Ql NAA+non-probe	4180186
1002400	单纯疱疹病毒 2 型 DNA:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
1002401	4-chloro-N-[1-(2-phenylethyl)-2-piperidinylidene]-benzenesulfonamide; Addiction; C19H21ClN2O2S; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Synthetic opioid; UA; UR; Urn	4180186
1002401	W-15 Ur Cfm-mCnc	4180186
1002401	W-15:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1002402	MH screen report	4180186
1002402	Asympt; Asymptomatic; DOC.MISC; Document; Emotional stability; Finding; Findings; MH screen report; MISC; Point in time; Random; Scn	4180186
1002402	心理健康筛查报告:发现:时间点:^患者:文档型	4182948
1002404	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; EF; Frac; Fract; Fractionation; Fractions; Hrt; Hrt ventr; L; LT; LV; LVEF; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Volfr; Volume fraction	4180186
1002404	LV EF A4C SP A-L	4180186
1002404	射血分数:体积分数:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002407	RAF Score	4180186
1002407	CLIN; CLIN.RISK; CMS-HCC; Fac; Fact; Point in time; QNT; Quan; Quant; Quantitative; RAF; Random; Risk adjustment model; Scale	4180186
1002407	风险调整因素:评分:时间点:^患者:定量型	4182948
1002408	EBV VCA IgM Ser Donr Ql IA	4180186
1002408	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CAP; Donr; EBV; EBV capsid Ab; EBV VCA; EIA; ELFA; ELISA; Enzyme immunoassay; Epstn; HHV-4; human herpesvirus 4; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Mono; Mononucleosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; VCA; Viral capsid	4180186
1002408	Epstein Barr 病毒衣壳 抗体.IgM:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1002409	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 DNA Pnl; HSV1; HSV1+2; i; II; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1002409	HSV 1+2 DNA Pnl Bld NAA+non-probe	4180186
1002409	单纯疱疹病毒 1 与 2 型组套:-:时间点:全血:-:非探针法.基因扩增.靶向	4182948
1002410	Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); D phenotyping; D typing; KEL1; Kell Blood Group System; Pan; PANEL.BLOODBANK; Panl; Pnl; Point in time; Random; Rh Ags+K Ag Pnl; Rh phenotyping; Rh typing; WB; Whole blood	4180186
1002410	Rh Ags+K Ag Pnl Bld BPU	4180186
1002410	Rh抗原与K抗原组套:-:时间点:全血^血液制品单位:-	4182948
1002412	Chr 12 copy num; Chromosom; Chromosomes; Fluorescent in situ hybridization; MDM2 copy num; Molecular pathology; MOLPATH; No; Num; Number ratio; Point in time; QNT; Quan; Quant; Quantitative; Random; Tissue; Tissue, unspecified	4180186
1002412	MDM2 copy num/Chr 12 copy num Tiss FISH	4180186
1002412	MDM2 基因拷贝数/染色体 12 拷贝数:计数型比率:时间点:组织与涂片:定量型:FISH	4182948
1002414	4 weeks; Finding; Findings; Job; Last; LMTED; LTD; Occupation; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.GNHLTH	4180186
1002415	Sodium 2h p Vaso SerPl-sCnc	4180186
1002415	120 min; 120 minutes; 120min; 2 hours; 2h p Vaso; ADH; Adiuretin; After; Antidiuretic hormone; Arginine vasopressin hormone; AVH; CHEMISTRY.CHALLENGE TESTING; Level; Na; Na+; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; VP	4180186
1002415	钠^在给予剂量后叶加压素之后2小时:物质的量浓度:时间点:血清/血浆:定量型	4182948
1002417	LV ES vol A4C SP A-L	4180186
1002417	2D US; A4C SP A-L; Calculated; CARD.US; Cardiac; Cardiology; Echography; ES vol; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002417	心脏收缩末期容积:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A4C+单平面面积-长度计算法	4182948
1002418	Chrom analy Bld/T Microarray	4180186
1002418	arrCGH; Blood; Chrom analy; Chromosom; Chromosomes; Cytogenetics; Document; Finding; Findings; Karyotype; Molecular pathology; MOLPATH; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1002418	染色体分析:发现:时间点:全血/组织:文档型:微阵列	4182948
1002420	HEDIS 2020 CT Colongrphy	4180186
1002420	HEDIS 2020 CT Colongrphy; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1002420	HEDIS 2020 取值集合 - CT 结肠成像:-:时间点:^患者:-	4182948
1002421	GABABR IgG SerPl Ql CBA IFA	4180186
1002421	4-aminobutanoic acid; 4-aminobutyrate; 4-aminobutyric acid; ABS; Aby; Aminobutric; Aminobutyric; Amino-n-butyrate; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; GABA; GABABR; GABABR Ab; Gamma aminobutyric acid; Gamma amino-butyric acid; Gamma amino-n-butyrate; Gamma amino-n-butyric acid; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Ordinal; Piperidic acid; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1002421	Gamma 氨基丁酸 B 受体 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:CBA IFA	4182948
1002424	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; F tular; F tularensis; IAA; Immune globulin M; Immunoglobulin M; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; Tularemia	4180186
1002424	F tular IgM Ser Ql IA	4180186
1002424	土拉弗朗西斯菌 抗体.IgM:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1002426	3 months; Finding; Findings; Ordinal; Ql; Qual; Qualitative; Screen; Survey; SURVEY.CSSRS	4180186
1002427	XR Hamate Bone dev stage	4180186
1002427	Arm; Bone dev stage; Carpal bone; Carpal bones; Carpal bones and joint; EXT; Imaging; Plain Films; Point in time; QNT; Quan; Quant; Quantitative; RADIOLOGY; Random; Scale; UE; Up; Upper extremity joint; Xray; X-ray	4180186
1002427	骨骼发育阶段:评分:时间点:上肢>腕部.钩状骨:定量型:X射线摄影术	4182948
1002428	Ang; Angio; Angiography; c; Contr; Contra; Contrst; Document; Finding; Findings; Imaging; Magnetic Resonance Angiographies; Magnetic resonance imaging; Mitral regurgitation maximum velocity; MR + MRA; MR angiography; MRA; MRI; MRI.angio; Point in time; Radiology; Random; Thorax; W contr IV; WC; WO & WC; WO+W contr; WO+W contr + W contr; WO+W contr IV; WWO	4180186
1002428	MR Chest WO+W contr IV+MRA W contr IV	4180186
1002428	多层^WO & W contrast IV && Multisection^W contrast IV:发现:时间点:胸部:文档型:MR && MR.血管造影术	4182948
1002429	Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH	4180186
1002430	Carbonic anhydride; cO2; EXCZ; Point in time; PULMONARY; QNT; Quan; Quant; Quantitative; Random; VEqCO2; Volume ratio	4180186
1002430	VEqCO2 W exercise	4180186
1002430	二氧化碳通气当量^采用运动:体积比率:时间点:^患者:定量型	4182948
1002432	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1002432	NMDAR1 IgG CSF Ql CBA IFA	4180186
1002432	N-甲基-D-天冬氨酸受体亚单位 1 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1002435	?Tm; dur cycle; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1002435	Calories burned dur cycle ?Tm	4180186
1002435	已消耗的热量^在骑行的过程中:功率:XXX:^患者:定量型	4182948
1002438	Centers for Medicare and Medicaid Assessment; Disch; Pan; Panel; PANEL.SURVEY.CMS; Panl; Pnl; Report period; Survey	4180186
1002439	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Circo virus; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; III; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; PCV; PCV3; PCV3 DNA; Point in time; Polymerase chain reaction; Pork; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; Swine; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1002439	PCV3 DNA Spec Ql NAA+probe	4180186
1002439	猪圆环病毒 3 型 DNA:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1002440	Arterial Stenosis; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Finding; Findings; Gestation; Gestations; Gravida; Ordinal; Point in time; Pregnancies; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.MTLHLTH; Sx	4180186
1002441	5 hours; 5.0Hr; 5HR; Chemistry; CR; Crea; Creat; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UCr; UR; Urn	4180186
1002441	Creat 5h Ur-sCnc	4180186
1002441	肌酐:物质的量浓度:5小时:尿液:定量型	4182948
1002443	aPTT-LA confirm p hep neut PPP	4180186
1002443	Activated partial thromboplastin time; After; aPTT; aPTT with Platelin LS; aPTT-LA; aPTT-LA confirm; Clot; Clottable; Coag; Coagulation assay; EXS; Hep; Hepar; Heparin Nt; Heparn; Lipid; Little(A)PTT; Neut; Neutr; p hep neut; Partial Thromboplastin Time; Phoslpd; Phospholipids; Pl; Plas; Platelet poor plasma; Point in time; PST; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1002443	表面诱导型凝血过程.狼疮敏感性.过量磷脂^在肝素中和之后:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1002444	Calories burned dur running ?Tm	4180186
1002444	?Tm; CLIN; dur running; Energy/time; Power; QNT; Quan; Quant; Quantitative	4180186
1002444	已消耗的热量^在跑行的过程中:功率:XXX:^患者:定量型	4182948
1002446	A. oryzae IgE Qn	4180186
1002446	A oryzae IgE; A. oryzae; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Asperg; Aspergil; Aspergilis; Aspergilla; Aspergillin; Aspergillosis; Aspergils; Aspergilus; Autoantibodies; Autoantibody; Immune globulin E; Immunoglobulin E; k87; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR	4180186
1002446	米曲霉 抗体.IgE:任意型浓度:时间点:血清:定量型	4182948
1002447	C-SSRS Lifetime/Recent; Pan; Panel; PANEL.SURVEY.CSSRS; Panl; Pnl; Point in time; Random; Survey; SURVEY.CSSRS	4180186
1002451	EV RNA Spec Ql NAA+non-probe	4180186
1002451	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1002451	肠道病毒 RNA:存在情况或阈值:时间点:XXX:序数型:非探针法.基因扩增.靶向	4182948
1002452	ANTIBIOTIC SUSCEPTIBILITIES; AST; Baxdela; DLX; Epsilometer; Estrip; E-strip; Fluoroquinolone; Grad strip; Islt; Isol; MIC; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1002452	DLX Islt Grad strip	4180186
1002452	德拉沙星:抗生素敏感性:时间点:分离株:定量型或序数型:梯度胶条法	4182948
1002453	Variant interaction assoc therapy resist	4180186
1002453	Blood; Genetics; Genomic; Identity or presence; Interaction assoc tx resist; Molecular pathology; MOLPATH; Nominal; Point in time; Random; Resist; Resistanc; Resistant; Resistent; Tissue; Tissue, unspecified; Tx; WB; Whole blood; Whole blood or Tissue	4180186
1002453	因为遗传变异之间的相互作用而导致耐受的治疗:存在与否或特征标识:时间点:全血/组织:名义型	4182948
1002456	LV SV A2C MOD	4180186
1002456	2D US; A2C MOD; Calculated; CARD.US; Cardiac; Cardiac output/Heart beat; Cardiology; Echography; Hrt; Hrt ventr; L; LT; LV; Point in time; QNT; Quan; Quant; Quantitative; Random; Sonogram; Sonograph; Sonography; SV; ULS; Ultrasound; Ultrasound - 2-dimensional; Ventricular; Vol; Volume	4180186
1002456	心搏量:体积型属性:时间点:心脏.心室.左侧:定量型:超声.2D.A2C+圆盘单平面计算法	4182948
1002457	1OH-midazolam Ur Ql Scn	4180186
1002457	1-Hydroxy midazolam; 1OH-midazolam; Alpha hydroxymidazolam; Alpha-hydroxymidazolam; Chlonazepam metabolite; DRUG/TOXICOLOGY; Drugs; i; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1002457	1-羟基咪达唑仑:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1002458	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; H seoul; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; Immune globulin G; Immunoglobulin G; Microbiology; Ordinal; Orthohantavirus; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Seoul orthohantavirus; SerP; SerPl; SerPlas; Serum; Serum or plasma; SNV; SR	4180186
1002458	H seoul IgG SerPl Ql Line blot	4180186
1002458	汉坦病毒 汉城型 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:线点印迹法	4182948
1002460	Lg B-cell lymph+COO Tiss	4180186
1002460	大B细胞淋巴瘤和细胞起源:类型:时间点:组织与涂片:名义型	4182948
1002460	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; BCELLS; BLYM; Lg B-cell lymph; Lg B-cell lymph+COO; Nominal; Pathology; Point in time; Random; Tissue; Tissue, unspecified; Typ	4180186
1002664	CHAL.ROUTINE	4180186
1002670	BDYWGT.MOLEC	4180186
1002709	RESP.TIMED.MOLEC	4180186
1002795	RESP.MOLEC	4180186
1002800	What Y was building built	4180186
1002979	HRTRATE.PSTN.MOLEC	4180186
1003043	BDYTMP.ATOM	4180186
1003106	HRTRATE.ATOM	4180186
1003116	BDYHGT.ATOM	4180186
1003260	Pelvis>Coccyx	4180186
1003380	HEMODYN.MOLEC	4180186
1003398	BDYTMP.TIMED.MOLEC	4180186
1003530	BP.CENT.MOLEC	4180186
1003545	What Y did you turn 18	4180186
1003605	BP.PSTN.MOLEC	4180186
1003761	BDYCRC.MOLEC	4180186
1003912	BDYHGT.MOLEC	4180186
1003929	BP.TIMED.MOLEC	4180186
1004039	BDYCRC.ATOM	4180186
1004079	DOC.ONTOLOGY	4180186
1004165	Liver+Biliary ducts+Pancreas	4180186
1004166	Special treatments &or programs - none of above - while a resident	4180186
1004167	Special treatments &or programs - none of above - while NOT a resident	4180186
1004170	History of falling; immediate or within 3Mo	4180186
1004218	Flag for Date 1st cancer Rx (any).SEERS not populated	4180186
1004338	Extracellular fld	4180186
1004339	EngRatFr	4180186
1004392	PPresDiff	4180186
1004422	VFrDiff	4180186
1004436	BCP	4180186
1004463	How often did you eat bread, toast or dinner rolls, including bread as part of a sandwich in past 30D	4180186
1004466	When you ate cold cereal, how much did you usually eat in the past 30D	4180186
1004468	Each time you ate cheese, how much did you usually eat in the past 30D	4180186
1004469	How often did you eat ice cream, ice cream bars, milk shakes, or frozen yogurt in the past 30D	4180186
1004470	Each time you ate ice cream, ice cream bars, milkshakes, or frozen yogurt, how much did you usually eat in the past 30D	4180186
1004473	How often did you eat mexican foods such as tacos, tostados, burritos, tamales, fajitas, enchiladas, quesadillas, or chimichangas in the past 30D	4180186
1004475	How often did you drink milk as a beverage in the past 30D	4180186
1004478	How often was the orange juice you drank calcium fortified in the past 30D	4180186
1004479	How often did you drink 100 percent orange juice in the past 30D	4180186
1004481	How often did you eat pizza in the past 30D	4180186
1004482	Each time you ate pizza, how much did you usually eat in past 30D	4180186
1004485	How often did you eat cooked dried beans, such as refried beans, baked beans, bean soup, and pork and beans in past 30D	4180186
1004487	When you ate cereal, which kinds did you usually eat in past 30D	4180186
1004488	How often did you eat any kind of cheese in past 30D	4180186
1004489	How often did you eat french fries, home fries, or hash brown potatoes in past 30D	4180186
1004490	How often did you drink 100 percent fruit juice, such as orange, mango, apple, and grape juices in past 30D	4180186
1004492	How often did you have salsa in past 30D	4180186
1004493	How often did you drink regular, carbonated soda or soft drinks that contain sugar in past 30D	4180186
1004494	How often did you have tomato sauces such as spaghetti sauce or pizza with tomato sauce in past 30D	4180186
1004495	How often did you eat whole grain bread including toast, rolls and in sandwiches in past 30D	4180186
1004501	How often did you drink decaffeinated coffee (instant & brewed)	4180186
1004502	What is your serving size for decaffeinated coffee (instant & brewed)	4180186
1004524	How many Y did you take zinc	4180186
1004526	Not counting lettuce salads, white potatoes, cooked dried beans, and not counting rice, how often did you eat other vegetables in past 30D	4180186
1004532	Did you take any dietary supplements during the past Y, at least once a W	4180186
1004537	How many Y did you take garlic, as a pill, tablet, or capsule	4180186
1004542	How often did you take fish oil or omega 3 fatty acids	4180186
1004543	How many Y did you take fish oil or omega 3 fatty acids	4180186
1004546	How often did you take coenzyme Q 10	4180186
1004564	How many Y did you take Folic acid, Folate	4180186
1004568	How often did you drink fruit flavored drinks with sugar (such as kool aid, hi C, lemonade, or cranberry cocktail) in past 30D	4180186
1004569	How often did you eat fruit in past 30D	4180186
1004575	How often did you eat cold cereal in the past 12Mo	4180186
1004576	About how often did you drink skim milk, on cereal or to drink in past 12Mo	4180186
1004578	About how often did you eat sausage or bacon, regular fat, in past 12Mo	4180186
1004579	About how often did you eat margarine or butter on bread, rolls, pancakes in past 12Mo	4180186
1004580	About how often did you drink orange juice or grapefruit juice in past 12Mo	4180186
1004582	About how often did you eat beef or pork hot dogs, regular fat, in past 12Mo	4180186
1004583	About how often did you eat cheese or cheese spread, regular fat, in past 12Mo	4180186
1004585	About how often did you eat margarine or butter on vegetables, including potatoes in past 12Mo	4180186
1004586	About how often did you eat mayonnaise, regular fat, in past 12Mo	4180186
1004590	When you prepared foods with margarine or ate margarine in past 12Mo, how often did you use reduced fat margarine	4180186
1004591	Overall, when you think about the foods you ate over the past 12Mo, would you say your diet was high, medium, or low in fat	4180186
1004600	How would you rate your pain on average in past 7D	4180186
1004601	How would you rate your fatigue on average in past 7D	4180186
1004603	How often have you been bothered by emotional problems such as feeling anxious, depressed or irritable in past 7D	4180186
1004721	When I was in pain I became irritable in past 7D	4180186
1004724	When I was in pain I moved extremely slowly in past 7D	4180186
1004725	When I was in pain I became angry in past 7D	4180186
1004726	When I was in pain I clenched my teeth in past 7D	4180186
1004727	When I was in pain I tried to stay very still in past 7D	4180186
1004728	When I was in pain I appeared upset or sad in past 7D	4180186
1004729	When I was in pain I gasped in past 7D	4180186
1004732	Pain caused me to bend over while walking in past 7D	4180186
1004734	When I was in pain I moved stiffly in past 7D	4180186
1004735	When I was in pain I called out for someone to help me in past 7D	4180186
1004736	Pain caused me to curl up in a ball in past 7D	4180186
1004740	I limped because of pain in past 7D	4180186
1004742	When I was in pain I frowned in past 7D	4180186
1004743	When I was in pain I asked for help when walking or changing positions in past 7D	4180186
1004744	When I was in pain I groaned in past 7D	4180186
1004745	When I was in pain I isolated myself from others in past 7D	4180186
1004746	When I was in pain I drew my knees up in past 7D	4180186
1004748	When I was in pain I flung my arms or limbs around in past 7D	4180186
1004749	When I was in pain I screamed in past 7D	4180186
1004751	When I was in pain I walked carefully in past 7D	4180186
1004752	When I was in pain I bit or pursed my lips in past 7D	4180186
1004754	When I was in pain I protected the part of my body that hurt in past 7D	4180186
1004755	When I was in pain my body became stiff in past 7D	4180186
1004756	When I was in pain I clenched my jaw or gritted my teeth in past 7D	4180186
1004757	When I was in pain I winced in past 7D	4180186
1004758	When I was in pain I moved my limbs protectively in past 7D	4180186
1004761	How difficult was it for you to take in new information because of pain in past 7D	4180186
1004763	How much did pain interfere with your close personal relationships in past 7D	4180186
1004766	How much did pain interfere with your enjoyment of recreational activities in past 7D	4180186
1004767	How often did you feel emotionally tense because of your pain in past 7D	4180186
1004770	How much did pain interfere with doing your tasks away from home (e.g., getting groceries, running errands)in past 7D	4180186
1004775	How much did pain interfere with work around the home in past 7D	4180186
1004777	How often did pain keep you from socializing with others in past 7D	4180186
1004780	How often did pain make you feel discouraged in past 7D	4180186
1004781	How much did pain interfere with your household chores in past 7D	4180186
1004783	How much did pain interfere with your enjoyment of social activities in past 7D	4180186
1004784	How often did pain make you feel anxious in past 7D	4180186
1004786	How often did pain make simple tasks hard to complete in past 7D	4180186
1004789	How often did pain make it difficult for you to plan social activities in past 7D	4180186
1004790	How often did pain prevent you from standing for more than 30 minutes in past 7D	4180186
1004791	How much did pain interfere with your ability to do household chores in past 7D	4180186
1004793	How often did pain prevent you from sitting for more than 30 minutes in past 7D	4180186
1004794	How often did pain prevent you from sitting for more than 10 minutes in past 7D	4180186
1004795	How often was it hard to plan social activities because you didn't know if you would be in pain in past 7D	4180186
1004798	How often did pain prevent you from sitting for more than one hour in past 7D	4180186
1004804	How often did you have to push yourself to get things done because of your fatigue in past 7D	4180186
1004805	How often did your fatigue interfere with your social activities in past 7D	4180186
1004808	How often were you too tired to watch television in past 7D	4180186
1004809	How often did your fatigue make it difficult to plan activities ahead of time in past 7D	4180186
1004810	How often did your fatigue make it difficult to start anything new in past 7D	4180186
1004811	How often did your fatigue make you more forgetful in past 7D	4180186
1004813	How often did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D	4180186
1004816	How often did your fatigue make it difficult to make decisions in past 7D	4180186
1004819	How often did your fatigue make you feel less alert in past 7D	4180186
1004822	How often did you have trouble starting things because of your fatigue in past 7D	4180186
1004824	How often were you too tired to socialize with your family in past 7D	4180186
1004825	To what degree did you have trouble starting things because of your fatigue in past 7D	4180186
1004826	How hard was it for you to carry on a conversation because of your fatigue in past 7D	4180186
1004827	How often were you too tired to leave the house in past 7D	4180186
1004828	How often were you too tired to think clearly in past 7D	4180186
1004830	To what degree did you have to limit your social activities because of your fatigue in past 7D	4180186
1004831	To what degree did your fatigue make it difficult to organize your thoughts when doing things at home in past 7D	4180186
1004832	To what degree did your fatigue make it difficult to start anything new in past 7D	4180186
1004833	Due to your fatigue were you less effective at work (include work at home) in past 7D	4180186
1004834	To what degree did your fatigue make it difficult to make decisions in past 7D	4180186
1004837	To what degree did your fatigue make it difficult to organize your thoughts when doing things at work (include work at home) in past 7D	4180186
1004840	To what degree did you have to force yourself to get up and do things because of your fatigue in past 7D	4180186
1004841	To what degree did your fatigue interfere with your social activities in past 7D	4180186
1004843	Did fatigue make you less effective at home in past 7D	4180186
1004846	How often were you too tired to take a short walk in past 7D	4180186
1004847	How often did you have to force yourself to get up and do things because of your fatigue in past 7D	4180186
1004848	How often were you too tired to socialize with your friends in past 7D	4180186
1004849	How often did you feel run-down in past 7D	4180186
1004851	How often did you feel tired even when you hadn't done anything in past 7D	4180186
1004853	To what degree did you feel tired even when you hadn't done anything in past 7D	4180186
1004854	How bushed were you on average in past 7D	4180186
1004857	How often were you physically drained in past 7D	4180186
1004859	How fatigued were you when your fatigue was at its worst in past 7D	4180186
1004860	How often were you bothered by your fatigue in past 7D	4180186
1004862	How often were you too tired to enjoy life in past 7D	4180186
1004864	How often did you feel totally drained in past 7D	4180186
1004865	How often were you energetic in past 7D	4180186
1004867	How much were you bothered by your fatigue on average in past 7D	4180186
1004869	How fatigued were you on the day you felt most fatigued in past 7D	4180186
1004871	How run-down did you feel on average in past 7D	4180186
1004872	How much mental energy did you have on average in past 7D	4180186
1004874	How energetic were you on average in past 7D	4180186
1004875	How sluggish were you on average in past 7D	4180186
1004877	How often did you find yourself getting tired easily in past 7D	4180186
1004878	How often did you think about your fatigue in past 7D	4180186
1004880	How easily did you find yourself getting tired on average in past 7D	4180186
1004881	How wiped out were you on average in past 7D	4180186
1004882	How often did you have physical energy in past 7D	4180186
1004883	What was the level of your fatigue on most D in past 7D	4180186
1004885	I felt weak all over in past 7D	4180186
1004886	I felt listless (washed out) in past 7D	4180186
1004889	I had trouble finishing things because I was tired in past 7D	4180186
1004890	I needed to sleep during the day in past 7D	4180186
1004893	I was frustrated by being too tired to do the things I want to do in past 7D	4180186
1004894	I had to limit my social activity because I was tired in past 7D	4180186
1004895	I had energy in past 7D	4180186
1004896	I am able to do my usual activities in past 7D	4180186
1004898	When I was frustrated, I let it show in past 7D	4180186
1004899	I was irritated more than people knew in past 7D	4180186
1004900	I felt envious of others in past 7D	4180186
1004901	I disagreed with people in past 7D	4180186
1004902	I made myself angry about something just by thinking about it in past 7D	4180186
1004905	When I was mad at someone, I gave them the silent treatment in past 7D	4180186
1004907	I felt like I was ready to explode in past 7D	4180186
1004909	I felt resentful when I didn't get my way in past 7D	4180186
1004910	I felt guilty about my anger in past 7D	4180186
1004912	I felt people are trying to anger me in past 7D	4180186
1004913	I stayed angry for hours in past 7D	4180186
1004914	I held grudges towards others in past 7D	4180186
1004916	I was grouchy in past 7D	4180186
1004920	I had trouble controlling my temper in past 7D	4180186
1004921	I was angry when I was delayed in past 7D	4180186
1004922	Even when I expressed my anger, I had trouble forgetting about it in past 7D	4180186
1004924	I was angry when something blocked my plans in past 7D	4180186
1004925	I felt like yelling at someone in past 7D	4180186
1004926	Just being around people irritated me in past 7D	4180186
1004928	I felt fearful in past 7D	4180186
1004933	I was concerned about my mental health in past 7D	4180186
1004936	I was anxious if my normal routine was disturbed in past 7D	4180186
1004938	Easily startled in past 7D	4180186
1004940	I avoided public places or activities in past 7D	4180186
1004943	I felt worried in past 7D	4180186
1004944	I felt terrified in past 7D	4180186
1004947	My worries overwhelmed me in past 7D	4180186
1004948	I had twitching or trembling muscles in past 7D	4180186
1004952	I had difficulty sleeping in past 7D	4180186
1004953	I had trouble relaxing in past 7D	4180186
1004954	I felt uneasy in past 7D	4180186
1004956	I had difficulty calming down in past 7D	4180186
1004959	I felt helpless in past 7D	4180186
1004961	I felt that nothing could cheer me up in past 7D	4180186
1004966	I felt like a failure in past 7D	4180186
1004967	I had trouble feeling close to people in past 7D	4180186
1004970	I felt lonely in past 7D	4180186
1004972	I had trouble making decisions in past 7D	4180186
1004975	I felt I had no reason for living in past 7D	4180186
1004976	I felt hopeless in past 7D	4180186
1004977	I felt ignored by people in past 7D	4180186
1004979	I felt pessimistic in past 7D	4180186
1004985	My sleep was deep in past 7D	4180186
1004987	My sleep was refreshing in past 7D	4180186
1004992	I woke up too early and could not fall back asleep in past 7D	4180186
1004993	Trouble staying asleep in past 7D	4180186
1004994	I had trouble sleeping in past 7D	4180186
1004996	My sleep was light in past 7D	4180186
1004999	I had a problem with my sleep 7D	4180186
1005000	I had difficulty falling asleep in past 7D	4180186
1005001	I felt physically tense at bedtime in past 7D	4180186
1005006	I had trouble getting into a comfortable position to sleep in past 7D	4180186
1005007	I tried hard to get to sleep in past 7D	4180186
1005008	Stress disturbed my sleep in past 7D	4180186
1005010	I was afraid I would not get back to sleep after waking up in past 7D	4180186
1005014	I was sleepy during the daytime in past 7D	4180186
1005015	I had trouble staying awake during the day in past 7D	4180186
1005020	I felt irritable because of poor sleep in past 7D	4180186
1005021	I had a hard time controlling my emotions because of poor sleep in past 7D	4180186
1005022	I had difficulty waking up in past 7D	4180186
1005025	I felt alert when I woke up in past 7D	4180186
1005026	When I woke up I felt ready to start the day in past 7D	4180186
1005029	I was satisfied with my current level of social activity in past 7D	4180186
1005030	I was satisfied with my ability to do all of the community activities that are really important to me in past 7D	4180186
1005031	I was satisfied with my ability to do things for my friends in past 7D	4180186
1005033	I was satisfied with my current level of activities with my friends in past 7D	4180186
1005034	I was satisfied with my ability to do things for fun outside my home in past 7D	4180186
1005035	I felt good about my ability to do things for my friends in past 7D	4180186
1005037	I was satisfied with the amount of time I spend visiting friends in past 7D	4180186
1005038	I was satisfied with my ability to do things for fun at home (like reading, listening to music, etc.) in past 7D	4180186
1005039	I was satisfied with my ability to do all of the leisure activities that Are really important to me in past 7D	4180186
1005044	I was satisfied with my ability to do the work that is really important to me (include work at home) in past 7D	4180186
1005045	I was satisfied with the amount of time I spend doing work (include work at home) in past 7D	4180186
1005048	The quality of my work is as good as I want it to be (include work at home) in past 7D	4180186
1005049	I was satisfied with the amount of time I spend performing my daily routines in past 7D	4180186
1005051	I was satisfied with my ability to do regular personal and household responsibilities in past 7D	4180186
1005054	I was satisfied with my ability to run errands in past 7D	4180186
1005056	I felt like something awful might happen in past 7D	4180186
1005057	I got scared really easy in past 7D	4180186
1005060	I was worried I might die in past 7D	4180186
1005061	I woke up at night scared in past 7D	4180186
1005063	I worried when I was away from home in past 7D	4180186
1005064	I worried when I was at home in past 7D	4180186
1005065	I thought about scary things in past 7D	4180186
1005066	I was afraid of going to school in past 7D	4180186
1005070	My chest felt tight because of my asthma in past 7D	4180186
1005075	My asthma bothered me in past 7D	4180186
1005077	I got tired easily because of my asthma in past 7D	4180186
1005079	I had trouble walking because of my asthma in past 7D	4180186
1005080	I missed school because of asthma in past 7D	4180186
1005083	My asthma bothered me when I was with my friends in past 7D	4180186
1005084	My body felt bad when I was out of breath in past 7D	4180186
1005086	I felt too sad to eat in past 7D	4180186
1005090	It was hard for me to have fun in past 7D	4180186
1005093	I felt like I couldn't do anything right in past 7D	4180186
1005095	I felt stressed in past 7D	4180186
1005098	Being tired kept me from having fun in past 7D	4180186
1005099	Being tired made it hard for me to keep up with my schoolwork in past 7D	4180186
1005102	I felt too tired to spend time with my friends in past 7D	4180186
1005104	I got tired easily in past 7D	4180186
1005105	I had trouble finishing things because I was too tired in past 7D	4180186
1005106	I had trouble starting things because I was too tired in past 7D	4180186
1005107	I was so tired it was hard for me to focus on my work in past 7D	4180186
1005109	I was too tired to do sports or exercise in past 7D	4180186
1005111	I was too tired to enjoy the things I like to do in past 7D	4180186
1005112	I was too tired to go out with my family in past 7D	4180186
1005119	I could get in and out of a car in past 7D	4180186
1005121	I could do sports and exercise that other kids my age could do in past 7D	4180186
1005124	I could get into bed by myself in past 7D	4180186
1005126	I could get down on my knees without holding on to something in past 7D	4180186
1005128	I used a wheelchair to get around in past 7D	4180186
1005133	I could get up from the floor in past 7D	4180186
1005136	I could turn my head all the way to the side in past 7D	4180186
1005139	I could bend over to pick something up in past 7D	4180186
1005140	I could walk across the room in past 7D	4180186
1005145	I hurt a lot in past 7D	4180186
1005148	It was hard for me to run when I had pain in past 7D	4180186
1005150	I missed school when I had pain in past 7D	4180186
1005151	It was hard to get along with other people when I had pain in past 7D	4180186
1005156	I felt accepted by other kids my age in past 7D	4180186
1005158	I liked being around other kids my age in past 7D	4180186
1005159	I played alone and kept to myself in past 7D	4180186
1005160	I shared with other kids (food, games, pens, etc) in past 7D	4180186
1005161	I spent time with my friends in past 7D	4180186
1005162	I was a good friend in past 7D	4180186
1005163	I was able to count on my friends in past 7D	4180186
1005164	I was able to have fun with my friends in past 7D	4180186
1005167	My friends and I helped each other out in past 7D	4180186
1005169	Other kids wanted to be with me in past 7D	4180186
1005170	Other kids wanted to talk to me in past 7D	4180186
1005172	I could button my shirt or pants in past 7D	4180186
1005173	I could open a jar by myself in past 7D	4180186
1005174	I could open the rings in school binders in past 7D	4180186
1005177	I could pull open heavy doors in past 7D	4180186
1005178	I could put on my shoes by myself in past 7D	4180186
1005179	I could use a key to unlock a door in past 7D	4180186
1005181	I felt fed up in past 7D	4180186
1005185	When I got mad, I stayed mad in past 7D	4180186
1005186	PROMIS pediatric short form - emotional distress - anxiety 8a - version 1.0	4180186
1005187	I was afraid that I would make mistakes in past 7D	4180186
1005201	Each time you ate cold cereal, how much did you usually eat in the past 30D	4180186
1005208	It was hard for me to get out of bed in the morning because I was too tired in past 7D	4180186
1005219	I could put toothpaste on my toothbrush by myself in past 7D	4180186
1005220	I could lift a cup to drink in past 7D	4180186
1005221	I could zip up my clothes in past 7D	4180186
1005222	I could pull on and fasten my seatbelt in past 7D	4180186
1005223	I could open my clothing drawers in past 7D	4180186
1005225	I could cut paper with scissors in past 7D	4180186
1005226	I could dry my back with a towel in past 7D	4180186
1005228	I used a pencil with a special grip to write in past 7D	4180186
1005230	I could tie shoelaces by myself in past 7D	4180186
1005231	I could put on my clothes by myself in past 7D	4180186
1005232	I could turn door handles by myself in past 7D	4180186
1005233	I could use a mouse or touch pad for the computer in past 7D	4180186
1005234	I could hold a full cup in past 7D	4180186
1005235	I could hold an empty cup in past 7D	4180186
1005236	I could brush my teeth by myself in past 7D	4180186
1005265	Krabbe disease newborn screening comment-discussion	4180186
1005266	Gaucher disease newborn screening comment-discussion	4180186
1005362	PhenX domain - Alcohol, tobacco & other substances	4180186
1005367	PhenX measure - alcohol - 30D quantity - frequency	4180186
1005640	PhenX measure - physical activity - readiness	4180186
1005876	Pompe disease newborn screening comment-discussion	4180186
1005878	Where were you born	4180186
1005882	Where was your father's father born	4180186
1005890	What was your best estimate of the total income of all family members from all sources, before taxes, in last Y	4180186
1005913	At what age did you begin to drink regularly - that is, drinking at least once a month for 6Mo or more	4180186
1005915	In your lifetime, what is the largest number of drinks you have ever had in a 24H period, including all types of alcohol	4180186
1005921	Has there ever been a period in your life when you smoked cigarettes every day for at least 6Mo	4180186
1005923	Whole body scan image name	4180186
1005929	During the past 30D, have you smoked part or all of a cigarette	4180186
1005937	During the past 30D, on how many D did you drink one or more drinks of an alcoholic beverage	4180186
1005938	On the D that you drank during the past 30D, how many drinks did you usually have each D	4180186
1005957	Did you continue to drink after you knew it caused you any of these emotional or psychological problems	4180186
1005961	Has drinking ever caused you this emotional or psychological problem for more than 24H to the point that it interfered with your functioning or relationships	4180186
1005962	When you stopped, cut down or went without drinking, did you ever experience this problem for most of the day for 2D or longer	4180186
1005964	On the number of D you reported you smoked cigarettes during the past 30D, how many cigarettes did you smoke per D, on average	4180186
1005981	During the past 30D, on how many D did you use drugs	4180186
1005984	Problem, related to marijuana use, that occurred for more than 24H to the point that it interfered with functioning or relationships	4180186
1005991	When you stopped, cut down, or went without marijuana, did you ever experience any of these problems for most of the day for 2D or longer	4180186
1006019	Has use of this drug ever caused you emotional or psychological problems for more than 24H to the point that it interfered with your functioning or relationships	4180186
1006025	Problem when you stopped, cut down or went without marijuana for 2D or longer	4180186
1006031	What Y did you start living there	4180186
1006033	What Mo did you move from there	4180186
1006034	What Y did you move from there	4180186
1006045	During which Mo do you usually stop using air conditioning	4180186
1006049	During which Mo do you usually stop using heating devices	4180186
1006050	In the last 12Mo, did any dogs, cats or other small furry animals, such as a rabbit, guinea pig or hamster, live or spend time inside your home	4180186
1006069	How many Y were you regularly exposed to this material	4180186
1006076	Which of the following best describes the H you usually work at you main job or business	4180186
1006084	What was the name of the company where you first or next worked, for 6Mo or longer	4180186
1006086	In what Y did you start working at this job	4180186
1006095	Have you participated for 6Mo or longer in this hobby	4180186
1006096	In what Y were you first involved in this hobby	4180186
1006097	In what Y were you last involved in in this hobby	4180186
1006099	On average, about how many hours per W, Mo, or Y have you participated in this hobby	4180186
1006103	How many cigarettes per D do you usually smoke anywhere inside the home	4180186
1006104	At this job or business, that is at your employer, in your occupation, how many H per D can you smell the smoke from other peoples cigarettes, cigars, or pipes	4180186
1006114	In what Mo and Y did child end the first or next attendance of day care or preschool	4180186
1006115	About how many H per W did or does child attend day care or preschool outside the home	4180186
1006118	In the past Y has there been a major renovation to this house or apartment, such as adding a room, putting up or taking down a wall, replacing windows, or refinishing floors	4180186
1006121	Within the last 6Mo were rugs, drapes or furniture professionally cleaned	4180186
1006125	In the past Y, was the inside of this house or apartment painted	4180186
1006130	Air contaminant in the home	4180186
1006131	Have you, or has someone near you, used this air contaminant in the last 48H	4180186
1006140	During the last 48H, the study period, have you operated or been near diesel engines, e.g. bus terminal, truck stop	4180186
1006157	On a typical weekday in the summer, about how many H did you generally spend in the mid-day sun	4180186
1006158	On a typical weekend D in the summer, about how many H did you generally spend in the mid-day sun	4180186
1006165	Has there been renovation in your home during the past 12Mo	4180186
1006184	How many Mo a Y did you usually have a tan	4180186
1006186	Have you ever consumed alcoholic beverages, such as beer, wine, or liquor at least once a W for 6Mo or more	4180186
1006192	Average H per W you participated in moderate exercise activities or sports like brisk walking, golf, volleyball, cycling on level streets, recreational tennis, or softball during this age range	4180186
1006196	Average D per W did you spend doing this activity	4180186
1006198	For how many Y were you exposed to smoke from other peoples cigarettes or tobacco products during this time at this location	4180186
1006199	At the present time, how many H per D are you exposed to the smoke of others	4180186
1006208	How many Y in total did you take estrogens other than premarin pills - exclude any time when you temporarily stopped	4180186
1006212	How many Y in total did you take progesterone or a progestin - excluding any time when you temporarily stopped	4180186
1006250	During the past 12Mo, did any doctor, dentist, nurse, or any other health professional advise you to quit smoking	4180186
1006273	Age range for lifetime alcohol exposure	4180186
1006274	How many drinks per D, W, Mo, or Y did you usually have	4180186
1006284	How often was your baby put to bed with a bottle of formula, breast milk, juice drink, or any other kind of milk in past 2W	4180186
1006285	Did you give your baby a bottle in the past 2W	4180186
1006290	Did your child consume this beverage during the past W	4180186
1006315	Did you have painful sores or irritations around the lips or on the tongue, cheeks, or gums more than once in past 6Mo	4180186
1006316	Did you first have the sores or irritations more than 6Mo ago	4180186
1006322	Did you have this pain or toothache more than once, in past 6Mo	4180186
1006339	Post-bronchodilator forced expiratory volume in 1 second attempt	4180186
1006340	Post-bronchodilator forced vital capacity attempt	4180186
1006346	Repair done in your home during the past 12Mo if other	4180186
1006358	Critical care medicine.medical student	4180186
1006385	Do you usually cough as much as 4 to 6 times a D, 4 or more D out of the W	4180186
1006393	Do you usually bring up phlegm at all during the rest of the D or at night	4180186
1006395	For how many Y have you had trouble with phlegm	4180186
1006400	For how many Y has this wheezing been present	4180186
1006443	Have you ever worked full time, 30H per W or more, for 6Mo or more	4180186
1006449	Total Y worked in job or industry with gas or chemical fume	4180186
1006452	Do you now smoke cigarettes, as of 1Mo ago	4180186
1006459	On the average over the entire time you smoked a pipe, how much pipe tobacco did you smoke per W	4180186
1006465	On the average over the entire time you smoked cigars, how many cigars did you smoke per W	4180186
1006481	In the last 12Mo, does your chest ever sound wheezy or whistling more than once a W	4180186
1006482	In the last 12Mo, does your chest ever sound wheezy or whistling most Ds and nights	4180186
1006483	In the last 12Mo, have you been awakened from sleep by coughing, apart from a cough associated with a cold or chest infection	4180186
1006484	In the last 12Mo, have you been awakened from sleep by shortness of breath or a feeling of tightness in your chest	4180186
1006487	In the past 12Mo, have you had periods or episodes of cough with phlegm that lasted 1 W or more	4180186
1006488	For how many Y have you had at least one such episode of cough with phlegm that lasted 1 W or more per Y	4180186
1006489	About how many such episodes of cough with phlegm that lasted 1 W or more have you had in the past 12Mo	4180186
1006492	In the past Y, have you been treated with antibiotics for a chest illness	4180186
1006494	In the past Y, have you been treated with steroid pills or injections, such as predniSONE or solumedrol, for a chest illness	4180186
1006499	In the last 12Mo, how often, on average, has your sleep been disturbed due to wheezing	4180186
1006500	In the last 12Mo, has wheezing ever been severe enough to limit your speech to only one or two words at a time between breaths	4180186
1006504	In the past 12Mo, have you had a problem with sneezing, or a runny or blocked nose, when you did not have a cold or the flu	4180186
1006505	In the past 12Mo, has this nose problem been accompanied by itchy or watery eyes	4180186
1006506	In which of the past 12Mo did this nose problem occur	4180186
1006507	In the past 12Mo, how much did this nose problem interfere with your daily activities	4180186
1006508	Have you ever had an itchy rash which was coming and going for at least 6Mo	4180186
1006515	Has your child had wheezing or whistling in the chest in the last 12Mo	4180186
1006516	How many attacks of wheezing has your child had in the last 12Mo	4180186
1006529	Full time advanced practice nurse staff positions vacant at end of period	4180186
1006542	End stage renal disease facility survey - OMB CMS form 2744	4180186
1006589	Dialysis patients age 18 to 54 Y attending school full-time or part-time at end of reporting period	4180186
1006616	In the last 12Mo, has wheezing ever been severe enough to limit your childs speech to only one or two words at a time between breaths	4180186
1006618	In the last 12Mo, has your childs chest sounded wheezy during or after exercise	4180186
1006625	Has your child ever had an itchy rash that was coming and going for at least 6Mo	4180186
1006626	Has your child had this itchy rash at any time in the last 12Mo	4180186
1006628	In the last 12Mo, how often, on average, has your child been kept awake at night by this itchy rash	4180186
1006704	Does your child describe restlessness of the legs when in bed	4180186
1006724	Does your child have nightmares once a W or more on average	4180186
1006759	Does your child drink caffeinated beverages on a typical D - cola, tea, coffee	4180186
1006760	How many cups or cans of caffeinated beverages per D	4180186
1006834	How many Mo have you used evista	4180186
1006840	How many Mo did you use prescription hormones	4180186
1006841	Are you currently using them - within the last Mo	4180186
1006849	What was your D per Mo pattern of oral or patch estrogen use	4180186
1006864	What Y was your most recent treatment or medication, if any	4180186
1006870	Over the past 4W when you had erections with sexual stimulation, how often were your erections hard enough for penetration	4180186
1006872	Over the past 4W during sexual intercourse, how often were you able to maintain your erection after you had penetrated - entered your partner	4180186
1006876	Over the past 4W how much have you enjoyed sexual intercourse	4180186
1006878	Over the past 4W when you had sexual stimulation or intercourse, how often did you have the feeling of orgasm or climax	4180186
1006879	Over the past 4W how often have you felt sexual desire	4180186
1006883	Over the past 4W how do you rate your confidence that you could get and keep an erection	4180186
1006885	Since the age of 18, have you ever experienced a time interval of 3 or more Mo when you did not have a menstrual period	4180186
1006889	On average, during the last Y, how many D were there in a typical menstrual cycle, that is, from the beginning of bleeding of one menstrual period to the beginning of bleeding of the next period	4180186
1006895	Has the force of your urinary stream or water decreased over the Y	4180186
1006906	During the last 3Mo of your pregnancy, how many times did you drink 4 alcoholic drinks or more in one sitting	4180186
1006912	How many Mo did it take for your partner to achieve pregnancy	4180186
1006919	With how many different partners have you had vaginal intercourse in the past 12Mo	4180186
1006920	How many times have you had vaginal intercourse in the past 12Mo	4180186
1006930	In the last 12Mo, have you noticed this eye problem	4180186
1006934	During the last 12Mo have you noticed your child frequently squinting	4180186
1006965	During the past 12Mo, if child less than 12Mo, the childs age in Mos, has your child appeared to have any difficulty seeing	4180186
1006971	When did your child first have this type of operation	4180186
1006975	In the 3Mo before you got pregnant, how many cigarettes did you smoke on an average D	4180186
1006977	During the 3Mo before you got pregnant, how many alcoholic drinks did you have in an average W	4180186
1006979	What Y did you move from that city or town	4180186
1006983	When you were living in your city or town in your occupation, how many H each D during a typical 5D work week in April through September did you spend outside in direct sunlight between 10 AM and 4 PM	4180186
1007237	Was your child speaking by 2Y old	4180186
1007326	During the past 30D, about how often did you feel so depressed that nothing could cheer you up	4180186
1007330	During the past 30D, about how often did you feel that everything was an effort	4180186
1007331	During the past 30D, how many times did you see a doctor or other health professional about these feelings	4180186
1007332	During the past 30D, about how often did you feel worthless	4180186
1007333	During the past 30D, how often have physical health problems been the main cause of these feelings	4180186
1007467	Because of your headaches on how many Ds in the last 3Mo did you miss work or school	4180186
1007468	Because of your headaches on how many Ds in the last 3Mo was your productivity at work or school reduced by half or more	4180186
1007470	Because of your headaches on how many Ds in the last 3Mo was your productivity in house-hold work reduced by half or more	4180186
1007471	Because of your headaches on how many Ds in the last 3Mo did you miss family, social, or leisure activities	4180186
1007493	Hands resting in lap for 15S	4180186
1007494	Arms held at 90 degrees for 15S - arm sustention	4180186
1007495	Arms held in wing position for 15S	4180186
1007506	Head while patient is seated for 10S	4180186
1007531	Has your child experienced periods of several Ds or more when he or she was unable to sit still, and had to keep moving or jumping from one activity to another	4180186
1007534	Has your child had periods of extreme happiness and intense energy lasting several Ds or more when he or she also felt much more anxious	4180186
1007535	Have there been times of several Ds or more when, although your child was feeling unusually happy and intensely energetic, he or she also had to struggle very hard to control rage	4180186
1007536	Has your child had periods of extreme happiness and intense energy, when it took him or her over an H to get to sleep at night	4180186
1007564	Have you ever had a time in your life when you felt sad, blue, or depressed for 2W or more in a row	4180186
1007565	Have you ever had a time in your life lasting 2W or more when you lost interest in most things like hobbies, work, or activities that usually give you pleasure	4180186
1007566	How much of the D did these feelings usually last	4180186
1007576	About how many Ws altogether did you feel this way - the total period of depression or loss of interest was	4180186
1007577	How many periods like this did you have in your life, lasting 2 or more Ws	4180186
1007579	About how old were you the last time you had a period of 2Ws like this	4180186
1007587	Feeling sad in past 7D	4180186
1007589	Increased appetite in past 7D	4180186
1007590	Increased weight within the last 2W	4180186
1007594	Energy level in past 7D	4180186
1007596	Feeling restless in past 7D	4180186
1007601	During the past 6Mo have there been times when you felt you have eaten what other people would regard as an unusually large amount of food - a quart of ice cream - given the circumstances	4180186
1007603	How many D per W on average over the past 6Mo have you eaten an unusually large amount of food and experienced a loss of control	4180186
1007604	How many times per W on average over the past 3Mo have you eaten an unusually large amount of food and experienced a loss of control	4180186
1007611	Did you worry most D	4180186
1007620	How many Mo have you had any of these fears	4180186
1007631	About how many M does it usually take for you to fall asleep	4180186
1007633	How many H and M does it take for you to become fully awake from regular sleep, after first opening your eyes in the morning	4180186
1007642	Do you usually follow the same sleep schedule, that is, no more than a 1H difference in sleep and wake times, on both work or school and non-work or school D	4180186
1007647	At what time of the D do you usually take naps	4180186
1007648	How many H and Ms of sleep do you usually get when you take a nap	4180186
1007652	How difficult is it for you to adapt to a sleep loss of 3H or more - sleeping 3 or more H less than you normally do the night before	4180186
1007675	In the past Y, have you had difficulty getting to sleep	4180186
1007677	In the past Y, have you awakened too early in the morning and couldn't get back to sleep	4180186
1007683	Has your difficulty with sleeping occurred or worsened during a few Ds before menstruation	4180186
1007684	How many separate times in your life have you had difficulty getting to sleep, staying asleep or falling back to sleep after waking up during the night, for at least 1Mo	4180186
1007686	How old were you the last time you experienced this insomnia, for at least 1Mo	4180186
1007690	How often do you feel so sleepy during the D that it interrupts your normal activities	4180186
1007691	What is the longest period of time that you have felt so sleepy during the D that it interrupts your normal activities on most Ds	4180186
1007734	What Mo and Y did child first begin wearing glasses or contact lenses	4180186
1007784	Have you ever had any sudden loss or changes in speech lasting 24 H or longer	4180186
1007799	Have you ever had sudden numbness, tingling, or loss of feeling on one side of your body, including your face, arm, or leg which lasted 24H or longer	4180186
1007808	Have you had any sudden spells of dizziness, loss of balance, or sensation of spinning which lasted 24H or longer	4180186
1007814	View for cyst	4180186
1007815	Sagittal sinus vein.left+Jugular vein.left	4180186
1007816	Sagittal sinus vein.left	4180186
1007817	Sagittal sinus vein.right	4180186
1007818	Sagittal sinus vein.right+Jugular vein.right	4180186
1007912	How many times per W on average over the past 3Mo have you engaged in excessive exercise specifically to counteract the effects of overeating episodes	4180186
1007913	Over the past 3Mo, how many menstrual periods have you missed	4180186
1007945	How many Hs do you normally sleep	4180186
1007989	Delusions and hallucinations last for one W	4180186
1008013	Hands hanging at sides for 10S	4180186
1008022	Hand dominance - 42Mo	4180186
1008040	Have you ever used oral contraceptives for 2Mo or more for any reason - contraception, acne, menstrual irregularity, etc	4180186
1008082	On the average during the last 2W, how many of these pills, or medication items, did you take a D, W, or Mo	4180186
1008162	6M	4180186
1008187	Were you employed in the last 7D	4180186
1008188	If yes, which Ds	4180186
1008197	Compared to your physical activity over the past 3Mo, was last week's physical activity more, less, or about the same	4180186
1008204	Problem with 7D interview	4180186
1008227	How many of the Ds that the actiGraph was worn were valid	4180186
1008237	Records how many Ds the actigraph was worn on actigraph return and reading form	4180186
1008238	Records how many valid Ds the actigraph was worn on actigraph return and reading form	4180186
1008260	How much difficulty do you have sitting for about 2H	4180186
1008269	It is within a 10-15M walk to a transit stop, such as bus, train, trolley, or tram, from my home	4180186
1008274	I can be physically active during my free time on most Ds	4180186
1008276	I can be physically active during my free time on most Ds even if I could watch TV or play video games instead	4180186
1008279	I can be physically active during my free time on most Ds even if I have a lot of homework	4180186
1008280	I have the coordination I need to be physically active during my free time on most Ds	4180186
1008282	Circumstances in which you could exercise 3 time per W in the next 3Mos	4180186
1008283	Degree of confidence for exercising 3 times per W in the next 3Mo	4180186
1008301	Is the child or teen pregnant, or is there a chance she could become pregnant during the next Mo	4180186
1008302	Has the child received vaccinations in the past 4W	4180186
1008312	Travelled to country last Y	4180186
1008314	Travelled to country 3Ys ago	4180186
1008318	Stay was longer than 30 consecutive Ds last Y	4180186
1008321	Stay was longer than 30 consecutive Ds 4Ys ago	4180186
1008350	Physical &or occupational therapy sequence	4180186
1008351	Physical &or occupational therapy type	4180186
1008400	Did you live for more than 1Y in a country where sunshine is high - africa, french west indies, south of united states, australia	4180186
1008417	Have you had sexual intercourse in the past 7Ds	4180186
1008435	Proteinuria greater than or equal to 3.5 gm in 24H	4180186
1008445	Pericarditis for 6Mo, or pericardiectomy	4180186
1008602	In the last Mo, how often have you been upset because of something that happened unexpectedly	4180186
1008606	In the last Mo, how often have you felt that things were going your way	4180186
1008607	In the last Mo, how often have you found that you could not cope with all the things that you had to do	4180186
1008608	In the last Mo, how often have you been able to control irritations in your life	4180186
1008609	In the last Mo, how often have you felt that you were on top of things	4180186
1008610	In the last Mo, how often have you been angered because of things that were outside of your control	4180186
1008654	Albumin.pericard fld	4180186
1008655	Albumin.periton fld	4180186
1008697	Before you turned 12Y old (when you were in grade school), did anyone ever hit you, kick you, beat you, punch you, slap you around, or hurt your body in some other way	4180186
1008719	How many times in the last Y have you purposely damaged or destroyed property that did not belong to you	4180186
1008727	How many times in the last Y have you stolen or tried to steal money or things worth 100 dollars or more	4180186
1008728	How many times in the last Y have you taken something from a store without paying for it	4180186
1008730	How many times in the last Y have you taken something from a car that did not belong to you	4180186
1008734	How many times in the last Y have you used checks illegally or used a slug or fake money to pay for something	4180186
1008738	How many times in the last Y have you hit someone with the idea of hurting them, other than the events just mentioned	4180186
1008741	How many times in the last Y have you been involved in gang fights	4180186
1008743	How many times in the last Y have you physically hurt or threatened to hurt someone to get them to have sex with you	4180186
1008746	How many times in the last Y have you sold hard drugs such as heroin, cocaine, and LSD	4180186
1008750	How many times in the last Y have you run away from home	4180186
1008751	How many times in the last Y have you skipped classes or school without an excuse	4180186
1008752	How many times in the last Y have you been suspended or sent home from school for bad behavior	4180186
1008755	How many times in the last Y have you hitchhiked where it was illegal to do so	4180186
1008758	How many times in the last Y have you begged for money or things from strangers	4180186
1008761	How many times in the last Y did you run away from your home and stay away overnight	4180186
1008762	How many times in the last Y did you break into, or try to break into a building, to steal something	4180186
1008765	How many times in the last Y did you steal, or try to steal, money or things worth over 500 dollars	4180186
1008768	How many times in the last Y have you stolen, or tried to steal, a motor vehicle such as a car or motorcycle to keep or sell	4180186
1008769	How many times in the last Y have you used worthless checks or fake money to pay for something	4180186
1008770	How many times in the last Y have you tried to cheat someone by selling them something that was worthless, or not what you said it was	4180186
1008771	How many times in the last Y have you been so angry with a child that you attacked them with a weapon, or with the idea of seriously hurting them	4180186
1008776	How many times in the last Y have you committed a serious driving offense, such as driving while drunk, driving recklessly, or speeding 50 km per hour over the posted speed limit	4180186
1008778	How many times in the last Y have you lied about your age	4180186
1008779	How many times in the last Y have you made obscene telephone calls, such as calling someone and saying rude things	4180186
1008785	How many times in the last Y did you interfere with the work of the law by trying to get away from police, by hiding someone that the police were looking for, or by telling a lie to a police officer or judge	4180186
1008786	How many times in the last Y have you driven a vehicle when you did not have a driver's license or after your license had been suspended or disqualified	4180186
1008787	How many times in the last Y have you sold marijuana or hashish	4180186
1008788	How many times in the last Y have you used marijuana	4180186
1008792	How many times in the last Y did you threaten or hurt someone to get them to have sex with you	4180186
1008793	How many times in the last Y have you contributed to the delinquency of a person under age 17	4180186
1008794	How many times in the last Y have you failed to obey the courts	4180186
1008882	During the past 12Mo, what is the longest time that one episode of this pain has lasted	4180186
1008883	On how many Ds in the past 12Mo have you had this pain	4180186
1008975	How often did you have difficulty getting a good night's sleep because of your heartburn or regurgitation in the past 7D	4180186
1008976	How often did you take additional medications for your heartburn or regurgitation other than what your physician told you to take, such as tums, rolaids, maalox in the past 7D	4180186
1008979	Have you had a cold, sinus problem or earache in the last 24H	4180186
1008998	My child's ability to understand what others say to him or her is-	4180186
1009133	Do you ever get noises in your head or ears, tinnitus, which usually last longer than 5M	4180186
1009167	Have you ever been treated for a serious infection with an antibiotic, other than penicillin, which was administered by injection or drip for a W or more	4180186
1009194	NEMSIS	4180186
1009221	Cardiopulmonary resuscitation technique	4180186
1009399	Have you been exposed to solvents such as thrichloroethylene, toluene, evaporations from paints or lacquers, for more than one Y in one of your jobs	4180186
1009403	Have you ever worked for more than 1Y in a place where you had to raise your voice to make yourself heard by someone standing 1 mile away from you	4180186
1009410	How many Ys did you smoke up to now	4180186
1009428	RelMRat	4180186
1009452	fentaNYL & Norfentanyl	4180186
1009467	Employment status - 6Mo prior to renal failure	4180186
1009475	{Transplant}	4180186
1009535	I felt nervous when my normal routine was disturbed in the past 7D	4180186
1009536	I felt fearful about my future in the past 7D	4180186
1009538	I felt that I had no energy in the past 7D	4180186
1009539	I felt fatigued in the past 7D	4180186
1009542	I was frustrated by being too tired to do the things I wanted to do in the past 7D	4180186
1009543	I had to limit my social activity because I was tired in the past 7D	4180186
1009544	I needed help doing my usual activities because of my fatigue in the past 7D	4180186
1009545	I needed to sleep during the day in the past 7D	4180186
1009546	I had trouble starting things because I was too tired in the past 7D	4180186
1009548	I was too tired to take a short walk in the past 7D	4180186
1009551	I felt weak all over in the past 7D	4180186
1009554	I had to force myself to get up and do things because I was physically too weak in the past 7D	4180186
1009568	How much difficulty do you currently have taking a 20M brisk walk, without stopping to rest	4180186
1009580	How much difficulty do you currently have planning an activity several D in advance, like a meal, trip, or visit to friends	4180186
1009586	I had trouble keeping track of what I was doing if I was interrupted in the past 7D	4180186
1009587	I had difficulty doing more than one thing at a time in the past 7D	4180186
1009589	I had trouble thinking clearly in the past 7D	4180186
1009591	I had to work really hard to pay attention or I would make a mistake in the past 7D	4180186
1009592	I had trouble concentrating in the past 7D	4180186
1009594	Words I wanted to use seemed to be on the tip of my tongue in the past 7D	4180186
1009596	I walked into a room and forgot what I meant to get or do there in the past 7D	4180186
1009597	I had trouble remembering the name of a familiar person in the past 7D	4180186
1009600	I had trouble getting started on very simple tasks in the past 7D	4180186
1009603	It was hard to control my behavior in the past 7D	4180186
1009604	I said or did things without thinking in the past 7D	4180186
1009608	I became easily upset in the past 7D	4180186
1009615	It was hard to adjust to unexpected changes in the past 7D	4180186
1009616	I had a hard time accepting criticism from other people in the past 7D	4180186
1009618	Lately I had a sense of well being	4180186
1009643	I was sleepy during the daytime in the past 7D	4180186
1009645	I had difficulty falling asleep in the past 7D	4180186
1009646	Pain woke me up in the past 7D	4180186
1009651	I am able to socialize with my friends in the past 7D	4180186
1009660	I am able to do all of the family activities that I want to do in the past 7D	4180186
1009664	I feel limited in my ability to visit friends in the past 7D	4180186
1009666	I have to limit the things I do for fun at home, like reading, listening to music, etc in the past 7D	4180186
1009668	I have to limit my hobbies or leisure activities in the past 7D	4180186
1009670	I am able to do all of the community activities that I want to do in the past 7D	4180186
1009671	I am able to do all of the leisure activities that people expect me to do in the past 7D	4180186
1009672	I have to do my hobbies or leisure activities for shorter periods of time than usual for me in the past 7D	4180186
1009674	I have trouble keeping in touch with others in the past 7D	4180186
1009676	I am able to do all of the community activities that people expect me to do in the past 7D	4180186
1009677	I am able to go out for entertainment as much as I want in the past 7D	4180186
1009678	I have to limit the things I do for fun outside my home in the past 7D	4180186
1009679	I am doing fewer social activities with groups of people than usual for me in the past 7D	4180186
1009680	I am able to run errands without difficulty in the past 7D	4180186
1009682	I am accomplishing as much as usual at work for me in the past 7D	4180186
1009684	I can do everything for work that I want to do in the past 7D	4180186
1009685	I have trouble doing my regular chores or tasks in the past 7D	4180186
1009688	I have to do my work for shorter periods of time than usual for me in the past 7D	4180186
1009690	I am disappointed in my ability to socialize with my family in the past 7D	4180186
1009692	I am disappointed in my ability to meet the needs of my friends in the past 7D	4180186
1009693	I am satisfied with my ability to do household chores or tasks in the past 7D	4180186
1009694	I feel that my family is disappointed in my ability to socialize with them in the past 7D	4180186
1009695	I am disappointed in my ability to meet the needs of my family in the past 7D	4180186
1009697	I feel that my friends are disappointed in my ability to socialize with them in the past 7D	4180186
1009698	I am disappointed in my ability to do things for my friends in the past 7D	4180186
1009700	I am disappointed in my ability to keep in touch with others in the past 7D	4180186
1009704	I feel that I am disappointing other people at work in the past 7D	4180186
1009705	I am disappointed in my ability to perform my daily routines in the past 7D	4180186
1009708	I am disappointed in my ability to take care of personal and household responsibilities in the past 7D	4180186
1009709	I am bothered by limitations in performing my work in the past 7D	4180186
1009710	I am satisfied with my ability to take care of personal and household responsibilities in the past 7D	4180186
1009711	I am satisfied with my ability to work in the past 7D	4180186
1009742	NeuroQol.Peds	4180186
1009778	I was less interested in doing things I usually enjoy in the past 7D	4180186
1009779	It was hard for me to care about anything in the past 7D	4180186
1009782	My mood swings from good feelings to bad feelings in the past 7D	4180186
1009787	I felt afraid to go out alone in the past 7D	4180186
1009789	It was hard to do schoolwork because I was nervous or worried in the past 7D	4180186
1009790	I felt afraid in the past 7D	4180186
1009791	I worry that my health might get worse in the past 7D	4180186
1009792	I worry about doing well in school in the past 7D	4180186
1009793	I become anxious when I go back to the hospital or clinic in the past 7D	4180186
1009796	I worry about getting a good job because of my medical condition in the past 7D	4180186
1009798	I worried when I was away from my family in the past 7D	4180186
1009799	I got scared easily in the past 7D	4180186
1009800	I was worried that I might die in the past 7D	4180186
1009801	Because of my health, I worry about being able to go to college in the past 7D	4180186
1009802	Because of my health, I worry about getting a job to support myself in the past 7D	4180186
1009803	Being angry made it hard for me to be with my friends in the past 7D	4180186
1009808	I was so mad that I felt like yelling at someone in the past 7D	4180186
1009809	I was so mad that I felt like breaking things in the past 7D	4180186
1009811	I felt close to my friends in the past 7D	4180186
1009812	I felt comfortable with others my age in the past 7D	4180186
1009820	I wanted to spend time with my friends in the past 7D	4180186
1009821	I did things with other kids my age in the past 7D	4180186
1009823	I felt loved by my parents or guardians in the past 7D	4180186
1009825	My parents or guardians spent enough time with me in the past 7D	4180186
1009827	My teachers accepted me in the past 7D	4180186
1009828	My teachers respected me in the past 7D	4180186
1009845	Being tired makes me sad in the past 7D	4180186
1009846	Being tired makes me mad in the past 7D	4180186
1009849	I got upset by being too tired to do things I wanted to do in the past 7D	4180186
1009852	I had so much pain that I had to stop what I was doing in the past 7D	4180186
1009856	It was hard for me to play or hang out with my friends when I had pain in the past 7D	4180186
1009858	I could get on and off the toilet without using my arms in the past 7D	4180186
1009859	I could get on and off a low chair in the past 7D	4180186
1009862	I could stand on my tiptoes to reach for something in the past 7D	4180186
1009863	I could stand on my tiptoes to put something, like a 5 lb bag of sugar, on a shelf in the past 7D	4180186
1009864	I fall down easily in the past 7D	4180186
1009865	I could walk on slightly uneven surfaces such as cracked pavement in the past 7D	4180186
1009867	I could walk up and down ramps or hills in the past 7D	4180186
1009868	I could walk up and down curbs in the past 7D	4180186
1009873	I could move up and down inclines or ramps using a wheelchair in the past 7D	4180186
1009874	I could move on rough, uneven surfaces like lawns or gravel driveway using a wheelchair in the past 7D	4180186
1009875	I could move between my wheelchair and another seat such as a chair or bed in the past 7D	4180186
1009876	I could move around within a room, including making turns in my wheelchair in the past 7D	4180186
1009881	I could walk for 15M in the past 7D	4180186
1009883	I could park a wheelchair in a narrow space like in an elevator in the past 7D	4180186
1009884	I could back out of an elevator in a wheelchair if there was no room to turn around in the past 7D	4180186
1009887	I could reverse direction in my wheelchair in the past 7D	4180186
1009893	I could move for 15M using a wheelchair in the past 7D	4180186
1009896	With a walking aid, I could walk on slightly uneven surfaces, cracked pavement in the past 7D	4180186
1009901	With a walking aid, I could walk within a room in the past 7D	4180186
1009902	With a walking aid, I could walk across the room in the past 7D	4180186
1009904	With a walking aid I could get in and out of a car in the past 7D	4180186
1009905	I was able to use my fingers to point to something in the past 7D	4180186
1009906	I was able to take off my socks in the past 7D	4180186
1009907	I was able to put on and fasten my pants by myself in the past 7D	4180186
1009908	I was able to button and unbutton my shirt in the past 7D	4180186
1009910	I was able to wipe myself thoroughly after using the toilet in the past 7D	4180186
1009914	I was able to take a shower by myself in the past 7D	4180186
1009916	I was able to make a phone call using a touch tone key-pad in the past 7D	4180186
1009917	I was able to get out of bed by myself in the past 7D	4180186
1009919	I was able to open a jar by myself in the past 7D	4180186
1009920	I was able to put toothpaste on my toothbrush by myself in the past 7D	4180186
1009922	I was able to dry my back with a towel in the past 7D	4180186
1009929	I am able to do all of the activities with friends that I want to do in the past 7D	4180186
1009942	Cause of death.primary	4180186
1009945	Cause of death.other	4180186
1009958	End stage renal disease death notification - OMB CMS form 2746	4180186
1009962	Dialysis setting.primary	4180186
1009967	Dialysis sessions per W	4180186
1009971	Vitr fld.spun	4180186
1009973	Allergies &or adverse reactions	4180186
1009980	Dialysis Hs per session	4180186
1009985	Live births.now dead	4180186
1009995	Not able to stop or control worrying in the last 2W	4180186
1009997	How many servings of fruits-vegetables did you eat each D in past 7D	4180186
1010001	How many D of moderate to strenuous exercise, like a brisk walk, did you do in the last 7D	4180186
1010008	To what extent did the following common sources contributed to your overall stress in the last W	4180186
1010010	How many times in the past Y have you used an illegal drug or used a prescription medication for non-medical reasons	4180186
1010022	Have you used smokeless tobacco product in the last 30D	4180186
1010031	Neurology w special qualifications in child neuro	4180186
1010058	Views 5 + Swimmers	4180186
1010060	Views PA + lateral + Waters + Towne	4180186
1010075	Neuro & emotional & behavioral status - start of care	4180186
1010107	RatDiff	4180186
1010167	OPTIMAL	4180186
1010224	Citharexylum caudatum	4180186
1010316	Bothered by stomach pain in last 4W	4180186
1010319	Bothered by menstrual cramps or other problems with your period in last 4W	4180186
1010325	Bothered by shortness of breath in last 4W	4180186
1010327	Bothered by nausea, gas, or indigestion in last 4W	4180186
1010328	Feeling nervous, anxious, on edge, or worrying a lot about different things in last 4W	4180186
1010334	Becoming easily annoyed or irritable in last 4W	4180186
1010338	How many times per W on average over the past 3Mo have you made yourself vomit to prevent weight gain or counteract the effects of eating	4180186
1010340	Fasted - not eaten anything at all for at least 24H - often in last 3Mo in order to avoid gaining weight	4180186
1010344	You missed or were late for work, school, or other activities because you were drinking or hung over, more than once in last 6Mo	4180186
1010345	You had a problem getting along with other people while you were drinking more than once in last 6Mo	4180186
1010359	In the last 4W, have you had an anxiety attack - suddenly feeling fear or panic	4180186
1010365	If you checked yes to any of these ways of avoiding gaining weight, were any as often, on average, as twice a W	4180186
1010370	Feeling nervous, anxious or on edge in last 2W	4180186
1010371	Tissue transglutaminase Ab.IgA+gliadin peptides Ab.IgA & IgG panel	4180186
1010374	Feeling tired or having low energy level in past 4W	4180186
1010376	Worrying too much about different things in last 2W	4180186
1010377	Trouble relaxing in last 2W	4180186
1010378	Being so restless that it is hard to sit still in last 2W	4180186
1010402	HHS.ACA Section 4302	4180186
1010419	VRtoPctDiff	4180186
1010420	VPctDiff	4180186
1010438	AFr	4180186
1010464	Avoid thinking about or talking about a stressful experience from the past or avoid having feelings related to it in the last Mo	4180186
1010465	Avoid activites or situations because they remind you of a stressful experience from the past in the last Mo	4180186
1010468	Feeling distant or cut off from other people in the last Mo	4180186
1010469	Feeling as if your future will somehow be cut short in the last Mo	4180186
1010470	Trouble falling or staying asleep in the last Mo	4180186
1010471	Feeling irritable or having angry outbursts in the last Mo	4180186
1010472	Having difficulty concentrating in the last Mo	4180186
1010474	Feeling jumpy or easily startled in the last Mo	4180186
1010488	I have pain in my stomach area in the past 7D	4180186
1010491	I need help doing my usual activities in the past 7D	4180186
1010494	I am self-conscious about the way I dress in the past 7D	4180186
1010495	One or more of my arms are swollen or tender in the past 7D	4180186
1010498	I worry that other members of my family might someday get the same illness I have in the past 7D	4180186
1010500	I am bothered by a change in weight in the past 7D	4180186
1010505	I am interested in sex in the past 7D	4180186
1010506	For men only - I am able to have and maintain an erection in the past 7D	4180186
1010507	I have emotional ups and downs in the past 7D	4180186
1010510	I have bone pain in the past 7D	4180186
1010512	I am bothered by the change in my personality in the past 7D	4180186
1010513	I am able to make decisions and take responsibility in the past 7D	4180186
1010514	I am bothered by the drop in my contribution to the family in the past 7D	4180186
1010515	I am able to put my thoughts together in the past 7D	4180186
1010516	I am able to put my thoughts into action in the past 7D	4180186
1010518	I am able to write like I used to in the past 7D	4180186
1010520	I have trouble feeling sensation in my arms, hands or legs in the past 7D	4180186
1010521	I have had seizures - convulsions - in the past 7D	4180186
1010522	I have weakness in my arms or legs in the past 7D	4180186
1010523	I have trouble with coordination in the past 7D	4180186
1010528	I feel independent in the past 7D	4180186
1010529	I am able to find the right words to say what I mean in the past 7D	4180186
1010530	I have difficulty expressing my thoughts in the past 7D	4180186
1010531	I am bothered by fevers - episodes of high body temperature - in the past 7D	4180186
1010532	I have swelling or cramps in my stomach area in the past 7D	4180186
1010534	I have control of my bowels in the past 7D	4180186
1010538	I like the appearance of my body in the past 7D	4180186
1010539	I am embarrassed by my ostomy appliance in the past 7D	4180186
1010541	I am able to maintain my balance in the past 7D	4180186
1010542	I am able to walk in the past 7D	4180186
1010543	I have strength in my arms in the past 7D	4180186
1010544	I have strength in my legs in the past 7D	4180186
1010545	I have numbness in my legs in the past 7D	4180186
1010547	I am bothered by discharge or bleeding from my vagina in the past 7D	4180186
1010549	I am afraid to have sex in the past 7D	4180186
1010550	My vagina feels too narrow or short in the past 7D	4180186
1010555	I have difficulty swallowing soft or mashed foods in the past 7D	4180186
1010556	I have difficulty swallowing liquids in the past 7D	4180186
1010557	I have a pain in my chest when I swallow in the past 7D	4180186
1010558	I choke when I swallow in the past 7D	4180186
1010560	I wake at night because of coughing in the past 7D	4180186
1010561	I have trouble digesting food in the past 7D	4180186
1010562	I have discomfort or pain in my pelvic area in the past 7D	4180186
1010563	I have hot flashes in the past 7D	4180186
1010565	I have cold sweats in the past 7D	4180186
1010566	I have night sweats in the past 7D	4180186
1010568	I have pain or discomfort with intercourse in the past 7D	4180186
1010570	My digestive problems interfere with my usual activities in the past 7D	4180186
1010573	I am bothered by reflux or heartburn in the past 7D	4180186
1010575	I have discomfort or pain when I eat in the past 7D	4180186
1010576	I have stomach problems that worry me in the past 7D	4180186
1010578	I feel sad in the past 7D	4180186
1010581	I feel nervous in the past 7D	4180186
1010582	I worry about dying in the past 7D	4180186
1010583	I worry that my condition will get worse in the past 7D	4180186
1010585	My work - include work at home - is fulfilling in the past 7D	4180186
1010587	I have accepted my illness in the past 7D	4180186
1010588	I am sleeping well in the past 7D	4180186
1010590	I am content with the quality of my life right now in the past 7D	4180186
1010592	I have nausea in the past 7D	4180186
1010596	I feel ill in the past 7D	4180186
1010597	I am forced to spend time in bed in the past 7D	4180186
1010598	I feel close to my friends in the past 7D	4180186
1010602	I am satisfied with family communication about my illness in the past 7D	4180186
1010604	I am satisfied with my sex life in the past 7D	4180186
1010605	I am unhappy about a change in my appearance in the past 7D	4180186
1010610	I have discomfort or pain in my stomach area in the past 7D	4180186
1010611	I feel weak all over in the past 7D	4180186
1010615	I can eat solid foods in the past 7D	4180186
1010618	I have trouble breathing in the past 7D	4180186
1010619	My voice has its usual quality and strength in the past 7D	4180186
1010620	I am able to eat as much food as I want in the past 7D	4180186
1010622	I can swallow naturally and easily in the past 7D	4180186
1010623	I smoke cigarettes or other tobacco products in the past 7D	4180186
1010625	I have to limit my social activity because of my condition in the past 7D	4180186
1010626	I have to limit my physical activity because of my condition in the past 7D	4180186
1010627	My thinking is clear in the past 7D	4180186
1010628	I have been coughing in the past 7D	4180186
1010631	I regret my smoking in the past 7D	4180186
1010632	Because of my illness, I have difficulty planning for the future in the past 7D	4180186
1010635	I need help caring for myself - bathing, dressing, eating, etc in the past 7D	4180186
1010636	I am bothered by lumps or swelling in certain part of my body - neck, armpits, or groin - in the past 7D	4180186
1010637	I feel isolated from others because of my illness or treatment in the past 7D	4180186
1010638	I am bothered by itching in the past 7D	4180186
1010640	I have pain at my melanoma site or surgical site in the past 7D	4180186
1010642	I have swelling as a result of surgery in the past 7D	4180186
1010644	Movement of my swollen area is painful in the past 7D	4180186
1010645	Swelling keeps me from doing the things I want to do in the past 7D	4180186
1010647	I feel numbness at my surgical site in the past 7D	4180186
1010650	I worry about the appearance of surgical scars in the past 7D	4180186
1010654	I have difficulty thinking clearly - remembering, concentrating - in the past 7D	4180186
1010655	I have trouble walking because of the pain in the past 7D	4180186
1010656	I feel overwhelmed by my condition in the past 7D	4180186
1010658	I have difficulty moving my neck and shoulders because of stiffness in the past 7D	4180186
1010659	I am bothered by ringing in my ears in the past 7D	4180186
1010661	I have trouble smelling the in past 7D	4180186
1010662	I can enjoy the taste of food in the past 7D	4180186
1010663	I am bothered by having a blocked nose in the past 7D	4180186
1010666	I have been vomiting in the past 7D	4180186
1010672	I bruise easily in the past 7D	4180186
1010674	I am bothered by odor coming from my vulva in the past 7D	4180186
1010677	I am bothered by itching - burning in my vulva area in the past 7D	4180186
1010679	I have trouble bending in the past 7D	4180186
1010686	I have vaginal discharge in the past 7D	4180186
1010688	Functional assessment of cancer therapy for patients with breast cancer questionnaire - version 4	4180186
1010693	Functional well being	4180186
1010696	Functional assessment of chronic illness therapy - general measures panel	4180186
1010697	Functional assessment of chronic illness therapy - cancer specific measures panel	4180186
1010719	I am bothered by the chills in the past 7D	4180186
1010722	I feel discouraged about my illness in the past 7D	4180186
1010729	I have joint pain or muscle cramps in the past 7D	4180186
1010750	My pain keeps me from doing things I want to do in the past 7D	4180186
1010751	My problems with urinating limit my activities in the past 7D	4180186
1010753	I have mouth sores in the past 7D	4180186
1010755	I have pain in my hands or feet when I am exposed to cold temperatures in the past 7D	4180186
1010756	I have had blood in my urine in the past 7D	4180186
1010758	I have difficulty urinating in the past 7D	4180186
1010773	I believe that waiting up to 60M before eating breakfast in the morning will be inconvenient	4180186
1010777	I experience a pleasant feeling of fullness during or after my tube feeding in the past 7D	4180186
1010779	I feel uncomfortably full during or after my tube feeding in the past 7D	4180186
1010780	I have constipation during or after my tube feeding in the past 7D	4180186
1010782	Tube feeding limits what I can do inside the house - for example housework, watching TV or reading - in the past 7D	4180186
1010786	I miss being able to take more food or drink by mouth now that I have a feeding tube in the past 7D	4180186
1010789	I worry about the tube coming out by accident in the past 7D	4180186
1010794	I feel dependent on others because I have a feeding tube in the past 7D	4180186
1010796	I feel left out when others are eating in the past 7D	4180186
1010797	I am more confident about my nutrition because of my feeding tube in the past 7D	4180186
1010800	My skin or scalp feels irritated in the past 7D	4180186
1010801	My skin or scalp is dry or flaky in the past 7D	4180186
1010802	My skin or scalp itches in the past 7D	4180186
1010803	My skin bleeds easily in the past 7D	4180186
1010808	I am embarrassed by my skin condition in the past 7D	4180186
1010810	I feel unattractive because of how my skin looks in the past 7D	4180186
1010812	The skin side effects from treatment have interfered with household tasks in the past 7D	4180186
1010821	I get a ringing or buzzing in my ears in the past 7D	4180186
1010822	I have trouble buttoning buttons in the past 7D	4180186
1010823	I have trouble feeling the shape of small objects when they are in my hand in the past 7D	4180186
1010826	I have difficulty breathing when I am exposed to cold temperatures in the past 7D	4180186
1010831	I am concerned about keeping my job - include work at home - in the past 7D	4180186
1010832	I feel distant from other people in the past 7D	4180186
1010833	I worry that the transplant will not work in the past 7D	4180186
1010838	My eyesight is blurry in the past 7D	4180186
1010841	The cost of my treatment is a burden on me or my family in the past 7D	4180186
1010843	I am bothered by sweating in the past 7D	4180186
1010848	I feel motivated to do things in the past 7D	4180186
1010850	I feel bloated in the past 7D	4180186
1010856	I can remember things in the past 7D	4180186
1010857	MCPctDiff	4180186
1010858	18 deg C incubation	4180186
1010861	I am bothered by a change in the way food tastes in the past 7D	4180186
1010862	I have trouble with my bowels in the past 7D	4180186
1010863	I have pain in my joints in the past 7D	4180186
1010866	Functional assessment of chronic illness therapy - treatment specific measures panel	4180186
1010867	Functional assessment of chronic illness therapy - non cancer specific measures panel	4180186
1010871	The amount I eat is sufficient to meet my needs in the past 7D	4180186
1010874	I am concerned about how thin I look in the past 7D	4180186
1010875	My interest in food drops as soon as I try to eat in the past 7D	4180186
1010880	My general health is improving in the past 7D	4180186
1010882	Stomach pain interferes with my daily functioning in the past 7D	4180186
1010889	I have to limit my sexual activity because of the infection in the past 7D	4180186
1010894	I have accepted that I have this infection in the past 7D	4180186
1010895	I worry that the infection will get worse in the past 7D	4180186
1010896	I have hidden this problem so others will not notice in the past 7D	4180186
1010898	I worry about other peoples attitudes towards me in the past 7D	4180186
1010899	I feel embarrassed about the infection in the past 7D	4180186
1010901	I was careful who I told about the infection in the past 7D	4180186
1010903	I am frustrated by the infection in the past 7D	4180186
1010908	I get emotional support from family members in the past 7D	4180186
1010913	I have to limit my social activity because of diarrhea in the past 7D	4180186
1010914	I have to limit my physical activity because of diarrhea in the past 7D	4180186
1010915	I have to limit my sexual activity because of diarrhea in the past 7D	4180186
1010916	I am embarrassed by having diarrhea in the past 7D	4180186
1010919	I must move my bowels frequently to avoid accidents in the past 7D	4180186
1010924	I have trouble finishing things because I am tired in the past 7D	4180186
1010925	I have energy in the past 7D	4180186
1010929	I am frustrated by being too tired to do the things I want to do in the past 7D	4180186
1010930	I have to limit my social activity because I am tired in the past 7D	4180186
1010931	Functional assessment of chronic illness therapy - fatigue questionnaire -13 items - version 4	4180186
1010938	I have a poor range of arm movements on this side in the past 7D	4180186
1010943	It hurts when I put weight or pressure on the place where I have bone pain in the past 7D	4180186
1010945	I need help doing my usual activities because of bone pain in the past 7D	4180186
1010946	I am forced to rest during the day because of bone pain in the past 7D	4180186
1010947	I have trouble walking because of bone pain in the past 7D	4180186
1010948	Bone pain interferes with my ability to care for myself - bathing, dressing, eating, etc - in the past 7D	4180186
1010949	Bone pain interferes with my social activities in the past 7D	4180186
1010951	I am frustrated by my bone pain in the past 7D	4180186
1010952	I feel depressed about my bone pain in the past 7D	4180186
1010953	I worry that my bone pain will get worse in the past 7D	4180186
1010958	I have had trouble concentrating in the past 7D	4180186
1010959	I have had trouble finding my way to a familiar place in the past 7D	4180186
1010963	I have had trouble finding the right words to express myself in the past 7D	4180186
1010967	I have had to work really hard to pay attention or I would make a mistake in the past 7D	4180186
1010968	I have forgotten names of people soon after being introduced in the past 7D	4180186
1010970	My reactions in everyday situations have been slow in the past 7D	4180186
1010975	I have had to work harder than usual to express myself clearly in the past 7D	4180186
1010977	I have trouble keeping track of what I am doing if I am interrupted in the past 7D	4180186
1010979	Other people have told me I seemed to have trouble speaking clearly in the past 7D	4180186
1010981	Other people have told me I seemed confused in the past 7D	4180186
1010983	I have been able to concentrate in the past 7D	4180186
1010990	I am able to shift back and forth between two activities that require thinking in the past 7D	4180186
1010991	I am able to keep track of what I am doing, even if I am interrupted in the past 7D	4180186
1010996	These problems have interfered with my ability to do things I enjoy in the past 7D	4180186
1010999	I have vaginal itching - irritation - in the past 7D	4180186
1011000	I have vaginal dryness in the past 7D	4180186
1011001	I have lost interest in sex in the past 7D	4180186
1011002	I have breast sensitivity - tenderness - in the past 7D	4180186
1011006	I worry about getting sick due to low blood counts in the past 7D	4180186
1011007	I avoid public places for fear of getting an infection in the past 7D	4180186
1011008	I get aches and pains that bother me in the past 7D	4180186
1011011	My low blood counts interfere with my intimate relationships in the past 7D	4180186
1011016	I am bothered by nosebleeds in the past 7D	4180186
1011017	I am bothered by pinpoint bruising beneath my skin in the past 7D	4180186
1011021	I worry that my treatment will be delayed, because of low blood counts, in the past 7D	4180186
1011023	I worry about the possibility of serious bleeding in the past 7D	4180186
1011025	I am inconvenienced by platelet transfusions in the past 7D	4180186
1011026	I avoid or limit social activity, because of concern with bleeding or bruising, in the past 7D	4180186
1011032	I am embarrassed by my condition in the past 7D	4180186
1011033	My condition wakes or keeps me up at night in the past 7D	4180186
1011034	I can be far from home - work without fearing soilage in the past 7D	4180186
1011036	My condition wakes me up at night in the past 7D	4180186
1011038	I wear protection for leakage of urine in the past 7D	4180186
1011044	My doctor gave me explanations that I could understand in the past 7D	4180186
1011045	My doctor explained the possible benefits of my treatment in the past 7D	4180186
1011046	I feel that I received the treatment that was right for me in the past 7D	4180186
1011118	Arm.right	4180186
1011122	Bacillus subtilis Ab.IgE	4180186
1011124	Parakeet+Parrot droppings Ab.IgE	4180186
1011125	Toxocara canis Ab.IgE	4180186
1011138	Why you did not do this in the past 7D	4180186
1011143	How short of breath did you get putting on socks or stockings in the past 7D	4180186
1011145	How short of breath did you get walking 10 steps - paces on flat ground at a normal speed without stopping in the past 7D	4180186
1011147	How short of breath did you get walking up 5 stairs without stopping in the past 7D	4180186
1011148	How short of breath did you get walking up 10 stairs, 1 flight, without stopping in the past 7D	4180186
1011152	How short of breath did you get lifting something weighing more than 20 lbs, about 9 kg, like a medium-sized suitcase in the past 7D	4180186
1011160	How short of breath did you get walking, faster than your usual speed, for at least 1 mile, a little more than 1.5 km, without stopping in the past 7D	4180186
1011161	How short of breath did you get singing or humming in the past 7D	4180186
1011168	I have a reason for living in the past 7D	4180186
1011169	My life has been productive in the past 7D	4180186
1011170	I have trouble feeling peace of mind in the past 7D	4180186
1011171	I am able to reach down deep into myself for comfort in the past 7D	4180186
1011173	My life lacks meaning and purpose in the past 7D	4180186
1011174	I find strength in my faith or spiritual beliefs in the past 7D	4180186
1011175	My illness has strengthened my faith or spiritual beliefs in the past 7D	4180186
1011177	Functional assessment of chronic illness therapy - spiritual well being, expanded version questionnaire - version 4	4180186
1011178	I feel connected to a higher power, or God, in the past 7D	4180186
1011179	I feel connected to other people in the past 7D	4180186
1011181	I feel love for others in the past 7D	4180186
1011182	I am able to forgive others for any harm they have ever caused me in the past 7D	4180186
1011186	I feel a sense of appreciation for the beauty of nature in the past 7D	4180186
1011187	I feel compassion for others in the difficulties they are facing in the past 7D	4180186
1011190	My pharmacist advises me on the proper use of my medicines in the past 7D	4180186
1011191	My pharmacist advises me on the adverse - side - effects of my medicines in the past 7D	4180186
1011194	My pharmacist helps with the arrangements necessary to obtain my medicines in the past 7D	4180186
1011250	I have trouble getting around in public places in the past 7D	4180186
1011254	Emotional well being - FAMS	4180186
1011255	I feel trapped by my condition in the past 7D	4180186
1011257	I feel useless in the past 7D	4180186
1011262	I feel left out of things in the past 7D	4180186
1011265	I am bothered by muscle spasms in the past 7D	4180186
1011266	Difficult times have strengthened my faith or spiritual beliefs in the past 7D	4180186
1011267	Even during difficult times, I know that things will be okay in the past 7D	4180186
1011268	Walking 50 steps - paces on flat ground at a normal speed without stopping in the past 7D	4180186
1011272	I feel like a burden to my family in the past 7D	4180186
1011275	My mouth and throat are dry in the past 7D	4180186
1011276	I feel useful in the past 7D	4180186
1011279	I feel hopeful in the past 7D	4180186
1011280	I am able to make decisions in the past 7D	4180186
1011281	I have been able to reconcile, make peace, with other people in the past 7D	4180186
1011284	Physical well being - FAHI	4180186
1011291	I am unhappy with my appearance in the past 7D	4180186
1011293	I worry about spreading my infection in the past 7D	4180186
1011294	I am concerned about what the future holds for me in the past 7D	4180186
1011297	I have trouble learning new tasks or directions in the past 7D	4180186
1011315	I have been throwing up in the past 7D	4180186
1011316	I have pain in my stomach in the past 7D	4180186
1011318	I have energy or strength in the past 7D	4180186
1011319	I lose balance or fall down easily in the past 7D	4180186
1011320	I have trouble getting myself dressed in the past 7D	4180186
1011322	My arms or legs feel weak in the past 7D	4180186
1011324	I have trouble writing with a pen or pencil in the past 7D	4180186
1011330	I worry about getting another cancer-tumor in the past 7D	4180186
1011336	I worry about being able to go to college because of my illness in the past 7D	4180186
1011337	I worry about getting a job because of my illness in the past 7D	4180186
1011338	Other people pick on - tease me in the past 7D	4180186
1011339	I think I have fewer friends than others in the past 7D	4180186
1011342	I would rather do something by myself than with other people in the past 7D	4180186
1011344	My parents spoil me in the past 7D	4180186
1011351	My child loses balance or falls down easily in the past 4W	4180186
1011352	My child has trouble getting dressed on his-her own in the past 4W	4180186
1011353	My child has trouble running like other people in the past 4W	4180186
1011354	My child gets tired easily in the past 4W	4180186
1011356	My child gets ill easily in the past 4W	4180186
1011358	My child has pain in the past 7D	4180186
1011359	My child seems happy in the past 4W	4180186
1011361	The cancer-tumor experience makes my child a stronger person in the past 7D	4180186
1011362	The cancer-tumor experience has taught my child to appreciate life in the past 7D	4180186
1011364	My child worries about getting another cancer-tumor in the past 4W	4180186
1011366	My child worries when we go back to the hospital or clinic in the past 4W	4180186
1011369	My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 7D	4180186
1011370	My child worries about being able to have a girlfriend or boyfriend because of his-her illness in the past 4W	4180186
1011372	My child worries about getting a job because of his-her illness in the past 4W	4180186
1011373	Physical well being - FACIT-peds	4180186
1011375	Social - family well being - FAACT-peds	4180186
1011377	My child has fewer friends than others in the past 4W	4180186
1011381	My child thinks I worry too much about him-her in the past 7D	4180186
1011382	My child thinks I spoil him-her in the past 7D	4180186
1011391	My child seems happy in the past 7D	4180186
1011399	My child worries about being able to go to college because of his-her illness in the past 7D	4180186
1011404	My child prefers to do something alone in the past 7D	4180186
1011406	My child eats as much as s-he wants in the past 7D	4180186
1011409	Most food tastes bad to my child in the past 7D	4180186
1011410	My child is worried about how thin s-he is in the past 7D	4180186
1011412	My child is afraid to eat because it may make her-him sick in the past 7D	4180186
1011413	Family or friends try to get my child to eat more in the past 7D	4180186
1011415	When my child eats, s-he seems to get full quickly in the past 7D	4180186
1011416	My child has pain in his-her stomach in the past 7D	4180186
1011418	Social - family well being - FAACT-parent_adoles	4180186
1011419	My child loses balance or falls down easily in the past 7D	4180186
1011423	My child's arms or legs seem weak in the past 7D	4180186
1011424	My child gets ill easily in the past 7D	4180186
1011425	My child has trouble writing with a pen or pencil in the past 7D	4180186
1011429	Other children avoid playing with my child because s-he is different in the past 7D	4180186
1011431	I lose my balance or fall down easily in the past 4W	4180186
1011432	I have trouble getting myself dressed in the past 4W	4180186
1011437	I have trouble writing with a pen or pencil in the past 4W	4180186
1011439	When I try to do something, I usually believe I will do it well in the past 4W	4180186
1011440	The illness experience makes me a stronger person in the past 4W	4180186
1011443	I worry about being sick again in the past 4W	4180186
1011444	I often switch from good moods to bad moods in the past 4W	4180186
1011445	I worry when I go back to the hospital or clinic in the past 4W	4180186
1011450	I worry about getting a job to support myself because of my illness history in the past 4W	4180186
1011451	Other people pick on - tease me in the past 4W	4180186
1011452	I think I have fewer friends than others in the past 4W	4180186
1011453	Other people avoid hanging out with me because of my illness history in the past 4W	4180186
1011454	I feel lonely in the past 4W	4180186
1011455	I would rather do something by myself than with other people in the past 4W	4180186
1011456	I am bothered by being shorter than other people in the past 4W	4180186
1011457	I am bothered by being unable to see well in the past 4W	4180186
1011458	I am bothered by being unable to hear well in the past 4W	4180186
1011459	I am bothered by headaches in the past 4W	4180186
1011460	When I speak, people have trouble understanding me in the past 4W	4180186
1011461	I need to work harder than other people to get my school work done in the past 4W	4180186
1011462	My grades are worse than they were before I was sick in the past 4W	4180186
1011463	I forget things easily in the past 4W	4180186
1011465	I have to read things several times so I can understand them in the past 4W	4180186
1011466	When I play games or sports, I react more slowly than most people my age in the past 4W	4180186
1011467	It is hard for me to find the right words to say what I mean in the past 4W	4180186
1011469	Emotional well being and illness experience - FACT-Br -peds-child	4180186
1011474	Social and family well being - FACT-Br -peds-parent_child	4180186
1011476	My child is bothered by being shorter than his-her peers in the past 4W	4180186
1011477	My child is bothered by poor vision in the past 4W	4180186
1011480	My child's speech is hard for others to understand in the past 4W	4180186
1011487	My child has difficulty using the right words in the past 4W	4180186
1011488	My child often feels inferior to other children in the past 4W	4180186
1011489	I feel weak in the past 7D	4180186
1011491	Being tired made me mad-angry in the past 7D	4180186
1011495	I have been able to laugh and see the funny side of things in the past 7D	4180186
1011496	EPDS	4180186
1011499	I have been anxious or worried for no good reason in the past 7D	4180186
1011500	I have felt scared or panicky for no very good reason in the past 7D	4180186
1011502	I have been so unhappy that I have had difficulty sleeping in the past 7D	4180186
1011504	I have been so unhappy that I have been crying in the past 7D	4180186
1011505	The thought of harming myself has occurred to me in the past 7D	4180186
1011506	Edinburgh Postnatal Depression Scale	4180186
1011549	I have aches and pains that bother me in the past 7D	4180186
1011551	I am able to feel like a man in the past 7D	4180186
1011552	I am able to have and maintain an erection in the past 7D	4180186
1011556	Aggl.ring test.heat inact	4180186
1011565	NFr.DF	4180186
1011567	CSub	4180186
1011573	Received scheduled pain medication regimen in last 5D	4180186
1011575	Received non-medication intervention for pain in last 5D	4180186
1011607	SLUMS	4180186
1011608	IQCODE	4180186
1011645	I feel sad, down in the dumps or unhappy in the last 2W or more	4180186
1011648	I feel tired - have no energy in the last 2W or more	4180186
1011652	I have lost some appetite in the last 2W or more	4180186
1011655	I feel worried or fearful in the last 2W or more	4180186
1011656	I have attacks of anxiety or panic in the last 2W or more	4180186
1011657	I worry about dying or losing control in the last 2W or more	4180186
1011658	I am nervous or shaky in social situations in the last 2W or more	4180186
1011659	I have nightmares or flashbacks in the last 2W or more	4180186
1011662	I can't get certain things out of my mind in the last 2W or more	4180186
1011663	I feel I must repeat certain acts or rituals in the last 2W or more	4180186
1011664	I feel the need to check and recheck things in the last 2W or more	4180186
1011695	Prostatic fld	4180186
1011697	VFr.DF	4180186
1011759	Feeling emotionally numb or being unable to have loving feelings for those close to you in the last Mo	4180186
1011773	Did you feel tired during the past 4W	4180186
1011775	Did you feel worn out during the past 4W	4180186
1011777	Did you have a lot of energy during the past 4W	4180186
1011778	Have you felt calm and peaceful during the past 4W	4180186
1011779	Have you felt so down in the dumps that nothing could cheer you up during the past 4W	4180186
1011780	Have you been a very nervous person during the past 4W	4180186
1011783	How much bodily pain have you had during the past 4W	4180186
1011785	As a result of any emotional problems, have you accomplished less than you would like in the past 4W	4180186
1011786	As a result of any emotional problems, have you cut down the amount of time you spent on work or other activities in the past 4W	4180186
1011787	As a result of your physical health, have you had difficulty performing the work or other activities - for example, it took extra effort in the past 4W	4180186
1011788	As a result of your physical health, were you limited in the kind of work in the past 4W	4180186
1011790	As a result of your physical health, have you cut down the amount of time you spent on work or other activities in the past 4W	4180186
1011800	During the past 4W, how much of the time has your physical health or emotional problems interfered with your social activities - like visiting with friends, relatives, etc.	4180186
1011829	PROMIS-10 Global Mental Health score	4180186
1011832	VR-36 Role emotion score - oblique method	4180186
1011833	VR-36 Social functioning score - oblique method	4180186
1011836	VR-36 Bodily pain score - oblique method	4180186
1011837	VR-36 Role physical score - oblique method	4180186
1011840	VR-36 Mental component summary score - oblique method	4180186
1011842	VR-36 Role emotion score - orthogonal method	4180186
1011847	VR-36 Bodily pain score - orthogonal method	4180186
1011848	VR-36 Role physical score - orthogonal method	4180186
1011849	VR-36 Physical functioning score - orthogonal method	4180186
1011852	VR-12 Social functioning score - oblique method	4180186
1011860	VR-12 Mental component summary score - oblique method	4180186
1011863	VR-12 Mental component summary score - orthogonal method	4180186
1011897	Sodium profiling-modeling prescribed for any dialysis sessions in the reporting Mo	4180186
1011908	Did prescribed dialysate sodium concentration exceed 138 mEq/L for any dialysis session during the Mo	4180186
1011930	Vital signs & oximetry - admission, home health, interim, discharge	4180186
1011932	Alcohol use disorder identification test-consumption	4180186
1011937	AUDIT	4180186
1011941	BS II	4180186
1011945	MAST-G	4180186
1011946	CRAFFT	4180186
1011947	P.E.D.S.	4180186
1011948	P.E.D.S.-DM	4180186
1011951	IDI	4180186
1011952	HAQ	4180186
1011954	ASQ	4180186
1011962	MLHFQ	4180186
1011963	Total score - Ages and stages questionnaires 2 Mo	4180186
1011965	Total score - Ages and stages questionnaires 6 Mo	4180186
1011968	Total score - Ages and stages questionnaires 10 Mo	4180186
1011970	Total score - Ages and stages questionnaires 14 Mo	4180186
1011971	Total score - Ages and stages questionnaires 16 Mo	4180186
1011974	Total score - Ages and stages questionnaires 22 Mo	4180186
1011975	Total score - Ages and stages questionnaires 24 Mo	4180186
1011979	Total score - Ages and stages questionnaires 36 Mo	4180186
1012000	Ser/Plas+Synv fld	4180186
1012010	Given pyrimethamine sulfadoxine - starting at 4th Mo	4180186
1012026	Albumin.CSF	4180186
1012035	Surgical operation note - recommended C-CDA R1.1 & R2.0 & R2.1 sections	4180186
1012039	Mini-Cog	4180186
1012042	Glucose.serum	4180186
1012043	Glucose.synv fld	4180186
1012045	Neutrophil oxidative burst stimulated/unstimulated	4180186
1012047	Wound tunneling & undermining panel	4180186
1012064	Neutrophil oxidative burst stimulated	4180186
1012070	Severity of pain on average over the past Mo	4180186
1012071	Level of fatigue on average over the past Mo	4180186
1012089	CFr.DF	4180186
1012095	Guidance for repair of central venous catheter without port or pump	4180186
1012096	Guidance for repair of central venous catheter with port or pump	4180186
1012103	I got drunk in last W	4180186
1012104	I took drugs in last W	4180186
1012105	I took medication that had not been prescribed or if had been prescribed, I took more than the prescribed dose in last W	4180186
1012109	I felt as if I was far away from myself in last W	4180186
1012110	I felt worthless in last W	4180186
1012112	Now we would like to know in addition the quality of your overall personal state in the course of the last W	4180186
1012114	I told other people that I was going to kill myself in last W	4180186
1012116	I had episodes of binge eating in last W	4180186
1012117	I induced vomiting in last W	4180186
1012123	I was absent-minded and unable to remember what I was actually doing in last W	4180186
1012125	I thought of hurting myself in last W	4180186
1012126	I didn't trust other people in last W	4180186
1012134	My mood rapidly cycled in terms of anxiety, anger, and depression in last W	4180186
1012137	I felt vulnerable in last W	4180186
1012138	Everything seemed senseless to me in last W	4180186
1012139	I was afraid of losing control in last W	4180186
1012140	BSL-23	4180186
1012141	cfDNA	4180186
1012143	The idea of death had a certain fascination for me in last W	4180186
1012155	Multisection for physiologic artery study	4180186
1012158	Stalwart of Standardization + Vocabulary Curator Virtuoso	4180186
1012179	NDC labeler code request.animal drug	4180186
1012180	Tscore	4180186
1012181	Bld/Tiss/Sal	4180186
1012202	PctDiff	4180186
1012208	Reagin Ab & Treponema pallidum Ab	4180186
1012215	MFrDiff	4180186
1012216	EntSRto	4180186
1012266	Dosage of chromosome specific cf DNA	4180186
1012297	Arm.left	4180186
1012304	Surg	4180186
1012308	Problem alleviating &or exacerbating factors	4180186
1012322	Number of Y alcohol consumed	4180186
1012342	Injury severity score body region	4180186
1012344	Blood group 8	4180186
1012346	Cytokeratin 7 & Thyroid transcription factor 1	4180186
1012405	Work Ds per W	4180186
1012410	NMMDS	4180186
1012427	interRAI contact assessment	4180186
1012428	interRAI home care	4180186
1012430	interRAI emergency screener for psychiatry	4180186
1012431	interRAI acute care	4180186
1012432	interRAI palliative care	4180186
1012433	interRAI community health assessment - deafblind supplement	4180186
1012434	interRAI community health assessment - assisted living supplement	4180186
1012445	Weight difference pre dialysis & post dialysis panel	4180186
1012449	VP shunt	4180186
1012464	How many times in the last Y did you use a false name or alias so you couldn't be	4180186
1012466	Streptococcus pneumoniae DNA & Haemophilus influenza DNA & Streptococcus agalactiae	4180186
1012474	Antibody screen.autologous	4180186
1012475	Antibody screen.cell II	4180186
1012476	Antibody screen.cells I+II+III	4180186
1012493	Patient safety event report - hospital - healthcare event reporting form - version 1.2	4180186
1012514	Patient safety event report - hospital - summary of initial report - version 1.2	4180186
1012521	Event discovery date & time	4180186
1012544	Health information technology device was involved	4180186
1012545	Best characterization of health information technology device	4180186
1012565	Staphylococcus aureus.methicillin resistant isolate	4180186
1012570	Vital signs, weight, height, head circumference, oximetry, BMI, & BSA panel	4180186
1012633	CSF Venereal Disease Research Laboratory test was performed & test findings	4180186
1012634	Leukocyte count or protein test was performed on CSF & test findings	4180186
1012658	Norton scale score.total	4180186
1012668	How intense was your pain at its worse in the past 7D	4180186
1012717	Amnio fld/CVS	4180186
1012720	Plas/Bld	4180186
1012723	Plas.cfDNA	4180186
1012741	Social work.case manager	4180186
1012743	Mental health.nurse	4180186
1012744	Preventive medicine.nurse	4180186
1012745	Primary care.nurse	4180186
1012748	Primary care.physician	4180186
1012751	Primary care.team	4180186
1012765	HIV 1+2 Ab & HIV1 p24	4180186
1012768	Coagulation surface induced.lupus sensitive with 1:1 Pooled Normal Plasma actual	4180186
1012782	Patient seen in this ED in last 72H and discharged	4180186
1012787	TimeFr	4180186
1012801	Over the past W, are you able to shampoo your hair	4180186
1012802	Over the past W, are you able to stand up from a straight chair	4180186
1012803	Over the past W, are you able to get in and out of bed	4180186
1012806	Over the past W, are you able to walk outdoors on flat ground	4180186
1012807	Over the past W, are you able to climb up five steps	4180186
1012819	Over the past W, are you able to take a tub bath	4180186
1012820	Over the past W, are you able to reach and get down a 5 pound object (such as a bag of sugar) from just above your head	4180186
1012821	Over the past W, are you able to bend down and pick up clothing from the floor	4180186
1012825	Over the past W, are you able to run errands and shop	4180186
1012826	Over the past W, are you able to get in and out of a car	4180186
1012829	Over the past W, are you able to wait in line for 15 minutes	4180186
1012830	Over the past W, are you able to do outside work (such as yard work)	4180186
1012831	Over the past W, are you able to lift heavy objects	4180186
1012832	Over the past W, are you able to move heavy objects	4180186
1012833	Over the past W, are you able to go up two or more flights of stairs	4180186
1012835	During the past 2Ws, what was the hardest physical activity you could do for at least 2 minutes	4180186
1012848	During the past 2Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health	4180186
1012851	How would you rate your overall health now compared to 2Ws ago	4180186
1012854	How have things been going for you during the past 2Ws	4180186
1012856	CDAI	4180186
1012859	Number of falls in the past 12Mo	4180186
1012861	AXIN2 gene deletion+duplication &	4180186
1012868	Guidance for percutaneous aspiration of fluid	4180186
1012877	Thoughts on cardiopulmonary resuscitation	4180186
1012893	Bld/Urine	4180186
1012896	During the past 4Ws, how would you rate your health in general	4180186
1012897	How would you rate your overall health now compared to 4Ws ago	4180186
1012898	During the past 4Ws, how much bodily pain have you generally had	4180186
1012899	During the past 4Ws, has your physical and emotional health limited your social activities with family, friends, neighbors or groups	4180186
1012900	During the past 4Ws, how much difficulty have you had doing your usual activities or tasks, both inside and outside the house because of your physical and emotional health	4180186
1012901	During the past 4Ws, how much have you been bothered by emotional problems such as feeling anxious, depressed, irritable or downhearted and blue	4180186
1012902	During the past 4Ws, what was the hardest physical activity you could do for at least 2 minutes	4180186
1012926	AAAM	4180186
1012930	My child felt uneasy in past 7D	4180186
1012937	How many D in the past W did your child miss taking one or more medications	4180186
1012974	CNAP	4180186
1012981	IEEE Rosetta central nervous system panel	4180186
1012984	IEEE Rosetta temperature panel	4180186
1012985	IEEE Rosetta skin transcutaneous panel	4180186
1012986	IEEE Rosetta laboratory panel	4180186
1012994	IEEE Rosetta body measurement panel	4180186
1012998	Freq	4180186
1013001	ScoreRange	4180186
1013002	Bld/Tiss^Donor	4180186
1013063	I have trouble starting things because I am tired during the past 7D	4180186
1013073	Licensed nursing staff & sex panel	4180186
1013421	How often in the past 12Mo would you say the patient was worried or stressed about having enough money to buy nutritious meals	4180186
1013422	On a typical weekday in the past W, how much time did the patient spend watching TV &or DVDs	4180186
1013431	Within the last Y, have you been humiliated or emotionally abused in other ways by your partner or ex-partner	4180186
1013432	Within the last Y, have you been afraid of your partner or ex-partner	4180186
1013433	Within the last Y, have you been raped or forced to have any kind of sexual activity by your partner or ex-partner	4180186
1013441	In a typical W, how many times do you talk on the telephone with family, friends, or neighbors	4180186
1013457	Prosigna	4180186
1013459	On a typical weekday in the past W, how much time did the patient spend playing video games and computer games	4180186
1013461	Calculated.Prosigna	4180186
1013463	Calculated.VectraDA	4180186
1013467	In the past W, how many times were dinners prepared at home and eaten together	4180186
1013470	How much formula does the patient drink per D	4180186
1013478	Total combined household income range in last 12Mo	4180186
1013484	Yesterday, how many times did the patient eat food from any type of restaurant	4180186
1013485	30D	4180186
1013492	Ds per W of moderate to vigorous physical activity	4180186
1013544	Salivary gland protein 1 & Carbonic anhydrase 6 & Parotid secretory protein Ab.IgA & IgG & IgM	4180186
1013548	UPDRS	4180186
1013575	Females & males of reproductive potential	4180186
1013581	Nursing staff job positions, quantity, turnover, & retention panel	4180186
1013595	Mean number of nursing staff	4180186
1013606	Management, administrative, &or support staff	4180186
1013613	RptPeriod	4180186
1013628	HLA-DP & DQ & DR (class II)	4180186
1013632	I could rely on my family in past 4W	4180186
1013636	I could trust others in my family in past 4W	4180186
1013640	I felt I really belonged in my family in past 4W	4180186
1013641	I felt important in my family in past 4W	4180186
1013645	I felt really respected by my family in past 4W	4180186
1013648	I felt that I had similar values and beliefs as others in my family in past 4W	4180186
1013650	I felt that my family really respected me in past 4W	4180186
1013651	I felt that my family understood me in past 4W	4180186
1013659	I have been able to concentrate in past 7D	4180186
1013661	I have been able to form thoughts clearly in past 7D	4180186
1013665	I have been able to keep track of what I am doing, even if I am interrupted in past 7D	4180186
1013668	I have been able to multi-task as easily as usual without extra effort in past 7D	4180186
1013669	I have been able to pay attention and keep track of what I am doing without extra effort in past 7D	4180186
1013670	I have been able to remember telephone numbers in past 7D	4180186
1013673	I have been able to remember things as easily as usual without extra effort in past 7D	4180186
1013674	I have been able to remember to do things, like take medicine or buy something I needed in past 7D	4180186
1013676	I have been able to think as clearly as usual without extra effort in past 7D	4180186
1013677	I have been able to think clearly in past 7D	4180186
1013679	I have been upset about my problems with memory, concentration, or making mental mistakes in past 7D	4180186
1013680	I have forgotten names of people soon after being introduced in past 7D	4180186
1013682	I have had more problems conversing with others in past 7D	4180186
1013685	I have had to work harder than usual to keep track of what I was doing in past 7D	4180186
1013686	I have had to work really hard to pay attention or I would make a mistake in past 7D	4180186
1013687	I have had trouble adding or subtracting numbers in my head in past 7D	4180186
1013692	I have had trouble recalling the name of an object while talking to someone in past 7D	4180186
1013697	I have had trouble speaking fluently in past 7D	4180186
1013702	I knew my family would help me if I needed it in past 4W	4180186
1013708	My ability to concentrate has been good in past 7D	4180186
1013709	My ability to count money has been as good as usual in past 7D	4180186
1013710	My ability to follow driving directions has been as good as usual in past 7D	4180186
1013711	My ability to keep track of lists has been as good as usual in past 7D	4180186
1013712	My ability to remember important dates has been as good as usual in past 7D	4180186
1013713	My ability to remember names has been as good as usual in past 7D	4180186
1013716	My child felt a sense of togetherness with our family in past 4W	4180186
1013718	My child felt everyone in our family loved him or her in past 4W	4180186
1013721	My child felt he or she got all the help he or she needed from our family in past 4W	4180186
1013725	My child felt he or she was really important to our family in past 4W	4180186
1013729	My child felt our family treated him or her fairly in past 4W	4180186
1013730	My child felt really respected by our family in past 4W	4180186
1013737	My child felt that our family understood him or her in past 4W	4180186
1013739	My child felt totally accepted by our family in past 4W	4180186
1013741	My child knew everyone in our family loved him or her in past 4W	4180186
1013746	My child knew our family was interested in what he or she was doing in past 4W	4180186
1013747	My child knew our family would help if he or she needed it in past 4W	4180186
1013748	My child knew that everyone in our family could be completely trusted in past 4W	4180186
1013749	My child knew that our family would be there if he or she needed them in past 4W	4180186
1013751	My child wanted to help our family however he or she could in past 4W	4180186
1013754	My family was interested in what I was doing in past 4W	4180186
1013759	My problems with memory, concentration, or making mental mistakes have interfered with the quality of my life in past 7D	4180186
1013762	My thinking has been clear in past 7D	4180186
1013763	My thinking has been foggy in past 7D	4180186
1013764	My thinking has been slow in past 7D	4180186
1013766	Other people have told me I seemed to have trouble remembering information in past 7D	4180186
1013767	People in my family helped each other in past 4W	4180186
1013769	People in our family made my child feel good about himself or herself in past 4W	4180186
1013774	Everyone in my family could be completely trusted in past 4W	4180186
1013850	Falling scale	4180186
1013889	Can pronounce naive	4180186
1013917	Chest>Vessels	4180186
1013918	Neck>Vessels	4180186
1013934	Being tired made it hard for me to remember things in past 7D	4180186
1013936	I could jump up and down in past 7D	4180186
1013937	I could pick up coins from a table in past 7D	4180186
1013939	I could thread a needle in past 7D	4180186
1013940	I could wash my hair by myself in past 7D	4180186
1013941	I felt sad for no reason in past 7D	4180186
1013942	I felt tired even when I had not done anything in past 7D	4180186
1013944	I needed help walking when I was in pain in past 7D	4180186
1013945	I walked carefully when I was in pain in past 7D	4180186
1013947	I was angry when things didn't go my way in past 7D	4180186
1013949	I worried that something might happen to my parents or guardians in past 7D	4180186
1013950	It was hard for me to be away from home because I had pain in past 7D	4180186
1013951	It was hard to do things with my family because I had pain in past 7D	4180186
1013953	My pain was so bad that I needed to take medicine to treat it in past 7D	4180186
1013971	Heart.ventricle.left.mid anterior lateral	4180186
1013974	Mitral valve.annulus.lateral	4180186
1013978	During the past 24H, how has pain interfered with your general activity	4180186
1013979	During the past 24H, how has pain interfered with your mood	4180186
1013982	During the past 24H, how has pain interfered with your relations with other people	4180186
1013983	During the past 24H, how has pain interfered with your sleep	4180186
1013984	During the past 24H, how has pain interfered with your enjoyment of life	4180186
1014024	How much time did you usually spend on one of those D doing moderate physical activities	4180186
1014026	During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, digging, aerobics, or fast bicycling for at least 10M at a time	4180186
1014031	Salmo salar roe	4180186
1014049	Unified Parkinson's Disease Rating Scale panel	4180186
1014050	Mean time to access a patient	4180186
1014115	PROMIS alcohol - negative expectancies - version 1.0 T-score	4180186
1014116	PROMIS alcohol - positive outcomes - version 1.0 T-score	4180186
1014119	PROMIS alcohol - positive expectancies - version 1.0 T-score	4180186
1014121	PROMIS instrumental support - version 2.0 T-score	4180186
1014123	PROMIS emotional support - version 2.0 T-score	4180186
1014125	PROMIS ability to participate in social roles and activities - version 2.0 T-score	4180186
1014128	PROMIS satisfaction with participation in roles - version 1.0 T-score	4180186
1014132	PROMIS emotional distress - depression - version 1.0 T-score	4180186
1014135	PROMIS fatigue - version 1.0 T-score	4180186
1014136	PROMIS pain interference - version 1.0 T-score	4180186
1014141	PROMIS pediatric physical function - mobility - version 1.0 T-score	4180186
1014143	PROMIS pediatric asthma - version 1.0 T-score	4180186
1014144	PROMIS pediatric emotional distress - anxiety - version 1.0 T-score	4180186
1014167	Hospitalized for condition of interest	4180186
1014185	Bld MC	4180186
1014187	EntLogNum	4180186
1014200	Excursion distance.systole	4180186
1014204	CT.perfusion	4180186
1014227	Does your health now limit you in doing 2H of physical labor	4180186
1014230	Does your health now limit you in doing 8H of physical labor	4180186
1014244	Views GE 2	4180186
1014247	PPresRto	4180186
1014248	BldA+Resp.alv	4180186
1014278	Posterior descending from left circumflex artery	4180186
1014279	Ramus intermedius from left main coronary artery	4180186
1014280	Dothiepin+nordothiepin & dothiepin sulfoxide panel	4180186
1014283	Cardiovascular disease+Pulmonary disease	4180186
1014287	GPCOG	4180186
1014290	AreaFr	4180186
1014301	Calculated.AlloMap	4180186
1014302	Intravenous contrast	4180186
1014313	Myocardial infarction in past 24H	4180186
1014319	Posterolateral from right coronary artery	4180186
1014320	Diagonal artery 1a	4180186
1014321	Diagonal artery 2a	4180186
1014328	Multisection for leg measurement	4180186
1014329	Vessels.right	4180186
1014331	Multisection by reconstruction	4180186
1014333	CT.densitometry	4180186
1014338	Superficial biopsy.needle	4180186
1014340	CT.scanogram	4180186
1014361	Compared to a few Y ago, is the patient less able to manage money and financial affairs (e.g. paying bills, budgeting)	4180186
1014362	Compared to a few Y ago, when speaking, does the patient have more difficulty in finding the right word or tend to use the wrong words more often	4180186
1014369	Fluid intake.intravascular.lipids	4180186
1014373	Fluid output.enteral tube	4180186
1014375	Fluid output.musculoskeletal drain	4180186
1014382	N-methyl-D-aspartate receptor Ab	4180186
1014385	Objective refraction	4180186
1014390	Snellen eye chart	4180186
1014394	ERG device	4180186
1014401	Reese-Ellsworth system	4180186
1014406	Conjunctiva+Sclera.right	4180186
1014407	Conjunctiva+Sclera.left	4180186
1014408	Eyelid & Lashes & Adnexa	4180186
1014409	Pupil.right	4180186
1014411	ElpotRto	4180186
1014415	Optic nerve.left	4180186
1014418	Macula.right	4180186
1014420	Confrontation	4180186
1014433	LogInvPct	4180186
1014434	Multivitamin &or mineral supplement intake	4180186
1014436	Breast milk &or formula intake panel	4180186
1014468	Meal &or snack pattern panel	4180186
1014500	VR-12 Physical component summary score change - oblique method	4180186
1014502	VR-12 Mental component summary score change - orthogonal method	4180186
1014503	TscoreDiff	4180186
1014533	180D	4180186
1014539	Fat.saturated intake	4180186
1014556	Amino acid.essential intake	4180186
1014569	Enteral tube.nutritional intake panel	4180186
1014598	Vitamin B7 intake	4180186
1014599	Vitamin B9 intake	4180186
1014605	US.2D.A2C+Calc by single plane method of disks	4180186
1014610	Vitamin B1 intake	4180186
1014619	Symptoms & diseases of genitourinary system	4180186
1014629	Mineral &or trace element intake panel	4180186
1014678	Heart.ventricle.right.base	4180186
1014679	Heart.ventricle.right.mid-cavity	4180186
1014685	ArArea	4180186
1014691	Retinal vessels.right	4180186
1014692	Retinal vessels.left	4180186
1014693	Chorioretina.left	4180186
1014696	SCncSq	4180186
1014699	ICRB	4180186
1014701	LogLenRto	4180186
1014734	Fluid intake.enteral tube.nutritional formula composition	4180186
1014735	EngCnc	4180186
1014737	Number of W postpartum	4180186
1014760	7D	4180186
1014762	D per W alcoholic drinks consumed	4180186
1014769	MR	4180186
1014774	Pelvis>Veins	4180186
1014777	Multisection for high grade tumor	4180186
1014778	TmStpRange	4180186
1014781	Multisection for new diagnosis tumor	4180186
1014787	Multisection for motor function	4180186
1014788	Multisection endovaginal	4180186
1014790	Multisection for implant	4180186
1014801	Coag.kaolin induced	4180186
1014802	Coag.diatomaceous earth induced	4180186
1014830	How often have you found it difficult to postpone urination over the past Mo	4180186
1014831	How often have you had a weak urinary stream over the past MO	4180186
1014832	How often have you had to push or strain to begin urination over the past MO	4180186
1014833	How many times did you most typically get up to urinate from the time you went to bed at night until the time you got up in the morning over the past Mo	4180186
1014836	Multisection limited for graft	4180186
1014837	Multisection for pregnancy+fetal abnormality	4180186
1014839	Multisection for pregnancy+second or third trimester	4180186
1014840	Umbilical artery^fetus	4180186
1014841	Multisection transabdominal + transvaginal for pregnancy+first trimester	4180186
1014843	Guidance for biopsy.vacuum	4180186
1014844	Multisection for torsion	4180186
1014846	Multisection for transplanted kidney	4180186
1014849	Multisection for multiple gestation pregnancy+second or third trimester	4180186
1014850	Multisection transabdominal + transvaginal for multiple gestation pregnancy+first trimester	4180186
1014851	Multisection transvaginal for pregnancy	4180186
1014854	Multisection for multiple gestation pregnancy+fetal abnormality	4180186
1014856	Guidance for placement of central venous catheter	4180186
1014857	Guidance for placement of large bore central venous catheter	4180186
1014858	Guidance for removal of central venous catheter	4180186
1014861	Multisection limited for transplanted kidney	4180186
1014867	Multisection for motion	4180186
1014870	Multisection for transplanted liver	4180186
1014874	Umbilical vessels^fetus	4180186
1014875	Gastrointestinal tract.upper	4180186
1014876	AUASI	4180186
1014877	ExtendedID	4180186
1014883	Cardiogenic shock within 24H prior to procedure	4180186
1014887	DXA	4180186
1014898	EngDiff	4180186
1014900	Acute & chronic leukemia	4180186
1014901	US && MG	4180186
1014903	Breast.left & ^Breast specimen.left	4180186
1014905	Multisection for pediatrics	4180186
1014912	Metabolic equivalent of task & Resting metabolic rate panel	4180186
1014922	Source used for reported activity metabolic rate	4180186
1014926	Metabolic equivalent of task by standard resting metabolic rate panel	4180186
1014928	Population resting metabolic rate	4180186
1014942	Goals &or preferences in order of priority	4180186
1014987	Non-probe.amp.tar	4180186
1014997	Multisection limited for simulation	4180186
1014998	Multisection for amyloidosis	4180186
1015002	Multisection for infection or inflammation	4180186
1015003	PT.perfusion	4180186
1015013	Views for blood flow+kidney function	4180186
1015016	Views limited for thyroid tumor metastasis	4180186
1015019	Views gated+blood pool+ejection fraction+wall motion	4180186
1015020	Views for blood flow GE 4	4180186
1015021	Views for blood flow LT 4	4180186
1015027	XR	4180186
1015029	Views first pass+blood pool	4180186
1015030	Multisection for tissue viability	4180186
1015032	Multisection metabolic	4180186
1015040	Views for thyroid tumor metastasis	4180186
1015047	Scope.modifier.doc template	4180186
1015050	Tobacco smoking status.tobacco smoker	4180186
1015051	3-Hydroxyoctanoylcarnitine	4180186
1015059	Sukharev	4180186
1015060	Progress note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015061	Procedure note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015062	Referral note - recommended C-CDA R2.0 & R2.1 sections	4180186
1015069	Care plan - recommended C-CDA R2.0 & R2.1 sections	4180186
1015078	Gestational age in W at onset of illness	4180186
1015086	Enhanced procedure note - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015088	Enhanced surgical operation note - recommended CDP Set 1 R1.0 & R1.1 sections	4180186
1015093	Probe.amp.tar.primer-probe set H5b	4180186
1015094	Reference source	4180186
1015105	How often did anyone at least 5Y older than you or an adult, ever touch you sexually	4180186
1015106	How often did anyone at least 5Y older than you or an adult, force you to have sex	4180186
1015107	BRFSS Adverse Childhood Experience Module	4180186
1015136	FGFR3 gene p.Gly380Arg	4180186
1015149	Symptoms & diseases	4180186
1015153	Diagnosis.secondary	4180186
1015155	RelTime	4180186
1015158	Episode of care diagnosis.primary	4180186
1015160	Bld.dot	4180186
1015164	Overall Plan of Care &or Advance Care Directives panel	4180186
1015170	How often did anyone at least 5Y older than you or an adult, try to make you touch sexually	4180186
1015172	Views limited for tumor	4180186
1015177	IA	4180186
1015178	IA.rapid	4180186
1015197	Metabolic equivalent of task by predicted resting metabolic rate panel	4180186
1015208	Blood transfusion &or organ transplant	4180186
1015217	RF.angio	4180186
1015219	XR.tomography	4180186
1015221	Level 3 emergency medical services patient care report - recommended CDA R1 & R2 sections	4180186
1015223	KOOSJR	4180186
1015227	Amount of knee pain experienced while going up or down stairs in the last W	4180186
1015229	Degree of difficulty experienced due to your knee while bending to floor &or pick up an object in the last W	4180186
1015232	Amount of knee pain experienced while twisting &or pivoting on your knee in the last W	4180186
1015233	Amount of knee pain experienced while straightening knee fully in the last W	4180186
1015234	How severe is your knee stiffness after first wakening in the morning during the last W	4180186
1015243	(View AP	4180186
1015244	(Views AP	4180186
1015252	Indexing - risk evaluation & mitigation strategies	4180186
1015257	How often have you used your rescue inhaler or nebulizer medication (such as albuterol) during the past 4W	4180186
1015260	DAST-10	4180186
1015261	Views & AP	4180186
1015262	(View oblique) + (views^W R-bending + W L-bending)	4180186
1015263	Views AP + axillary + Y	4180186
1015266	(Views) + (view AP^W standing)	4180186
1015267	(Views) + (view^W manual stress)	4180186
1015270	(Views 2) + (View tunnel^W standing)	4180186
1015276	Views lateral & PA	4180186
1015277	Views for blood flow+function	4180186
1015279	Chest>Ribs.right & Chest	4180186
1015282	Obstetrics.midwife	4180186
1015285	Chest & Abdomen	4180186
1015287	Views ventilation+equilibrium+washout	4180186
1015288	Views ventilation+perfusion	4180186
1015291	(Views) + (view	4180186
1015307	Mitral valve.leaflet.tip	4180186
1015314	Dopamine receptor D2 long Ab	4180186
1015383	BSL-SUPP	4180186
1015397	Amyotrophic lateral sclerosis functional rating scale - revised (ALSFRS-R)	4180186
1015398	ACE	4180186
1015400	A little n W little j Ab	4180186
1015403	CMS Assessment	4180186
1015435	Transplant surgery.case manager	4180186
1015436	Vascular surgery.nurse	4180186
1015439	Vascular surgery.technician	4180186
1015442	Surgery.case manager	4180186
1015443	Plastic surgery.nurse	4180186
1015445	Orthopaedic surgery.nurse practitioner	4180186
1015454	Infectious disease.nurse	4180186
1015455	Pulmonary disease.nurse	4180186
1015456	Orthopaedic surgery.nurse	4180186
1015459	Dentistry.nurse	4180186
1015461	Dermatology.nurse	4180186
1015462	Dermatology.nurse practitioner	4180186
1015464	Diabetology.nurse	4180186
1015489	IRF-PAI - Mobility - admission performance during 3D assessment period	4180186
1015499	Multisection for pulmonary embolus+deep vein thrombosis	4180186
1015501	IRF-PAI - Mobility - discharge performance during 3D assessment period	4180186
1015505	Multisection for calcium score^WO contrast && Multisection^W contrast IV	4180186
1015506	D-3-phosphoglycerate dehydrogenase Ab.IgG	4180186
1015510	LCDS v3.00 - Mobility - admission performance during 3D assessment period	4180186
1015517	Injection drug use in the past Y	4180186
1015519	Sexual activity while intoxicated &or high on drugs in the past Y	4180186
1015521	Sexual activity with anonymous partner in the past Y	4180186
1015522	Sexual activity with a male in the past Y	4180186
1015523	Sexual activity with a female in the past Y	4180186
1015527	Treatment stopped for at least 1W	4180186
1015541	Geriatric medicine.pharmacist	4180186
1015542	Geriatric medicine.team	4180186
1015548	Hepatology.nurse	4180186
1015550	Interventional radiology.nurse	4180186
1015553	Mental health.interdisciplinary	4180186
1015561	Nephrology.nurse practitioner	4180186
1015562	Nephrology.team	4180186
1015563	Neurology.nurse	4180186
1015564	Neurology.team	4180186
1015570	AP postural sway score^eyes open+on solid surface	4180186
1015572	eyes open+on foam surface	4180186
1015579	Additional [ft_i] past last 10 [ft_i] mark	4180186
1015580	Remainder [in_i] past last 10 [ft_i] mark	4180186
1015598	Nutrition and dietetics.nurse	4180186
1015607	(Views AP + lateral + Merchants) + (views^W standing)	4180186
1015612	BIMS	4180186
1015615	Spinal cord injury medicine.physician	4180186
1015616	Spinal cord injury medicine.physician assistant	4180186
1015617	Spinal cord injury medicine.team	4180186
1015618	Urology.interdisciplinary	4180186
1015620	Urology.nurse practitioner	4180186
1015623	Obstetrics and gynecology.nurse	4180186
1015624	Obstetrics and gynecology.nurse practitioner	4180186
1015625	Occupational medicine.nurse	4180186
1015631	Views GE 3 AP + oblique + cone	4180186
1015633	(Views GE 5) + (Views GE 1^W R-bending + W L-bending)	4180186
1015635	(Views 2 or 3) + (Views^W flexion + W extension) + (Views oblique)	4180186
1015638	Pelvis && Lower extremity.left>Hip	4180186
1015641	Views 2 && View AP	4180186
1015645	Views LE 3 AP + lateral	4180186
1015650	Neutrophil membrane Ab.IgG	4180186
1015651	Thymus Ab.IgG	4180186
1015652	XR && RF	4180186
1015662	Eating - functional goal recorded during 3D assessment period	4180186
1015664	Oral hygiene - functional goal recorded during 3D assessment period	4180186
1015665	Toileting hygiene - functional ability during 3D assessment period	4180186
1015666	Toileting hygiene - functional goal recorded during 3D assessment period	4180186
1015667	Shower &or bathe self - functional ability during 3D assessment period	4180186
1015673	Putting on and taking off footwear - functional ability during 3D assessment period	4180186
1015675	Roll left and right - functional ability during 3D assessment period	4180186
1015677	Sit to lying - functional ability during 3D assessment period	4180186
1015678	Sit to lying - functional goal recorded during 3D assessment period	4180186
1015680	Lying to sitting on side of bed - functional goal recorded during 3D assessment period	4180186
1015681	Sit to stand - functional ability during 3D assessment period	4180186
1015683	Bed-to-chair transfer - functional ability during 3D assessment period	4180186
1015684	Bed-to-chair transfer - functional goal recorded during 3D assessment period	4180186
1015686	Toilet transfer - functional goal recorded during 3D assessment period	4180186
1015695	Walking 10 feet on uneven surfaces - functional ability during 3D assessment period	4180186
1015697	1 step (curb) - functional ability during 3D assessment period	4180186
1015703	Picking up object - functional ability during 3D assessment period	4180186
1015704	Picking up object - functional goal recorded during 3D assessment period	4180186
1015706	Wheel 50 feet with two turns - functional goal recorded during 3D assessment period	4180186
1015707	Wheel 150 feet - functional ability during 3D assessment period	4180186
1015708	Wheel 150 feet - functional goal recorded during 3D assessment period	4180186
1015709	Bladder continence during 3D assessment period	4180186
1015710	Bowel continence during 3D assessment period	4180186
1015713	IRF-PAI v3.0 - Swallowing &or nutritional status - admission	4180186
1015714	Usual ability to swallow during 3D assessment period	4180186
1015719	Spinal cord injury medicine.interdisciplinary	4180186
1015720	Speech-language pathology.team	4180186
1015721	Social work.interdisciplinary	4180186
1015722	Social work.team	4180186
1015723	Social work.nurse	4180186
1015724	Research.nurse	4180186
1015726	Radiation oncology.nurse	4180186
1015727	Radiation oncology.therapist	4180186
1015731	Psychiatry.nurse	4180186
1015733	Psychiatry.case manager	4180186
1015735	Primary care.nurse practitioner	4180186
1015736	Primary care.interdisciplinary	4180186
1015737	Primary care.case manager	4180186
1015740	Physical therapy.team	4180186
1015744	Physical medicine and rehab.physician	4180186
1015745	Physical medicine and rehab.nurse	4180186
1015746	Physical medicine and rehab.case manager	4180186
1015747	Pathology.nurse	4180186
1015749	Palliative care.team	4180186
1015750	Palliative care.physician	4180186
1015752	Palliative care.nurse	4180186
1015753	Pain medicine.team	4180186
1015758	Podiatry.nurse	4180186
1015760	MG.tomosynthesis	4180186
1015765	AP postural sway score^eyes open+on foam surface	4180186
1015768	(Views AP + oblique) + (View lateral^W flexion + W extension)	4180186
1015771	(Views 2) + (view tunnel	4180186
1015774	(Views AP + oblique) + (View lateral	4180186
1015780	Views GE 4 && Views	4180186
1015781	Views 4 && Views	4180186
1015782	Views 2 && Views	4180186
1015784	Views PA + lateral && Views	4180186
1015786	View AP && Views	4180186
1015789	ePCAM	4180186
1015815	Acupuncture.nurse	4180186
1015821	Pharmacology.technician	4180186
1015825	Physical medicine and rehab	4180186
1015842	Inner City Asthma Survey	4180186
1015844	MESA Air Pollution	4180186
1015852	PEG Study	4180186
1016184	Positive Affect Survey - scale score	4180186
1016185	Positive Affect Survey - national percentile	4180186
1016186	Positive Affect Survey - unadjusted scale score	4180186
1016189	Positive Affect Survey version 2.0 - CAT item bank - ages 13-17	4180186
1016191	Positive Affect Survey version 2.0 - parent report - fixed length form - ages 3-7	4180186
1016203	General Life Satisfaction Survey version 2.0 - CAT item bank - ages 8-12	4180186
1016212	Emotional Support Survey version 2.0 - fixed length form - ages 8-17	4180186
1016214	Positive Affect Survey version 2.0 - fixed length form - ages 13-17	4180186
1016225	Friendship Survey version 2.0 - fixed length form - ages 8-17	4180186
1016239	10Y	4180186
1016245	Prior functioning.indoor mobility-ambulation	4180186
1016291	UPPS-R-C	4180186
1016317	Internal medicine.nurse	4180186
1016318	Internal medicine.interdisciplinary	4180186
1016324	Dopamine receptor D1 Ab.IgG	4180186
1016325	Dopamine receptor D2 long Ab.IgG	4180186
1016351	Mo of pregnancy when rubella-like symptoms appeared	4180186
1016379	Treated for Chlamydia trachomatis or Neisseria gonorrhoeae in last 3 to 12Mo	4180186
1016415	Blood establishment registration & product listing	4180186
1016451	Blood establishment registration & product listing change in information	4180186
1016452	Human cell and tissue establishment registration & product listing change in information	4180186
1016457	Anorectal/isolate	4180186
1016463	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by causing swelling in your ankles or legs	4180186
1016465	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your walking about or climbing stairs difficult	4180186
1016468	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sleeping well at night difficult	4180186
1016469	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your relating to or doing things with your friends or family difficult	4180186
1016470	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your working to earn a living difficult	4180186
1016477	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your sexual activities difficult	4180186
1016478	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you eat less of the foods you like	4180186
1016482	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by costing you money for medical care	4180186
1016483	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by giving you side effects from treatments	4180186
1016484	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel you are a burden to your family or friends	4180186
1016485	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel a loss of self-control in your life	4180186
1016486	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you worry	4180186
1016487	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making it difficult for you to concentrate or remember things	4180186
1016488	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making you feel depressed	4180186
1016510	Womens health.nurse practitioner	4180186
1016513	Thoracic and cardiac surgery.interdisciplinary	4180186
1016529	Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during 3D assessment period	4180186
1016530	Level of consciousness - Alert (normal) during 3D assessment	4180186
1016531	Level of consciousness - Vigilant or lethargic or stupor or coma during 3D assessment	4180186
1016534	Wash upper body - functional ability during 3D assessment period	4180186
1016535	Wash upper body - functional goal during 3D assessment period	4180186
1016537	Indicate the patient's primary medical condition category during 3D assessment period	4180186
1016540	KFRE	4180186
1016555	LCDS v3.00 - Mobility - discharge performance during 3D assessment period	4180186
1016563	Streptococcus pneumoniae Danish serotype 6A Ab,IgG	4180186
1016575	Guidance for removal of tunneled central venous catheter	4180186
1016583	Arthralgia &or arthritis	4180186
1016585	Walking 1 block on level ground was limited by heart failure over the past 2W	4180186
1016586	Doing yardwork, housework or carrying groceries was limited by heart failure over the past 2W	4180186
1016587	Climbing a flight of stairs without stopping was limited by heart failure over the past 2W	4180186
1016591	Bothered by swelling in your feet, ankles or legs over the past 2W	4180186
1016592	Fatigue limited your ability to do what you wanted over the past 2W	4180186
1016593	Bothered by fatigue over the past 2W	4180186
1016595	Bothered by shortness of breath over the past 2W	4180186
1016596	Sleep sitting up in a chair or with at least 3 pillows to prop you up because of shortness of breath over the past 2W	4180186
1016599	Enjoyment of life limited by heart failure over the past 2W	4180186
1016601	Felt discouraged or down in the dumps because of heart failure over the past 2W	4180186
1016602	Participation in hobbies, recreational activities limited by heart failure over the past 2W	4180186
1016603	Participation in working or doing household chores limited by heart failure over the past 2W	4180186
1016624	Senecavirus A Ab.IgG	4180186
1016627	MG.stereotactic	4180186
1016628	Guidance for percutaneous aspiration.fine needle &or biopsy.core needle	4180186
1016630	Community health care.nurse	4180186
1016635	MG	4180186
1016642	OASIS C2 - Integumentary status - start of care or resumption of care	4180186
1016643	OASIS C2 - Current number of unhealed pressure injuries at each stage - start of care or resumption of care	4180186
1016646	Head+Neck>Carotid artery.bilateral+Vertebral artery.bilateral	4180186
1016647	OASIS C2 - Respiratory status - start of care or resumption of care	4180186
1016697	Did your heart failure prevent you from living as you wanted during the past Mo (4W) by making your recreational pastimes, sports or hobbies difficult	4180186
1016700	Does the patient use a wheelchair or scooter during 3D assessment period	4180186
1016726	Ebola & Marburg virus	4180186
1016730	Neuro & emotional & behavioral status - start of care or resumption of care	4180186
1016736	MG.FFD	4180186
1016756	Vision.ability to see in adequate light in last 7D	4180186
1016761	Head+Neck>Jugular vein.left	4180186
1016762	Head+Neck>Jugular vein.right	4180186
1016764	Reported.PHQ-9.CMS	4180186
1016774	Diagnostic mammogram & ultrasound panel	4180186
1016785	Views & Guidance for injection of non-vascular shunt	4180186
1016787	Breast.bilateral && ^Breast specimen.bilateral	4180186
1016799	Sexual activity in the last Y	4180186
1016823	When anxious within the last 14D	4180186
1016827	Ostomy for bowel elimination in the last 14D	4180186
1016852	MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge goal during 3D assessment period	4180186
1016855	MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge performance during 3D assessment period	4180186
1016862	Tobacco use in last 7D	4180186
1016868	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status	4180186
1016873	Mean fluid intake per day by IV or tube feeding in last 7D - while not a resident	4180186
1016874	Mean fluid intake per day by IV or tube feeding in last 7D - while a resident	4180186
1016875	Mean fluid intake per day by IV or tube feeding during entire 7D	4180186
1016883	HIV 1 & 2 tests - FPAR 2.0 set	4180186
1016896	Nutritional approaches during last 7D - while not a resident	4180186
1016897	Nutritional approaches during last 7D - while a resident	4180186
1016899	Number of D antipsychotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016900	Number of D antianxiety received in last 7D or since admission &or reentry if less than 7D	4180186
1016902	Number of D hypnotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016903	Number of D anticoagulant received in last 7D or since admission &or reentry if less than 7D	4180186
1016904	Number of D antibiotic received in last 7D or since admission &or reentry if less than 7D	4180186
1016912	Speech-language pathology and audiology services - co-treatment minutes during 7D assessment period	4180186
1016913	Distinct calendar days of therapy in last 7D	4180186
1016921	Occupational therapy - individual minutes in the last 7D	4180186
1016922	Physical therapy - concurrent minutes in the last 7D	4180186
1016926	Speech-language pathology and audiology services - group minutes in the last 7D	4180186
1016927	Speech-language pathology and audiology services - individual minutes in the last 7D	4180186
1016928	Number of D of active range of motion in last 7 calendar D	4180186
1016929	Number of D of splint or brace assistance in last 7 calendar D	4180186
1016931	Number of D of training & skill practice in bed mobility in last 7 calendar D	4180186
1016937	Number of D of training & skill practice in eating or swallowing in last 7 calendar D	4180186
1016946	Breast.bilateral &&	4180186
1016955	Occupational therapy - co-treatment minutes during 7D assessment period	4180186
1016957	Previous rehabilitation therapy regimen (speech, occupational, &or physical therapy) ended, & regimen now resumed at exactly the same level for each discipline	4180186
1016962	Cause of death+related information	4180186
1016974	MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO	4180186
1016992	MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) & Nursing home quarterly (NQ) item set	4180186
1016995	MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set	4180186
1016998	MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1017005	Ser^fetus	4180186
1017008	Resident mood interview (PHQ-9) - symptom presence in the last 2W	4180186
1017009	Resident mood interview (PHQ-9) - symptom frequency in the last 2W	4180186
1017011	Staff assessment of resident mood (PHQ-9-OV) - symptom frequency in the last 2W	4180186
1017013	Cytolethal distending toxin B & Vinculin	4180186
1017067	Age range for infant less than 1Mo old	4180186
1017111	Symptoms present for at least 24H	4180186
1017128	NACA	4180186
1017146	Lower extremity>Lower leg vessel	4180186
1017162	Guidance for conversion of gastrostomy tube to gastrojejunostomy tube	4180186
1017171	Guidance for exchange of jejunostomy tube	4180186
1017189	Guidance for paracentesis+insertion of tube	4180186
1017200	Guidance for placement of gastrostomy tube	4180186
1017211	Guidance for removal of gastrojejunostomy tube	4180186
1017222	Guidance therapeutic for puncture+drainage	4180186
1017227	Guidance GE 21 for stab phlebectomy	4180186
1017233	Guidance for transjugular biopsy+venography	4180186
1017234	Guidance for transjugular biopsy+hemodynamic evaluation	4180186
1017246	Thyroglobulin & thyroperoxidase Ab panel	4180186
1017268	Dialysis.nurse	4180186
1017269	Dialysis.physician	4180186
1017270	Dialysis.interdisciplinary	4180186
1017278	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 1.5	4180186
1017279	(Multisection^WO contrast) + (Multisection for left ventricular function	4180186
1017280	IRF-PAI v3.0 - Medical information	4180186
1017281	Estimated body mass index greater than 40	4180186
1017294	Understanding verbal and non-verbal content during 3D assessment period	4180186
1017312	Is there documentation of reason(s) in the patient's medical record that the patient was deemed medically unready for SBT by day 2 of stay	4180186
1017315	LCDS v4.00 - Special treatments, procedures, and programs - discharge	4180186
1017342	Determination of pressure injury risk in last 7D	4180186
1017344	Number of pressure injuries present upon admission &or reentry - stage 2	4180186
1017345	Number of pressure injuries present upon admission &or reentry - stage 3	4180186
1017346	Number of pressure injuries present upon admission &or reentry - stage 4	4180186
1017349	Number of pressure injuries - unstageable due to coverage of wound bed by slough &or eschar	4180186
1017352	Number of pressure injuries present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution	4180186
1017364	Stage 3 pressure injuries not present or at a lesser stage on admission &or reentry	4180186
1017365	Stage 4 pressure injuries not present or at a lesser stage on admission &or reentry	4180186
1017367	Unstageable pressure injury due to slough &or eschar not present or at a lesser stage on admission &or reenty	4180186
1017370	Lower extremity.unilateral>Femoral artery+Popliteal artery	4180186
1017386	H little y Ag	4180186
1017398	HVS	4180186
1017399	Within the past 12Mo we worried whether our food would run out before we got money to buy more	4180186
1017413	Blood pressure with exercise & post exercise panel	4180186
1017415	U.S. Food Security Survey	4180186
1017418	Chemotherapy infusion start & stop date and time panel	4180186
1017421	Cornea/Conjunctiva	4180186
1017425	Guidance for aspiration.fine needle	4180186
1017430	Calcidiol+ercalcidiol goal	4180186
1017433	Intravascular systolic goal	4180186
1017463	MDS v3.0 - RAI v1.15.1 - Nursing home & Swing bed OMRA (NO & SO) item set	4180186
1017469	MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set	4180186
1017478	Date specimen sent to public health laboratory	4180186
1017480	How supplied & storage & handling section	4180186
1017492	Memory &or recall ability during 3D assessment period	4180186
1017493	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 2.0	4180186
1017495	SAQ	4180186
1017496	Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W	4180186
1017497	Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W	4180186
1017499	Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W	4180186
1017501	How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W	4180186
1017513	Polytrauma.nurse	4180186
1017514	Polytrauma.case manager	4180186
1017532	How much time did you usually spend on one of those D doing vigorous physical activities as part of your work during the last 7D	4180186
1017534	How much time did you usually spend on one of those D doing moderate physical activities as part of your work during the last 7D	4180186
1017535	OASIS D - Patient history and diagnoses - start of care or resumption of care	4180186
1017536	During the last 7D, on how many D did you walk for at least 10M at a time as a part of your work, not counting any walking you did to travel to or from work	4180186
1017539	During the last 7D, on how many D did you travel in a motor vehicle like a train, bus, car, or tram	4180186
1017541	During the last 7D, on how many D did you bicycle for at least 10M at a time to go from place to place	4180186
1017543	During the last 7D, on how many D did you walk for at least 10M at a time to go from place to place	4180186
1017546	During the last 7D, on how many D did you do vigorous physical activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard for at least 10M at a time	4180186
1017547	How much time did you usually spend on one of those D doing vigorous physical activities in the garden or yard during the last 7D	4180186
1017548	During the last 7D, on how many D did you do moderate activities like carrying light loads, sweeping, washing windows, and raking in the garden or yard for at least 10M at a time	4180186
1017549	How much time did you usually spend on one of those D doing moderate physical activities in the garden or yard during the last 7D	4180186
1017550	During the last 7D, on how many D did you do moderate activities like carrying light loads, washing windows, scrubbing floors and sweeping inside your home for at least 10M at a time	4180186
1017553	Not counting any walking you have already mentioned, during the last 7D, on how many D did you walk for at least 10M at a time in your leisure time	4180186
1017557	During the last 7D, on how many D did you do moderate physical activities like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your leisure time for at least 10M at a time	4180186
1017561	During the last 7D, how much time did you usually spend sitting on a weekend D	4180186
1017578	How much time did you usually spend doing vigorous physical activities on one of those D	4180186
1017591	Sleep medicine.physician	4180186
1017598	Guidance for dilation of stricture+placement of stent	4180186
1017602	Have you modified your life style to avoid activities potentially damaging to your knee	4180186
1017603	How much are you troubled with lack of confidence in your knee	4180186
1017604	In general, how much difficulty do you have with your knee	4180186
1017607	Difficulties to stride out when walking during the last W	4180186
1017608	How severe is your hip joint stiffness after first wakening in the morning during the last W	4180186
1017630	OASIS D - Respiratory status - start of care or resumption of care	4180186
1017632	OASIS E - Bladder and Bowel - DC	4180186
1017634	OASIS D - ADL and IADLs - start of care or resumption of care	4180186
1017655	Amount of hip pain experienced at night while in bed in the last W	4180186
1017657	Amount of hip pain experienced while standing upgright in the last W	4180186
1017661	Degree of difficulty experienced due to your hip while twisting or pivoting on loaded leg during the last W	4180186
1017680	Ulcers, wounds and skin problems in the last 7D	4180186
1017683	Timed Up and Go test & physical findings of gait panel	4180186
1017689	Degree of difficulty experienced due to your hip while running during the last W	4180186
1017691	Amount of hip pain experienced while straightening your hip fully in the last W	4180186
1017693	Degree of difficulty experienced due to your hip while getting in or out of car in the last W	4180186
1017696	Degree of difficulty experienced due to your hip while ascending stairs in the last W	4180186
1017699	Degree of difficulty experienced due to your hip while getting on or off toilet in the last W	4180186
1017700	Degree of difficulty experienced due to your hip while getting in or out of bath in the last W	4180186
1017703	Degree of difficulty experienced due to your hip while descending stairs in the last W	4180186
1017710	Melanoma-associated antigen A4 Ab	4180186
1017715	Degree of difficulty experienced due to your knee while twisting or pivoting on your injured knee during the last W	4180186
1017716	Degree of difficulty experienced due to your knee while jumping during the last W	4180186
1017719	How severe is your knee stiffness after sitting, lying or resting later in the day during the last W	4180186
1017720	Can you bend your knee fully during the last W	4180186
1017721	Can you straighten your knee fully during the last W	4180186
1017722	Does your knee catch or hang up when moving during the last W	4180186
1017724	Do you have swelling in your knee during the last W	4180186
1017725	Amount of knee pain experienced while sitting or lying in the last W	4180186
1017726	Amount of knee pain experienced at night while in bed in the last W	4180186
1017732	Degree of difficulty experienced due to your knee while getting in or out of car in the last W	4180186
1017733	Degree of difficulty experienced due to your knee while walking on a flat surface in the last W	4180186
1017734	Degree of difficulty experienced due to your knee while standing in the last W	4180186
1017735	Degree of difficulty experienced due to your knee while ascending stairs in the last W	4180186
1017739	Degree of difficulty experienced due to your knee while sitting in the last W	4180186
1017740	Degree of difficulty experienced due to your knee while getting in or out of bath in the last W	4180186
1017742	Degree of difficulty experienced due to your knee while taking off socks or stockings in the last W	4180186
1017743	Degree of difficulty experienced due to your knee while rising from bed in the last W	4180186
1017750	I have been able to add and subtract numbers in my head without difficulty in past 7D	4180186
1017766	Medication follow-up in the last 3D	4180186
1017775	Reported.PHQ.Teen	4180186
1017780	ADAPTABLE	4180186
1017793	BRAF gene.p.Val600 mutations	4180186
1017794	MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set	4180186
1017795	MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set	4180186
1017802	MDS v3.0 - RAI v1.16.1 - Nursing home & Swing bed tracking (NT & ST) item set	4180186
1017815	BDI	4180186
1017822	Isolate/Specimen	4180186
1017823	Cells.CD38+ IgM-	4180186
1017827	Mobility - discharge performance during 3D assessment period	4180186
1017828	Mobility - admission performance during 3D assessment period	4180186
1017829	Mobility - discharge goal during 3D assessment period	4180186
1017844	Compared to 10Y ago, has there been any change in remembering where he or she has placed objects	4180186
1017846	Compared to 10Y ago, has there been any change in remembering the current date or day of the week	4180186
1017847	Compared to 10Y ago, has there been any change in remembering he or she has already told someone something	4180186
1017848	Compared to 10Y ago, has there been any change in remembering appointments, meetings, or engagements	4180186
1017849	Compared to 10Y ago, has there been any change in forgetting the names of objects	4180186
1017851	Compared to 10Y ago, has there been any change in finding the right words to use in a conversation	4180186
1017853	Compared to 10Y ago, has there been any change in following a story in a book or on TV	4180186
1017854	Compared to 10Y ago, has there been any change in understanding the point of what other people are trying to say	4180186
1017855	Compared to 10Y ago, has there been any change in remembering the meaning of common words	4180186
1017857	Compared to 10Y ago, has there been any change in understanding spoken directions or instructions	4180186
1017863	Compared to 10Y ago, has there been any change in finding his or her way around a familiar store	4180186
1017864	Compared to 10Y ago, has there been any change in finding his or her way around a house visited many times	4180186
1017865	Compared to 10Y ago, has there been any change in planning the sequence of stops on a shopping trip	4180186
1017869	Compared to 10Y ago, has there been any change in thinking ahead	4180186
1017872	Compared to 10Y ago, has there been any change in keeping financial records organized	4180186
1017873	Compared to 10Y ago, has there been any change in prioritizing tasks by importance	4180186
1017876	Compared to 10Y ago, has there been any change in returning to a task after being interrupted	4180186
1017877	Compared to 10Y ago, has there been any change in the ability to concentrate on a task without being distracted by external things in the environment	4180186
1017878	Compared to 10Y ago, has there been any change in cooking or working and talking at the same time	4180186
1017886	ECog.Partner	4180186
1017888	ECog	4180186
1017924	Compared to 10Y ago, has there been any change in finding my way around a familiar store	4180186
1017927	Compared to 10Y ago, has there been any change in finding my car in a parking lot	4180186
1017929	Compared to 10Y ago, has there been any change in remembering I have already told someone something	4180186
1017932	Compared to 10Y ago, has there been any change in keeping mail and papers organized	4180186
1017935	Compared to 10Y ago, has there been any change in the ability to anticipate weather changes and plan accordingly (i.e. bring a coat or umbrella)	4180186
1017958	Chair &or bed-to-chair transfer - functional goal	4180186
1017974	Shower &or bathe self - functional goal	4180186
1017999	Cardiopulmonary resuscitation flowsheet	4180186
1018000	Cardiopulmonary resuscitation note	4180186
1018015	CUBS	4180186
1018023	Gynecology.nurse	4180186
1018025	Obstetrics.nurse practitioner	4180186
1018026	Obstetrics.nurse	4180186
1018096	CDC.EOC	4180186
1018107	PERC	4180186
1018109	Wells PE risk	4180186
1018110	Geneva.Revised	4180186
1018113	How many D per W did you engage in moderate to strenuous physical activity in the last 30D	4180186
1018123	Ethics.team	4180186
1018125	Wound care management.team	4180186
1018126	Cardiac surgery.team	4180186
1018127	Vascular surgery.team	4180186
1018142	I had unpleasant thoughts that wouldn't leave my mind in past 7D	4180186
1018145	I felt lonely even when I was with other people in past 7D	4180186
1018150	I felt like I needed help for my depression in past 7D	4180186
1018153	I had mood swings in past 7D	4180186
1018159	Are you able to do 2H of physical labor	4180186
1018169	Condition triggering emergency operation center response termination	4180186
1018186	NuPDQ	4180186
1018188	POEM	4180186
1018189	Over the last W, on how many D has your or your child's skin been itchy because of eczema	4180186
1018191	Over the last W, on how many D has your or your child's skin been bleeding because of the eczema	4180186
1018193	Over the last W, on how many D has your or your child's skin been cracked because of the eczema	4180186
1018215	CRQ-SAS	4180186
1018225	PROMIS pain interference - version 1.1 T-score	4180186
1018238	It was hard for my child to walk one block when he or she had pain in past 7D	4180186
1018240	It was hard for my child to get along with other people when he or she had pain in past 7D	4180186
1018242	It was hard for my child to run when he or she had pain in past 7D	4180186
1018243	It was hard for my child to pay attention when he or she had pain in past 7D	4180186
1018246	My child felt angry when he or she had pain in past 7D	4180186
1018269	PsoSat	4180186
1018286	Over the past W, are you able to get in and out of a car, bus, train, or airplane	4180186
1018287	Over the past W, are you able to walk two miles or three kilometers, if you wish	4180186
1018289	Over the past W, are you able to get a good night's sleep	4180186
1018292	Pain severity in the past W - 0-10 (0.5 increments) numeric rating	4180186
1018296	During the past Mo, how often did you eat hot or cold cereals	4180186
1018300	It is hard for your child to add or subtract numbers in his or her head in past 4W	4180186
1018303	It is hard for your child to find his or her way to a place that he or she has visited several times before in past 4W	4180186
1018306	It is hard for your child to pay attention to one thing for more than 5-10 minutes in past 4W	4180186
1018307	It is hard for your child to pay attention to something boring he or she has to do in past 4W	4180186
1018311	When your child has a big project to do, he or she has trouble deciding where to start in past 4W	4180186
1018312	Your child forgets things easily in past 4W - frequency	4180186
1018313	Your child forgets to bring things to and from school that he or she needs for homework in past 4W - frequency	4180186
1018316	Your child has a hard time keeping track of his or her homework in past 4W - frequency	4180186
1018321	Your child has trouble paying attention to the teacher in past 4W - frequency	4180186
1018323	Your child has trouble remembering the names of people he or she knows in past 4W	4180186
1018325	Your child has trouble remembering where he or she put things, like his or her watch or his or her homework in past 4W	4180186
1018327	Your child walks into a room and forgets what he or she wanted to get or do in past 4W	4180186
1018328	Your child reacts slower than most people his or her age when he or she plays games in past 4W - severity	4180186
1018329	Your child has trouble remembering to do things like school projects or chores in past 4W - severity	4180186
1018330	Your child has trouble paying attention to the teacher in past 4W - severity	4180186
1018331	Your child has to work really hard to pay attention or he or she makes mistakes in past 4W - severity	4180186
1018332	Your child has to use written lists more often than other people his or her age so he or she will not forget things in past 4W - severity	4180186
1018337	Your child forgets things easily in past 4W - severity	4180186
1018340	It is hard for your child to concentrate in school in past 4W - severity	4180186
1018374	It is hard for me to concentrate in school in past 4W - frequency	4180186
1018376	I forget to bring things to and from school that I need for homework in past 4W - frequency	4180186
1018377	It takes me longer than other people to get my school work done in past 4W - frequency	4180186
1018378	I have trouble paying attention to the teacher in past 4W - frequency	4180186
1018380	It is hard for me to concentrate in school in past 4W - severity	4180186
1018381	I have a hard time keeping track of my homework in past 4W - severity	4180186
1018383	It takes me longer than other people to get my school work done in past 4W - severity	4180186
1018385	It is hard for me to find my way to a place that I have visited several times before in past 4W	4180186
1018387	I have trouble remembering the names of people I have just met in past 4W	4180186
1018389	I have trouble recalling the names of things in past 4W	4180186
1018391	It is hard for me to do more than one thing at a time in past 4W	4180186
1018393	I walk into a room and forget what I wanted to get or do in past 4W	4180186
1018395	I have trouble remembering the date or day of the week in past 4W	4180186
1018397	I have to read things several times to understand them in past 4W - frequency	4180186
1018398	I react slower than most people my age when I play games in past 4W - frequency	4180186
1018399	It is hard for me to find the right words to say what I mean in past 4W - frequency	4180186
1018400	I forget things easily in past 4W - frequency	4180186
1018401	I forget what I am going to say in past 4W - frequency	4180186
1018403	I have trouble remembering to do things like school projects or chores in past 4W - frequency	4180186
1018405	It is hard for me to learn new things in past 4W	4180186
1018406	It is hard for me to understand pictures that show how to make something in past 4W	4180186
1018408	It is hard for me to add or subtract numbers in my head in past 4W	4180186
1018411	It is hard for me to find the right words to say what I mean in past 4W - severity	4180186
1018412	I forget things easily in past 4W - severity	4180186
1018415	I have trouble remembering to do things like school projects or chores in past 4W - severity	4180186
1018422	FRAX	4180186
1018423	Major osteoporotic fracture 10Y probability	4180186
1018591	Hip fracture 10Y probability	4180186
1018593	100 Cells.235a	4180186
1018597	CT && CT.perfusion && CT.angio	4180186
1018606	Estimated from physical examination	4180186
1018608	During the past Mo, how often did you drink regular soda or pop that contains sugar	4180186
1018609	During the past Mo, how often did you drink coffee or tea that had sugar or honey added to it	4180186
1018610	During the past Mo, how often did you eat a green leafy or lettuce salad, with or without other vegetables	4180186
1018612	During the past Mo, how often did you eat any other kind of potatoes, such as baked, boiled, mashed potatoes, sweet potatoes, or potato salad	4180186
1018613	During the past Mo, how often did you eat refried beans, baked beans, beans in soup, pork and beans or any other type of cooked dried beans	4180186
1018614	During the past Mo, how often did you eat brown rice or other cooked whole grains, such as bulgur, cracked wheat, or millet	4180186
1018616	During the past Mo, how often did you eat any kind of cheese	4180186
1018618	During the past Mo, how often did you eat ice cream or other frozen desserts	4180186
1018619	Frequency of DHEA, androstenedione, or human growth hormone used to improve muscle mass or strength in past Y	4180186
1018620	Frequency of anabolic steroids used to improve muscle mass or strength in past Y	4180186
1018621	Frequency of creatine used to improve muscle mass or strength in past Y	4180186
1018624	Paroxysmal nocturnal hemoglobinuria GPI-Linked WBC & RBC	4180186
1018625	Aerobic culture+Antimicrobial neutralizer	4180186
1018635	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking 50 steps or paces on flat ground at a normal speed without stopping	4180186
1018638	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when washing dishes	4180186
1018639	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when sweeping or mopping	4180186
1018640	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when making a bed	4180186
1018642	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another	4180186
1018644	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a bath without help	4180186
1018645	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when taking a shower	4180186
1018647	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when standing for at least 5 minutes	4180186
1018649	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking a half mile (almost 1 km) on flat ground at a normal speed without stopping	4180186
1018650	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 5 stairs without stopping	4180186
1018651	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when walking up 10 stairs (1 flight) without stopping	4180186
1018653	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when scrubbing the floor or counter	4180186
1018657	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when carrying something weighing less than 5 lbs (about 2 kg, like a houseplant) from one room to another	4180186
1018659	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when getting in or out of a car	4180186
1018660	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when dining out	4180186
1018661	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when low-intensity leisure activity (gardening, etc.)	4180186
1018662	Considering your shortness of breath over the past 7D, rate the amount of difficulty you had when moderate-intensity leisure activity (bicycling on level terrain, etc.)	4180186
1018668	PROMIS dyspnea functional limitations - version 1.0 T-score	4180186
1018669	Words I wanted to use have seemed to be on the tip of my tongue in past 7D	4180186
1018670	I have had trouble finding the right words to express myself in past 7D	4180186
1018671	What number best describes how pain has interfered with your enjoyment of life during the past W	4180186
1018672	What number best describes how pain has interfered with your general activity during the past W	4180186
1018683	Thinking about the past 4W, my child's life was outstanding	4180186
1018684	Thinking about the past 4W, my child's life was excellent	4180186
1018686	Thinking about the past 4W, my child's life was good	4180186
1018687	Thinking about the past 4W, my child's life was going very well	4180186
1018688	Thinking about the past 4W, my child's life was just right	4180186
1018690	Thinking about the past 4W, my child's life situation was excellent	4180186
1018691	Thinking about the past 4W, my child was happy with the way things were	4180186
1018692	Thinking about the past 4W, my child had what he or she wanted in life	4180186
1018693	Thinking about the past 4W, my child had what he or she needed in life	4180186
1018694	Thinking about the past 4W, my child got the things he or she wanted in life	4180186
1018695	Thinking about the past 4W, my child felt that his or her life was better than most kids' lives	4180186
1018696	Thinking about the past 4W, my child enjoyed his or her life more than most kids enjoyed their lives	4180186
1018698	Thinking about the past 4W, my child's life was as good as most kids' lives	4180186
1018699	Thinking about the past 4W, my child was satisfied with the friends he or she has	4180186
1018702	Thinking about the past 4W, my child was happy with his or her life at school	4180186
1018704	Thinking about the past 4W, my child was happy with life in his or her neighborhood	4180186
1018705	Thinking about the past 4W, my child was happy with life in his or her community	4180186
1018707	Thinking about the past 4W, my child was satisfied with his or her skills and talents	4180186
1018708	Thinking about the past 4W, my child was satisfied with his or her life	4180186
1018709	Thinking about the past 4W, my child felt extremely positive about his or her life	4180186
1018711	Thinking about the past 4W, my child felt very good about his or her life	4180186
1018715	Thinking about the past 4W, my child had fun	4180186
1018716	Thinking about the past 4W, my child had a lot of fun	4180186
1018717	Thinking about the past 4W, my child enjoyed his or her life	4180186
1018719	Thinking about the past 4W, my child's life was worthwhile	4180186
1018721	Thinking about the past 4W, my child felt he or she lived his or her life well	4180186
1018722	Thinking about the past 4W, my child was satisfied with his or her life in general	4180186
1018726	Thinking about the past 4W, my life was the best	4180186
1018730	Thinking about the past 4W, my life was good	4180186
1018732	Thinking about the past 4W, my life was just right	4180186
1018734	Thinking about the past 4W, my life situation was excellent	4180186
1018739	Thinking about the past 4W, my life was better than most kids' lives	4180186
1018742	Thinking about the past 4W, my life was as good as most kids' lives	4180186
1018743	Thinking about the past 4W, I was satisfied with the friends I have	4180186
1018744	Thinking about the past 4W, I was happy with my social life	4180186
1018745	Thinking about the past 4W, I was happy with my family life	4180186
1018746	Thinking about the past 4W, I was happy with my life at school	4180186
1018747	Thinking about the past 4W, I was happy with my life at home	4180186
1018750	Thinking about the past 4W, I was satified with my free time	4180186
1018751	Thinking about the past 4W, I was satisfied with my skills and talents	4180186
1018753	Thinking about the past 4W, I felt extremely positive about my life	4180186
1018754	Thinking about the past 4W, I was happy with my life	4180186
1018755	Thinking about the past 4W, I felt very good about my life	4180186
1018758	Thinking about the past 4W, I felt positive about my life	4180186
1018759	Thinking about the past 4W, I had fun	4180186
1018760	Thinking about the past 4W, I had a lot of fun	4180186
1018761	Thinking about the past 4W, I enjoyed my life	4180186
1018762	Thinking about the past 4W, I liked the way I lived my life	4180186
1018763	Thinking about the past 4W, my life was worthwhile	4180186
1018764	Thinking about the past 4W, my life went well	4180186
1018765	Thinking about the past 4W, I lived my life well	4180186
1018814	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status	4180186
1018816	MDS v3.0 - RAI v1.17.2 - Swallowing &or nutritional status - OSA	4180186
1018822	Number of D with at least 15M of occupational therapy during assessment period	4180186
1018823	Number of D with at least 15M of physical therapy during assessment period	4180186
1018824	Number of D with at least 15M of speech language pathology and audiology services during assessment period	4180186
1018832	Percent intake by artificial route while a resident and during the last 7D	4180186
1018837	Physical therapy since the start date of the residents most recent Medicare Part A stay	4180186
1018845	Speech-language pathology and audiology services since the start date of the residents most recent Medicare Part A stay	4180186
1018853	Other kids wanted to be my child's friend in past 7D	4180186
1018856	My child shared with other kids (food, games, pens, etc.) in past 7D	4180186
1018860	My child was good at making friends in past 7D	4180186
1018862	Other kids wanted to be with my child in past 7D	4180186
1018863	I shared with other kids (food, games, pens, etc.) in past 7D	4180186
1018868	My child was able to talk about everything with his or her friends in past 7D	4180186
1018869	My child has been physically able to do the activities he or she enjoys most in past 7D	4180186
1018870	My child could ride a bike in past 7D	4180186
1018871	My child could do sports and exercise that other kids his or her age could do in past 7D	4180186
1018873	My child could go up one step in past 7D	4180186
1018874	My child could run a mile in past 7D	4180186
1018875	My child could walk up stairs without holding on to anything in past 7D	4180186
1018876	My child could get up from a regular toilet in past 7D	4180186
1018877	My child could stand up on his or her tiptoes in past 7D	4180186
1018878	My child could turn his or her head all the way to the side in past 7D	4180186
1018880	My child could get into bed by himself or herself in past 7D	4180186
1018882	My child used a walker, cane or crutches to get around in past 7D	4180186
1018884	My child could get up from the floor in past 7D	4180186
1018886	My child could get in and out of a car in past 7D	4180186
1018887	My child could walk more than one block in past 7D	4180186
1018888	My child could keep up when he or she played with other kids in past 7D	4180186
1018889	My child could get out of bed by himself or herself in past 7D	4180186
1018900	Heart failure.team	4180186
1018905	Multi-specialty program.social worker	4180186
1018906	Mental health.social worker	4180186
1018908	Addiction medicine.social worker	4180186
1018909	Community health care.social worker	4180186
1018911	Primary care.social worker	4180186
1018924	Anesthesiology.attending	4180186
1018925	Cardiovascular disease.attending	4180186
1018926	Cardiovascular disease.fellow	4180186
1018931	Critical care medicine.attending	4180186
1018936	Endocrinology.attending	4180186
1018938	Endocrinology.resident	4180186
1018940	Gastroenterology.fellow	4180186
1018946	Gynecology.attending	4180186
1018948	Hematology+Medical oncology.attending	4180186
1018950	Hematology+Medical oncology.resident	4180186
1018952	Infectious disease.fellow	4180186
1018959	Mental health.resident	4180186
1018960	Nephrology.attending	4180186
1018962	Nephrology.resident	4180186
1018965	Neurology.attending	4180186
1018967	Nuclear medicine.attending	4180186
1018969	Obstetrics and gynecology.attending	4180186
1018970	Obstetrics and gynecology.resident	4180186
1018971	Obstetrics.attending	4180186
1018972	Obstetrics.resident	4180186
1018973	Ophthalmology.attending	4180186
1018979	Orthopaedic surgery.attending	4180186
1018983	Palliative care.attending	4180186
1018986	Physical medicine and rehab.attending	4180186
1018987	Physical medicine and rehab.resident	4180186
1018989	Plastic surgery.attending	4180186
1018990	Plastic surgery.fellow	4180186
1018991	Plastic surgery.resident	4180186
1018993	Podiatry.resident	4180186
1018995	Primary care.resident	4180186
1018996	Psychiatry.attending	4180186
1018998	Psychology.intern	4180186
1019000	Pulmonary disease.fellow	4180186
1019001	Pulmonary disease.resident	4180186
1019004	Radiology.attending	4180186
1019006	Rheumatology.fellow	4180186
1019008	Spinal cord injury medicine.attending	4180186
1019009	Spinal cord injury medicine.fellow	4180186
1019010	Spinal cord injury medicine.resident	4180186
1019011	Surgery.attending	4180186
1019013	Surgery.resident	4180186
1019015	Thoracic and cardiac surgery.fellow	4180186
1019016	Thoracic and cardiac surgery.resident	4180186
1019020	Urology.resident	4180186
1019021	Vascular surgery.attending	4180186
1019022	Vascular surgery.resident	4180186
1019056	DUKE-AD	4180186
1019061	I have had pain in the shoulder or neck at some time in the last 2W	4180186
1019062	I have only walked short distances because of my back pain in the last 2W	4180186
1019063	I have dressed more slowly than usual because of back pain in the last 2W	4180186
1019064	Thinking about the last 2W, it's not really safe for a person with a condition like mine to be physically active	4180186
1019065	Worrying thoughts have been going through my mind a lot of the time in the last 2W	4180186
1019066	Thinking about the last 2W, I feel that my back pain is terrible and it's never going to get any better	4180186
1019067	Thinking about the last 2W, in general I have not enjoyed all the things I used to enjoy	4180186
1019114	PUSH	4180186
1019130	Thromboelastography.resonance	4180186
1019137	When my child was in pain he or she tried not to move in past 7D	4180186
1019138	When my child was in pain his or her face looked sad in past 7D	4180186
1019139	When my child was in pain he or she asked for help with doing things in past 7D	4180186
1019141	When my child was in pain he or she moved stiffly in past 7D	4180186
1019142	When my child was in pain he or she yelled for someone to help him or her in past 7D	4180186
1019144	When my child was in pain he or she used something for support (cane, crutches, wheelchair) to move from place to place in past 7D	4180186
1019145	When my child was in pain he or she limped in past 7D	4180186
1019151	When my child was in pain he or she screamed in past 7D	4180186
1019153	When my child was in pain he or she tightened his or her jaw in past 7D	4180186
1019154	When my child was in pain he or she talked about his or her pain in past 7D	4180186
1019156	When my child was in pain he or she rubbed his or her body where it hurt in past 7D	4180186
1019157	When my child was in pain he or she moved slower in past 7D	4180186
1019165	When my child was in pain he or she went to sleep in past 7D	4180186
1019167	When my child was in pain he or she avoided lifting or carrying heavy things in past 7D	4180186
1019168	When my child was in pain he or she stayed near to someone who cares about him or her in past 7D	4180186
1019171	When my child was in pain he or she asked to see a doctor in past 7D	4180186
1019172	When my child was in pain he or she pulled away if someone touched him or her where it hurt in past 7D	4180186
1019173	When my child was in pain he or she argued with people in past 7D	4180186
1019174	When my child was in pain he or she avoided using the part of his or her body that hurt in past 7D	4180186
1019177	When my child was in pain he or she had a fixed or dazed expression in past 7D	4180186
1019179	When my child was in pain he or she had circles under his or her eyes in past 7D	4180186
1019180	When my child was in pain he or she sighed in past 7D	4180186
1019181	When my child was in pain he or she took breaks from what he or she was doing in past 7D	4180186
1019182	When my child was in pain he or she told people he or she couldn't do his or her usual chores in past 7D	4180186
1019186	When my child was in pain he or she lay down in past 7D	4180186
1019187	When my child was in pain he or she felt his or her body get tense in past 7D	4180186
1019230	I felt as if I needed to move my legs a lot in past 7D	4180186
1019231	A sudden noise made me jump in past 7D	4180186
1019232	My muscles felt tight in past 7D	4180186
1019233	I could not stay still for long in past 7D	4180186
1019234	My mouth was dry in past 7D	4180186
1019235	My breathing was fast, even when I was not exercising or playing hard in past 7D	4180186
1019236	My palms were sweaty in past 7D	4180186
1019237	I was sweaty, even when I was not exercising or playing hard in past 7D	4180186
1019238	My heart pounded, even when I was not exercising or playing hard in past 7D	4180186
1019239	My heart beat faster than usual, even when I was not exercising or playing hard in past 7D	4180186
1019240	I had trouble breathing, even when I was not exercising or playing hard in past 7D	4180186
1019244	My legs shook in past 7D	4180186
1019247	My neck hurt in past 7D	4180186
1019249	I had a bad stomach ache in past 7D	4180186
1019251	My appetite changed in past 7D	4180186
1019252	I felt some food coming up into my throat in past 7D	4180186
1019254	My neck felt tight in past 7D	4180186
1019257	My child felt like he or she couldn't do anything right in past 7D	4180186
1019258	My child felt everything in his or her life went wrong in past 7D	4180186
1019260	My child felt lonely in past 7D	4180186
1019261	My child felt unhappy in past 7D	4180186
1019262	My child felt too sad to eat in past 7D	4180186
1019263	My child didn't care about anything in past 7D	4180186
1019264	My child felt sad in past 7D	4180186
1019265	It was hard for my child to have fun in past 7D	4180186
1019269	My child got tired easily because of his or her asthma in past 7D	4180186
1019270	My child was bothered by asthma when he or she was with friends in past 7D	4180186
1019272	My child's body felt bad when he or she was out of breath in past 7D	4180186
1019274	It was hard for my child to play sports or exercise because of asthma in past 7D	4180186
1019275	My child had trouble sleeping at night because of asthma in past 7D	4180186
1019276	It was hard for my child to play with pets because of asthma in past 7D	4180186
1019278	My child felt wheezy because of his or her asthma in past 7D	4180186
1019279	My child had asthma attacks in past 7D	4180186
1019281	It was hard for my child to take a deep breath because of asthma in past 7D	4180186
1019282	My child had trouble breathing because of his or her asthma in past 7D	4180186
1019289	How many D were you strong enough to hold a full plate or tray of food in past 7D	4180186
1019290	How many D were you strong enough to get out of bed and stand without help in past 7D	4180186
1019291	How many D were you strong enough to jump up and down in past 7D	4180186
1019295	How many D were you strong enough to get down on the floor in past 7D	4180186
1019296	How many D were you strong enough to lift heavy things over your head in past 7D	4180186
1019298	How many D was your child strong enough to carry heavy things with his or her hands in past 7D	4180186
1019299	How many D was your child strong enough to go up and down stairs in past 7D	4180186
1019301	How many D was your child strong enough to open a heavy door in past 7D	4180186
1019303	How many D was your child strong enough to get out of bed and stand without help in past 7D	4180186
1019305	How many D was your child strong enough to pour a drink from a full pitcher or carton in past 7D	4180186
1019306	How many D was your child strong enough to open a jar by himself or herself in past 7D	4180186
1019312	Everything bothered me in past 7D	4180186
1019315	I felt overwhelmed in past 7D	4180186
1019319	I felt so upset that I could not remember what happened or what I did in past 7D	4180186
1019320	I had trouble concentrating in past 7D	4180186
1019321	I had trouble controlling my thoughts in past 7D	4180186
1019324	I felt unable to react to something that bothered me in past 7D	4180186
1019326	I felt I had too much going on in past 7D	4180186
1019327	My child felt concerned about what was going on in his or her life in past 7D	4180186
1019329	Everything bothered my child in past 7D	4180186
1019330	My child felt under pressure in past 7D	4180186
1019331	My child felt that his or her problems kept piling up in past 7D	4180186
1019334	My child had trouble concentrating in past 7D	4180186
1019335	My child's thoughts went very fast in past 7D	4180186
1019337	My child felt he or she had too much going on in past 7D	4180186
1019339	My child felt peaceful in past 7D	4180186
1019341	My child felt content in past 7D	4180186
1019342	My child felt grateful in past 7D	4180186
1019343	My child felt thankful in past 7D	4180186
1019345	My child felt carefree in past 7D	4180186
1019355	My child felt cheerful in past 7D	4180186
1019356	My child felt happy in past 7D	4180186
1019359	My child felt delighted in past 7D	4180186
1019363	My child felt merry in past 7D	4180186
1019367	My child felt blissful in past 7D	4180186
1019368	My child felt enthusiastic in past 7D	4180186
1019369	My child felt energetic in past 7D	4180186
1019370	My child had a lot of energy in past 7D	4180186
1019374	My child felt full of pep in past 7D	4180186
1019376	My child felt healthy in past 7D	4180186
1019377	I felt calm in past 7D	4180186
1019381	I felt grateful in past 7D	4180186
1019383	I felt positive in past 7D	4180186
1019385	I felt relaxed in past 7D	4180186
1019386	I felt comfortable in past 7D	4180186
1019387	I felt fulfilled in past 7D	4180186
1019388	I felt respected in past 7D	4180186
1019389	I felt appreciated in past 7D	4180186
1019393	I felt great in past 7D	4180186
1019394	I felt cheerful in past 7D	4180186
1019398	I felt delighted in past 7D	4180186
1019400	I smiled a lot in past 7D	4180186
1019402	I was merry in past 7D	4180186
1019403	I was in a good mood in past 7D	4180186
1019404	I was in good spirits in past 7D	4180186
1019409	I had a lot of energy in past 7D	4180186
1019411	I felt refreshed in past 7D	4180186
1019413	I felt full of pep in past 7D	4180186
1019416	How many D did you exercise so much that you breathed hard in past 7D	4180186
1019417	How many D did you play sports for 10M or more in past 7D	4180186
1019418	How many D were you so physically active that you sweated in past 7D	4180186
1019419	How many D did you exercise or play so hard that your body got tired in past 7D	4180186
1019420	How many D did you exercise or play so hard that your muscles burned in past 7D	4180186
1019421	How many D did you exercise or play so hard that you felt tired in past 7D	4180186
1019422	On a usual day, how physically active were you in past 7D	4180186
1019423	How many D did you exercise really hard for 10M or more in past 7D	4180186
1019424	How many D were you physically active for 10M or more in past 7D	4180186
1019426	How many D did your child exercise so much that he or she breathed hard in past 7D	4180186
1019428	How many D was your child so physically active that he or she sweated in past 7D	4180186
1019429	How many D did your child exercise or play so hard that his or her body got tired in past 7D	4180186
1019430	How many D did your child exercise or play so hard that his or her muscles burned in past 7D	4180186
1019432	On a usual day, how physically active was your child in past 7D	4180186
1019440	Twelve or more drinks in a D	4180186
1019441	Four or more drinks in 2H or less	4180186
1019443	Five or more drinks in a period of 2H or less	4180186
1019489	Have you been under or felt you were under any strain, stress, or pressure during the past Mo	4180186
1019490	Have you been anxious, worried, or upset during the past Mo	4180186
1019505	ORT	4180186
1019515	Plasma cells.abnormal	4180186
1019520	Bacterial cephalosporin resistance (bla(CTX-M)) gene	4180186
1019548	Because of my health situation I have problems in my work with fatigue AndOr lack of energy	4180186
1019552	QWLQ-CS	4180186
1019555	Percent intake by artificial route during the last 7D	4180186
1019626	Bld/Bone mar^Donor	4180186
1019627	Bld^Father	4180186
1019660	PPP^Fetus	4180186
1019662	PRP^Donor	4180186
1019670	Ser/Plas/Bld^Donor	4180186
1019671	Ser/Plas^Fetus	4180186
1019679	Amnio fld cells	4180186
1019750	BldCoA	4180186
1019752	BldCoV	4180186
1019869	Lung.FNA	4180186
1019904	J little o super little a	4180186
1019913	PlasA	4180186
1019914	PlasV	4180186
1019915	Lymph node.FNA	4180186
1019918	Salivary gland.FNA	4180186
1019919	Prostate.FNA	4180186
1019920	Liver.FNA	4180186
1019921	Pancreas.FNA	4180186
1019923	Soft tissue.FNA	4180186
1019925	Pelvis.FNA	4180186
1019929	Bld^control	4180186
1019932	Heart.atrium.right.mid	4180186
1019935	Aggl.cord RBC	4180186
1019937	3D 37 deg C incubation	4180186
1019939	Cytology.non-gyn	4180186
1019941	TPN	4180186
1019944	Allergic & immunologic	4180186
1019954	Anterior chamber.left	4180186
1019957	Adrenal artery.bilateral	4180186
1019958	Carotid artery.external.bilateral	4180186
1019961	Biliary duct.common	4180186
1019963	Bld^BPU	4180186
1019964	Bld^Donor	4180186
1019968	Brachiocephalic artery.left	4180186
1019972	Carotid artery.extracranial	4180186
1019973	Carotid artery.intracranial	4180186
1019980	Choroidea.right	4180186
1019981	Ciliary body.left	4180186
1019990	Contact lens.prescription.right	4180186
1019991	Contact lens.right	4180186
1019992	Cornea.left	4180186
1020001	Eye lid.left	4180186
1020002	Eye lid.right	4180186
1020014	Glasses prescription.lens.left	4180186
1020027	Heart.interventricular septum.defect	4180186
1020044	Iris.right	4180186
1020046	Kidney.bilateral+Collecting system+Renal vessels	4180186
1020047	Lacrimal gland.left	4180186
1020050	Liver+Pancreas	4180186
1020053	LM glasses.lens.right	4180186
1020055	Mastoid.left	4180186
1020059	Mouth & throat	4180186
1020069	Pelvis+Fetus	4180186
1020070	Pelvis>Symphysis pubis	4180186
1020075	Plas+CSF	4180186
1020089	Pulmonary vein.left lower	4180186
1020092	Pulmonary vein.right upper	4180186
1020098	Rectum+Colon	4180186
1020099	Rectum+Urinary bladder	4180186
1020104	Retina.right	4180186
1020107	Ser+Saliva	4180186
1020109	Ser/Plas^Donor	4180186
1020116	Spinal artery.bilateral	4180186
1020117	Spinal artery.left	4180186
1020118	Spinal artery.right	4180186
1020122	Thigh.bilateral	4180186
1020129	Lower extremity.left>Tibial artery	4180186
1020144	Vaccine.administered	4180186
1020145	Adrenal vein.bilateral	4180186
1020146	Peripheral veins.bilateral	4180186
1020148	Head>Intracranial vessel & Neck>Neck vessel	4180186
1020159	Head>Zygomatic arch.right	4180186
1021157	Pleural space.left	4180186
1021263	Skin.scar	4180186
1023719	CVS	4180186
1024395	Nph	4180186
1025601	How have you been feeling in general during the past Mo	4180186
1025603	Have you been bothered by nervousness or your nerves during the past Mo	4180186
1025606	Have you been in firm control of your behavior, thoughts, emotions, or feelings during the past Mo	4180186
1025609	Have you had any reason to wonder if you were losing your mind, or losing control over the way you act, talk, think, feel, or of your memory during the past Mo	4180186
1025610	Have you been waking up fresh and rested during the past Mo	4180186
1025611	Has your daily life been full of things that were interesting to you during the past Mo	4180186
1025612	Have you been feeling emotionally stable and sure of yourself during the past Mo	4180186
1025613	Have you felt tired, worn out, used-up, or exhausted during the past Mo	4180186
1025615	How relaxed or tense have you been during the past Mo	4180186
1025616	How much energy, pep, and vitality have you felt during the past Mo	4180186
1025643	Are you able to walk briskly for 20M without stopping to rest	4180186
1025666	Are you able to hit the backboard with a basketball from the free-throw line (13 ft or 4 m)	4180186
1025677	Are you able to dig a 2-foot (.5 m) deep hole in the dirt with a shovel	4180186
1025697	LW super little b Ag	4180186
1025698	J little o super little a Ag	4180186
1025708	Adult self-report short form total score	4180186
1025713	CSF3R gene exons 14 & 17	4180186
1025735	When I was in pain I asked people to let me be by myself in past 7D	4180186
1025737	When I was in pain I criedin past 7D	4180186
1025740	When I was in pain I became quiet in past 7D	4180186
1025741	When I was in pain I asked for help getting around in past 7D	4180186
1025742	When I was in pain I stayed away from other people in past 7D	4180186
1025743	When I was in pain I asked for medicine in past 7D	4180186
1025744	When I was in pain I tightened my jaw in past 7D	4180186
1025750	When I was in pain I didn't want anyone to touch me in past 7D	4180186
1025751	When I was in pain I avoided standing in past 7D	4180186
1025753	When I was in pain I couldn't stay still in past 7D	4180186
1025755	When I was in pain I tried to think of something nice or fun in past 7D	4180186
1025760	When I was in pain I tried to rest or relax in past 7D	4180186
1025761	When I was in pain I complained in past 7D	4180186
1025764	When I was in pain I argued with people in past 7D	4180186
1025765	When I was in pain I avoided using the part of my body that hurt in past 7D	4180186
1025767	When I was in pain I got mad and threw or hit something in past 7D	4180186
1025771	When I was in pain it showed on my face in past 7D	4180186
1025774	When I was in pain I lay down in past 7D	4180186
1025784	My child was too tired to go out with his or her family in past 7D	4180186
1025787	My child felt tired in past 7D	4180186
1025791	My child was too tired to do sports or exercise in past 7D	4180186
1025793	It was hard for my child to get out of bed in the morning because he or she was too tired in past 7D	4180186
1025801	PROMIS parent proxy item bank - fatigue - version 2.0	4180186
1025806	Cholestane-3-beta, 5-alpha, 6-beta triol & Lyso-sphingomyelin panel	4180186
1025815	My child got scared really easy in past 7D	4180186
1025817	My child woke up at night scared in past 7D	4180186
1025818	My child worried when he or she was away from home in past 7D	4180186
1025819	My child felt nervous in past 7D	4180186
1025821	My child felt like something awful might happen in past 7D	4180186
1025822	My child felt scared in past 7D	4180186
1025824	My child worried when he or she went to bed at night in past 7D	4180186
1025825	My child worried when he or she was at home in past 7D	4180186
1025827	My child felt worried in past 7D	4180186
1025841	Electroencephalography study	4180186
1025842	Video electroencephalography study	4180186
1025853	A sudden noise made my child jump in past 7D	4180186
1025855	My child could not stay still for long in past 7D	4180186
1025857	My child's breathing was fast, even when he or she was not exercising or playing hard in past 7D	4180186
1025858	My child's palms were sweaty in past 7D	4180186
1025860	My child's heart pounded, even when he or she was not exercising or playing hard in past 7D	4180186
1025861	My child's heart beat faster than usual, even when he or she was not exercising or playing hard in past 7D	4180186
1025862	My child had trouble breathing, even when he or she was not exercising or playing hard in past 7D	4180186
1025864	My child's breathing was fast in past 7D	4180186
1025865	My child's hands shook in past 7D	4180186
1025871	My child had a bad stomach ache in past 7D	4180186
1025874	My child felt some food coming up into his or her throat in past 7D	4180186
1025876	My child had trouble staying asleep in past 7D	4180186
1025882	Aggl.micro	4180186
1025888	Aggl.slide	4180186
1025892	Saline	4180186
1025893	RIPA	4180186
1025902	BldC^fetus	4180186
1025903	RelCCnc	4180186
1025912	PressDiff	4180186
1025964	{Provider}	4180186
1025974	Cardiology	4180186
1025977	CT.3D	4180186
1025985	Detection limit <= 20 mg/L test strip	4180186
1025989	Enteroscopy.thru stoma	4180186
1025993	Estimated.Bolton analysis	4180186
1026009	MRI.angio	4180186
1026034	Pulmonary	4180186
1026050	US.derived.LWT	4180186
1026056	US+Estimated from AC.Shinozuka 1996	4180186
1026057	US.estimated from Alexander 1996	4180186
1026058	US.estimated from APAD.Lessoway 1998	4180186
1026062	US.estimated from Arbuckle 1993 male twins	4180186
1026063	US.estimated from ASUM 2000	4180186
1026066	US+Estimated from BPD&FTA&FL.Osaka 1990	4180186
1026068	US+Estimated from BPD.ASUM 1989	4180186
1026069	US+Estimated from BPD.Hansmann 1986	4180186
1026070	US+Estimated from BPD.Jeanty 1982	4180186
1026071	US+Estimated from BPD.Lessoway 1998	4180186
1026072	US+Estimated from BPD.Merz 1988	4180186
1026077	US.estimated from Brenner 1976	4180186
1026079	US.estimated from Campbell 1997	4180186
1026081	US.estimated from clavicle length.Yarkoni 1985	4180186
1026082	US+Estimated from CRL.ASUM 1991	4180186
1026084	US+Estimated from CRL.Daya 1993	4180186
1026085	US+Estimated from CRL.Hansmann 1986	4180186
1026087	US+Estimated from CRL.Osaka 1989	4180186
1026088	US+Estimated from CRL.Rempen 1991	4180186
1026092	US.estimated from EFW2.Shinozuka 1996	4180186
1026094	US.estimated from fibula length.Jeanty 1983	4180186
1026095	US+Estimated from FL.Chitty 1997	4180186
1026096	US+Estimated from FL.Hansmann 1986	4180186
1026097	US+Estimated from FL.Jeanty 1982	4180186
1026102	US.estimated from FTA.Osaka 1989	4180186
1026103	US.estimated from Goldstein 1987	4180186
1026105	US+Estimated from GSD.Hansmann 1982	4180186
1026109	US.estimated from Hadlock 1981	4180186
1026110	US.estimated from Hadlock 1984	4180186
1026111	US.estimated from Hadlock 1985	4180186
1026112	US.estimated from Hadlock 1991	4180186
1026118	US+Estimated from HC.Hansmann 1986	4180186
1026119	US+Estimated from HC.Jeanty 1982	4180186
1026120	US+Estimated from HC.Lessoway 1998	4180186
1026123	US+Estimated from HL.Osaka 1989	4180186
1026127	US.estimated from Jeanty 1983	4180186
1026130	US+Estimated from O-I BPD.Chitty 1997	4180186
1026131	US+Estimated from O-O BPD.Chitty 1997	4180186
1026132	US+Estimated from OFD.ASUM 2000	4180186
1026133	US+Estimated from OFD.Hansmann 1985	4180186
1026135	US+Estimated from OFD.Lessoway 1998	4180186
1026137	US+Estimated from OOD.Trout 1994	4180186
1026141	US.estimated from spine length.Tokyo 1989	4180186
1026144	US+Estimated from TAD.Tokyo 1986	4180186
1026145	US+Estimated from TC.Chitkara 1987	4180186
1026147	US+Estimated from TCD.Chitty 1994	4180186
1026148	US+Estimated from TCD.Goldstein 1987	4180186
1026149	US+Estimated from TCD.Hill 1990	4180186
1026150	US+Estimated from Tokyo 1987	4180186
1026156	XR.DXA	4180186
1026157	XR.fluor	4180186
1026158	XR.fluor.angio	4180186
1026159	XR.measured	4180186
1026160	XR.tomo	4180186
1026210	Critical care	4180186
1026213	General medicine.medical student	4180186
1026214	General medicine.nurse	4180186
1026265	MSCnc	4180186
1026267	LnCnc	4180186
1026269	Compli	4180186
1026310	Views AP & lateral	4180186
1026318	Femoral vessel+Popliteal artery	4180186
1026324	Leg.left	4180186
1026343	Guidance for substance removal of foreign body	4180186
1026351	Guidance for removal of embolus	4180186
1026364	Views limited diagnostic	4180186
1026367	Guidance for biopsy.core needle	4180186
1026368	Guidance for biopsy.needle	4180186
1026376	View apical lordotic	4180186
1026385	Views+views uptake	4180186
1026387	Views AP R-lateral decubitus	4180186
1026392	Views PA + lateral + apical lordotic upright	4180186
1026407	Multisection & 3D reconstruction	4180186
1026410	Abdomen+Fetus	4180186
1026425	View lateral^W hyperextension	4180186
1026454	Views AP + axillary	4180186
1026455	Views AP + axillary + outlet	4180186
1026456	Views AP + axillary + outlet + Zanca	4180186
1026457	Views AP + lateral crosstable	4180186
1026458	Views AP + lateral + Mortise	4180186
1026463	Views AP & odontoid & lateral	4180186
1026466	Views AP + lateral + Sunrise + tunnel	4180186
1026468	Views AP + lateral + oblique + tunnel	4180186
1026469	Views AP + lateral + oblique + Sunrise + tunnel	4180186
1026470	Views AP + oblique	4180186
1026471	Views AP + odontoid + lateral crosstable	4180186
1026472	Views AP + Serendipity	4180186
1026473	Views AP + Stryker Notch	4180186
1026474	Views AP + West Point	4180186
1026476	Views AP & axillary & Y	4180186
1026477	Views axillary + Y	4180186
1026478	Views R-lateral + L-lateral	4180186
1026480	Views lateral + Y	4180186
1026482	Views outlet + Y	4180186
1026484	Views PA + lateral + Ball Catcher	4180186
1026486	Views PA + lateral + R-oblique	4180186
1026487	Views PA + lateral + oblique + Towne	4180186
1026492	Views oblique + Sunrise	4180186
1026494	Views Sunrise + tunnel	4180186
1026498	Views lateral + Caldwell + Waters + submentovertex	4180186
1026499	Views lateral + Caldwell + Waters + submentovertex + Towne	4180186
1026501	Aortic arch+Subclavian artery.left	4180186
1026502	Adrenal artery.left	4180186
1026504	Celiac artery+Superior mesenteric artery+Inferior mesenteric artery	4180186
1026505	Upper extremity arteries.left	4180186
1026506	Gastric artery.left	4180186
1026508	Superior mesenteric artery+Inferior mesenteric artery	4180186
1026509	Celiac artery+Gastric artery.left+Superior mesenteric artery	4180186
1026510	Subclavian artery.bilateral	4180186
1026512	Head+Neck>Vertebral artery.bilateral	4180186
1026513	Head+Neck>Vertebral artery.left	4180186
1026525	Views AP + transthoracic	4180186
1026528	Spine.cervical vessels	4180186
1026530	Spine.thoracic vessels	4180186
1026537	Finger.third.left	4180186
1026541	Views Law + Mayer + Stenver + Towne	4180186
1026543	Views open mouth + closed mouth	4180186
1026545	Views magnification+spot	4180186
1026554	Views AP + inlet	4180186
1026555	Views AP + Judet	4180186
1026561	View for scoliosis	4180186
1026570	Views AP + lateral + axillary	4180186
1026575	Views PA + lateral + Caldwell + Waters	4180186
1026578	Views lateral + Caldwell + Waters + Towne	4180186
1026579	Adrenal artery.right	4180186
1026580	Adrenal vein.right	4180186
1026583	Carotid artery.external.right	4180186
1026587	Subclavian artery.right	4180186
1026588	Upper extremity arteries.right	4180186
1026589	Head+Neck>Vertebral artery.right	4180186
1026591	Spine.thoracolumbar junction	4180186
1026603	Views AP + lateral + oblique + odontoid + swimmers	4180186
1026604	Views AP + L-posterior oblique	4180186
1026609	Breast.duct.left	4180186
1026617	How short of breath did you get walking up 20 stairs (2 flights) without stopping over past 7D	4180186
1026623	How short of breath did you get carrying something weighing 10-20 lbs (about 4.5-9 kg, like a large bag of groceries) from one room to another over past 7D	4180186
1026624	How short of breath did you get walking (faster than your usual speed) for .5 mile (almost 1 km) without stopping over past 7D	4180186
1026628	How short of breath did you get standing for at least 5M over past 7D	4180186
1026631	How short of breath did you get walking .5 mile (almost 1 km) on flat ground at a normal speed without stopping over past 7D	4180186
1026632	How short of breath did you get walking up 5 stairs without stopping over past 7D	4180186
1026633	How short of breath did you get walking up 10 stairs (1 flight) without stopping over past 7D	4180186
1026637	How short of breath did you get lifting something weighing more than 20 lbs (about 9 kg, like a medium-sized suitcase) over past 7D	4180186
1026639	How short of breath did you get carrying something weighing 5-10 lbs (about 2-4.5 kg, like a basket of clothes) from one room to another over past 7D	4180186
1026641	How short of breath did you get dining out over past 7D	4180186
1026642	How short of breath did you get low-intensity leisure activity (gardening, etc.) over past 7D	4180186
1026647	How short of breath did you get talking while walking over past 7D	4180186
1026670	Finger.third.right	4180186
1026678	Finger.fourth.right	4180186
1026775	LISS	4180186
1026935	Planned intervention &or services panel	4180186
1026944	Guidance for drainage of abscess+placement of chest tube	4180186
1026948	Guidance for drainage of pseudocyst+placement of drainage catheter	4180186
1026949	Guidance for drainage of cyst+placement of drainage catheter	4180186
1026956	Codon &or region with poor sequence quality	4180186
1026960	Other intervention &or service plan to provide	4180186
1027025	Power of attorney+Living will	4180186
1027043	Pain severity.total	4180186
1027046	Pain severity.legs	4180186
1027048	Pain severity.cry	4180186
1027050	Pain severity.consolability	4180186
1027051	TmMCnc	4180186
1027062	Friction & shear	4180186
1027063	Braden scale score.total	4180186
1027089	Natural & feet together & tandem stance assessment	4180186
1027095	Planned intervention &or services duration	4180186
1027096	Planned intervention &or services visit frequency	4180186
1027098	Hepatitis B virus core Ab & surface and little e Ab & Ag panel	4180186
1027099	Hepatitis A & B & C virus immunity &or previous exposure panel	4180186
1027100	Chronic hepatitis differentiation between B & C virus panel	4180186
1027107	Alpha globin gene cluster & HS-40 region	4180186
1027111	Candida sp & Gardnerella vaginalis & Trichomonas vaginalis DNA panel	4180186
1027118	Views AP + PA	4180186
1027120	Length.crown rump	4180186
1027125	Views for patency of biliary structures+ejection fraction	4180186
1027127	Views AP + PA upright	4180186
1027139	Views AP (KUB & upright)	4180186
1027140	Views R-lateral-decubitus + L-lateral-decubitus	4180186
1027174	Have you or any family members you live with been unable to get any of the following when it was really needed in past 1Y	4180186
1027178	Have you spent more than 2 nights in a row in a jail, prison, detention center, or juvenile correctional facility in past 1Y	4180186
1027182	Chlamydophila pneumoniae & Mycoplasma pneumoniae DNA panel	4180186
1027184	Human coronavirus 229E+HKU1+NL63+OC43 & Parainfluenza virus 1+2+3+4 RNA panel	4180186
1027185	Human metapneumovirus & Respiratory syncytial virus RNA panel	4180186
1027186	Range of motion in the last 7D	4180186
1027188	Measles & Mumps & Rubella virus Ab.IgG panel	4180186
1027211	Allergy+Immunology.nurse	4180186
1027223	Splenic vein+Portal vein	4180186
1027244	Views Grashey + outlet	4180186
1027246	Views Grashey + outlet + Serendipity	4180186
1027248	Aortic arch+Subclavian artery.right	4180186
1027250	Tibia.right	4180186
1027251	Breast.duct.right	4180186
1027252	Carotid artery.cervical.left	4180186
1027253	Carotid artery.internal.left	4180186
1027269	Apt-Downey	4180186
1027270	Beta-N-acetylhexosaminidase A & B	4180186
1027274	RelACnc	4180186
1027276	Multisection limited for pelvimetry	4180186
1027278	Views AP + lateral + apical lordotic	4180186
1027279	Views AP + lateral + Merchants	4180186
1027280	Views AP + lateral + R-oblique + L-oblique	4180186
1027298	Wound irrigation &or cleaning fluid	4180186
1027302	Wound.base	4180186
1027327	Views AP internal rotation + AP external rotation + Y	4180186
1027328	View AP internal rotation + West Point	4180186
1027332	Views 3 + radial deviation	4180186
1027337	Views + oblique	4180186
1027342	Views 2 + tunnel	4180186
1027344	Views 4 + oblique	4180186
1027345	Views 4 + tunnel	4180186
1027346	Views 4 + Sunrise + tunnel	4180186
1027347	Views + tunnel	4180186
1027350	Views 3 + axillary	4180186
1027351	Views 3 + Y	4180186
1027352	Views AP internal rotation + AP external rotation + West Point	4180186
1027354	Views + Carpal tunnel	4180186
1027355	Views AP + Grashey + axillary	4180186
1027358	Views lateral + R-oblique + L-oblique	4180186
1027359	Views lateral + R-anterior oblique	4180186
1027365	Views AP + Danelius Miller	4180186
1027366	Views + Danelius Miller	4180186
1027371	Views PA + R-lateral + L-lateral + Towne	4180186
1027374	Guidance limited for localization of abscess	4180186
1027375	Guidance for localization of abscess	4180186
1027398	Multisection ventilation+perfusion	4180186
1027410	Views first pass+ejection fraction	4180186
1027411	Views for infarct+first pass	4180186
1027422	Views first pass+wall motion+ventricular volume	4180186
1027423	Views first pass+wall motion+ventricular volume+ejection fraction	4180186
1027424	Views first pass+wall motion+ejection fraction	4180186
1027425	View first pass & wall motion & ejection fraction	4180186
1027426	Multisection gated+ejection fraction	4180186
1027430	Multisection gated+wall motion	4180186
1027431	Views gated+first pass	4180186
1027432	Views gated+wall motion+ejection fraction	4180186
1027438	Views ventilation+perfusion+differential	4180186
1027439	Views ventilation+equilibrium	4180186
1027444	Cytokeratin AE1+AE3	4180186
1027450	37 deg C incubation	4180186
1027451	Ser^control	4180186
1027456	RFLP	4180186
1027461	Flexion.active range of motion	4180186
1027462	Flexion.passive range of motion	4180186
1027463	Extension.active range of motion	4180186
1027465	Abduction.active range of motion	4180186
1027468	Adduction.passive range of motion	4180186
1027471	External rotation.active range of motion	4180186
1027477	Probe.amp detection limit = 2.6 log copies/mL	4180186
1027495	Insulin name + ID	4180186
1027520	Salmonella & Shigella sp	4180186
1027521	Views lateral + Mortise + Broden	4180186
1027536	Submandibular gland.left	4180186
1027538	Gastrointestinal tract.upper+Small bowel+Gallbladder	4180186
1027543	Contributing factor.environment	4180186
1027545	Contributing factor.staff-related	4180186
1027547	Contributing factor.other	4180186
1027553	Event description.medication	4180186
1027554	Event description.procedure &or treatment &or surgery	4180186
1027559	Event description.equipment &or device	4180186
1027560	Event description.laboratory	4180186
1027564	Event description.environmental hazard &or safety	4180186
1027565	Event description.crime &or intentional harm	4180186
1027568	Contributing factor.technical	4180186
1027573	Lt 1H	4180186
1027574	Gt 1H	4180186
1027591	Views && view PA	4180186
1027592	Views 4 && view PA	4180186
1027593	Views lateral & PA chest	4180186
1027595	(View Sunrise) + (views^W standing)	4180186
1027633	Older adult behavior alteration.sixty five Y and older	4180186
1027651	Views GE 3	4180186
1027654	Aorta+Lower extremity vessels	4180186
1027655	Ovary.bilateral	4180186
1027658	Views GE 5	4180186
1027659	Mandible.right	4180186
1027660	Mandible.left	4180186
1027663	Study observation.general	4180186
1027666	View AP && View upright	4180186
1027668	Views limited for blood flow	4180186
1027670	Views qualitative+quantitative for infarct	4180186
1027688	Views Grashey + Y	4180186
1027693	Age.at delivery	4180186
1027694	Metanephrine & Normetanephrine	4180186
1027699	Multisection limited cine for function	4180186
1027702	Views GE 4	4180186
1027704	Ribs.unilateral+Chest	4180186
1027725	Hepatitis B virus & Hepatitis D virus	4180186
1027732	Aerobic culture 25 deg C incubation	4180186
1027733	Anaerobic culture 25 deg C incubation	4180186
1027735	Alder Ab	4180186
1027738	Ash Ab	4180186
1027747	Disialylganglioside GD1a Ab.IgM	4180186
1027750	Disialylganglioside GD1b Ab.IgM	4180186
1027752	Helianthus annuus Ab.IgG	4180186
1027753	Helianthus annuus Ab	4180186
1027754	Hepatitis B virus & hepatitis D virus Ab	4180186
1027761	Microfilaria sp identified	4180186
1027763	Monosialoganglioside GM1 Ab.IgG	4180186
1027766	O NOS Ag	4180186
1027768	Pneumocystis carinii Ag	4180186
1027772	Spermatozoa.head Ab.IgA	4180186
1027773	Spermatozoa.head Ab.IgG	4180186
1027774	Spermatozoa.head Ab.IgM	4180186
1027775	Spermatozoa.midpiece Ab.IgA	4180186
1027777	Spermatozoa.midpiece Ab.IgM	4180186
1027780	Spermatozoa.tail Ab.IgM	4180186
1027781	Spermatozoa.tail tip Ab.IgA	4180186
1027783	Spermatozoa.tail tip Ab.IgM	4180186
1027797	Tetrasialylganglioside GQ1b Ab.IgG	4180186
1027799	Wuchereria bancrofti + Brugia malayi Ag	4180186
1027800	Yeast bakers Ab.IgG	4180186
1027801	Yeast bakers Ab	4180186
1027815	Views GE 2 + PA + lateral	4180186
1027823	Rheumatoid factor & cyclic citrullinated peptide Ab.IgG	4180186
1027825	Rheumatoid factor & Cyclic citrullinated peptide Ab.IgG panel	4180186
1027826	Rheumatoid factor & Cyclic citrullinated peptide	4180186
1027834	MLH1 gene deletion+duplication & full mutation analysis	4180186
1027838	CSF3R gene exons 14 & 17 targeted mutation analysis	4180186
1027850	Fetal chromosome X & Y aneuploidy	4180186
1027875	NuMoM2b	4180186
1027876	Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form	4180186
1027897	Monotypic plasma cell identification & risk stratification panel	4180186
1027898	During the past 4W, because of my health situation I feel uncertain about the future	4180186
1027899	During the past 4W, because of my health situation I have little trust in my own body	4180186
1027905	During the past 4W, I have good relations with my immediate superior	4180186
1027906	During the past 4W, my immediate superior understands my health situation and possible health problems	4180186
1027909	During the past 4W, I have good relations with my colleagues	4180186
1027910	During the past 4W, I am content with my work	4180186
1027912	During the past 4W, I feel there is a positive atmosphere in my working environment	4180186
1027917	During the past 4W, I do my work well	4180186
1027918	During the past 4W, I consider my work important	4180186
1027920	During the past 4W, I think it is good to work	4180186
1027921	During the past 4W, working gives me structure in my life	4180186
1027942	Cells.cytogenetic abnormality	4180186
1027952	TPMT gene & NUDT15 gene	4180186
1027955	Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve	4180186
1027970	Pressure gradient.2.mean	4180186
1027974	Regurgitant pressure gradient.max	4180186
1027977	Coarctation.pressure gradient.max	4180186
1027978	HTR2A gene.c.614-2211T>C	4180186
1027983	Radiology.team	4180186
1028011	Blood flow velocity.mean	4180186
1028020	Regurgitant pressure gradient.mean	4180186
1028023	Regurgitant pressure gradient.diastole.max	4180186
1028025	Upper extremity>Hand.metacarpal.first	4180186
1028026	Upper extremity>Hand.metacarpal.third	4180186
1028028	Upper extremity>Thumb.proximal phalanx	4180186
1028029	Upper extremity>Finger.third.proximal phalanx	4180186
1028033	Upper extremity>Finger.third.distal phalanx	4180186
1028034	Upper extremity>Finger.fifth.distal phalanx	4180186
1028035	Upper extremity>Thumb.distal phalanx	4180186
1028037	Upper extremity>Wrist.hamate	4180186
1028038	Upper extremity>Wrist.triquetrum	4180186
1028042	Upper extremity>Wrist.trapezoid	4180186
1028051	Regurgitant pressure gradient.systole.max	4180186
1028054	Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0	4180186
1028076	IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge	4180186
1028079	IRF-PAI v4.0, LCDS v5.00 - Medications - discharge	4180186
1028111	LCDS v5.00 - Swallowing &or nutritional status - admission	4180186
1028165	Actual lethality or medical damage most lethal suicide attempt	4180186
1028170	Potential lethality initial or first suicide attempt	4180186
1028176	4-Fluorofentanyl	4180186
1028177	Hearing.ability to hear during 3D assessment period	4180186
1028178	Vision.ability to see in adequate light during 3D assessment period	4180186
1028201	Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes	4180186
1028226	Parainfluenza virus 1+2+3+4 Ab.IgG	4180186
1028227	Glial fibrillary acidic protein.alpha subunit	4180186
1028232	Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel	4180186
1028234	Glial fibrillary acidic protein.alpha subunit Ab.IgG	4180186
1028246	SILS	4180186
1028267	Blood flow reversal.diastolic	4180186
1028271	Atrial contraction strain rate.max	4180186
1028285	Orthopaedic surgery.team	4180186
1028286	Hematology.team	4180186
1028293	NTRK1 gene & NTRK2 gene & NTRK3 gene	4180186
1028294	NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements	4180186
1028296	^Escort	4180186
1028328	Nonalcoholic steatohepatitis & fibrosis panel	4180186
1028332	Francisella tularensis Ab.IgG & IgM	4180186
1028333	Francisella tularensis Ab.IgG & IgM panel	4180186
1028337	Gas & CO & electrolytes panel	4180186
1028338	Velocity-time integral.left ventricular outflow tract	4180186
1028339	Blood flow velocity.max.left ventricular outflow tract	4180186
1028356	Emergency department visits in last 6Mo	4180186
1028358	Number of times hospitalized in last 6Mo	4180186
1028360	Brassica oleracea var capitata f rubra	4180186
1028362	Brassica oleracea var capitata f rubra Ab	4180186
1028363	Brassica oleracea var botrytis cooked Ab.IgE	4180186
1028365	Brassica oleracea var gongylodes	4180186
1028366	Allium schoenoprasum	4180186
1028370	Melissa officinalis	4180186
1028371	HTLV I & II Ab.IgG band	4180186
1028376	Lymphocytes.villous	4180186
1028385	Rh antigens & K Ag panel	4180186
1028390	ABO & Rh group post transfusion reaction panel	4180186
1028418	ABO & Rh group during infancy panel	4180186
1028420	Rh antigens & K Ag during infancy panel	4180186
1028430	NOP56 gene.GGCCTG repeats	4180186
1028450	UGT1A1 gene.TA repeats & c.211G>A	4180186
1028506	Color Me Healthy - children's symptom assessment app panel	4180186
1028507	LRat	4180186
1028508	MR && MR.angio	4180186
1028516	Chikungunya virus Ab.IgM & IgG panel	4180186
1028683	Abuse.status	4180186
1028686	Cognition.status	4180186
1028689	Digestion-hydration.status	4180186
1028690	Family planning.status	4180186
1028691	Grief.status	4180186
1028695	Income.status	4180186
1028697	Medication regimen.status	4180186
1028700	Neuro-musculo-skeletal function.status	4180186
1028701	Nutrition.status	4180186
1028705	Physical activity.status	4180186
1028709	Residence.status	4180186
1028710	Respiration.status	4180186
1028711	Role change.status	4180186
1028712	Sanitation.status	4180186
1028715	Skin.status	4180186
1028719	Spirituality.status	4180186
1028724	Abuse.knowledge	4180186
1028726	Bowel function.knowledge	4180186
1028728	Circulation.knowledge	4180186
1028729	Cognition.behavior	4180186
1028730	Cognition.knowledge	4180186
1028734	Consciousness.knowledge	4180186
1028735	Digestion-hydration.behavior	4180186
1028740	Grief.knowledge	4180186
1028741	Growth and development.behavior	4180186
1028742	Growth and development.knowledge	4180186
1028745	Hearing.behavior	4180186
1028747	Income.behavior	4180186
1028749	Interpersonal relationship.behavior	4180186
1028750	Interpersonal relationship.knowledge	4180186
1028753	Mental health.behavior	4180186
1028755	Neglect.behavior	4180186
1028757	Neuro-musculo-skeletal function.behavior	4180186
1028759	Nutrition.behavior	4180186
1028764	Pain.knowledge	4180186
1028767	Physical activity.behavior	4180186
1028769	Postpartum function.behavior	4180186
1028771	Pregnancy function.behavior	4180186
1028774	Reproductive function.knowledge	4180186
1028775	Residence.behavior	4180186
1028777	Respiration.behavior	4180186
1028779	Role change.behavior	4180186
1028781	Sanitation.behavior	4180186
1028782	Sanitation.knowledge	4180186
1028786	Skin.knowledge	4180186
1028788	Sleep and rest pattern.knowledge	4180186
1028791	Speech and language.behavior	4180186
1028792	Speech and language.knowledge	4180186
1028794	Spirituality.knowledge	4180186
1028795	Substance use.behavior	4180186
1028796	Substance use.knowledge	4180186
1028799	Vision.behavior	4180186
1028803	Cytokeratin 5+6	4180186
1028804	Cytokeratin HMW	4180186
1028805	NKI-C3	4180186
1028830	HIV care & family status section	4180186
1028832	1D cold incubation	4180186
1028833	2D cold incubation	4180186
1028837	3D cold incubation	4180186
1028842	6D cold incubation	4180186
1028849	Acridine orange and Giemsa stain	4180186
1028851	Acute respiratory distress culture	4180186
1028853	Agar diffusion	4180186
1028855	Aggl.card	4180186
1028856	Aggl.plate	4180186
1028857	Aggl.plate.buffered acidified	4180186
1028861	Aggl.serial ring test	4180186
1028871	Anaerobic culture	4180186
1028872	Anaerobic+Aerobic culture	4180186
1028873	Angiogram	4180186
1028874	Angiogram.visual estima	4180186
1028875	Angiography.biplane	4180186
1028893	Multisection sagittal & coronal	4180186
1028894	Multisection sagittal & coronal disarticulation	4180186
1028906	Calcofluor white preparation	4180186
1028908	Calculated.HWL	4180186
1028909	Calculated.PLN	4180186
1028915	Breast.ductal lavage	4180186
1028929	Coag	4180186
1028930	Coag inverse ratio	4180186
1028931	Coag.saline 1:1	4180186
1028937	Concentration.Baermann	4180186
1028981	Dye test	4180186
1028982	EEG	4180186
1028983	EGD	4180186
1028988	Electromyogram	4180186
1028991	Views 2 && View PA	4180186
1028992	Views 3 + Swimmers	4180186
1028994	Electrophoresis.agarose gel	4180186
1028996	Probe.amp.tar detection limit = 1.7 log copies/mL	4180186
1029024	Probe.amp.tar detection limit = 2.6 log copies/mL	4180186
1029025	Fick	4180186
1029044	Guidance for injection of sentinel lymph node	4180186
1029045	GC	4180186
1029057	HAI	4180186
1029073	HPLC	4180186
1029075	ICA	4180186
1029076	Immune diffusion	4180186
1029078	IF rat kidney substrate	4180186
1029079	IF rat liver substrate	4180186
1029080	IFA	4180186
1029091	Incubation.1M	4180186
1029092	India ink preparation	4180186
1029097	Intravascular line culture	4180186
1029100	Ivy	4180186
1029102	Kleihauer-Betke	4180186
1029107	SCB	4180186
1029108	LA	4180186
1029113	Gestational age in W	4180186
1029114	Gestational age in D	4180186
1029117	BldCRRT	4180186
1029118	Antibody score	4180186
1029120	Lee White	4180186
1029121	LHR	4180186
1029127	California encephalitis virus Ab.IgG & IgM	4180186
1029128	Macro/Micro ID	4180186
1029148	Microscopy.electron	4180186
1029150	Microscopy.electron.thin section	4180186
1029172	Nuclear.blood pool	4180186
1029184	Oxygen analyzer	4180186
1029204	Perm mount	4180186
1029207	PET scan	4180186
1029208	Phosphotungstic acid hematoxyl	4180186
1029264	Calcidiol & Calciferol	4180186
1029272	Probe.amp.tar detection limit = 5 IU/mL	4180186
1029274	RBCs diluted	4180186
1029276	Reaction: pyruvate to lactate	4180186
1029289	RFLP probe	4180186
1029292	RIA	4180186
1029293	Ring and weigh	4180186
1029315	Sedimentation	4180186
1029334	LnRto	4180186
1029338	BldA+BldMV	4180186
1029340	Spun Westergren tube	4180186
1029345	Dial fld+Ser/Plas	4180186
1029359	Antibody titered	4180186
1029363	Test strip.automated	4180186
1029368	TLC	4180186
1029372	Trichrome modified	4180186
1029383	US	4180186
1029385	MDS.full	4180186
1029386	Electrophoresis pH 6.0	4180186
1029387	BldCoMV	4180186
1029388	US.2D.aortic root.calculated	4180186
1029393	US.2D.mitral valve.calculated	4180186
1029394	US.2D.mod	4180186
1029396	US.2D.mod.biplane	4180186
1029400	BldA+Inhl gas	4180186
1029405	US.2D.mod.single-plane.calculated	4180186
1029408	US.2D.tricuspid valve	4180186
1029409	US.2D.tricuspid valve.calculated	4180186
1029411	US.composite.estimated	4180186
1029412	US.continuity	4180186
1029414	US.continuity.Vmax+Diameter	4180186
1029415	US.continuity.VTI+Area	4180186
1029422	US.derived from OFD&O-I BPD	4180186
1029424	US.derived.AUT	4180186
1029425	IgM.CSF	4180186
1029427	US.derived.HWL	4180186
1029429	US.derived.PLN	4180186
1029431	US.doppler	4180186
1029435	US.doppler.derived.full Bernoulli	4180186
1029436	US.doppler+Calculated by simplified Bernoulli	4180186
1029437	US.doppler.pressure half time	4180186
1029439	US.doppler.velocity+Diameter.calculated	4180186
1029442	US.doppler.Vmax+Area.calculated	4180186
1029444	US.doppler.VTI+Aorta.calculated	4180186
1029447	US.doppler.VTI+LVOT.calculated	4180186
1029448	US+Estimated	4180186
1029449	US+Estimated from AC	4180186
1029451	US+Estimated from AC&BPD&FL	4180186
1029454	US+Estimated from AC&BPD&FL&HC.Roberts 1985	4180186
1029458	US+Estimated from AC&BPD.Eik-Nes 1982	4180186
1029460	US+Estimated from AC&BPD.Shepard 1982	4180186
1029462	US+Estimated from AC&BPD.Warsof 1977	4180186
1029466	US+Estimated from AC&FL&HC.Hadlock 1984	4180186
1029470	US+Estimated from AC&FL&HC.Weiner 1985	4180186
1029471	US+Estimated from AC&FL.Hadlock 1984	4180186
1029473	US+Estimated from AC&FL.Woo 1985	4180186
1029475	US+Estimated from AC&HC	4180186
1029477	US+Estimated from AC&HC.Jordaan 1983	4180186
1029479	US+Estimated from AC.Hadlock 1982	4180186
1029481	Probe.amp.tar detection limit = 0.5 log copies/mL	4180186
1029482	US+Estimated from AC.Jeanty 1984	4180186
1029486	US+Estimated from AD&BPD	4180186
1029487	US+Estimated from AD&BPD&FL	4180186
1029489	Head & Ears & Eyes & Nose & Throat	4180186
1029494	US+Estimated from AD&BPD.Rose 1987	4180186
1029495	US+Estimated from AD&BPD.Vintzileos 1987	4180186
1029496	US+Estimated from AD&FL	4180186
1029499	US+Estimated from BD	4180186
1029505	US+Estimated from BD.Jeanty 1984	4180186
1029506	US.estimated from BPC	4180186
1029509	US+Estimated from BPD.Doubilet 1993	4180186
1029511	US+Estimated from BPD.Hadlock 1984	4180186
1029512	US+Estimated from BPD.Hansmann 1985	4180186
1029513	US+Estimated from BPD.Hobbins 1983	4180186
1029514	US+Estimated from BPD.Jeanty 1984	4180186
1029519	US+Estimated from BPD.Sabbagha 1978	4180186
1029521	US.estimated from cerebellar diameter	4180186
1029526	US+Estimated from CRL.Hadlock 1992	4180186
1029527	US+Estimated from CRL.Hansmann 1985	4180186
1029528	Diam	4180186
1029529	US+Estimated from CRL.Jeanty 1984	4180186
1029530	US+Estimated from CRL.Nelson 1981	4180186
1029531	US+Estimated from CRL.Robinson 1975	4180186
1029533	US.estimated from fibula length	4180186
1029535	US.estimated from fibula length.Merz 1987	4180186
1029536	US+Estimated from FL	4180186
1029538	US+Estimated from FL.Hansmann 1985	4180186
1029540	US+Estimated from FL.Jeanty 1984	4180186
1029542	US+Estimated from FL.Merz 1987	4180186
1029544	US+Estimated from GSD	4180186
1029546	US+Estimated from GSD.Rempen 1991	4180186
1029547	US+Estimated from HC	4180186
1029556	US.estimated from radius length	4180186
1029557	US.estimated from radius length.Merz 1987	4180186
1029558	US+Estimated from tibia length	4180186
1029559	US+Estimated from tibia length.Jeanty 1984	4180186
1029560	US+Estimated from tibia length.Merz 1987	4180186
1029561	US.estimated from ulna length	4180186
1029563	US.estimated from ulna length.Merz 1987	4180186
1029564	US.M-mode	4180186
1029565	US.M-mode.calculated	4180186
1029569	US.mod.single-plane.calculated	4180186
1029570	US.modified Simpson.calculated	4180186
1029571	US.Teichholz	4180186
1029589	Westergren.2H reading	4180186
1029598	Accel	4180186
1029599	ACnc	4180186
1029601	Addr	4180186
1029602	Anat	4180186
1029605	ARat	4180186
1029608	AreaRto	4180186
1029609	ArEnrg	4180186
1029611	ArVol	4180186
1029617	CFr	4180186
1029619	CircFr	4180186
1029622	CRat	4180186
1029623	Desc	4180186
1029625	Elpot	4180186
1029627	EngRat	4180186
1029628	Enrg	4180186
1029629	EntNum	4180186
1029631	EntLen	4180186
1029632	EntMass	4180186
1029634	Equ	4180186
1029635	Fcn	4180186
1029636	Find	4180186
1029638	FldResist	4180186
1029641	ID	4180186
1029642	Imp	4180186
1029643	Instrct	4180186
1029645	Len	4180186
1029646	LenFr	4180186
1029647	LenRto	4180186
1029648	Loc	4180186
1029654	MFr	4180186
1029655	Morph	4180186
1029667	MRto	4180186
1029670	Naric	4180186
1029699	NRat	4180186
1029705	NRto	4180186
1029706	Num	4180186
1029715	Prctl	4180186
1029718	PresRto	4180186
1029719	Prid	4180186
1029721	RelRto	4180186
1029724	Resis	4180186
1029725	RelMCnc	4180186
1029726	SCnc	4180186
1029727	SCnt	4180186
1029731	SFr	4180186
1029734	Sub	4180186
1029735	Susc	4180186
1029743	TmStp	4180186
1029744	TQ2	4180186
1029751	VelRto	4180186
1029756	VRatCnt	4180186
1029766	1D	4180186
1029767	1H	4180186
1029768	1M	4180186
1029772	1Mo	4180186
1029774	Glucose CSF	4180186
1029778	Protein.CSF	4180186
1029779	Protein.plr fld	4180186
1029780	1W	4180186
1029784	Lactate dehydrogenase.plr fld	4180186
1029785	IgA.CSF	4180186
1029792	2D	4180186
1029793	2H	4180186
1029795	Coagulation surface induced^after addition of protein C activator+factor V depleted plasma/Coagulation surface induced	4180186
1029798	30M	4180186
1029803	45M	4180186
1029805	4H	4180186
1029810	72H	4180186
1029811	8H	4180186
1029812	90M	4180186
1029815	Procedure dur	4180186
1029816	Pt	4180186
1029817	Stdy	4180186
1029823	Dial fld prt+Ser/Plas	4180186
1029827	Coagulation surface induced^after addition of protein C activator	4180186
1029831	Abdomen.mid	4180186
1029834	Semin plas	4180186
1029837	Airway.proximal	4180186
1029842	Views supine + upright	4180186
1029843	View PA && Views supine + upright	4180186
1029847	Amnio fld	4180186
1029852	Am fld space	4180186
1029854	Views+AP	4180186
1029855	View PA && View AP	4180186
1029856	Views L-lateral-decubitus + R-lateral-decubitus	4180186
1029862	Anatomic part.*	4180186
1029863	Views PA + lateral + AP lateral-decubitus	4180186
1029864	Views PA + lateral + AP L-lateral-decubitus	4180186
1029865	Views PA + lateral + AP R-lateral-decubitus	4180186
1029866	Views AP + AP R-lateral-decubitus	4180186
1029871	Aorta.abdominal.proximal	4180186
1029873	Aorta.root	4180186
1029875	Aorta.thoracic.ascending	4180186
1029876	Aorta.thoracic.descending	4180186
1029877	Aorta.thoracic.proximal ascending	4180186
1029878	LsCnc	4180186
1029882	Computer assisted	4180186
1029885	Aortic valve.annulus	4180186
1029886	Aortic valve.regurgitant jet	4180186
1029893	Asp	4180186
1029895	CSF.spun	4180186
1029911	BBL	4180186
1029914	HIV 2 Ab Signal	4180186
1029919	Bld	4180186
1029920	Bld.postductal	4180186
1029921	Bld.preductal	4180186
1029923	Bld/Bone mar	4180186
1029924	Bld/Tiss	4180186
1029928	BldA	4180186
1029929	BldC	4180186
1029931	BldMV	4180186
1029932	BldP	4180186
1029937	Brachial artery.left	4180186
1029938	Brachial artery.right	4180186
1030000	Calf.left	4180186
1030001	Calf.right	4180186
1030016	Cancer.XXX.morphology	4180186
1030030	5M RT incubation	4180186
1030041	Cervical canal.internal os	4180186
1030043	CFTR gene.p.IVS8 polyT 7T	4180186
1030045	Cervix.externally palpable surface	4180186
1030052	Circulatory system.XXX	4180186
1030054	Clavicle.diaphysis	4180186
1030057	Cnl	4180186
1030067	CSF	4180186
1030071	Lactate dehydrogenase.periton fld	4180186
1030072	Periton fld+Ser/Plas	4180186
1030073	MoM	4180186
1030076	Cvx	4180186
1030077	Cvx/Vag	4180186
1030079	Dial fld.spun	4180186
1030085	Deep tendon reflexes	4180186
1030086	Deep tissue.FNA	4180186
1030091	Digital artery.right	4180186
1030094	Dorsal pedal artery.right	4180186
1030100	Duod fld	4180186
1030101	Duod fld/Gast fld	4180186
1030103	Ears & nose & mouth & throat	4180186
1030108	Edit overrides &or Conversion history &or System admin section	4180186
1030112	{HIV ART medication} doses missed 2D ago	4180186
1030115	{HIV ART medication} doses missed 4D ago	4180186
1030146	Accommodation width.measured	4180186
1030165	Alcohol binge episodes per M	4180186
1030169	Endoscopy procedure.XXX	4180186
1030205	Exhl gas	4180186
1030217	Blood flow.diastolic.atrial wave	4180186
1030241	Eye.left	4180186
1030251	Eye.right	4180186
1030262	Carcinogenesis & mutagenesis & impairment of fertility section	4180186
1030268	Census block group 1970&80&90	4180186
1030270	Census tract certainty 1970&80&90	4180186
1030283	Circumference.at nipple line	4180186
1030296	COC site & type override flag	4180186
1030379	Date last menstrual period	4180186
1030391	Date of vaccination temporary contraindication &or precaution expiration	4180186
1030470	Drug &or laboratory test interactions section	4180186
1030473	Dx &or stage	4180186
1030486	ED disposition consult &or referral	4180186
1030488	Small intes fixed	4180186
1030495	ED procedure practitioner ID	4180186
1030497	Tiss fixed	4180186
1030521	Examination level.ultrasound	4180186
1030540	Gastrointestinal tract.lower	4180186
1030576	Gradient.diastole	4180186
1030603	Genital loc	4180186
1030614	Vag	4180186
1030615	Hospitalization	4180186
1030655	GI cnt	4180186
1030661	Hospital sequence & site override flag	4180186
1030719	Head.choroid plexus	4180186
1030720	Intrachamber.systole	4180186
1030721	Intratumoral + Peritumoral lymphocytic response	4180186
1030725	Head.fourth ventricle	4180186
1030728	Invasive carcinoma.uninvolved margin distance.closest	4180186
1030729	Invasive carcinoma.uninvolved margin.closest	4180186
1030730	Invasive component size.additional dimension 1	4180186
1030733	Head.intracranial anatomy	4180186
1030744	Labor & delivery section	4180186
1030752	Lesion size.additional dimension 1	4180186
1030754	Leukemia & lymphoma override flag	4180186
1030756	Head.third ventricle	4180186
1030757	Licensed blood intermediate &or paste label	4180186
1030767	Major axis.diastole	4180186
1030768	Major axis.systole	4180186
1030804	Minor axis.systole	4180186
1030835	Heart.atria	4180186
1030851	Operations (?)	4180186
1030856	Heart.atrium.right	4180186
1030869	Heart.great vessels	4180186
1030878	Heart.interventricular septum	4180186
1030882	Overrides&conversion&system administration battery	4180186
1030911	Heart.valves	4180186
1030916	Heart.ventricle	4180186
1030924	Physical findings.sensation	4180186
1030925	Physical findings.shoulder shrug	4180186
1030929	Heart.ventricle.left	4180186
1030935	Planned &or next follow-up	4180186
1030941	Heart.ventricle.left.basal anterior	4180186
1030943	Position.placenta	4180186
1030953	Pressure half time.velocity	4180186
1030955	Heart.ventricle.left.basal lateral	4180186
1030976	Heart.ventricle.left.inferior apical	4180186
1031008	Heart.ventricle.left.mid inferior	4180186
1031024	Heart.ventricle.left.mid septum	4180186
1031028	Relevant diagnostic tests &or laboratory data	4180186
1031045	RR duration	4180186
1031051	Heart.ventricle.left.posterior wall	4180186
1031061	Heart.ventricle.posterior wall.left	4180186
1031067	Sequence number&diagnosis confirm override flag	4180186
1031069	Short axis.systole	4180186
1031075	Site & behavior override flag	4180186
1031076	Site & extent of disease & diagnosis date override flag	4180186
1031078	Site & laterality & extent of disease override flag	4180186
1031079	Site & laterality & morphology override flag	4180186
1031082	Site&type override flag	4180186
1031086	Size.additional dimension	4180186
1031101	Specimen size.additional dimension 1	4180186
1031111	Stage &or prognostic factors section	4180186
1031117	Stage.summary & regional lymph nodes positive override flag	4180186
1031119	Stage.summary & TNM-N override flag	4180186
1031121	Heart.ventricle.XXX	4180186
1031129	Heart.ventricles	4180186
1031136	Subject participation+Epochs section	4180186
1031155	Surgery&diagnosis confirm override flag	4180186
1031176	Surgical operation note postoperative Dx	4180186
1031187	Telephone	4180186
1031212	Inhl gas	4180186
1031219	Treatment of subjects+Epochs section	4180186
1031225	Iliac artery.right	4180186
1031238	Incubator.pediatric	4180186
1031256	Vaccination contraindication &or precaution	4180186
1031269	Intravascular space.XXX	4180186
1031272	Views AP & lateral & oblique	4180186
1031274	Views multiple sagittal & coronal	4180186
1031308	Forced vital capacity.post bronchodilation	4180186
1031318	Glasgow coma score.total	4180186
1031343	Thickness.septal wall	4180186
1031347	Volume at 25-75% of forced expiration	4180186
1031382	Behavioral &or mental health screen follow-up status	4180186
1031384	Behavioral &or mental health screen results indicator	4180186
1031454	Little finger arteries.right	4180186
1031457	Destination site longitude	4180186
1031462	Diagnosis.addressed by plan	4180186
1031465	Dictating practitioner ID	4180186
1031527	Follow-up (referred to) provider &or specialist, catchment location indicator	4180186
1031529	Follow-up (referred to) provider &or specialist, network location indicator	4180186
1031532	Follow-up (referred to) provider &or specialist, state location indicator	4180186
1031557	Hemoglobin test status &or results	4180186
1031570	Bone mar	4180186
1031575	Include all data of the selected type that represents observations made 3Mo or fewer before the starting date of service	4180186
1031577	Include all data of the selected type that represents observations made nine Mo or fewer before the starting date of service	4180186
1031579	Include all data of the selected type that represents observations made six Mo or fewer before the starting date of service	4180186
1031613	Medication.administered	4180186
1031620	Medications.administered.report request	4180186
1031622	Medications.current.report request	4180186
1031623	Medications.discharge.report request	4180186
1031624	Medications.report request	4180186
1031640	New &or revised	4180186
1031675	Middle finger arteries.left	4180186
1031690	Past medical history+Level of function	4180186
1031710	Prenatal interview w infants primary care provider indicator	4180186
1031723	Mitral valve.annulus	4180186
1031742	Reason for follow-up (referred to) provider &or specialist	4180186
1031756	Rehabilitation.alcohol &or substance abuse service attachment	4180186
1031758	Mitral valve.regurgitant jet	4180186
1031819	Mouth & throat & teeth	4180186
1031869	12 steps-interior during 2D assessment period	4180186
1031878	Absence of contact with family &or friends	4180186
1031924	Nose/Trac	4180186
1031940	CMS certification number	4180186
1031944	Allergies & Adverse Drug Reactions	4180186
1031952	Altered level of consciousness &or alertness during 2D assessment period	4180186
1031958	Occupation & industry Hx	4180186
1031959	Antepartum &or postpartum	4180186
1032000	Average fluid intake per D by IV or tube in last 7D	4180186
1032005	Aware of normal hazards & take appropriate precautions	4180186
1032026	Ovary.largest follicle	4180186
1032053	Ovary.left	4180186
1032056	Bowel elimination pattern regular - at least one movement every three D	4180186
1032068	Can recall staff names &or faces	4180186
1032071	Ovary.right	4180186
1032077	Continuity assessment record and evaluation tool - acute care	4180186
1032078	Continuity assessment record and evaluation tool - expired	4180186
1032079	Continuity assessment record and evaluation tool - interim	4180186
1032101	Change in communication &or hearing	4180186
1032132	Completes normal workday & week WO interruptions from psych symptoms & performs at consistent pace WO unreasonable number & length of rests	4180186
1032144	Continence in last 14D section	4180186
1032149	Covert &or open conflict with or repeated criticism of staff	4180186
1032177	Daily animal companion &or presence	4180186
1032179	Daily contact with relatives &or close friends	4180186
1032197	Dehydration &or fluid maintenance trigger	4180186
1032219	Did not use toilet room &or commode &or urinal	4180186
1032245	Disorganized thinking during 2D assessment period	4180186
1032286	Plas	4180186
1032291	Eating during 2D assessment period	4180186
1032293	Eats between meals all or most D	4180186
1032300	End-Stage disease, 6 or fewer Mo to live	4180186
1032302	Enemas &or irrigation	4180186
1032308	Evaluation by a licensed mental health specialist in last 90D	4180186
1032343	Feeling tired or having little energy in last 2W	4180186
1032344	Fell in past 30D	4180186
1032359	Four steps-exterior during 2D assessment period	4180186
1032378	Gas &or bloating	4180186
1032386	Geriatric depression scale total	4180186
1032388	Popliteal artery.right	4180186
1032391	Goes out 1 or more D a W	4180186
1032394	Grip strength during 2D assessment period	4180186
1032418	Height & weight	4180186
1032422	Hip fracture in last 180D	4180186
1032425	Falls in the past Y	4180186
1032428	History of stay at mental health &or psychiatric setting	4180186
1032441	PPP	4180186
1032460	Inattention during 2D assessment period	4180186
1032483	Inpatient stay within last 14D - ICD code	4180186
1032484	Insomnia &or change in sleeping pattern	4180186
1032522	Laundry during 2D assessment period	4180186
1032531	Light shopping during 2D assesssment	4180186
1032534	Limited activities because of pain during last 2D	4180186
1032535	Little interest or pleasure in doing things in last 2W	4180186
1032540	Prostate.adenoma	4180186
1032559	Maintains socially appropriate behavior & adheres to basic standards of neatness & cleanliness	4180186
1032564	Major treatments admitted &or discharged with	4180186
1032566	Major treatments admitted &or discharged with panel	4180186
1032571	Major treatments used on or 1D prior to day of death	4180186
1032573	Major treatments used within 2D interim period	4180186
1032574	Major treatments used within 2D interim period panel	4180186
1032584	Periton fld	4180186
1032608	Medical procedures &or treatments assistance needed	4180186
1032610	Medical services received in the last 2Mo	4180186
1032616	Medication management-inhalant &or mist medications during 2D assessment period	4180186
1032618	Medication management-injectable medications during 2D assessment period	4180186
1032619	Medication management-oral medications during 2D assessment period	4180186
1032627	Memory &or recall ability during 2D assessment period	4180186
1032640	Mobility endurance - able to walk or wheel 50 feet during 2D assessment period	4180186
1032657	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W	4180186
1032658	Pulmonary artery.wedge	4180186
1032664	Nails &or calluses trimmed during last 90D	4180186
1032674	Neighborhood &or workplace safety	4180186
1032712	Number of D injections received	4180186
1032714	Number hospital admissions in last 90D	4180186
1032715	Number of D antianxiety medication received	4180186
1032716	Number of D antidepressant medication received	4180186
1032717	Number of D antipsychotic medication received	4180186
1032722	Number of D of other rehabilitation or restorative techniques or procedures	4180186
1032725	Number of D of training & skill practice in amputation or prosthesis care	4180186
1032726	Number of D of training & skill practice in bed mobility	4180186
1032727	Number of D of training & skill practice in communication	4180186
1032729	Number of D of training & skill practice in eating or swallowing	4180186
1032730	Number of D of training & skill practice in transfer	4180186
1032731	Number of D of training & skill practice in walking	4180186
1032732	Number of D physician orders changed in last 14D	4180186
1032734	Number of D with at least 15M of physical therapy in the last 7D	4180186
1032735	Number of D with at least 15M of psychological therapy by any licensed mental health professional in the last 7D	4180186
1032737	Number of D with at least 15M of speech language pathology and audiology services in the last 7D	4180186
1032742	Number of D physician examined the patient in last 14D	4180186
1032755	Pulmonic valve.annulus	4180186
1032774	Observational Assessment of Cognitive Status at 2D Assessment Period	4180186
1032781	One step (curb) during 2D assessment period	4180186
1032782	Pulmonic valve.regurgitant jet	4180186
1032785	Openly expresses conflict &or anger with family &or friends	4180186
1032787	Oral hygiene during 2D assessment period	4180186
1032794	Oral status &or disease prevention - none of above	4180186
1032805	Other current diagnoses & ICD9 codes (quarterly)	4180186
1032817	Radial artery.left	4180186
1032822	Other fracture in last 180D	4180186
1032843	Overall Plan of Care &or Advance Care Directives - Subheading	4180186
1032849	Pads &or briefs used	4180186
1032853	Pain has made it hard to sleep during last 2D	4180186
1032854	Radius.diaphysis	4180186
1032890	RBC	4180186
1032912	Picking up objects during 2D assessment period	4180186
1032953	Prior functioning.functional cognition	4180186
1032959	Region of interest.XXX	4180186
1032992	Proportion of total calories received through parenteral or tube feeding in last 7D	4180186
1033000	Psychomotor retardation during 2D assessment period	4180186
1033001	Psychosocial well being section	4180186
1033003	Psychosocial well being trigger	4180186
1033008	Push &or pull	4180186
1033025	Reason for one on one 24H supervision	4180186
1033036	Recent loss of close family member &or friend	4180186
1033042	Regimen change in past 14D - ICD code	4180186
1033062	Renal pelvis.right	4180186
1033068	Resident assessment protocol 14--Dehydration &or Fluid maint - proceed with care	4180186
1033088	Resident assessment protocol 5--ADL functional &or Rehab - triggered	4180186
1033101	Resident expresses &or indicates preference to return to the community	4180186
1033107	Resident-specific deliberate changes in the environment to address mood &or behavior patterns	4180186
1033111	Respiratory status with oxygen therapy during 2D assessment period	4180186
1033121	Roll left and right during 2D assessment period	4180186
1033138	Sense of initiative &or involvement	4180186
1033150	Retinal artery.left	4180186
1033177	Ring finger arteries.right	4180186
1033184	Social Security & Medicare numbers	4180186
1033197	Special treatments &or programs - none of above	4180186
1033217	Stay projected to be of a short duration - discharge projected within 90D	4180186
1033219	Ser+Bld	4180186
1033229	Suctioning frequency per H during stay.max	4180186
1033255	Ser+Prostate	4180186
1033257	Telephone-answering during 2D assessment period	4180186
1033258	Telephone-placing call during 2D assessment period	4180186
1033263	Temporal Orientation &or Mental Status	4180186
1033264	Ser+RBC	4180186
1033268	Therapy orders to begin in 1st 14D of stay	4180186
1033281	Toilet transfer during 2D assessment period	4180186
1033289	Total minutes of respiratory therapy in the last 7D	4180186
1033290	Total minutes of speech language pathology and audiology services in the last 7D	4180186
1033292	Total population of age 10-14Y	4180186
1033293	Total population of age 1-4Y	4180186
1033297	Ser/Bld	4180186
1033298	Total population of age 29D to 1Y	4180186
1033300	Total population of age 35-39Y	4180186
1033304	Total population of age 55-59Y	4180186
1033305	Total population of age 5-9Y	4180186
1033307	Total population of age 60-64Y	4180186
1033308	Total population of age 65-69Y	4180186
1033309	Total population of age 70-74Y	4180186
1033310	Total population of age 75-79Y	4180186
1033315	Ser/Plas+Stool	4180186
1033324	Ser/Plas.ultracentrifugate	4180186
1033338	Trouble falling or staying asleep, or sleeping too much in last 2W	4180186
1033340	Tube feeding during 2D assessment period	4180186
1033343	Ser/Plas/Bld	4180186
1033356	Unable to assess memory &or recall ability during 2D assessment period .specified reason	4180186
1033360	Understands & remembers very short & simple instructions	4180186
1033364	Unknown customary routine - resident &or family unable to provide information	4180186
1033371	Upper body dressing during 2D assessment period	4180186
1033377	Urinary tract infection in last 7D	4180186
1033393	Verbal behavioral symptoms directed towards others during 2D assessment period	4180186
1033409	Walk 100 ft (30 m) during 2D assessment period	4180186
1033418	Walking 10 feet on uneven surfaces during 2D assessment period	4180186
1033422	Wash upper body during 2D assessment period	4180186
1033426	Weight gain or loss of 3+ Lbs. within a 7D period	4180186
1033428	Weight-bearing restrictions during 2D assessment period	4180186
1033431	Wheel 100 ft (30 m) during 2D assessment period	4180186
1033432	Wheel 150 ft (45 m) during 2D assessment period	4180186
1033435	Wheel long ramp during 2D assessment period	4180186
1033447	Wipe down surface during 2D assessment period	4180186
1033459	Synv fld	4180186
1033502	Cheek.left	4180186
1033503	Cheek.right	4180186
1033504	Clavicle.diaphysis.right	4180186
1033507	Femur.diaphysis.right	4180186
1033508	Fibula.diaphysis.right	4180186
1033510	Head.lateral cerebral ventricle.right	4180186
1033514	Lung.left	4180186
1033515	Lung.right	4180186
1033531	Tibia.diaphysis.right	4180186
1033532	Ulna.diaphysis.right	4180186
1033535	MDS	4180186
1033543	Subclavian vein.left	4180186
1033546	Fluid intake.urinary bladder irrigation	4180186
1033547	Fluid output.biliary drain	4180186
1033549	Fluid output.cerebral ventricle drain	4180186
1033550	Fluid output.chest tube	4180186
1033556	Fluid output.misc.route	4180186
1033559	Fluid output.subarachnoid drain	4180186
1033560	Fluid output.total	4180186
1033563	Fluid output.urine in and out urethral catheter	4180186
1033564	Fluid output.wound drain identifier	4180186
1033574	Surgical procedure	4180186
1033603	Fluid intake.nasogastric tube	4180186
1033604	Fluid intake.oral	4180186
1033606	Fluid intake.synovial	4180186
1033609	Testis.left	4180186
1033610	Testis.right	4180186
1033619	Velocity slope.XXX	4180186
1033624	Caretaking &or parenting.knowledge	4180186
1033625	Caretaking &or parenting.status	4180186
1033628	Communicable &or infectious condition function.status	4180186
1033634	Thigh.left	4180186
1033635	Neighborhood &or workplace safety.knowledge	4180186
1033636	Neighborhood &or workplace safety.status	4180186
1033640	Thigh.right	4180186
1033642	Thorax+Lungs	4180186
1033647	Volume at 25-75% of forced expiration.post bronchodilation	4180186
1033648	Volume at 25-75% of forced expiration.pre bronchodilation	4180186
1033651	AHIC	4180186
1033655	Thrt	4180186
1033658	Thumb arteries.left	4180186
1033660	USSG-FHT	4180186
1033664	Thumb arteries.right	4180186
1033676	Thyroid.FNA	4180186
1033683	Tiss	4180186
1033684	Tiss.FNA	4180186
1033685	TLGI	4180186
1033689	Trachea.airway	4180186
1033694	Tricuspid valve.annulus	4180186
1033695	Tricuspid valve.orifice	4180186
1033699	Tube/Drain	4180186
1033703	Ulna.diaphysis	4180186
1033704	Ulnar artery.left	4180186
1033705	Ulnar artery.right	4180186
1033709	Umbilical artery.between fetus and placenta	4180186
1033715	Urinary bladder irrigation tube	4180186
1033727	Ventilator.alarm	4180186
1033729	Ventilator.neonatal	4180186
1033730	Ventilator.servo	4180186
1033731	Ventilator.synchronized intermittent mandatory	4180186
1033732	Vitr fld	4180186
1033733	Volume.planimetry	4180186
1033741	Wound.shlw	4180186
1033753	IF Hep2 substrate	4180186
1033754	IF rat liver+stomach+kidney substrate	4180186
1033756	Glucose & Protein	4180186
1033763	Activities of Daily Living (ADL) Assistance in last 7D	4180186
1033768	Additional ICD diagnosis 3 in last 7D	4180186
1033770	Additional ICD diagnosis 5 in last 7D	4180186
1033771	Additional ICD diagnosis 6 in last 7D	4180186
1033773	Additional ICD diagnosis 8 in last 7D	4180186
1033774	Additional ICD diagnosis 9 in last 7D	4180186
1033775	Additional ICD diagnosis 10 in last 7D	4180186
1033800	Heart &or circulation	4180186
1033807	Psychiatric &or mood disorder	4180186
1033819	Oral &or dental status	4180186
1033843	Comatose in last 7D	4180186
1033851	Can recall current season in last 7D	4180186
1033852	Can recall location of own room in last 7D	4180186
1033853	Can recall staff names and faces in last 7D	4180186
1033854	Can recall that he or she is in a nursing home in last 7D	4180186
1033855	None of the above were recalled in last 7D	4180186
1033856	Cognitive skills for daily decision making in last 7D	4180186
1033857	Procedural memory OK in last 7D	4180186
1033860	Inattention in last 7D	4180186
1033862	Altered level of consciousness in last 7D	4180186
1033869	Little interest or pleasure in doing things in last 2W.frequency	4180186
1033871	Feeling down, depressed or hopeless in last 2W.frequency	4180186
1033873	Trouble falling or staying asleep, or sleeping too much in last 2W.frequency	4180186
1033874	Feeling tired or having little energy in last 2W.presence	4180186
1033875	Feeling tired or having little energy in last 2W.frequency	4180186
1033879	Feeling bad about yourself - or that you are a failure or have let yourself or your family down in last 2W.frequency	4180186
1033889	Feeling or appearing down, depressed, or hopeless in last 2W.frequency	4180186
1033890	Indicating that (s)he feels bad about self, is a failure, or has let self or family down in last 2W.presence	4180186
1033892	States that life isn't worth living, wishes for death, or attempts to harm self in last 2W.presence	4180186
1033894	Being short-tempered, easily annoyed in last 2W.presence	4180186
1033895	Being short-tempered, easily annoyed in last 2W.frequency	4180186
1033911	Rejection of care - presence and frequency in last 7D	4180186
1033913	Wandering places resident at significant risk of getting to a potentially dangerous place in last 7D	4180186
1033914	Wandering significantly intrudes on the privacy or activities of others in last 7D	4180186
1033958	Toilet transfer in last 7D	4180186
1033960	Walk in room in last 7D	4180186
1033961	Walk in facility in last 7D	4180186
1033962	Locomotion in last 7D	4180186
1033963	Dressing upper body in last 7D	4180186
1033964	Dressing lower body in last 7D	4180186
1033965	Eating in last 7D	4180186
1033967	Bathing in last 7D	4180186
1033974	Walker normally used in last 7D	4180186
1033975	Wheelchair (manual or electric) normally used in last 7D	4180186
1033981	Ostomy (including suprapubic catheter, ileostomy, and colostomy) present in last 7D	4180186
1033982	Intermittent catheterization used in last 7D	4180186
1033988	Bowel continence in last 7D	4180186
1033992	Anemia in last 7D	4180186
1033994	Coronary artery disease in last 7D	4180186
1033999	Peripheral vascular disease in last 7D	4180186
1034002	Ulcerative colitis &or Crohn's disease &or inflammatory bowel disease in last 7D	4180186
1034005	HIV infection in last 30D	4180186
1034006	Staphylococcus aureus.methicillin resistant or Enterococcus species.vancomycin resistant or Clostridium difficile infections &or colonization in last 30D	4180186
1034010	Urinary tract infection in last 30D	4180186
1034012	Diabetes mellitus in last 7D	4180186
1034013	Hyponatremia in last 7D	4180186
1034017	Arthritis in last 7D	4180186
1034019	Hip fracture in last 7D	4180186
1034020	Other fracture in last 7D	4180186
1034021	Alzheimer's disease in last 7D	4180186
1034022	Aphasia in last 7D	4180186
1034027	Paraplegia in last 7D	4180186
1034028	Quadriplegia in last 7D	4180186
1034035	Depression other than bipolar in last 7D	4180186
1034036	Manic depression other than schizophrenia in last 7D	4180186
1034037	Schizophrenia in last 7D	4180186
1034038	Post-traumatic stress disorder in last 7D	4180186
1034039	Asthma &or chronic obstructive lung disease or chronic lung disease in last 7D	4180186
1034040	Cataracts &or glaucoma or macular degeneration in last 7D	4180186
1034041	None of the above active diagnoses in last 7D	4180186
1034042	On scheduled pain medication regimen in last 7D	4180186
1034043	Received PRN pain medications in last 7D	4180186
1034044	Received non-medication intervention for pain in last 7D	4180186
1034047	Pain frequency in last 5D	4180186
1034050	Pain severity in last 5D	4180186
1034052	Vocal complaints of pain in last 5D	4180186
1034055	None of these signs of pain observed or documented in last 5D	4180186
1034057	Shortness of breath or trouble breathing with exertion in last 7D	4180186
1034058	Shortness of breath or trouble breathing when sitting at rest in last 7D	4180186
1034059	Shortness of breath or trouble breathing when lying flat in last 7D	4180186
1034060	None of the above shortness of breath symptoms in last 7D	4180186
1034063	Fall one or more times in the last Mo prior to admission	4180186
1034071	Loss of liquids &or solids from mouth when eating or drinking in last 7D	4180186
1034073	Coughing or choking during meals or when swallowing medications in last 7D	4180186
1034077	Parenteral &or IV feeding in last 7D	4180186
1034078	Nasogastric or abdominal feeding tube in last 7D	4180186
1034080	Therapeutic diet in last 7D	4180186
1034081	Nutritional approaches in last 7D - none of the above	4180186
1034085	No natural teeth or tooth fragments in last 7D	4180186
1034086	Abnormal mouth tissue in last 7D	4180186
1034088	Inflamed or bleeding gums or loose natural teeth in last 7D	4180186
1034091	Pressure injury risk by resident has a stage 1 or greater, a scar over bony prominence, or a non-removable dressing, device in last 7D	4180186
1034097	Number of pressure ulcers present upon admission &or reentry - stage 2	4180186
1034107	Proportion of total calories the resident received through parenteral or tube feedings in the last 7D	4180186
1034110	Moving or speaking so slowly that other people have noticed. Or the opposite - being so fidgety or restless that (s)he has been moving around a lot more than usual in last 2W.frequency	4180186
1034115	Date of onset of pressure ulcers onset in this facility - oldest or only unstageable due to coverage of wound bed by slough &or eschar	4180186
1034117	Number of pressure ulcers present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution	4180186
1034121	Venous or arterial ulcers in last 7D	4180186
1034122	Diabetic foot pressure injury(ies) in last 7D	4180186
1034125	Surgical wound(s) in last 7D	4180186
1034127	Second or third degree burns in last 7D	4180186
1034128	Other ulcers, wounds, and skin problems - none of above in last 7D	4180186
1034129	Number of venous and arterial ulcers in last 7D	4180186
1034131	Pressure reducing device for chair provided in last 7D	4180186
1034133	Turning &or repositioning provided in last 7D	4180186
1034134	Nutrition or hydration intervention to manage skin problems provided in last 7D	4180186
1034138	Applications of ointments &or medications other than to feet provided in last 7D	4180186
1034142	Medications received in last 7D or since admission &or reentry if less than 7D	4180186
1034143	Antipsychotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034144	Antianxiety received in last 7D or since admission &or reentry if less than 7D	4180186
1034146	Hypnotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034150	Chemotherapy in last 14D - while not a resident	4180186
1034151	Chemotherapy in last 14D - while a resident	4180186
1034155	Oxygen therapy in last 14D - while a resident	4180186
1034157	Suctioning in last 14D - while a resident	4180186
1034159	Tracheostomy care in last 14D - while a resident	4180186
1034160	Ventilator or respirator in last 14D - while not a resident	4180186
1034161	Ventilator or respirator in last 14D - while a resident	4180186
1034163	BIPAP &or CPAP machine in last 14D - while a resident	4180186
1034165	IV medications in last 14D - while a resident	4180186
1034166	Transfusions in last 14D - while not a resident	4180186
1034169	Dialysis in last 14D - while a resident	4180186
1034171	Hospice care in last 14D - while a resident	4180186
1034174	Isolation or quarantine for active infectious disease in last 14D - while not a resident	4180186
1034188	Total minutes of recreational and music therapy in last 7D	4180186
1034192	Nursing rehabilitation &or restorative care in last 7D	4180186
1034236	Other special treatments and programs in last 14D	4180186
1034258	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.presence	4180186
1034259	Moving or speaking so slowly that other people could have noticed. Or the opposite - being so fidgety or restless that you have been moving around a lot more than usual in last 2W.frequency	4180186
1034291	Number of male sexual partners in 6Mo before symptom onset	4180186
1034330	Views & (view AP	4180186
1034331	(View Sunrise) + (views	4180186
1034333	View oblique & (views	4180186
1034368	Blood pressure systolic & diastolic	4180186
1034386	Reported.PHQ-2	4180186
1034406	Horizontal adduction.passive range of motion	4180186
1034424	PhenX measure - mid upper arm circumference	4180186
1034434	ALSPAC	4180186
1034467	Albumin.serum	4180186
1034469	Phenx - hand dominance - 42Mo and older protocol 020601	4180186
1034486	ED accepting or admitting provider	4180186
1034547	Serology & blood bank studies	4180186
1034566	Neuro & emotional & behavioral status	4180186
1034634	Patient &or caregiver drug education intervention	4180186
1034678	Hemoglobin disorders newborn screening comment-discussion	4180186
1034679	Infectious diseases newborn screening comment-discussion	4180186
1034683	Hearing loss newborn screening comment-discussion	4180186
1034699	Entry &or discharge reporting	4180186
1034700	Multidrug-resistant organism (MDRO) in last 7D	4180186
1034702	Neurogenic bladder in last 7D	4180186
1034703	Obstructive uropathy in the last 7D	4180186
1034705	Tourette's syndrome in last 7D	4180186
1034706	Psychotic disorder (other than schizophrenia) in last 7D	4180186
1034707	Respiratory failure in last 7D	4180186
1034711	Prior Functioning ADL and IADL	4180186
1034714	Other disease diagnoses in last 7D	4180186
1034720	Number of D the physician changed the resident's insulin orders in last 7D or since admission &or reentry if less than 7D	4180186
1034721	Antibiotic received in last 7D or since admission &or reentry if less than 7D	4180186
1034750	Cognitive loss &or dementia - addressed in care plan	4180186
1034754	ADL functional &or rehabilitation potential - addressed in care plan	4180186
1034757	Psychosocial well being - care area triggered	4180186
1034758	Psychosocial well being - addressed in care plan	4180186
1034840	Mention of the participant having either trauma, a surgical procedure, or rhabdomyolysis within 1W prior to the cardiac enzymes measurement	4180186
1034855	Y permanent pacemaker inserted	4180186
1034871	Rheumatic fever in the past 12Mo	4180186
1034951	Velocity-time integral.pulmonary vein A wave	4180186
1035277	Respiratory system.airway opening	4180186
1036708	Acinetobacter Infection	4180186
1036708	Infection, Acinetobacter	4180186
1036708	Infection, Mimae	4180186
1036708	Infections, Acinetobacter	4180186
1036708	Infections, Mimae	4180186
1036708	Mimae Infection	4180186
1036708	Mimae Infections	4180186
1036710	1,2-Propanediol, 3-chloro-	4180186
1036710	3 Chloro 1,2 propanediol	4180186
1036710	3-Chloro-1,2-propanediol	4180186
1036710	3 Chloropropanediol	4180186
1036710	3-Chloropropanediol	4180186
1036710	3-MCPD	4180186
1036710	3 Monochloropropane 1,2 diol	4180186
1036710	3-Monochloropropane-1,2-diol	4180186
1036710	alpha Chlorhydrin	4180186
1036710	alpha-Chlorhydrin	4180186
1036710	alpha Chlorohydrin	4180186
1036710	alpha-Monochlorohydrin, Glycerol	4180186
1036710	Glycerol alpha Monochlorohydrin	4180186
1036710	Glycerol alpha-Monochlorohydrin	4180186
1036710	U5897	4180186
1036710	U 5897	4180186
1036710	U-5897	4180186
1036711	Acid Maltase	4180186
1036711	alpha-D-Glucoside glucohydrolases	4180186
1036711	alpha Glucosidase	4180186
1036711	alpha-Glucosidase	4180186
1036711	alpha-Glucosidase, Lysosomal	4180186
1036711	alpha-Glucosidase, Neutral	4180186
1036711	alpha Glucosidases	4180186
1036711	Lysosomal alpha Glucosidase	4180186
1036711	Lysosomal alpha-Glucosidase	4180186
1036711	Maltase	4180186
1036711	Maltase Glucoamylase	4180186
1036711	Maltase-Glucoamylase	4180186
1036711	Maltases	4180186
1036711	Neutral alpha Glucosidase	4180186
1036711	Neutral alpha-Glucosidase	4180186
1036711	Neutral Maltase	4180186
1036714	Blood Viscosities	4180186
1036714	Viscosities, Blood	4180186
1036714	Viscosity, Blood	4180186
1036716	Body Compositions	4180186
1036716	Composition, Body	4180186
1036716	Compositions, Body	4180186
1036717	Body Heights	4180186
1036717	Height, Body	4180186
1036717	Heights, Body	4180186
1036718	Index, Body Mass	4180186
1036718	Index, Quetelet	4180186
1036718	Quetelet Index	4180186
1036718	Quetelet's Index	4180186
1036718	Quetelets Index	4180186
1036719	Area, Body Surface	4180186
1036719	Areas, Body Surface	4180186
1036719	Body Surface Areas	4180186
1036719	Surface Area, Body	4180186
1036719	Surface Areas, Body	4180186
1036721	Body Weight Change	4180186
1036721	Change, Body Weight	4180186
1036721	Changes, Body Weight	4180186
1036721	Weight Change, Body	4180186
1036721	Weight Changes, Body	4180186
1036723	Atrio Biventricular Pacing	4180186
1036723	Atrio-Biventricular Pacing	4180186
1036723	Biventricular Pacing	4180186
1036723	Cardiac Resynchronization	4180186
1036723	Cardiac Resynchronization Pacing Therapy	4180186
1036723	Pacing, Atrio-Biventricular	4180186
1036723	Pacing, Biventricular	4180186
1036723	Resynchronization, Cardiac	4180186
1036723	Resynchronization Pacing Therapy, Cardiac	4180186
1036723	Resynchronization Therapy, Cardiac	4180186
1036723	Therapy, Cardiac Resynchronization	4180186
1036724	Cardiac Toxicities	4180186
1036724	Cardiac Toxicity	4180186
1036724	Cardiotoxicities	4180186
1036724	Toxicity, Cardiac	4180186
1036726	Sensitivity, Contrast	4180186
1036726	Sensitivity, Visual Contrast	4180186
1036726	Visual Contrast Sensitivity	4180186
1036727	Brain Tumor, DIPG	4180186
1036727	DIPG Brain Tumor	4180186
1036727	DIPG Brain Tumors	4180186
1036727	DIPG, Diffuse Intrinsic Pontine Glioma	4180186
1036728	Erythrocyte Volumes	4180186
1036728	Masses, Red Cell	4180186
1036728	Mass, Red Cell	4180186
1036728	Red Cell Mass	4180186
1036728	Red Cell Masses	4180186
1036728	Volume, Erythrocyte	4180186
1036728	Volumes, Erythrocyte	4180186
1036732	Concentration, Hydrogen-Ion	4180186
1036732	Concentrations, Hydrogen-Ion	4180186
1036732	Hydrogen Ion Concentration	4180186
1036732	Hydrogen-Ion Concentrations	4180186
1036732	pH	4180186
1036734	1H-Indol-3-ol, hydrogen sulfate (ester)	4180186
1036734	1H-Indol-3-ol Hydrogen Sulfate Ester	4180186
1036734	Indican Monopotassium Salt	4180186
1036734	Indican Monosodium Salt	4180186
1036734	Indoxyl Sulfate	4180186
1036734	Monopotassium Salt, Indican	4180186
1036734	Monosodium Salt, Indican	4180186
1036734	Sulfate, Indoxyl	4180186
1036735	Intraocular Pressures	4180186
1036735	Ocular Tension	4180186
1036735	Ocular Tensions	4180186
1036735	Pressure, Intraocular	4180186
1036735	Pressures, Intraocular	4180186
1036735	Tension, Ocular	4180186
1036735	Tensions, Ocular	4180186
1036736	Lactobacillus fermentum	4180186
1036736	Lactobacillus cellobiosus	4180186
1036738	Lactococcus lactis subsp. lactis	4180186
1036738	Streptococcus lactis	4180186
1036739	Dose 50, Lethal	4180186
1036739	LD50	4180186
1036742	Concentration, Osmolar	4180186
1036742	Concentrations, Osmolar	4180186
1036742	Ionic Strength	4180186
1036742	Ionic Strengths	4180186
1036742	Osmolalities	4180186
1036742	Osmolality	4180186
1036742	Osmolar Concentrations	4180186
1036742	Osmolarities	4180186
1036742	Osmolarity	4180186
1036742	Strength, Ionic	4180186
1036742	Strengths, Ionic	4180186
1036745	Blood Plasma Volume	4180186
1036745	Blood Plasma Volumes	4180186
1036745	Plasma Volumes	4180186
1036745	Volume, Blood Plasma	4180186
1036745	Volume, Plasma	4180186
1036745	Volumes, Blood Plasma	4180186
1036745	Volumes, Plasma	4180186
1036754	Circumferences, Waist	4180186
1036754	Circumference, Waist	4180186
1036754	Waist Circumferences	4180186
1036760	oct-1-en-3-yl acetate	4180186
1036762	2-ethyl-1-hexanol	4180186
1036762	2-ethylhexanol, titanium (4+) salt	4180186
1036763	2-isopropyl-5-methyl-phenol	4180186
1036764	Isoeugenol acetate	4180186
1036764	Isoeugenyl acetate	4180186
1036767	4-cresol, aluminum salt	4180186
1036767	4-cresol, potassium salt	4180186
1036767	4-cresol, sodium salt	4180186
1036767	4-methylphenol	4180186
1036767	para-cresol	4180186
1036767	p-cresol	4180186
1036775	death cap mushroom	4180186
1036776	Gaffkya anaerobia	4180186
1036776	Peptostreptococcus tetradius	4180186
1036776	Tetracoccus anaerobius	4180186
1036777	ansuvimab-zykl	4180186
1036777	Ebanga	4180186
1036777	mAb114	4180186
1036777	mAb-114	4180186
1036779	Aspergillus rubrobrunneus	4180186
1036779	Aspergillus rubrum	4180186
1036779	Eurotium rubrum	4180186
1036780	atoltivimab-ebgn	4180186
1036780	REGN3470	4180186
1036780	REGN-3470	4180186
1036781	LY3819253	4180186
1036781	LY-3819253	4180186
1036781	LY-COV555	4180186
1036783	1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide	4180186
1036783	1H-pyrazole-5-carboxamide, 1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)	4180186
1036783	BCX7353	4180186
1036783	BCX-7353	4180186
1036788	burosumab-TWZA	4180186
1036788	Crysvita	4180186
1036788	KRN23	4180186
1036788	KRN-23	4180186
1036788	KRN23 monoclonal antibody	4180186
1036791	C auris infection	4180186
1036791	C. auris infection	4180186
1036797	3,7-dimethyl-6-octenenitrile	4180186
1036799	(-)-cocaine-3-acylhydrolase	4180186
1036799	cocaine carboxylesterase	4180186
1036799	CocE protein, Rhodococcus	4180186
1036802	semen loss syndrome	4180186
1036802	semen-loss syndrome	4180186
1036805	diethylmalonate	4180186
1036805	malonic acid, diethyl ester	4180186
1036805	propanedioic acid, diethyl ester	4180186
1036807	succinic acid, dimethyl ester	4180186
1036809	N-(2-(3-methoxyphenyl)-2-ethylbutyl-(1))-gamma-hydroxybutyramide	4180186
1036810	chrysosporium infection	4180186
1036810	Emergomyces africanus infection	4180186
1036810	Emergomycosis	4180186
1036810	Emmonsia helica infection	4180186
1036810	Emmonsia pasteurian infection	4180186
1036811	LY-CoV016	4180186
1036811	JS016	4180186
1036813	ethyl caproate	4180186
1036813	hexanoic acid ethyl ester	4180186
1036815	1,4-p-menthadiene	4180186
1036815	alpha-terpinene	4180186
1036815	beta-terpinene	4180186
1036820	grazoprevir anhydrous	4180186
1036820	grazoprevir monohydrate	4180186
1036820	MK5172	4180186
1036820	MK 5172	4180186
1036820	MK-5172	4180186
1036820	cyclopropanecarboxamide, n-((((1r,2r)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-l-valyl-(4R)-4-hydroxy-l-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, (1R,2S)-	4180186
1036820	cyclopropanecarboxamide, N-((((1R,2R)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, hydrate (1 :1) (1R,2S)-	4180186
1036820	grazoprevir hydrate	4180186
1036820	MK-5172 monohydrate	4180186
1036822	2-((4-amino-2-nitrophenyl)amino)ethanol	4180186
1036826	REGN-10987	4180186
1036827	Al-imidazole	4180186
1036827	Cu-imidazole	4180186
1036827	imidazole acetate	4180186
1036827	imidazole citrate	4180186
1036827	imidazole conjugate monoacid	4180186
1036827	imidazole monohydrochloride	4180186
1036827	imidazole monophosphonate	4180186
1036827	imidazole sodium	4180186
1036827	imidazolium chloride	4180186
1036828	isatuximab-irfc	4180186
1036828	SAR650984	4180186
1036828	SAR6 50984	4180186
1036828	Sarclisa	4180186
1036829	Candida kefyr	4180186
1036829	Candida pseudotropicalis	4180186
1036829	Dekkeromyces marxianus	4180186
1036829	Guilliermondella marxiana	4180186
1036829	Kluyveromyces cicerisporus	4180186
1036829	Kluyveromyces fragilis	4180186
1036829	Saccharomyces marxianus	4180186
1036829	Zygofabospora marxiana	4180186
1036829	Zygorenospora marxiana	4180186
1036829	Zygosaccharomyces marxianus	4180186
1036831	4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide	4180186
1036831	(+)4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-yl)-1-piperidinyl)-2-oxoethyl)-1-piperidinecarboxamide	4180186
1036831	SCH66336	4180186
1036831	SCH 66336	4180186
1036831	1-piperidinecarboxamide, 4(2-(4-(11R-3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine-11-yl)-1-piperidinyl)-2-oxoethyl)-	4180186
1036831	Sarasar	4180186
1036831	SCH-66336	4180186
1036831	Zokinvy	4180186
1036832	3-Methyl-N-(2-oxo-2-((2,2,2-trifluoroethyl)amino)ethyl)-5-((5S)-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl)-2-thiophenecarboxamide	4180186
1036832	Credelio	4180186
1036839	2-Propenoic acid, 2-methyl- 3-(trimethoxysilyl)propyl ester	4180186
1036839	3-methacryloyloxypropyl-trimethoxysilane	4180186
1036839	gamma-MAPS	4180186
1036839	gamma-methacryloxypropyltrimethoxysilane	4180186
1036839	gamma-MPTS	4180186
1036839	Kerr Ceramic Primer	4180186
1036839	KH 570	4180186
1036839	KH-570	4180186
1036839	MAOPTMS	4180186
1036839	Silanit	4180186
1036839	Silicoup adhesion primer	4180186
1036839	Silicoup silane coupling agents	4180186
1036839	Siliseal	4180186
1036841	Myopathy, Congenital, Due To Integrin Alpha-7 Deficiency	4180186
1036843	acetyl arginine	4180186
1036843	N-alpha-acetylarginine	4180186
1036844	2-butoxyethanol	4180186
1036844	butylcellosolve	4180186
1036844	ethyleneglycol monobutyl ether	4180186
1036844	n-butoxyethanol sodium salt	4180186
1036846	odesivimab-ebgn	4180186
1036846	REGN3471	4180186
1036846	REGN-3471	4180186
1036848	ABT-450	4180186
1036848	veruprevir	4180186
1036848	veruprevir anhydrous	4180186
1036848	(2R,6S,12Z,13aS,14aR,16aS)-N-(cyclopropylsulfonyl)-6-(5-methylpyrazin-2-carboxamido)-5,16-dioxo-2-(phenanthridin-6-yloxy)-1,2,3,6,7,8,9,10,11,13a,14,15,16,16atetradecahydrocyclopropa(E)pyrrolo(1,2-a)(1,4)diazacyclopentadecine-14a(5H)-carboxamide	4180186
1036848	ABT 450	4180186
1036848	ABT450	4180186
1036848	paritaprevir dihydrate	4180186
1036848	paritaprevir hydrate	4180186
1036850	Citromyces glaber	4180186
1036850	Penicillium frequentans	4180186
1036852	decalin perfluoride	4180186
1036852	DKLine	4180186
1036852	fluosol-DC	4180186
1036852	perfluorodecalin, (cis)-isomer	4180186
1036852	perfluorodecalin, (trans)-isomer	4180186
1036853	diphenyl ether	4180186
1036854	Pleospora betae	4180186
1036855	isobornyl acetate	4180186
1036856	PG-MG-DS	4180186
1036857	postlaminectomy syndrome	4180186
1036857	post-laminectomy syndrome	4180186
1036858	gavreto	4180186
1036858	BLU-667	4180186
1036858	Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, trans-	4180186
1036858	trans-N-((1S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)cyclohexanecarboxamide	4180186
1036860	orgovyx	4180186
1036860	1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea	4180186
1036860	TAK385	4180186
1036860	TAK 385	4180186
1036860	TAK-385	4180186
1036862	S. vasiformis infection	4180186
1036862	S vasiformis infections	4180186
1036862	S. vasiformis infections	4180186
1036862	Saksenaea erythrospora infection	4180186
1036862	Saksenaea erythrospora infections	4180186
1036862	Saksenaea infections	4180186
1036862	Saksenaea vasiformis infection	4180186
1036862	Saksenaea vasiformis infections	4180186
1036862	S erythrospora infection	4180186
1036862	S. erythrospora infection	4180186
1036862	S erythrospora infections	4180186
1036862	S. erythrospora infections	4180186
1036862	S vasiformis infection	4180186
1036864	satralizumab-mwge	4180186
1036864	enspryng	4180186
1036866	2-amino-1,3-propanediol	4180186
1036866	2-aminopropane-1,3-diol	4180186
1036866	serinol, (+-)-isomer	4180186
1036872	taijin-kyofusho	4180186
1036875	TBPi cpd	4180186
1036877	triethylene glycoldimethacrylate	4180186
1036877	triethyleneglycol dimethacrylate	4180186
1036877	2-Propenoic acid, 2-methyl-, 1,2-ethanediylbis(oxy-2,1-ethanediyl) ester	4180186
1036877	TEGDMA	4180186
1036877	TEGMA	4180186
1036877	trioxyethylene dimethacrylate	4180186
1036879	ukoniq	4180186
1036879	TGR-1202	4180186
1036882	viltepso	4180186
1175102	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ANED; Blood; Closure time; Closure Tme; COAGULATION; FCN; Func; Funct; Medication stress; Pan; PANEL.COAGULATION; Panl; Pl; Platelet function ADP-induced Pnl; Platelets; Platelt; Plt; Pnl; Res TEG; TEG; Thrombelastography; Thrombelastometry; Thrombocyte; Thrombocytes; WB; Whole blood	4180186
1175102	Platelet func ADP-ind Pnl Bld Res TEG	4180186
1175102	采用二磷酸腺苷诱导的血小板功能组套:-:-:全血:-:血栓弹力描记术.共振	4182948
1175103	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Porcine kobuvirus; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175103	Aichivirus C RNA Ct Spec Qn NAA+probe	4180186
1175103	爱知病毒 C 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175105	D/T of risk assessment; Date and time; Date+time; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175105	D/T of risk assessment	4180186
1175105	风险评估日期和时间:时间戳:时间点:^事件:定量型	4182948
1175107	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175111	C trach L1 IgA Titr Ser IA	4180186
1175111	沙眼衣原体 L1 型 抗体.IgA:滴定度:时间点:血清:定量型:免疫测定法	4182948
1175111	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C trac; C trach; C trach L1; C tracho; C trachom L1 Ab.IgA; C trachomatis; Chlam; Chlam trac; Chlamid; CT; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin A; Immunoglobulin A; Infectious Disease; InfectiousDisease; LGV; Lymphogranuloma venereum; MEIA; Microbiology; Point in time; Random; Serum; SmQn; SR; SUDS; Titer; Titered; Titre; Trachoma; Ttr	4180186
1175112	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Random; Visit note	4180186
1175112	Heart failure Phone Note	4180186
1175112	记录:发现:时间点:电话就医:文档型:心力衰竭	4182948
1175113	4 weeks; Finding; Findings; FR; Last; Non-protein bound; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175114	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175118	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175120	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; SVC; Tissue; Tissue, unspecified	4180186
1175120	Virus Tiss Shell Vial Cult	4180186
1175120	病毒 已鉴定的:存在与否或特征标识:时间点:组织与涂片:名义型:细胞培养瓶培养法	4182948
1175128	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175129	BAFF-R cells/100 CD19 cells NFr Bld	4180186
1175129	100 CD19 cells; B cell activating factor; B cell activating factor receptor; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; R prime; Random; Right; WB; Whole blood	4180186
1175129	BAFF-R 细胞/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
1175132	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175132	Openbite teeth	4180186
1175132	开咬合牙齿:数量(计数):时间点:牙齿与牙龈:定量型	4182948
1175133	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175136	Heparan sulfate DBS-sCnc	4180186
1175136	Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; HS; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Substance concentration; Sulf; WB; Whole blood	4180186
1175136	硫酸类肝素:物质的量浓度:时间点:全血.斑点:定量型	4182948
1175137	MAG/SGPG IgM Titr CSF IA	4180186
1175137	髓磷脂相关糖蛋白-硫酸化葡萄糖醛酸对红细胞糖苷酯 抗体.IgM:滴定度:时间点:脑脊液:定量型:免疫测定法	4182948
1175137	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); EIA; ELFA; ELISA; Enzyme immunoassay; gG; Glycoprot; Glycoproteins; GP; IAA; Immune globulin M; Immunoglobulin M; MAG; MAG/SGPG; MAGM; MAG-SGPG; MEIA; Neuro; Neurology; Point in time; Random; Serology; SGPG.IGM; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; SUDS; Titer; Titered; Titre; Ttr	4180186
1175138	Cnt; Count; Lung; Neuro; Neurology; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175138	Num central apnea	4180186
1175138	中枢性呼吸暂停:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175141	H+P; H+P.PX; Integument; Nominal; P prime; Point in time; Random; Typ	4180186
1175141	Emoji skin tone mod	4180186
1175141	表情符号皮肤色调修饰符号:类型:时间点:^患者:名义型:Unicode	4182948
1175142	Est; Est from PE; estimation; Fetal; GA; Gest; Gestation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; PEA; Point in time; predicted; Prenatal; QNT; Quan; Quant; Quantitative; Random	4180186
1175142	GA Est from PE	4180186
1175142	孕龄:时间:时间点:^胎儿:定量型:体格检查估计法	4182948
1175145	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175146	AQP4 H2O channel Ab CSF Ql IF	4180186
1175146	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; FA; Fluorescent antibody; Fluoresent; IFA; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF; Water channel aquaporin-4	4180186
1175146	水通道蛋白 4 受体 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
1175149	120 min; 120 minutes; 120min; 17-beta estradiol; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; E2; Level; Mass concentration; Oestradiol; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175149	Estradiol 2h p chal SerPl-mCnc	4180186
1175149	雌二醇^在XXX刺激之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1175150	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175151	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175153	AI; Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175153	Apnea index nRate	4180186
1175153	呼吸暂停指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175154	死亡人数评估日期和时间:时间戳:时间点:^事件:定量型	4182948
1175154	D/T of deaths assessment	4180186
1175154	D/T of deaths assessment; Date and time; Date+time; Death; Fatalities; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175156	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175157	ABS; Aby; Antby; Anti; Antibodies; Antibody; Assoc; Autoantibodies; Autoantibody; CASPR2; CASPR2 Ab; Cerebral spinal fluid; Cerebrospinal Fl; II; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175157	CASPR2 Ab CSF Ql CBA IFA	4180186
1175157	接触蛋白关联蛋白 2 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175158	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175159	4 weeks; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175160	Cnt; Count; Lung; Number; O2; O2 desaturation; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies; tO2	4180186
1175160	Num O2 desaturation	4180186
1175160	血氧饱和度降低:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175161	Blood; DNA; Document; Finding; Findings; Fluorescent in situ hybridization; gene fusion; gene translocation; Genetics; Heredity; Heritable; Inherited; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; Point in time; Random; RNA; T prime; t(14;20)(IGH,MAFB); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
1175161	t(14;20)(IGH,MAFB) Bld/T FISH	4180186
1175161	t(14;20)(q32;q12)(IGH,MAFB) 融合转录物:发现:时间点:全血/组织:文档型:FISH	4182948
1175162	abn; abnorm; Ejaculate; FERTILITY TESTING; Genitourinary; GU; Number Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Sem; Seminal fluid; Smn; SMPLS; Sperm; Sperm Abnorm; URO; Urology	4180186
1175162	Abnormal principal pieces NFr Smn	4180186
1175162	精子.异常主段/100 个精子:计数型分数:时间点:精液:定量型	4182948
1175164	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cardio; Cardiology; Cult; Cultures; Heart Disease; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; PCAR; Pericardial Fluid; Point in time; Random	4180186
1175164	Bacteria Pcar Aerobe Cult	4180186
1175164	细菌 已鉴定的:存在与否或特征标识:时间点:心包液:名义型:需氧微生物培养	4182948
1175168	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175169	ANTIBIOTIC SUSCEPTIBILITIES; AST; Genotype; Genotypic; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty	4180186
1175169	Bictegravir Islt Genotyp	4180186
1175169	比克替拉韦:抗生素敏感性:时间点:分离株:序数型:基因分型	4182948
1175175	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175176	bod; Bodies; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; W RNC IV; WB	4180186
1175176	SPECT+CT Whole body W RNC IV	4180186
1175176	多层^采用静脉注射放射性核素:发现:时间点:全身:文档型:NM.SPECT+CT	4182948
1175181	120 min; 120 minutes; 120min; 2 hours; 2h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175181	T4 2h p levo SerPl-mCnc	4180186
1175181	甲状腺素^在剂量左旋甲状腺素之后2小时:质量浓度:时间点:血清/血浆:定量型	4182948
1175182	Conc increment SerPl Calc-MCDiff	4180186
1175182	After; Calc; Calculation; Conc increment; DRUG/TOXICOLOGY; Drugs; MCDiff; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175182	XXX 刺激之后的峰值浓度 - 基线浓度增量:质量浓度差:时间点:血清/血浆:定量型:计算法	4182948
1175185	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175186	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-R; Nephric; Nephrology; Perc; Point in time; Pyelogram; R; Rad; RADIOLOGY; Random; Renal; RT	4180186
1175186	CT Guided Kidney-R Cyst asp	4180186
1175186	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>肾脏.右侧:文档型:CT	4182948
1175188	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175189	9-Hydroxy risperidone; 9-Hydroxy-risperidone; 9-OH-Risperidone; 9OH-risperidone; DRUG/TOXICOLOGY; Drugs; Invega; Ordinal; Paliperidone; Point in time; PR; QL; Qual; Qualitative; Random; Risperidone metabolite; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175189	9OH-risperidone Ur Ql Scn	4180186
1175189	9-羟基利培酮:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175190	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Chagas disease; Donr; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS; T cruzi; Trypanosomiasis; Trypanosomosis	4180186
1175190	T cruzi IgG Ser Donr Ql IA	4180186
1175190	克氏锥虫 抗体.IgG:存在情况或阈值:时间点:血清^供体:序数型:免疫测定法	4182948
1175191	Bili; Bilirubins; Billirubin; Bld ven; Bld venous; Blood - venous; Blood ven; Blood venus; Chemistry; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; TBIL; Venous	4180186
1175191	Bilirub BldV-sCnc	4180186
1175191	胆红素:物质的量浓度:时间点:静脉全血:定量型	4182948
1175193	Genetics; Heredity; Heritable; Inherited; ITPA g.9381A&gt;C; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.PHARMG; Nominal; PCR; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Typ	4180186
1175193	ITPA g.9381A>C SerPl	4180186
1175193	ITPA 基因.g.9381A>C:类型:时间点:血清/血浆:名义型:分子遗传学类实验室方法	4182948
1175194	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175195	Ang; Angio; Angiography; Angm; CAT scan; Computed tomography; Computerized tomography; CT Angiogram; CT angiography; CT scan; CTA; Document; Finding; Findings; Imaging; LMTED; LTD; Misc; Miscellaneous; Other; Point in time; Rad; Radiology; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175195	CTA Ltd	4180186
1175195	局部多层:发现:时间点:XXX:文档型:CT.血管造影术	4182948
1175198	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; ZIKV; ZIKV RNA	4180186
1175198	ZIKV RNA Bld Ql NAA+probe	4180186
1175198	寨卡病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
1175202	Abortus blauw; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blue-eared pig disease; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; Immune globulin A; Immunoglobulin A; Lelystad virus; MEIA; Microbiology; Misc; Miscellaneous; Mystery swine disease; Other; Point in time; Porcine epidemic abortion & respiratory syndrome; Porcine reproductive and respiratory syndrome; Pork; Pos; Pos cntrl; PRRS; PRRS virus Ab.IgA; PRRSV; PRRSV Ab; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Seuchenhafter spatabort der schweine; SIRSV; Spec; SUDS; Swine; Swine infertility and respiratory syndrome; Syndrome dysgenesique et respiratoire porcin; To be specified in another part of the message; Unspecified; Vet; Veterinary	4180186
1175202	PRRSV IgA/Pos cntrl Spec IA	4180186
1175202	猪繁殖与呼吸综合征病毒 抗体.IgA/阳性对照:相对比率:时间点:XXX:定量型:免疫测定法	4182948
1175203	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Rhino virus; RHV; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175203	Rhinovirus RNA Lower resp Ql NAA+probe	4180186
1175203	鼻病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
1175204	ADMIN; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175204	任务到期日期:日期:时间点:^事件:定量型	4182948
1175206	Cardio; Cardiology; Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; HF+TC; notes; Point in time; Random; TC; Visit note	4180186
1175206	HF+TC Consult note	4180186
1175206	会诊记录:发现:时间点:{环境}:文档型:心力衰竭+移植心脏病学	4182948
1175207	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175207	Nuc Medicine Consult note	4180186
1175207	会诊记录:发现:时间点:{环境}:文档型:核医学	4182948
1175208	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cervix; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Genital tract; Gyn; Gynecology; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; OB; ObGyn; Obstetrics; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; T vaginalis; TMA; Transcription mediated amplification; Tric; Trich; Trichimoniasis; Trichomonad; Trichomonads; Trichomoniasis	4180186
1175208	T vaginalis DNA Cvx Ql NAA+probe	4180186
1175208	阴道毛滴虫 DNA:存在情况或阈值:时间点:子宫颈:序数型:探针法.基因扩增.靶向	4182948
1175210	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175211	1 month; 1 month (30 days); 30 days; Count/time; f247; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Rf247; Survey; SURVEY.NHANES	4180186
1175212	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175215	Finding; Findings; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; SDOH; Survey; SURVEY.GNHLTH; Tx	4180186
1175219	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; OP; Point in time; Random; Visit note	4180186
1175219	Sports medicine OP Note	4180186
1175219	记录:发现:时间点:门诊病人:文档型:运动医学	4182948
1175221	4 weeks; Finding; Findings; Last; Must use written lists so will not forget things; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175222	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175224	Blood; Chemistry; Chondroitin sulfate B; DBS; Dried blood spot; Filter paper; FP; keratosulfate; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; SO4; SO4-2; Substance concentration; Sulf; WB; Whole blood	4180186
1175224	Keratan Sulfate DBS-sCnc	4180186
1175224	硫酸角质素:物质的量浓度:时间点:全血.斑点:定量型	4182948
1175228	CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid	4180186
1175228	CT Guided Perirectal Drain+cath place	4180186
1175228	旨在引流+引流导管置入的引导:发现:时间点:盆腔>直肠周区:文档型:CT	4182948
1175229	ADMIN; Nominal; Point in time; Random; Typ	4180186
1175229	应急团队领导职位:类型:时间点:工作人员:名义型	4182948
1175230	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; LMTED; Local; LTD; Misc; Miscellaneous; Other; PET Scan; PET+CT; Point in time; Position Emmision Tomography; Positron Emission Tomography; Rad; RADIOLOGY; Radnuc.PET; Random; Spec; To be specified in another part of the message; Tum loc Ltd; Unspecified; W 18F-FDG+contr IV; W contr IV; WC	4180186
1175230	PET+CT Tum loc Ltd--W 18F-FDG+contr IV	4180186
1175230	旨在肿瘤定位的局部引导^采用静脉注射 18F-FDG+采用静脉注射对比剂:发现:时间点:XXX:文档型:PT+CT	4182948
1175231	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; LE; Leg; LE-R; Low; Mid ft-R; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; Radiology; Random; RLE; RT; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175231	CT Mid ft-R WO+W contr IV	4180186
1175231	多层^不采用 & 采用静脉注射对比剂:发现:时间点:下肢.右侧>足中部:文档型:CT	4182948
1175232	Cnt; Count; NEG; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175232	Confirmed negative lab results Pop	4180186
1175232	存在确认阴性实验室结果的人员:数量(计数):时间点:^人群:定量型	4182948
1175233	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175235	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175237	bod; Bodies; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Imaging; Point in time; Rad; RADIOLOGY; Random; RN; RNC; Scan; W RNC IV; WB	4180186
1175237	SPECT+CT Skeletal W RNC IV	4180186
1175237	多层^采用静脉注射放射性核素:发现:时间点:全身>骨骼系统:文档型:NM.SPECT+CT	4182948
1175238	PNH GPI-Linked WBC + RBC Ag Bld-Imp	4180186
1175238	Antigen; Antigens; Blood; CELL MARKERS; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Narrative; PNH GPI-Linked WBC + RBC; PNH GPI-Lkd WBC + RBC Ag; Point in time; Random; Report; WB; Whole blood	4180186
1175238	阵发性睡眠性血红蛋白尿症 GPI-锚定白细胞与红细胞 抗原:印象:时间点:全血:叙述型	4182948
1175243	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Luvox; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175243	fluvoxaMINE Ur Cfm-mCnc	4180186
1175243	三氟戊肟胺:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175244	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175248	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175249	Chronic Respiratory Questionnaire Self-Administered, Individualized Format; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; Survey; SURVEY.GNHLTH	4180186
1175250	Chol; Choles; Cholest; Cholesterol total; Cholesterols; HEDIS 2019-20 Chol Tests not LDL; Lipid; Othr; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175250	HEDIS 2019-20 Chol Tests not LDL	4180186
1175250	HEDIS 2019 取值集合 - 除LDL外的胆固醇检验项目:-:时间点:^患者:-	4182948
1175253	Ang; Angio; Angiography; Angm; Arm; c; Cardio; Cardiology; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CT venography; CTA; CTV; Document; EXT; Extr-R; Finding; Findings; Heart Disease; Imaging; Point in time; R; Rad; RADIOLOGY; Random; RT; RUE; UE; UE vv; UE vv-R; UE-R; Up; Venogram; Venography; W contr IV; WC	4180186
1175253	CTA UE vv-R W contr IV	4180186
1175253	多层^采用静脉注射对比剂:发现:时间点:上肢.右侧>上肢静脉类:文档型:CT.血管造影术	4182948
1175254	VMA + HMA panel Ur	4180186
1175254	香草扁桃酸与同型香子兰酸组套:-:时间点:尿液:-	4182948
1175254	3-methoxy-4-hydroxymandelate; 3-methoxy-4-hydroxy-phenylacetic acid; 3-methyl,4-hydroxy mandelate; 3-methyl,4-oh mandelic acid; Catecholamine metabolite; Chemistry; HMMA; Homovanilic; Homovanillate Pnl; Homovanillic acid; HVA; Hydroxy-methoxy-mandelate; Hydroxy-methoxy-mandelic acid; MHMA; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Tumor marker; UA; UR; Urn; Vanillylmandelic acid; Vanilmandelate; VMA; VMA + HMA panel	4180186
1175256	病程记录:发现:时间点:{环境}:文档型:麻醉学	4182948
1175256	Anesthesia; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175256	Anesthesiology Prog note	4180186
1175259	死亡原因:发现:时间点:^事件:叙述型	4182948
1175259	Cause of deaths	4180186
1175259	Fatalities; Finding; Findings; Narrative; Point in time; Public Health; PUBLICHEALTH; Random; Report	4180186
1175260	Addiction; Blood; Desoxyn; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecstasy; Illicit; MDMA; Methamphet; Methamphet+MDMA; Ordinal; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175260	Methamphet+MDMA SerPlBld Ql Scn	4180186
1175260	甲基苯丙胺+亚甲基二氧甲基苯丙胺:存在情况或阈值:时间点:血清/血浆/全血:序数型:毒理学筛查试验	4182948
1175261	Addiction; B/F; Barb; Barbiturate; Barbs; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175261	Barbiturates Fld Ql Scn	4180186
1175261	巴比妥类药物:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175262	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175262	记录:发现:时间点:远程医疗:文档型:缓和照顾	4182948
1175264	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175266	AIDS; Blood; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Pl; PlasBld; Plasma; Plsm; Point in time; Random; Ribonucleic acid; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175266	HIV 1 RNA IN SerPlBld-Seq	4180186
1175266	HIV 1 型 RNA 整合酶基因:序列:时间点:血清/血浆/全血:名义型:序列测定	4182948
1175269	Email addr of person generating rprt	4180186
1175269	ADMIN; Nominal; Person generating report; Persons; Point in time; Random	4180186
1175269	负责生成报告的人员:电子邮件地址:时间点:工作人员:名义型	4182948
1175271	FDA insert Postmarketing exp section	4180186
1175271	DOCUMENT.REF; FDA insert; Narrative; Postmarketing exp section; Report; SPL; Structured Product Labelling	4180186
1175271	上市后经验小节:-:-:^FDA 包装说明书:叙述型	4182948
1175273	Abd; Abdo; Abdomen+; Abdominal; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Point in time; Pyelogram; Rad; Radiology; Random; Renal	4180186
1175273	CT Guided Kidney-L Ablation	4180186
1175273	旨在组织切除术的引导:发现:时间点:腹部>肾脏.左侧:文档型:CT	4182948
1175274	Clin Pharm; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Pharmacy; Point in time; Random; Visit note	4180186
1175274	Clin Pharm Procedure note	4180186
1175274	操作记录:发现:时间点:{环境}:文档型:临床药理学	4182948
1175275	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorg prel grow det pnl; Microorganisms; Org; Organism; Organisms; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random	4180186
1175275	Microorg prel grow det pnl Fld Cult	4180186
1175275	微生物初步生长情况检测组套:-:时间点:体液:-:培养	4182948
1175277	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175278	Bind; EIA; ELFA; ELISA; Endocrine; Endocrinology; Enzyme immunoassay; GH; GHBP; Growth hormone; HGH; Human growth hormone; Human growth hormone binding protein; IAA; Level; Mass concentration; MEIA; Pl; Plasma; Plsm; Point in time; PR; Prot; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Somatotropic hormone; SR; STH; SUDS	4180186
1175278	GHBP SerPl IA-mCnc	4180186
1175278	生长激素结合蛋白:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175279	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL5; LDL5c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175279	LDL5c SerPl-mCnc	4180186
1175279	胆固醇.LDL 5 之中的:质量浓度:时间点:血清/血浆:定量型	4182948
1175280	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Blood; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Pl; PlasBld; Plasma; Plsm; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175280	C burnet aroE SerPlBld Ql NAA+non-probe	4180186
1175280	贝氏柯克斯体 aroE 基因:存在情况或阈值:时间点:血清/血浆/全血:序数型:非探针法.基因扩增.靶向	4182948
1175282	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; Transrectal absc drainage	4180186
1175282	CT Guided Pelvis Transrect Absc drainage	4180186
1175282	旨在经直肠脓肿引流的引导:发现:时间点:盆腔:文档型:CT	4182948
1175283	Preliminary positive lab results Pop	4180186
1175283	Cnt; Count; Number; Point in time; Pos; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175283	存在初步阳性实验室结果的人员:数量(计数):时间点:^人群:定量型	4182948
1175284	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; Joint aspirate; Joint fld; Joint flu; Joint fluid; K kingae; K kingella; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Moraxella kingae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; SDA; SF; SNV; Strand Displacement Amplification; Syn; Syn fl; Synov; Synovial fluid; TMA; Transcription mediated amplification	4180186
1175284	K kingae DNA Snv Ql NAA+probe	4180186
1175284	金氏金菌 DNA:存在情况或阈值:时间点:滑液:序数型:探针法.基因扩增.靶向	4182948
1175285	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175287	HEDIS 2019-20 Chlamydia	4180186
1175287	Chlam; Chlamid; HEDIS 2019-20 Chlamydia; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175287	HEDIS 2019 取值集合 - 衣原体检验项目:-:时间点:^患者:-	4182948
1175290	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Visit note	4180186
1175290	咨询记录:发现:时间点:{环境}:文档型:临床遗传学	4182948
1175293	AF; Amn; Amn fl; Amn/CVS; Amnio; Amniotic flu; Amniotic fluid; Beta globulin gene; Beta thalessemia; beta-globin; CD113t-C; Chorionic villi; Chorionic villus sample; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Genetics; Gyn; Gynecology; Hemoglobin beta chain; Hemoglobin S gene; hemoglobin, beta; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Mut; Mutations; Next generation sequencing; NGS; OB; ObGyn; Obstetrics; Point in time; Random; sequencing of entire coding region; Sickle cell anemia	4180186
1175293	HBB gene Full Mut Anl Amn/CVS Seq	4180186
1175293	HBB 基因 全面突变分析:发现:时间点:羊水/绒毛膜绒毛样本:文档型:序列测定	4182948
1175299	Dentist; Dentistry Attend; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175299	Dentistry Attend Note	4180186
1175299	记录:发现:时间点:{环境}:文档型:牙科学.主治	4182948
1175300	A1; AFP; AFP Pnl; Alfa; Alpha fetoprotein; Alphafetoprotein; EIA; ELFA; ELISA; Enzyme immunoassay; Feto; i; IAA; Liver cancer Ab + AFP; Liver cancer Ab + AFP pnl; Maternal screen; Maternal screen 1; Maternal screen for neural tube defect; MEIA; msAFP; Pan; PANEL.SEROLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; Single marker screen; SR; SUDS; Tumor marker	4180186
1175300	Liver cancer Ab + AFP pnl SerPl IA	4180186
1175300	肝癌抗体类与 Alpha-1-胎儿球蛋白组套:-:时间点:血清/血浆:-:免疫测定法	4182948
1175301	BIFL; Bile fluid; Biliary fluid; Gie Stn; GMS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175301	Gie Stn Bifl	4180186
1175301	显微镜观察:存在与否或特征标识:时间点:胆汁:名义型:姬姆萨染色法	4182948
1175302	EM plan approver name; Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
1175303	Anaer cult+Abx neut; Anaero; Anaerobe; Anaerobe Cult; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175303	Microorg prel Bld Ql Anaer cult + neut	4180186
1175303	微生物初步生长情况:存在情况或阈值:时间点:全血:序数型:厌氧培养+抗微生物药物中和剂	4182948
1175304	ADMIN; Nominal; Person name; Persons; Point in time; Random	4180186
1175304	被指派任务的人员:人员姓名:时间点:工作人员:名义型	4182948
1175305	1 week; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175306	Anaero; Anaerobe; Anaerobe Cult; Blood; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood	4180186
1175306	Microorg prel grow Bld Ql Anaerobe Cult	4180186
1175306	微生物初步生长情况:存在情况或阈值:时间点:全血:序数型:厌氧微生物培养	4182948
1175308	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Norovirus 2; Norovirus G2; Norovirus GII; Norwalk virus; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Regurgitation; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Vom; Vomitus	4180186
1175308	Norovirus GII RNA Vom Ql NAA+probe	4180186
1175308	诺如病毒基因群 II RNA:存在情况或阈值:时间点:呕吐物:序数型:探针法.基因扩增.靶向	4182948
1175310	LGI1 Ab CSF Ql CBA IFA	4180186
1175310	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; i; Indirect Fluorescence Antibody; Leu; LGI1; LGI1 Ab; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175310	富亮氨酸胶质瘤失活蛋白 1 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175311	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175313	1 week; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175315	Event activate or deactivate; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.CDC; Typ	4180186
1175317	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175318	FDA insert Clinical trials exp section	4180186
1175318	Clinical trials exp section; DOCUMENT.REF; FDA insert; Narrative; Report; SPL; Structured Product Labelling	4180186
1175318	临床试验经验小节:-:-:^FDA 包装说明书:叙述型	4182948
1175320	Addiction; B/F; BEC; BEG; Benz; Benzoylec; Benzoylmethylecgonine; BF; bod; Bodies; Body fluid; Body fluid, unsp; BZE; Cocaine degradation production; Cocaine metabolite; Cocaine+BZE; Coke; Crack; Crack metabolite; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ecgonine methyl ester benzoate; Fl; Fld; FLU; Fluid; Illicit; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Snow	4180186
1175320	Cocaine+BZE Fld Ql Scn	4180186
1175320	可卡因+苯甲酰芽子碱:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175322	Finding; Findings; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Sx; Symptoms incident or outbreak	4180186
1175322	Symptoms incident or outbreak Pop	4180186
1175322	与事件或爆发相关的症状:发现:时间点:^人群:名义型	4182948
1175325	Calc; Calculation; Dental; Dentistry; Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Teeth+gum	4180186
1175325	Malocclusion index Score Teeth+gum Calc	4180186
1175325	错位咬合指数:评分:时间点:牙齿与牙龈:定量型:计算法	4182948
1175327	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Ileum-L; Imaging; L; LT; Perc; Point in time; Rad; RADIOLOGY; Random	4180186
1175327	CT Guided Ileum-L Cyst asp	4180186
1175327	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>回肠.左侧:文档型:CT	4182948
1175328	Etiology of a PH emergency	4180186
1175328	Etiology of a PH emergency; Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175328	公共卫生突发事件发生原因:类型:时间点:^事件:名义型	4182948
1175331	Inhalant Allerg Mix 6 IgE Ql	4180186
1175331	3gAllergy IP6; ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Allerscan; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C herbarum; Common silver birch; g006; g6; Hormodendrum; IFR; Immune globulin E; Immunoglobulin E; Inhalant Allerg Mix 6; IP6; Isoflavone reductase; m002; m2; Mugwort; Ordinal; Phleum pretense; Point in time; PR; QL; Qual; Qualitative; Random; rx6; Screen; Serum; Siemens IP6; Silver Birch; SR; t3; Timothy; Timothy grass; w006; w6	4180186
1175331	(草地梯牧草+北艾+多主枝孢+细链格孢+白桦) 抗体.IgE:存在情况或阈值:时间点:血清:序数型:Multidisk 法	4182948
1175335	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Genital warts; Gentyp; HPV; Human papillomavirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175335	HPV Gentyp Tiss NAA+probe	4180186
1175335	人乳头瘤病毒 基因型:存在与否或特征标识:时间点:组织与涂片:名义型:探针法.基因扩增.靶向	4182948
1175339	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Podiatry Attend; Point in time; Random; Visit note	4180186
1175339	Podiatry Attend Note	4180186
1175339	记录:发现:时间点:{环境}:文档型:足病学.主治	4182948
1175340	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175344	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1175344	Mycoplasma suis DNA Ct Spec Qn NAA+probe	4180186
1175344	猪支原体 DNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175347	Incident commander email	4180186
1175347	ADMIN; Nominal; Point in time; Random	4180186
1175347	意外事件指挥人员电子邮件地址:电子邮件地址:时间点:工作人员:名义型	4182948
1175349	Cardiac surg Team Conf eval note	4180186
1175349	Cardiac surg Team; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Surg; Visit note	4180186
1175349	会议记录:发现:时间点:{环境}:文档型:心脏外科学.团队	4182948
1175350	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175354	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; MeV; Microbiology; Msls; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Rubeola; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175354	MeV RNA Lower resp Ql NAA+probe	4180186
1175354	麻疹病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
1175355	Amount beef, pork, tuna, salmon eaten	4180186
1175355	Amount beef, pork, tuna, salmon eaten; Bos spp; f026; f027; f26; f27; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Past; Pig; Point in time; Porcine; QL; Qual; Qualitative; Random; Screen; Sus spp; Swine	4180186
1175355	在最近一次您吃任何东西时所进食的牛肉、猪肉、金枪鱼肉或鲑鱼肉的数量:发现:时间点:^患者:序数型	4182948
1175360	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; II; Level; Mass concentration; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; ST2.soluble; SUDS	4180186
1175360	ST2.soluble Ser IA-mCnc	4180186
1175360	致瘤性抑制因子 2.可溶性:质量浓度:时间点:血清:定量型:免疫测定法	4182948
1175363	Aerobe; Aerobe Cult; Aerobed; Bact; C&S; Cult; Cultures; Ejaculate; Genitourinary; GU; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random; Sem; Seminal fluid; Smn; SMPLS; URO; Urology	4180186
1175363	Bacteria Smn Aerobe Cult	4180186
1175363	细菌 已鉴定的:存在与否或特征标识:时间点:精液:名义型:需氧微生物培养	4182948
1175365	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Myco; Mycobact; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec; species; spp; Tuberculosis	4180186
1175365	Mycobacterium Lower resp Cult	4180186
1175365	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
1175367	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175369	Average; Avg; Count/time; Dextro; nRate; Number rate; Number Rate = Count/Time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Report period	4180186
1175369	New cases per D RptPeriod Mean nRate	4180186
1175369	每天的新发案件:计数型速率:报告期^平均值:^事件:定量型	4182948
1175370	Anaero; Anaerobe; Anaerobe Cult; Bact; C&S; Cath Tip; Catheter tip; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Point in time; Random	4180186
1175370	Bacteria Cath Tip Anaerobe Cult	4180186
1175370	细菌 已鉴定的:存在与否或特征标识:时间点:尿液管尖端:名义型:厌氧微生物培养	4182948
1175372	Cnt; Count; Dental; Dentistry; Number; Point in time; QNT; Quan; Quant; Quantitative; Random; Teeth+gum	4180186
1175372	Closed-spaced teeth	4180186
1175372	闭合间隙牙齿:数量(计数):时间点:牙齿与牙龈:定量型	4182948
1175377	Nuc Medicine Procedure note	4180186
1175377	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175377	操作记录:发现:时间点:{环境}:文档型:核医学	4182948
1175380	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175385	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175389	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175390	Bx; CAT scan; Computed tomography; Computerized tomography; CT scan; Deep Bx; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; XXX.tiss	4180186
1175390	CT Guided Tiss Deep Bx	4180186
1175390	旨在深部活组织检查的引导:发现:时间点:XXX>组织:文档型:CT	4182948
1175391	4 weeks; Cnc; Conc; Finding; Findings; Hard to concentrate in school; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175392	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Giardiasis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; species; spp; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175392	Giardia DNA Stl Ql NAA+probe	4180186
1175392	贾第鞭毛虫属单个未知种 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
1175393	Date and time; DOC.MISC; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175393	下一份报告到期日期:时间戳:时间点:报告:定量型	4182948
1175395	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Local; NDL; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine	4180186
1175395	CT Guided T-spine Needle loc	4180186
1175395	旨在针定位的引导:发现:时间点:胸部>脊椎.胸段:文档型:CT	4182948
1175400	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175403	4 weeks; Finding; Findings; FR; Last; Non-protein bound; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175404	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175407	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Mlk; Nominal; Point in time; Random; St; Stains; Stn	4180186
1175407	Acid fast Stn Mlk	4180186
1175407	显微镜观察:存在与否或特征标识:时间点:乳:名义型:抗酸染色法	4182948
1175411	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175413	Addiction; Cannabinoid; Delta-9-tetrahydrocannabinol; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Marijuana; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; THC; Tissue; Tissue, unspecified	4180186
1175413	Cannabinoids Tiss Ql Scn	4180186
1175413	大麻类:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验	4182948
1175414	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175416	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Multi-spec prog; Multi-spec prog SW; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175416	Multi-spec prog SW Note	4180186
1175416	记录:发现:时间点:{环境}:文档型:多专业计划.社会工作者	4182948
1175420	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175422	Activ; Actvty; Average; Avg; Point in time; Polyethylene Glycol; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PEG	4180186
1175426	CD3 Cells/lymph NFr Bld	4180186
1175426	Blood; CD3 Cells; Cell; CELL MARKERS; Cellularity; Leu4; Leu-4; Lymp; Lymph; Lympho; Lymphocyte; Lymphs; Lymphs%; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; T3; WB; Whole blood	4180186
1175426	细胞.CD3/100 个淋巴细胞:计数型分数:时间点:全血:定量型	4182948
1175428	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175429	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175430	7OH-chlorpromazine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175430	7OH-chlorpromazine Ur Cfm-mCnc	4180186
1175430	7-羟基氯丙嗪:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175431	Globotriaosylsphingosine SerPl-mCnc	4180186
1175431	Chemistry; Fabry disease; Globotriaosyl lysosphingolipid; Level; LGb3; Lysogb3; Lyso-Gb3; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175431	三聚己糖神经鞘氨醇:质量浓度:时间点:血清/血浆:定量型	4182948
1175434	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175435	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175441	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175445	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 7.5:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175445	NK cyto IL2 7.5:1 E:T/Pos cntrl Bld MC	4180186
1175445	自然杀伤细胞细胞毒性.IL-2 刺激型 效应细胞/靶细胞比 7.5:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
1175446	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175449	死亡人数:数量(计数):时间点:^事件:定量型	4182948
1175449	Cnt; Count; Fatalities; Number; Point in time; Public Health; PUBLICHEALTH; QNT; Quan; Quant; Quantitative; Random	4180186
1175449	Total event-associated deaths #	4180186
1175450	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175451	Dis; Diseases; Dz; Finding; Findings; Levels; Levl; LV; LVL; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.GNHLTH	4180186
1175452	Monoclonal gammopathy Pnl SerPl	4180186
1175452	Chemistry; Monoclonal gammopathy Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175452	单克隆丙球蛋白病组套:-:时间点:血清/血浆:-	4182948
1175453	AQP4 H2O channel IgG CSF Ql CBA IFA	4180186
1175453	ABS; Aby; Antby; Anti; Antibodies; Antibody; AQP4; AQP4 H2O channel; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Devic's disease; Immune globulin G; Immunoglobulin G; Indirect Fluorescence Antibody; Neuromyelitis optica; NMO; NMO spectrum disorders; NMOSD; Opticospinal multiple sclerosis; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Water channel aquaporin-4	4180186
1175453	水通道蛋白 4 受体 抗体.IgG:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175456	Aerobe; Aerobe Cult; Aerobed; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes	4180186
1175456	Bacteria Plts BPU Aerobe Cult	4180186
1175456	细菌 已鉴定的:存在与否或特征标识:时间点:血小板^血液制品单位:名义型:需氧微生物培养	4182948
1175457	沙眼衣原体与淋病奈瑟菌 rRNA 组套:-:时间点:肛门直肠:-:探针法.基因扩增.靶向	4182948
1175457	C trach+GC pnl Anorectl NAA+probe	4180186
1175457	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Anorectl; C trac; C trach; C trach+GC; C trach+GC pnl; C tracho; C trachomatis; Chlam; Chlam trac; Chlamid; CT; CT/GC; DNA NUCLEIC ACID PROBE; DNA probe; GC; Gen-Probe; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; LAT; LCR; LGV; Ligase chain reaction; Ligation-activated transcription; Lymphogranuloma venereum; Microbiology; N gonorrhoea; N gonorrhoeae; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Rectum; ribosomal RNA; SDA; Strand Displacement Amplification; TMA; Trachoma; Transcription mediated amplification	4180186
1175458	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175459	Est date next emerg resp plan	4180186
1175459	DOC.MISC; Est date next emerg resp plan; MISC; Point in time; QNT; Quan; Quant; Quantitative; Random	4180186
1175459	紧急响应方案新版本预计发布日期:日期:时间点:文档:定量型	4182948
1175460	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175464	Absorp; c99; CHEMISTRY.CHALLENGE TESTING; Levothyroxine absorption pnl; L-thyroxine; Pan; PANEL.CHALLENGE; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175464	Levothyroxine absorption pnl SerPl	4180186
1175464	左旋甲状腺素吸收组套:-:时间点:血清/血浆:定量型	4182948
1175467	Inter-agency communication doc type; Nominal; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random; Typ	4180186
1175467	Inter-agency communication doc type	4180186
1175467	机构间通信文件类型:类型:时间点:文档:名义型	4182948
1175468	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175471	Arm; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-L; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; L; LT; LUE; MSK; Musculoskeletal; Ortho; Orthopedics; PC fluid asp; Perc; Point in time; Rad; Radiology; Random; Should-L; UE; UE-L; Up; Upper extremity joint	4180186
1175471	CT Guided Should-L Arthrocentesis	4180186
1175471	旨在经皮穿刺抽吸的引导:发现:时间点:上肢.左侧>肩部:文档型:CT	4182948
1175475	Wound care management Prog note	4180186
1175475	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175475	病程记录:发现:时间点:{环境}:文档型:伤口护理管理	4182948
1175477	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pancr; Pancreatc; Pancreatic; Perc; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
1175477	CT Guided Pancreas Bx--W contr IV	4180186
1175477	旨在经皮活组织检查的引导^采用静脉注射对比剂:发现:时间点:腹部>胰:文档型:CT	4182948
1175478	Vilaz Ur Cfm-mCnc	4180186
1175478	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; Viibryd	4180186
1175478	维拉佐酮:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175479	1 week; Dextro; Finding; Findings; Fld; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175481	Bdy surface; bod; Bodies; BSA; Lung; O2; O2 delivery; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Surf; tO2; Volume rate/area; Volume Rate/Ratio	4180186
1175481	O2 delivery/BSA ArVRat	4180186
1175481	氧气供给/体表面积:单位面积体积速率:时间点:^患者:定量型	4182948
1175482	病程记录:发现:时间点:{环境}:文档型:药物基因组学	4182948
1175482	Pharmacogenomics Prog note	4180186
1175482	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175483	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175485	C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Misc; Miscellaneous; Nominal; Other; Point in time; Random; Spec; species; spp; To be specified in another part of the message; Unspecified	4180186
1175485	Acinetobacter Spec Cult	4180186
1175485	不动杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:微生物特异性培养	4182948
1175488	病程记录:发现:时间点:{环境}:文档型:心力衰竭	4182948
1175488	Heart failure Prog note	4180186
1175488	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; Heart function; notes; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175490	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175493	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175494	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175496	EM plan purpose; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175498	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175499	Abd; Abdo; Abdomen+; Abdominal; c; CAT scan; Cath; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Drain; Drain+cath place; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Removal of fluid; without contrast	4180186
1175499	CT Guided Abd Drain+cath place--WO contr	4180186
1175499	旨在引流+引流导管置入的引导^不采用对比剂:发现:时间点:腹部:文档型:CT	4182948
1175500	Ang; Angio; Angiography; Angm; Arm; Arm and hand vessels; Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT Angiogram; CT angiography; CT scan; CTA; Document; EXT; Extr ves; Extr-Bl; Finding; Findings; Imaging; Point in time; Rad; Radiology; Random; UE; UE ves; UE ves-Bl; UE-Bl; Up; Vesl; Vessels.XXX; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175500	CTA UE ves-Bl WO+W contr IV	4180186
1175500	多层^不采用 & 采用静脉注射对比剂:发现:时间点:上肢.双侧>上肢血管类:文档型:CT.血管造影术	4182948
1175504	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175505	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Gen-Probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175505	Fungal 18s rRNA gene L. Resp Ql NAA+probe	4180186
1175505	真菌 18s rRNA 基因:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
1175507	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175508	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.PROMIS	4180186
1175510	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175511	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Kidney-L; L; LT; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; RADIOLOGY; Random; Renal	4180186
1175511	CT Guided Kidney-L Cyst asp	4180186
1175511	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>肾脏.左侧:文档型:CT	4182948
1175512	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175514	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175515	Point in time; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1175516	Dental; Dentistry; Nominal; Point in time; Random; Typ	4180186
1175516	Severe traumatic deviations	4180186
1175516	影响正畸治疗情况的严重创伤性偏斜:类型:时间点:^患者:名义型	4182948
1175519	Document; Finding; Findings; Point in time; Public Health; Public Health Documents; PUBLICHEALTH; Random	4180186
1175519	Event Inter-agency communication doc	4180186
1175519	跨机构通讯文档:发现:时间点:^事件:文档型	4182948
1175522	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175526	Chemistry; Cl; Clear; Clearanc; Clearances; Clr; GFR; Iothal clear; Iothal clear Pnl; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn	4180186
1175526	Iothal clear Pnl Ur+SerPl	4180186
1175526	碘酞酸盐清除率组套:-:时间点:尿液+血清/血浆:-	4182948
1175528	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
1175528	Fungal ITS region Derm spec Ql NAA+probe	4180186
1175528	真菌内转录间隔区:存在情况或阈值:时间点:毛发/指或趾甲/皮肤:序数型:探针法.基因扩增.靶向	4182948
1175529	TPMT RBC production 6-MMP riboside-cCnc	4180186
1175529	Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MMP; production of 6-MMP riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
1175529	硫嘌呤甲基转移酶:催化浓度:时间点:红细胞:定量型:6-甲基巯基嘌呤核苷生成法	4182948
1175530	BON; Brain; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; Cranial; Cranium; CT scan; Document; Finding; Findings; Imaging; Intracranial; L; LT; Point in time; Rad; RADIOLOGY; Random; Skull; Temporal bone-L; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175530	CT Temporal bone-L WO+W contr IV	4180186
1175530	多层^不采用 & 采用静脉注射对比剂:发现:时间点:头部>颞骨.左侧:文档型:CT	4182948
1175533	Anaero; Anaerobe; Anaerobe Cult; Bact; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Nominal; Platelet; Plt; Plts; Point in time; Random; Thrb; Thrombocyte; Thrombocytes	4180186
1175533	Bacteria Plts BPU Anaerobe Cult	4180186
1175533	细菌 已鉴定的:存在与否或特征标识:时间点:血小板^血液制品单位:名义型:厌氧微生物培养	4182948
1175535	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175536	Encounter certificate	4180186
1175536	Admission certificate; DOC.ONT; Document; Finding; Findings; Point in time; Proof of visit; Random	4180186
1175536	就医证明类证据文件:发现:时间点:{环境}:文档型:{角色}	4182948
1175538	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175539	病程记录:发现:时间点:{环境}:文档型:妇科肿瘤学	4182948
1175539	Cancer; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Gyn Onc; notes; Oncology; Point in time; Prog note; Random; subsequent evaluation; subsequent visit evaluation; Visit note	4180186
1175539	Gyn Onc Prog note	4180186
1175540	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175541	D/T of event response status; Date and time; Date+time; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.CDC; Time stamp; Timestamp	4180186
1175545	Ident; Identifier; Nominal; Point in time; Public Health; PUBLICHEALTH; Random	4180186
1175545	对策名称:标识符:时间点:^事件:名义型	4182948
1175552	Cogn func; cognition; cognitive status; FCN; Func; Funct; Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175553	Vedol + Vedol Ab Pnl SerPl-mCnc	4180186
1175553	DRUG/TOXICOLOGY; Drugs; Entyvio; Level; Mass concentration; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Vedol; Vedolizumab + Vedolizumab Ab Pnl; VEMAB	4180186
1175553	维多珠单抗与维多珠单抗抗体组套:质量浓度:时间点:血清/血浆:定量型	4182948
1175555	Preg prevention intention Reported	4180186
1175555	Finding; Findings; Gestation; Gestations; Gravida; H+P; H+P.HX; Ordinal; P prime; Point in time; Preg prevention intention; Pregnancies; QL; Qual; Qualitative; Random; Screen	4180186
1175555	妊娠预防意愿:发现:时间点:^患者:序数型:报告法	4182948
1175556	inFLIXimab Ab Ser IA-aCnc	4180186
1175556	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Remicade; Serology; Serum; SR; SUDS	4180186
1175556	英利昔单抗 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
1175557	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175558	Palliative care SW LTC fac Note	4180186
1175558	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; LTC fac; LTCF; notes; Palliative care SW; Point in time; Random; Social work; SW; Visit note	4180186
1175558	记录:发现:时间点:长期医疗服务设施:文档型:缓和照顾.社会工作者	4182948
1175559	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; C diphtheriae; C diphtheriae Tox; Diphtheria; Diptheria; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; SUDS	4180186
1175559	C diphtheriae Tox IgG Ser Ql IA	4180186
1175559	白喉棒状杆菌毒素 抗体.IgG:存在情况或阈值:时间点:血清:序数型:免疫测定法	4182948
1175562	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C burnet; C burnet aroE; C burnetii; Coxiella burnettii; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Q fev; Q fever; QBR; Qfever; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175562	C burnet aroE Tiss Ql NAA+non-probe	4180186
1175562	贝氏柯克斯体 aroE 基因:存在情况或阈值:时间点:组织与涂片:序数型:非探针法.基因扩增.靶向	4182948
1175563	Chemistry; EIA; ELFA; ELISA; Enzyme immunoassay; i; IAA; Level; Mass concentration; MEIA; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; PTH; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175563	Parathyrin.1-84 SerPl IA-mCnc	4180186
1175563	甲状旁腺素.1-84:质量浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175564	4h p levo; After; c99; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Level; Levothyroxine; Levo-thyroxine; L-thyroxine; Mass concentration; p dose; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; T4; T-4; thyroid hormone; Thyrox; Thyroxin; Thyrx; Total T4; TT4	4180186
1175564	T4 4h p levo SerPl-mCnc	4180186
1175564	甲状腺素^在剂量左旋甲状腺素之后4小时:质量浓度:时间点:血清/血浆:定量型	4182948
1175565	100 CD19 cells; B Cells; B cells expressing CD19 as a percent of total lymphocytes; B4; B-4; Blood; CD19 Cells; Cell; CELL MARKERS; Cellularity; HD-37; Leu12; Leu-12; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; TACI cells; Transmembrane activator and calcium modulator and cyclophilin ligand interactor; WB; Whole blood	4180186
1175565	TACI cells/100 CD19 cells NFr Bld	4180186
1175565	细胞.TACI/100 个细胞.CD19:计数型分数:时间点:全血:定量型	4182948
1175567	PESI score interp PESI	4180186
1175567	CLIN; CLIN.RISK; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; PESI score interp; Point in time; Pulm; Pulmonary Function Test; QL; Qual; Qualitative; Random; Screen	4180186
1175567	肺栓塞严重程度指数评分解释:印象:时间点:^患者:序数型:PESI 法	4182948
1175568	Arm; Bil; Bilat; Both; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; Rad; RADIOLOGY; Random; Shoulder-Bl; UE; UE-Bl; Up; Upper extremity joint	4180186
1175568	CT Guided Shoulder-Bl Inj	4180186
1175568	旨在注射的引导:发现:时间点:上肢.双侧>肩部:文档型:CT	4182948
1175570	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Started; Survey; SURVEY.PROMIS	4180186
1175572	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Peds; Point in time; Random; Telemedicine; Visit note	4180186
1175572	Peds Telehealth Note	4180186
1175572	记录:发现:时间点:远程医疗:文档型:儿科学	4182948
1175574	Thromboemb Team Conf eval note	4180186
1175574	Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Thromboemb Team; Visit note	4180186
1175574	会议记录:发现:时间点:{环境}:文档型:血栓栓塞.团队	4182948
1175576	Anaplastic lymphoma kinase (Ki-1); Blood; DNA; Document; Finding; Findings; gene fusion; gene translocation; Genetics; Heredity; Heritable; II; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.TRANSLOCATION; NPM; Nucleolar phosphoprotein b23; Numatrin; PCR; Point in time; Random; RNA; T prime; t(2,5)(ALK,NPM1) gene translocation; t(2;5)(ALK,NPM1); Tissue; Tissue, unspecified; translocation; WB; Whole blood; Whole blood or Tissue	4180186
1175576	t(2;5)(ALK,NPM1) Bld/T	4180186
1175576	t(2;5)(p23;q35.1)(ALK,NPM1) 融合转录物:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1175577	HEDIS 2019-20 PSA Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175577	HEDIS 2019-20 PSA Tests	4180186
1175577	HEDIS 2019 取值集合 - PSA 检验项目:-:时间点:^患者:-	4182948
1175578	Addiction; Amphepramone; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; Diethylprop; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; Tenuate; WB; Whole blood	4180186
1175578	Diethylpropion SerPlBld Cfm-mCnc	4180186
1175578	二乙胺苯丙酮:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
1175580	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175581	DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175581	Vortioxetine SerPl-mCnc	4180186
1175581	沃替西汀:质量浓度:时间点:血清/血浆:定量型	4182948
1175583	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175584	Cnt; Count; Lung; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175584	Num mixed apnea	4180186
1175584	混合性呼吸暂停:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175585	SF IgG+IgM Pnl Titr Ser	4180186
1175585	斑点热群立克次体抗体.IgG 与 IgM 组套:滴定度:时间点:血清:定量型	4182948
1175585	Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Rick SF; Ricket; Rickettsial; Serum; SF IgG+IgM Pnl; SmQn; SR; Titer; Titered; Titre; Ttr	4180186
1175586	Vortioxetine Ur Ql Scn	4180186
1175586	DRUG/TOXICOLOGY; Drugs; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; UA; UR; Urn	4180186
1175586	沃替西汀:存在情况或阈值:时间点:尿液:序数型:毒理学筛查试验	4182948
1175587	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Orthopedic; Orthopedic surgery; Point in time; Random; Surg; Telemedicine; Visit note	4180186
1175587	记录:发现:时间点:远程医疗:文档型:矫形外科学	4182948
1175588	Finding; Findings; II; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175592	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; Point in time; promise; Random; Survey; SURVEY.PROMIS	4180186
1175594	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175599	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175602	Neo peri med OP Note	4180186
1175602	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Neo peri med; notes; OP; Point in time; Random; Visit note	4180186
1175602	记录:发现:时间点:门诊病人:文档型:新生儿围产医学	4182948
1175603	Count/time; Lung; nRate; Number rate; Number Rate = Count/Time; O2; O2 desaturation; O2 desaturation index; ODI; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies; tO2	4180186
1175603	O2 desaturation index nRate	4180186
1175603	血氧饱和度降低指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175605	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Aspirate; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175605	HSV1 DNA Aspirate Ql NAA+probe	4180186
1175605	单纯疱疹病毒 1 型 DNA:存在情况或阈值:时间点:吸出物:序数型:探针法.基因扩增.靶向	4182948
1175606	HEDIS 2019 Value Set - Ser K; k; K+; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Potass; Random; Ser; SR	4180186
1175606	HEDIS 2019 Value Set - Ser K	4180186
1175606	HEDIS 2019 取值集合 - 血清钾:-:时间点:^患者:-	4182948
1175607	4 weeks; Arterial Stenosis; Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175611	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B quintana; Cat Scratch Disease; Cat Scratch Fever; CSD; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Implnt dev; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Prostheses; Prosthesis; Prosthetic; QBR; QL; Qual; Qualitative; R quintana; Random; Rochalimae quintana; Rochalimaea quintana; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Trench fever	4180186
1175611	B quintana DNA Implnt dev Ql NAA+probe	4180186
1175611	五日热巴通体 DNA:存在情况或阈值:时间点:植入装置:序数型:探针法.基因扩增.靶向	4182948
1175612	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175613	TPMT RBC production 6-MTG riboside-cCnc	4180186
1175613	Catalytic Concentration; Chemistry; Erythrocytes; Methyl transferase; Point in time; production of 6-MTG riboside; QNT; Quan; Quant; Quantitative; Random; Red blood cells; Red blood corpusles; TPMT	4180186
1175613	硫嘌呤甲基转移酶:催化浓度:时间点:红细胞:定量型:6-甲基硫鸟嘌呤核苷生成法	4182948
1175614	Assessment; Clinical encounter note; DOC.ONT; Document; E/M note; Encounter; Eval; Evaluation and management; Evaluation and management note; Finding; Findings; H&P; History and physical; notes; Nuc med; Nuc Medicine; Point in time; Pre-Op; Pre-op note; Pre-Operative; Random; Visit note	4180186
1175614	Nuc Medicine Pre-op note	4180186
1175614	术前评价与管理记录:发现:时间点:{环境}:文档型:核医学	4182948
1175615	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175619	ADCC; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175619	SW ADCC Note	4180186
1175619	记录:发现:时间点:成人日间照护中心:文档型:社会工作者	4182948
1175621	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175622	1 month; 1 month (30 days); 30 days; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175623	Date of confinement; Deliv date; Due date; EDC; EDD; Est; Est from PE; estimation; Gyn; Gynecology; OB; ObGyn; OBSTERICAL; OBSTERICAL.ULTRASOUND; Obstetrical; Obstetrics; PEA; Point in time; predicted; QNT; Quan; Quant; Quantitative; Random	4180186
1175623	Deliv date Est from PE	4180186
1175623	分娩日期:日期:时间点:^患者:定量型:体格检查估计法	4182948
1175625	Breathing; Count/time; Lung; Lungs; nRate; Number rate; Number Rate = Count/Time; Point in time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Random; Respiratory; Respiratory rate; RS	4180186
1175625	Breaths.spontaneous	4180186
1175625	呼吸.自主:计数型速率:时间点:呼吸系统:定量型	4182948
1175626	Aerobe; Aerobe Cult; Aerobed; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen	4180186
1175626	Microorg prel grow Fld Ql Aerobe Cult	4180186
1175626	微生物初步生长情况:存在情况或阈值:时间点:体液:序数型:需氧微生物培养	4182948
1175628	DRUG/TOXICOLOGY; Drugs; Lanzek; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zypadhera; Zyprexa	4180186
1175628	OLANZapine SerPl Ql Scn	4180186
1175628	奥氮平:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
1175629	Drugs of abuse Pnl Hair	4180186
1175629	DAU; Drug; DRUG/TOXICOLOGY; Drugs; Drugs of abuse Pnl; Har; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random	4180186
1175629	滥用药物组套:-:时间点:毛发:-	4182948
1175630	Abd; Abd.reper; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Point in time; Rad; RADIOLOGY; Random; Retroperitoneal; W contr IV; WC	4180186
1175630	CT Guided Retroperitoneum Bx--W contr IV	4180186
1175630	旨在活组织检查的引导^采用静脉注射对比剂:发现:时间点:腹部>腹膜后腔:文档型:CT	4182948
1175631	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175632	Abd; Abdo; Abdomen+; Abdominal; Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Cyst asp; Document; Finding; Findings; Guid; Guide; Guided; Ileum-R; Imaging; Perc; Point in time; R; Rad; RADIOLOGY; Random; RT	4180186
1175632	CT Guided Ileum-R Cyst asp	4180186
1175632	旨在经皮囊肿抽吸的引导:发现:时间点:腹部>回肠.右侧:文档型:CT	4182948
1175637	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; ZIKV	4180186
1175637	ZIKV IgG SerPl Ql IA	4180186
1175637	寨卡病毒 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法	4182948
1175642	Count/time; Freq DHEA, A4 or hGH in past Y; gamma-4-Androstenedione; H+P; H+P.HX; Horm; Last; Musc; Muscl; nRate; Number rate; Number Rate = Count/Time; Ordinal; P prime; QL; Qual; Qualitative; Screen	4180186
1175642	Freq DHEA, A4 or hGH in past Y	4180186
1175642	去年为改善肌肉量或力量而使用脱氢表雄酮、雄烯二酮或人生长激素的频率:计数型速率:1年:^患者:序数型	4182948
1175645	Adalimumab Ab Ser IA-aCnc	4180186
1175645	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Humira; IAA; MEIA; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; Serum; SR; SUDS	4180186
1175645	阿达木单抗 抗体:任意型浓度:时间点:血清:定量型:免疫测定法	4182948
1175646	AMCBX2; Blood; CGD; CYBB full + NCF1 c.75_76delGT; CYBB gene full + NCF1 gene; cytochrome b-245, beta polypeptide; Cytochrome b-245, beta polypeptide (chronic granulomatous disease); Document; Finding; Findings; Genetics; GP91-1; GP91PHOX; GP91-PHOX; Heredity; Heritable; IMD34; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; NCF-1; NCF1A; NCF-47K; neutrophil cytosolic factor 1; Neutrophil cytosolic factor 1, (chronic granulomatous disease, autosomal 1); NOX2; NOXO2; p47phox; p91-PHOX; PCR; Point in time; Random; SH3PXD1A; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175646	CYBB full + NCF1 c.75_76delGT Bld/T	4180186
1175646	CYBB 基因全面分析与 NCF1 基因 c.75_76delGT 分析:发现:时间点:全血/组织:文档型:分子遗传学类实验室方法	4182948
1175648	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175649	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; EXT; Extr-R; Finding; Findings; Imaging; LE; Leg; LE-R; Low; Mid ft-R; Mid+Fore ft-R; MSK; Musculoskeletal; Ortho; Orthopedics; Point in time; R; Rad; RADIOLOGY; Random; RLE; RT	4180186
1175649	CT Mid+Fore ft-R	4180186
1175649	多层:发现:时间点:下肢.右侧>足中部+足前部:文档型:CT	4182948
1175650	Dental; Dental abnormalities orthodontic care; Dentistry; Finding; Findings; Nominal; Point in time; Random; Teeth+gum	4180186
1175650	Dental abnormalities orthodontic care	4180186
1175650	影响正畸照护服务的牙齿畸形:发现:时间点:牙齿与牙龈:名义型	4182948
1175654	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified	4180186
1175654	CT Guided Tendon or ligament Inj	4180186
1175654	旨在注射的引导:发现:时间点:XXX>肌腱或韧带:文档型:CT	4182948
1175656	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Kidney; Nephrology; notes; Point in time; Random; Renal; Telemedicine; Visit note	4180186
1175656	记录:发现:时间点:远程医疗:文档型:肾病学	4182948
1175657	3 Self-Sustaining Sequence Replication; 3SR SR; A,B; Amplif; Amplification; Amplified; Avian influenza; Bird flu; DNA NUCLEIC ACID PROBE; DNA probe; FLUA; FLUAV; FLUAV + FLUBV; FLUAV + FLUBV Pnl; FLUAV+FLUBV; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Strand Displacement Amplification; Tissue; Tissue, unspecified; TMA; Transcription mediated amplification	4180186
1175657	FLUAV + FLUBV Pnl Tiss NAA+probe	4180186
1175657	流感病毒 A 与 B 型 RNA 组套:-:时间点:组织与涂片:-:探针法.基因扩增.靶向	4182948
1175662	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Dorsal spine; Finding; Findings; Guid; Guide; Guided; Imaging; Inj; Jnt; Point in time; Rad; RADIOLOGY; Random; Spinal; Spinal Cord; Th/sp; Thorax; T-spine; T-spine facet joint; Zygapophysial Joint	4180186
1175662	CT Guided T-spine facet joint Inj	4180186
1175662	旨在注射的引导:发现:时间点:胸部>脊椎.胸段小面关节:文档型:CT	4182948
1175663	A1; AFP; Alfa; Alpha fetoprotein; Alphafetoprotein; Feto; i; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Liver cancer Ab + AFP; Oncology; Ordinal; Pl; Plasma; Plsm; Point in time; QL; Qual; Qualitative; Random; Screen; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Tumor marker	4180186
1175663	Liver cancer Ab + AFP SerPl-Imp	4180186
1175663	肝癌抗体类与 Alpha-1-胎儿球蛋白:印象:时间点:血清/血浆:序数型	4182948
1175664	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175664	Clinical Neurophys Phone Note	4180186
1175664	记录:发现:时间点:电话就医:文档型:临床神经生理学	4182948
1175668	Asp; CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Fld; Guid; Guide; Guided; Imaging; L; LT; Lung; PC fluid asp; Perc; Pl space; Pl space-L; Point in time; Pulmonary; Pulmonology; Rad; Radiology; Random; Respiratory; Thoracentesis; Thorax; Thorocentesis	4180186
1175668	CT Guided Pl space-L PC fluid asp	4180186
1175668	旨在经皮穿刺抽吸的引导:发现:时间点:胸部>胸膜腔.左侧:文档型:CT	4182948
1175670	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Tissue; Tissue, unspecified	4180186
1175670	Methadone+metab Tiss Ql Scn	4180186
1175670	美沙酮+代谢产物:存在情况或阈值:时间点:组织与涂片:序数型:毒理学筛查试验	4182948
1175671	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175672	Mat fetal med Phone Note	4180186
1175672	记录:发现:时间点:电话就医:文档型:母胎医学	4182948
1175672	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Mat fetal med; notes; Point in time; Random; Visit note	4180186
1175675	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175675	操作记录:发现:时间点:{环境}:文档型:心脏外科学	4182948
1175676	Ident; Identifier; Nominal; Point in time; Random; Survey; SURVEY.CDC	4180186
1175679	Cardio; Cardiology; Conf eval note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175679	Cardiac surgery Conf eval note	4180186
1175679	会议记录:发现:时间点:{环境}:文档型:心脏外科学	4182948
1175680	C auris; C&S; Cand; Candidiasis; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; To be specified in another part of the message; Unspecified	4180186
1175680	C auris Spec Ql Cult	4180186
1175680	耳道假丝酵母菌:存在情况或阈值:时间点:XXX:序数型:微生物特异性培养	4182948
1175684	D/T lab result reported	4180186
1175684	D/T lab result reported; Date and time; Date+time; Lab orders; Point in time; QNT; Quan; Quant; Quantitative; Random; Time stamp; Timestamp	4180186
1175684	实验室结果报告日期和时间:时间戳:时间点:^患者:定量型	4182948
1175687	3 Self-Sustaining Sequence Replication; 3SR SR; American plague; Amplif; Amplification; Amplified; Blood; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood; yellow jack; YFV	4180186
1175687	YFV RNA Bld Ql NAA+probe	4180186
1175687	黄热病病毒 RNA:存在情况或阈值:时间点:全血:序数型:探针法.基因扩增.靶向	4182948
1175689	Aerobe; Aerobe Cult; Aerobed; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes	4180186
1175689	Microorg prel Plts BPU Ql Aerob Cult	4180186
1175689	微生物初步生长情况:存在情况或阈值:时间点:血小板^血液制品单位:序数型:需氧微生物培养	4182948
1175691	1 week; Dextro; Finding; Findings; Integument; Ordinal; Past; QL; Qual; Qualitative; S prime; Screen; Survey; SURVEY.GNHLTH	4180186
1175692	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Imaging; LMTED; LTD; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; To be specified in another part of the message; Unspecified; W contr IV; WC	4180186
1175692	CT Ltd W contr IV	4180186
1175692	局部多层^采用静脉注射对比剂:发现:时间点:XXX:文档型:CT	4182948
1175693	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Perc; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC	4180186
1175693	CT Guided Abd Bx--W contr IV	4180186
1175693	旨在经皮活组织检查的引导^采用静脉注射对比剂:发现:时间点:腹部:文档型:CT	4182948
1175698	4 weeks; Cnc; Conc; Finding; Findings; Hard to concentrate in school; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175700	Activated partial thromboplastin time; aPTT; aPTT-FS; Clot; Clottable; Coag; Coagulation assay; Control; Fac; Fact; Hematology; Heme; i; Little(A)PTT; Mixing aPTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube	4180186
1175700	Mixing aPTT PPP	4180186
1175700	表面诱导型凝血过程.因子敏感性 且采用 1:1 混合正常血浆:时间:时间点:贫血小板血浆:定量型:凝血功能分析	4182948
1175701	Addiction; Dolophin; Dolophine; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Har; Illicit; Metab; Metabolites; Metb; METD; Methadose; MTD; Ordinal; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn	4180186
1175701	Methadone+metab Hair Ql Scn	4180186
1175701	美沙酮+代谢产物:存在情况或阈值:时间点:毛发:序数型:毒理学筛查试验	4182948
1175702	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175706	B-cell TACI + BAFF-R subsets panel Bld	4180186
1175706	B-细胞 TACI 与 BAFF-R 亚群组套:-:时间点:全血:-	4182948
1175706	B Cell; B-ALL; B-cell acute lymphoblastic leukemia; B-cell TACI + BAFF-R subsets panel; BCELLS; Blood; CELL MARKERS; Pan; PANEL.CELLMARK; Panl; Pnl; Point in time; R prime; Random; Right; WB; Whole blood	4180186
1175709	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175713	2; 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Human Calcivirus; ID; Identity or presence; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Norovirus 1; Norovirus G1; Norovirus GI; Norovirus GI + GII; Norovirus GI + GII RNA; Norovirus GI+II; Norwalk virus; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175713	Norovirus GI + GII RNA Spec NAA+probe	4180186
1175713	诺如病毒基因群 I 与 II RNA:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
1175717	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175721	FA omega-3 + omega-6 panel Bld	4180186
1175721	Acd; Acids; Blood; Chemistry; DHA; Docosahexaenoate; Docosapentaenic acid; DPA; Eicosapentaenoate; EPA; FA omega-3 + omega-6 panel; III; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; WB; Whole blood	4180186
1175721	脂肪酸 omega-3 与 omega-6 组套:-:时间点:全血:-	4182948
1175724	MH SW Note	4180186
1175724	DOC.ONT; Document; Emotional stability; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; MH SW; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175724	记录:发现:时间点:{环境}:文档型:心理健康.社会工作者	4182948
1175727	Knee/hip replacement satisfaction	4180186
1175727	CLIN; Finding; Findings; Knee/hip replacement satisfaction; Lower extremity joint; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1175727	膝关节和或髋关节置换术满意度结果:发现:时间点:^患者:序数型	4182948
1175728	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175730	Cnt; Count; Lung; Number; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175730	Num hypopnea	4180186
1175730	低通气:数量(计数):检查过程持续时间:^患者:定量型	4182948
1175731	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175732	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Corn/Cnjt; Corneal; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175732	EV RNA Corn/Cnjt Ql NAA+probe	4180186
1175732	肠道病毒 RNA:存在情况或阈值:时间点:角膜/结膜:序数型:探针法.基因扩增.靶向	4182948
1175733	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175736	B parapert; B parapertussis; B pert; B pert+parapert DNA Pnl; B pertussis; Deoxyribonucleic acid; ID; Infectious Disease; InfectiousDisease; Microbiology; Nasopharynx; Pan; PANEL.MICROBIOLOGY; Panl; Pertussis; Pnl; Point in time; Random; Whooping cough	4180186
1175736	B pert+parapert DNA Pnl Nph	4180186
1175736	百日咳博德特菌与副百日咳博德特菌 DNA 组套:-:时间点:鼻咽:-	4182948
1175738	Bx; CAT scan; Chest Pleura; Chest.pleura; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pleura-R; Point in time; R; Rad; RADIOLOGY; Random; RT; Thorax	4180186
1175738	CT Guided Pleura-R Bx	4180186
1175738	旨在活组织检查的引导:发现:时间点:胸部>胸膜.右侧:文档型:CT	4182948
1175740	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175741	Dialy; Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175742	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175743	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175745	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175746	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Dextro; DNA NUCLEIC ACID PROBE; DNA probe; FLUDV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; QNT; Quan; Quant; Quantitative; Random; Ribonucleic acid; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Vet; Veterinary	4180186
1175746	FLUDV RNA Ct Spec Qn NAA+probe	4180186
1175746	流感病毒 D 型 RNA:阈值循环圈数:时间点:XXX:定量型:探针法.基因扩增.靶向	4182948
1175749	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Derm spec; Dermatologic; DNA NUCLEIC ACID PROBE; DNA probe; Epidermis; Gen-Probe; Har; ID; Infectious Disease; InfectiousDisease; Integument; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; Nails; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; rDNA; ribosomal RNA; Screen; SDA; Skn; Strand Displacement Amplification; TMA; Transcription mediated amplification; Ungal nail	4180186
1175749	Fungal 18s rRNA gene Derm Ql NAA+probe	4180186
1175749	真菌 18s rRNA 基因:存在情况或阈值:时间点:毛发/指或趾甲/皮肤:序数型:探针法.基因扩增.靶向	4182948
1175750	Finding; Findings; Narrative; Point in time; Random; Report; Survey; SURVEY.CDC	4180186
1175758	Endocrin Team Conf eval note	4180186
1175758	Conf eval note; DOC.ONT; Document; Encounter; Endocrin Team; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175758	会议记录:发现:时间点:{环境}:文档型:内分泌学.团队	4182948
1175759	Adenosine 5'-Pyrophosphate; Adenosine Pyrophosphate; ADO; ADP; ADP MA; ANED; Blood; COAGULATION; Hematology; Heme; Length; MA ADP; MA, ADP; Medication stress; Point in time; QNT; Quan; Quant; Quantitative; Random; Res TEG; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood	4180186
1175759	MA ADP Bld Res TEG	4180186
1175759	最大凝块强度幅度.二磷酸腺苷诱导型:长度:时间点:全血:定量型:血栓弹力描记术.共振	4182948
1175760	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175761	HEDIS 2019-20 PSA Test Excl	4180186
1175761	HEDIS 2019-20 PSA Test Excl; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175761	HEDIS 2019 取值集合 - PSA 检验项目排除组合:-:时间点:^患者:-	4182948
1175763	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175765	ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; EIA; ELFA; ELISA; Enzyme immunoassay; FLUA; FLUAV; FLUV; Fowl plague; IAA; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; MEIA; Microbiology; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; Relative ratio; Serum; SR; SUDS	4180186
1175765	FLUAV Ab/Pos cntrl Ser IA	4180186
1175765	流感病毒 A 型 抗体/阳性对照:相对比率:时间点:血清:定量型:免疫测定法	4182948
1175770	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; R; RT; Screen; Survey; SURVEY.PROMIS	4180186
1175771	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS; Trouble paying attention to teacher	4180186
1175772	Finding; Findings; Ordinal; Othr; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175773	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Ral-A; Random; Ras-related protein; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175773	RalA Ab SerPl IA-aCnc	4180186
1175773	RalA 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175775	III; Pan; Panel; PANEL.SURVEY.GNHLTH; Panl; Pnl; Point in time; Random; RAPID-3; Survey; SURVEY.GNHLTH	4180186
1175776	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175777	AFP Ab SerPl IA-aCnc	4180186
1175777	A1; ABS; Aby; AFP; AFP-1 Ab; Alfa; Alpha fetoprotein; Alphafetoprotein; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; Feto; i; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS; Tumor marker	4180186
1175777	Alpha-1-胎儿球蛋白 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175779	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec; Tissue; Tissue, unspecified; Tuberculosis	4180186
1175779	Mycobact prelim grow Tiss Ql Cult	4180186
1175779	分枝杆菌初步生长情况:存在情况或阈值:时间点:组织与涂片:序数型:微生物特异性培养	4182948
1175782	1 day; 24 hours; 24HR; Alb; DL &lt;= 3 mg/L; Kidney; Left; Levo; MA; Malb; Mass rate; Micro albumin; Microalbumin; mRate; Nephrology; Protein.albumin; QNT; Quan; Quant; Quantitative; Renal; UA; UR; URINALYSIS; Urn	4180186
1175782	Microalbumin 24h Ur DL<=3.0 mg/L-mRate	4180186
1175782	白蛋白:质量速率:24小时:尿液:定量型:检测极限 <= 3.0 mg/L	4182948
1175783	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175783	Fungal BT2 gene Lower resp Ql NAA+probe	4180186
1175783	真菌 BT2 基因:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
1175784	Consc sedation proc note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; post conscious sedation; Pre conscious sedation; Random; Visit note; w conscious sedation	4180186
1175784	Consc sedation proc note	4180186
1175784	清醒性镇静操作记录:发现:时间点:{环境}:文档型:{角色}	4182948
1175788	AHI; Apnea+hypopnea; CAHI; Count/time; Lung; Neuro; Neurology; nRate; Number rate; Number Rate = Count/Time; PULMONARY; Pulmonology; QNT; Quan; Quant; Quantitative; Respiratory; Studies; Study; Sutdies	4180186
1175788	Central apnea hypopnea index nRate	4180186
1175788	中枢性呼吸暂停低通气指数:计数型速率:检查过程持续时间:^患者:定量型	4182948
1175790	ABS; Aby; Amiopep; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dipeptidyl peptidase-like protein 6; Dipeptidyl peptidase-like protein 6 Ab; DPPX; DPPX Ab; Indirect Fluorescence Antibody; Ordinal; Point in time; PR; Prot; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175790	DPPX Ab CSF Ql CBA IFA	4180186
1175790	二肽氨基肽酶样蛋白 6 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175791	After; Antiglob; BLOOD BANK; DAGT; DAT; DAT IgG-Sp Reag; DCT; Dir; Direct Coomb; Direct coombs test; Erythrocytes; Hematology; Heme; Immune globulin G; Immunoglobulin G; Ordinal; p transf; p transf rx; Point in time; PR; PST; QL; Qual; Qualitative; Random; React; Red blood cells; Red blood corpusles; Rxn; Screen; Spec; Transf React; Tx	4180186
1175791	DAT IgG-Sp Reag p transf rx RBC Ql	4180186
1175791	直接抗球蛋白试验.IgG 特异性试剂^在输血反应之后:存在情况或阈值:时间点:红细胞:序数型	4182948
1175792	Cardio; Cardiology; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Heart Disease; notes; Point in time; Random; Surg; Visit note	4180186
1175792	Cardiac surgery Phone Note	4180186
1175792	记录:发现:时间点:电话就医:文档型:心脏外科学	4182948
1175793	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Celbenin; Deoxyribonucleic acid; Dimethoxypenicillin; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Metacillin; Metin; Microbiology; MRSA; NAA+probe; NAAT; Nasal; NASBA; Nos; Nose (nasal passage); Nucleic acid sequence based analysis; o71; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S aureus; Screen; SDA; Smell; Staficyn; Staph; Staphicillin; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175793	MRSA DNA Nose Ql NAA+probe	4180186
1175793	金黄色葡萄球菌.甲氧西林耐药性 DNA:存在情况或阈值:时间点:鼻:序数型:探针法.基因扩增.靶向	4182948
1175798	PERC score interp	4180186
1175798	CLIN; CLIN.RISK; Impression; Impression/interpretation of study; Impressions; Interp; Interpret; Interpretation; Interpt; Intrp; Ordinal; PERC score interp; Point in time; Pulm; Pulmonary Function Test; QL; Qual; Qualitative; Random; Screen	4180186
1175800	Bx; CAT scan; Chest Pleura; Chest.pleura; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; L; LT; Pleura-L; Point in time; Rad; RADIOLOGY; Random; Thorax	4180186
1175800	CT Guided Pleura-L Bx	4180186
1175800	旨在活组织检查的引导:发现:时间点:胸部>胸膜.左侧:文档型:CT	4182948
1175802	C&S; Cult; Cultures; HPIV; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Low; Lower resp; Lung; Microbiology; Nominal; Para; Parainflu; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Spec	4180186
1175802	HPIV Lower resp Cult	4180186
1175802	副流感病毒 已鉴定的:存在与否或特征标识:时间点:呼吸道.下:名义型:微生物特异性培养	4182948
1175803	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175804	Addiction; Blood; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Ectasule; GCMS; Illicit; Level; Mass concentration; Pl; PlasBld; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; SerPlBld; Serum; Serum or plasma; Serum, plasma or whole blood; SR; WB; Whole blood	4180186
1175804	Ephedrin SerPlBld Cfm-mCnc	4180186
1175804	麻黄碱:质量浓度:时间点:血清/血浆/全血:定量型:毒理学确认试验	4182948
1175805	CDC Emergency Operations Centers; CDC EOC; Centers for Disease Control and Prevention; Pan; Panel; PANEL.SURVEY.CDC; Panl; Pnl; Point in time; Random; Survey; SURVEY.CDC	4180186
1175806	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175806	Fungal BT2 gene Spec Ql NAA+probe	4180186
1175806	真菌 BT2 基因:存在情况或阈值:时间点:XXX:序数型:探针法.基因扩增.靶向	4182948
1175807	DRUG/TOXICOLOGY; Drugs; Geodon; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Zeldox	4180186
1175807	Ziprasidone SerPl Ql Scn	4180186
1175807	齐拉西酮:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
1175808	Bdy weight; bod; Bodies; Exchange; Finding; Findings; H+P; H+P.HX; Nominal; P prime; Point in time; Random; Replace; Wt	4180186
1175808	体重变化目标:发现:时间点:^患者:名义型	4182948
1175809	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B burg; B burg bba64 gene; B burgdor; B burgdorferi; Bb; Blood; Burgdorf; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lyme; Lyme disease; Lymes; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; WB; Whole blood	4180186
1175809	B burg bba64 gene Bld Ql NAA+non-probe	4180186
1175809	伯氏疏螺旋体 bba64 基因:存在情况或阈值:时间点:全血:序数型:非探针法.基因扩增.靶向	4182948
1175810	Anaero; Anaerobe; Anaerobe Cult; Blood product unit; Blood Product Unit (Pack); C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Platelet; Platelet adequacy; Platelet estimate; Plt; Plts; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Thrb; Thrombocyte; Thrombocytes	4180186
1175810	Microorg prel Plts BPU Ql Anaer Cult	4180186
1175810	微生物初步生长情况:存在情况或阈值:时间点:血小板^血液制品单位:序数型:厌氧微生物培养	4182948
1175812	ABS; Aby; Allergen; Allergens; ALLERGY TESTING; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Etx; IgE RAST; Immune globulin E; Immunoglobulin E; o71; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rh Blood Group System; Rm225; S aureus; S aureus Etx; S aureus Etx E; Screen; Serum; SR; Staph; Staphylococcal enterotoxin	4180186
1175812	金黄色葡萄球菌肠毒素 E 抗体.IgE.RAST 类:存在情况或阈值:时间点:血清:序数型	4182948
1175812	Deprecated S aureus Etx E IgE RAST Ql	4180186
1175814	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Hanta virus; Hemorrhagic fever with renal syndrome; HFRS; HPS; HTNV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Low; Lower resp; Lung; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Orthohantavirus; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; Screen; SDA; SNV; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175814	Hantavirus RNA Lower resp Ql NAA+probe	4180186
1175814	汉坦病毒 RNA:存在情况或阈值:时间点:呼吸道.下:序数型:探针法.基因扩增.靶向	4182948
1175817	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Bos spp; Count/time; f026; f027; f26; f27; Last; month; nRate; Number rate; Number Rate = Count/Time; Pig; Porcine; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES; Sus spp; Swine	4180186
1175819	ADMIN; Nominal; Person name; Point in time; Random	4180186
1175819	Organization Contact name	4180186
1175819	联系人姓名:人员姓名:时间点:组织机构:名义型	4182948
1175824	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175825	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Other; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; STI Pnl; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified	4180186
1175825	STI Pnl Spec NAA+probe	4180186
1175825	性传播病原体类组套:-:时间点:XXX:-:探针法.基因扩增.靶向	4182948
1175826	1 week; QNT; Quan; Quant; Quantitative; Scale; Survey; SURVEY.GNHLTH; Tot; Totl	4180186
1175827	Nuc Medicine Note	4180186
1175827	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Nuc med; Nuc Medicine; Point in time; Random; Visit note	4180186
1175827	记录:发现:时间点:{环境}:文档型:核医学	4182948
1175829	AHF; AHG; Antihemophilic factor; Antihemophilic globulin; Associated; bnd; Circulating anticoagulant; Coag; EIA; ELFA; ELISA; Enzyme immunoassay; F8; Fac; Fact; Fact VIII; Fact VIII.recomb.bound; Factor 8; Factor VIII clotting activity; FVIII; Hematology; Heme; IAA; MEIA; Normandy; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Relative ratio; SUDS; Thrombocyte cofactor A; Type 2 Normandy; VIII:C; Von will; Vonwillebrand; vWf; vWF:Ag	4180186
1175829	Fact VIII.recomb.bound/vWF Ag Plas IA	4180186
1175829	凝血因子 VIII.重组.结合型/von Willebrand 因子 抗原:相对比率:时间点:血浆:定量型:免疫测定法	4182948
1175830	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175831	B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; C&S; Cult; Cultures; Fl; Fld; FLU; Fluid; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Microbiology; Microorg prel grow; Microorganisms; Ordinal; Org; Organism; Organisms; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Spec	4180186
1175831	Microorg prel grow Fld Ql Cult	4180186
1175831	微生物初步生长情况:存在情况或阈值:时间点:体液:序数型:微生物特异性培养	4182948
1175833	Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; PEDS; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175834	Bil; Bilat; Both; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; EXT; Extr-Bl; Finding; Findings; Imaging; LE; LE-Bl; Leg; Low; Pelvic; Pelvis+LE; Pelvis+LE-Bl; Point in time; Rad; RADIOLOGY; Random; W contr IV; WC; WO & WC; WO+W contr; WO+W contr IV; WWO	4180186
1175834	CT Pelvis+LE-Bl WO+W contr IV	4180186
1175834	多层^不采用 & 采用静脉注射对比剂:发现:时间点:盆腔+下肢.双侧:文档型:CT	4182948
1175835	Public communication doc name	4180186
1175835	Ident; Identifier; Nominal; Point in time; Public communication doc name; Public Health; Public Health Documents; PUBLICHEALTH; Random	4180186
1175835	大众传播文档名称:标识符:时间点:文档:名义型	4182948
1175839	Acd; Acid fast Stn; Acids; AFB stain; ID; Identity or presence; Infectious Disease; InfectiousDisease; Lung; Microbiology; Nominal; Point in time; Pulmonary; Pulmonology; Random; Respiratory; St; Stains; Stn; Up; Upper resp	4180186
1175839	Acid fast Stn Upper resp	4180186
1175839	显微镜观察:存在与否或特征标识:时间点:呼吸道.上:名义型:抗酸染色法	4182948
1175842	Osteoporotic fracture 10Y prob FRAX	4180186
1175842	CLIN; CLIN.RISK; Fracture Risk Assessment; Point in time; QNT; Quan; Quant; Quantitative; Random; Risk	4180186
1175843	Nominal; Point in time; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175843	风险评估原因:类型:时间点:^事件:名义型	4182948
1175851	ADMIN; Location; Nominal; Point in time; Random	4180186
1175851	任务地点:位置:时间点:^事件:名义型	4182948
1175854	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Survey; SURVEY.PROMIS; T prime; T-score	4180186
1175857	Donor bld study	4180186
1175857	Blood; DOC.MISC; Document; Donr; Finding; Findings; MISC; Point in time; Random; Study report; WB; Whole blood	4180186
1175857	供体血液检查:发现:时间点:全血^供体:文档型	4182948
1175859	Finding; Findings; Last; Ordinal; Othr; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175860	ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; EIA; ELFA; ELISA; Enzyme immunoassay; EpCAM; EpCAM Ab; Epi; Epith; Epithelia; IAA; MEIA; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Serology; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; SUDS	4180186
1175860	EpCAM Ab SerPl IA-aCnc	4180186
1175860	上皮细胞黏附分子 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法	4182948
1175865	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175869	Primary care SW Note	4180186
1175869	Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Primary care SW; Random; Social work; SW; Visit note	4180186
1175869	记录:发现:时间点:{环境}:文档型:初级保健服务.社会工作者	4182948
1175872	Addiction med SW; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; Substance abuse; SW; Visit note	4180186
1175872	Addiction med SW Note	4180186
1175872	记录:发现:时间点:{环境}:文档型:成瘾医学.社会工作者	4182948
1175873	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175875	Abd; Abdo; Abdomen+; Abdominal; Bx; c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Kidney; Nephric; Nephrology; Perc; Point in time; Pyelogram; Rad; Radiology; Random; Renal; without contrast	4180186
1175875	CT Guided Kidney Bx--WO contr	4180186
1175875	旨在经皮活组织检查的引导^不采用对比剂:发现:时间点:腹部>肾脏:文档型:CT	4182948
1175876	ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Cytopl; Cytoplas; FA; Fluorescent antibody; Fluoresent; IFA; II; Immune fluorescence; Immunoflour; Immunofluor; Immunofluorescence; Ordinal; Paraneoplastic syndrome; PCA-2; PCA-2 Ab; PCCA-2; Point in time; PR; Purkinje cell cytoplasmic antibody; Purkinje cells; QL; Qual; Qualitative; Random; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; TRF	4180186
1175876	PCA-2 Ab CSF Ql IF	4180186
1175876	浦肯雅细胞胞浆 2 型 抗体:存在情况或阈值:时间点:脑脊液:序数型:免疫荧光法	4182948
1175878	AIDS; Blood; Deoxyribonucleic acid; high-throughput sequencing; HIV type 1; HIV type I; HIV1; HIV1 proviral DNA; HIV1 proviral DNA RT + PR + IN; HTS; Human immunodeficiency virus; i; ID; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; PBMC; Peripheral blood mononuclear cells; Point in time; PR; Random; REV; RT; WB; Whole blood	4180186
1175878	HIV1 proviral DNA RT+PR+IN Bld MC-Seq	4180186
1175878	HIV 1 型前病毒 DNA 逆转录酶与蛋白酶与整合酶基因:序列:时间点:全血单个核细胞:名义型:序列测定	4182948
1175879	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175880	Chemistry; Cl; Clear; Clearanc; Clearances; Clr; Flow; GFR; Iothal clear; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UA; UR; Ur+SerPl; Urn; Volume rate; vRate	4180186
1175880	碘酞酸盐 清除:体积速率:时间点:尿液+血清/血浆:定量型	4182948
1175882	HEDIS 2019-20 HPV Tests; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random	4180186
1175882	HEDIS 2019-20 HPV Tests	4180186
1175882	HEDIS 2019 取值集合 - HPV 检验项目:-:时间点:^患者:-	4182948
1175885	Herp splx; Herpes simplex virus type 1; Herpes simplex virus type 1+2; Herpes simplex virus type I+II; HSV; HSV 1+2; HSV 1+2 Ab.IgG & IgM panel; HSV1; HSV1+2; i; ID; II; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Pan; PANEL.MICROBIOLOGY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175885	HSV 1+2 Ab.IgG & IgM panel SerPl	4180186
1175885	单纯疱疹病毒 1 与 2 抗体.IgG 与 IgM 组套:-:时间点:血清/血浆:-	4182948
1175886	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175887	Bdy weight; bod; Bodies; Finding; Findings; H+P; H+P.HX; Ordinal; P prime; Point in time; QL; Qual; Qualitative; Random; Screen; Self-perception of body wgt; Wt	4180186
1175887	Self-perception of body wgt	4180186
1175887	对于体重的自我认知:发现:时间点:^患者:序数型	4182948
1175889	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; i; LDL1; LDL1c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175889	LDL1c SerPl-sCnc	4180186
1175889	胆固醇.LDL 1 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175890	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Infectious Disease; InfectiousDisease; InternalLabUse; Lower respiratory; Lung; Microbiology; Myco; Mycobact; Mycobact prelim grow; Ordinal; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Spec; Spt; Sputum; Tuberculosis	4180186
1175890	Mycobact prelim grow Spt Ql Cult	4180186
1175890	分枝杆菌初步生长情况:存在情况或阈值:时间点:痰液:序数型:微生物特异性培养	4182948
1175891	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175893	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175895	Finding; Findings; Ordinal; Patient Reported Outcomes Information System; Point in time; promise; QL; Qual; Qualitative; Random; Screen; Survey; SURVEY.PROMIS	4180186
1175896	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175897	clinical genomics; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; Genetic; Genomic; Medical Genetics; medical genomics; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175897	记录:发现:时间点:远程医疗:文档型:临床遗传学	4182948
1175899	Emergency med Telehealth Note	4180186
1175899	DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Telemedicine; Visit note	4180186
1175899	记录:发现:时间点:远程医疗:文档型:急诊医学	4182948
1175902	Patient Reported Outcomes Information System; PEDS; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175904	Patient Reported Outcomes Information System; Point in time; promise; QNT; Quan; Quant; Quantitative; Random; Scale; Survey; SURVEY.PROMIS	4180186
1175909	Lipoprotein metabolism Pnl SerPl	4180186
1175909	Chemistry; Lip; Lipoprot; Lipoprotein metabolism Pnl; Lipoproteins; LP; Pan; PANEL.CHEMISTRY; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR	4180186
1175909	脂蛋白代谢组套:-:时间点:血清/血浆:-	4182948
1175910	Public comm target group	4180186
1175910	Nominal; Point in time; Public comm target group; Public Health; PUBLICHEALTH; Random; Typ	4180186
1175910	大众传播目标群体:类型:时间点:^事件:名义型	4182948
1175911	CHC SW; Comm hlth care; Continuity assessment record and evaluation; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Social work; SW; Visit note	4180186
1175911	CHC SW Note	4180186
1175911	记录:发现:时间点:{环境}:文档型:社区医疗保健服务.社会工作者	4182948
1175912	Ab; HEDIS 2019 Toxoplasma Ab; Pan; Panel; PANEL.HEDIS; Panl; Pnl; Point in time; Random; Toxo; Toxoplasmosis	4180186
1175912	HEDIS 2019 Toxoplasma Ab	4180186
1175912	HEDIS 2019 取值集合 - 弓形虫抗体:-:时间点:^患者:-	4182948
1175913	Amoeba; Bowel movement; Deoxyribonucleic acid; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; high-throughput sequencing; HTS; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Next generation sequencing; NGS; Nominal; Point in time; Random; species; spp; Stl; Stool = Fecal	4180186
1175913	Entamoeba DNA Stl Seq	4180186
1175913	内阿米巴属单个未知种 DNA:存在与否或特征标识:时间点:大便:名义型:序列测定	4182948
1175915	Pregnancy summary Doc	4180186
1175915	DOC.MISC; Document; Finding; Findings; Gestation; Gestations; Gravida; MISC; Point in time; Pregnancies; Random	4180186
1175915	妊娠摘要:发现:时间点:^患者:文档型	4182948
1175916	4 weeks; Finding; Findings; Job; Last; Occupation; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175917	Burn Consult note	4180186
1175917	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175917	会诊记录:发现:时间点:{环境}:文档型:烧伤管理	4182948
1175919	CLIN; CLIN.RISK; Finding; Findings; Interp; Interpret; Interpt; Intrp; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen	4180186
1175919	Revised Geneva score interp	4180186
1175920	4 weeks; Cogn func; cognition; cognitive status; FCN; Func; Funct; Pan; Panel; PANEL.SURVEY.PROMIS; Panl; Patient Reported Outcomes Information System; Pnl; promise; Survey; SURVEY.PROMIS	4180186
1175923	Consult note; DOC.ONT; Document; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note	4180186
1175923	Obesity med Consult note	4180186
1175923	会诊记录:发现:时间点:{环境}:文档型:肥胖医学	4182948
1175925	c; CAT scan; Computed tomography; Computerized tomography; Contr; Contra; Contrst; CT scan; Document; Finding; Findings; Guid; Guidance.stereotactic for localization; Guide; Guided; Imaging; Local; Misc; Miscellaneous; Other; Point in time; Rad; RADIOLOGY; Random; Spec; Stereo; Str loc; To be specified in another part of the message; Unspecified; without contrast	4180186
1175925	CT Guided Str loc--WO contr	4180186
1175925	旨在为立体定位的引导^不采用对比剂:发现:时间点:XXX:文档型:CT	4182948
1175926	Blood; HEMATOLOGY/CELL COUNTS; i; II; NK; NK cyto IL2 0.9:1 E:T; PBMC; Peripheral blood mononuclear cells; Point in time; Pos; Pos cntrl; QNT; Quan; Quant; Quantitative; Random; RlACnc; WB; Whole blood	4180186
1175926	NK cyto IL2 0.9:1 E:T/Pos cntrl Bld MC	4180186
1175926	自然杀伤细胞细胞毒性.IL-2 刺激型 效应细胞/靶细胞比 0.9:1/阳性对照:相对任意型浓度:时间点:全血单个核细胞:定量型	4182948
1175927	QUEtiapine SerPl Ql Scn	4180186
1175927	DRUG/TOXICOLOGY; Drugs; Ketipinor; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Seroquel; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Xeroquel	4180186
1175927	喹硫平:存在情况或阈值:时间点:血清/血浆:序数型:毒理学筛查试验	4182948
1175932	10 minutes; Average; Avg; Count/time; Fetal; Gyn; Gynecology; Heart beat; HEART RATE.MOLEC; nRate; Number rate; Number Rate = Count/Time; OB; ObGyn; Obstetrics; Pulse; QNT; Quan; Quant; Quantitative	4180186
1175932	Fet 10M Mean Heart rate	4180186
1175932	心率:计数型速率:10分钟^平均值:^胎儿:定量型	4182948
1175939	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; Pos; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175940	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175941	Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; BIFL; Bile fluid; Biliary fluid; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis	4180186
1175941	Mycobacterium Bifl Cult	4180186
1175941	分枝杆菌属单个未知种 已鉴定的:存在与否或特征标识:时间点:胆汁:名义型:微生物特异性培养	4182948
1175943	1 week; Activity; Arterial Stenosis; Exercise; Finding; Findings; Health Assessment Questionnaire; Last; Ordinal; Ql; Qual; Qualitative; Screen; Survey	4180186
1175944	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Helminths; ID; Identity or presence; Infectious Disease; InfectiousDisease; Isolated; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Maggot; Maggots; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nominal; Nucleic acid sequence based analysis; Other; PCR; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified; Worm; Worms	4180186
1175944	Worm Spec NAA+probe	4180186
1175944	蠕虫 已鉴定的:存在与否或特征标识:时间点:XXX:名义型:探针法.基因扩增.靶向	4182948
1175946	1 week; Last; Ordinal; Pain severity past W 0-10 (0.5 incr); Ql; Qual; Qualitative; Scale; Screen; Survey; SURVEY.GNHLTH	4180186
1175948	Cardio; Cardiology; Chemistry; Chol; Choles; Cholest; Cholesterol total; Cholesterols; Heart Disease; LDL4; LDL4c; LDLc; LDL-C; Level; Lipid; Low density lipoprotein cholesterol; Low density lipoprotein cholesterols; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration	4180186
1175948	LDL4c SerPl-sCnc	4180186
1175948	胆固醇.LDL 4 之中的:物质的量浓度:时间点:血清/血浆:定量型	4182948
1175949	3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Bowel movement; C pylori; Campylobacter pylori; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Faecal; Faeces; Fecal; Feces; Gastro; Gastroenterology; GI; H pyl; H pylori; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Stl; Stool = Fecal; Strand Displacement Amplification; TMA; Transcription mediated amplification	4180186
1175949	H pylori DNA Stl Ql NAA+probe	4180186
1175949	幽门螺杆菌 DNA:存在情况或阈值:时间点:大便:序数型:探针法.基因扩增.靶向	4182948
1175951	7OH-fluphenazine; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175951	7OH-fluphenazine Ur Cfm-mCnc	4180186
1175951	7-羟基氟奋乃静:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175953	1 month; 1 month (30 days); 30 days; Arterial Stenosis; Count/time; Last; month; nRate; Number rate; Number Rate = Count/Time; Othr; QNT; Quan; Quant; Quantitative; Survey; SURVEY.NHANES	4180186
1175954	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175956	Norquetiapine Ur Cfm-mCnc	4180186
1175956	Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; GCMS; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn	4180186
1175956	去甲基喹硫平:质量浓度:时间点:尿液:定量型:毒理学确认试验	4182948
1175961	Addiction; Angel dust; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Fl; Fld; FLU; Fluid; Illicit; Ordinal; PCP; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; Sernylan	4180186
1175961	PCP Fld Ql Scn	4180186
1175961	苯环利定:存在情况或阈值:时间点:体液:序数型:毒理学筛查试验	4182948
1175965	Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175966	Dental; Dentistry; Exam; Examination; Jaw; Mand; Nominal; Phys find; Physical findings of Mandible condyle; Point in time; Random; Typ	4180186
1175966	体格检查发现.下颌髁突:类型:时间点:下颔骨:名义型	4182948
1175969	ABS; Aby; Antby; Anti; Antibodies; Antibody; Asp; Aspartic acid; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dextro; Encephalitis; Glutamate receptor ionotropic, NMDA 1; i; Indirect Fluorescence Antibody; NMDA receptor; NMDAR; NMDAR1; N-Methylaspartate Receptors; N-Methyl-D-aspartic Acid; Ordinal; Paraneoplastic syndrome; Point in time; PR; QL; Qual; Qualitative; Random; Rec; Recept; Receptors; Recp; Recptr; Screen; Serology; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid	4180186
1175969	NMDAR1 Ab CSF Ql CBA IFA	4180186
1175969	N-甲基-D-天冬氨酸受体亚单位 1 抗体:存在情况或阈值:时间点:脑脊液:序数型:CBA IFA	4182948
1175970	4 weeks; Finding; Findings; Last; Ordinal; Patient Reported Outcomes Information System; promise; QL; Qual; Qualitative; Screen; Survey; SURVEY.PROMIS	4180186
1175972	CAT scan; Computed tomography; Computerized tomography; CT scan; Document; Finding; Findings; Guid; Guide; Guided; Imaging; Pelvic; Point in time; Rad; RADIOLOGY; Random	4180186
1175972	CT Guided Pelvis Cryoablation	4180186
1175972	旨在冷冻消融术的引导:发现:时间点:盆腔:文档型:CT	4182948
1175974	Blood; Connexin 26; Cx26; Deafness, autosomal dominant 3; Deafness, autosomal recessive 1; DFNA3; DFNA3A; DFNB1; DFNB1A; Document; Finding; Findings; full gene sequencing; Full Mut Anl; Gap junction beta-2 protein gene; gap junction protein, beta 2, 26kDa; Genetics; GJB2 full mut analysis; Heredity; Heritable; HID; high-throughput sequencing; HTS; Inherited; KID; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mutations; Next generation sequencing; NGS; NSRD1; Point in time; PPK; Random; sequencing of entire coding region; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	4180186
1175974	GJB2 gene Full Mut Anl Bld/T Seq	4180186
